{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": []
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "source": [
        "## Setup Notebook\n",
        "\n",
        "This section installs and imports the necessary modules for running this notebook. It also initializes necessary functions and constants.\n",
        "\n",
        "Run all cells in this section to setup the notebook."
      ],
      "metadata": {
        "id": "L5zuSln8UQtg"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install altair"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "xlM3tFZM8xhe",
        "outputId": "24a6b098-a4ff-4b97-c966-0530578db15e"
      },
      "execution_count": 62,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: altair in /usr/local/lib/python3.10/dist-packages (4.2.2)\n",
            "Requirement already satisfied: entrypoints in /usr/local/lib/python3.10/dist-packages (from altair) (0.4)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.10/dist-packages (from altair) (3.1.4)\n",
            "Requirement already satisfied: jsonschema>=3.0 in /usr/local/lib/python3.10/dist-packages (from altair) (4.19.2)\n",
            "Requirement already satisfied: numpy in /usr/local/lib/python3.10/dist-packages (from altair) (1.25.2)\n",
            "Requirement already satisfied: pandas>=0.18 in /usr/local/lib/python3.10/dist-packages (from altair) (2.0.3)\n",
            "Requirement already satisfied: toolz in /usr/local/lib/python3.10/dist-packages (from altair) (0.12.1)\n",
            "Requirement already satisfied: attrs>=22.2.0 in /usr/local/lib/python3.10/dist-packages (from jsonschema>=3.0->altair) (23.2.0)\n",
            "Requirement already satisfied: jsonschema-specifications>=2023.03.6 in /usr/local/lib/python3.10/dist-packages (from jsonschema>=3.0->altair) (2023.12.1)\n",
            "Requirement already satisfied: referencing>=0.28.4 in /usr/local/lib/python3.10/dist-packages (from jsonschema>=3.0->altair) (0.35.1)\n",
            "Requirement already satisfied: rpds-py>=0.7.1 in /usr/local/lib/python3.10/dist-packages (from jsonschema>=3.0->altair) (0.18.1)\n",
            "Requirement already satisfied: python-dateutil>=2.8.2 in /usr/local/lib/python3.10/dist-packages (from pandas>=0.18->altair) (2.8.2)\n",
            "Requirement already satisfied: pytz>=2020.1 in /usr/local/lib/python3.10/dist-packages (from pandas>=0.18->altair) (2023.4)\n",
            "Requirement already satisfied: tzdata>=2022.1 in /usr/local/lib/python3.10/dist-packages (from pandas>=0.18->altair) (2024.1)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.10/dist-packages (from jinja2->altair) (2.1.5)\n",
            "Requirement already satisfied: six>=1.5 in /usr/local/lib/python3.10/dist-packages (from python-dateutil>=2.8.2->pandas>=0.18->altair) (1.16.0)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import pandas as pd\n",
        "import numpy as np\n",
        "from sklearn.manifold import TSNE\n",
        "import os\n",
        "import altair\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "from scipy.spatial.distance import cdist\n",
        "from scipy.spatial.distance import pdist\n",
        "from scipy.spatial.distance import squareform"
      ],
      "metadata": {
        "id": "uxLi3OhfUUhg"
      },
      "execution_count": 63,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Library functions\n",
        "def subtract_dmso(df, ndims):\n",
        "  \"\"\"Subtracts average DMSO embedding per plate.\"\"\"\n",
        "  dmso_wells = df[df['compound'] == 'DMSO']\n",
        "  dmso_wells = dmso_wells.groupby('plate')[list(range(ndims))].agg(np.mean)\n",
        "  mask = df['plate'].isin(dmso_wells.index)\n",
        "  print('Dropping %d rows' % (~mask).sum())\n",
        "  df = df[mask]\n",
        "  matched_dmso = dmso_wells.loc[df['plate']][list(range(ndims))].values\n",
        "  df.loc[:, list(range(ndims))] = df[list(range(ndims))].values - matched_dmso\n",
        "  return df\n",
        "\n",
        "\n",
        "def add_tsne_embedding(data_df,\n",
        "                       ndims=512,\n",
        "                       perplexity=10,\n",
        "                       n_iter=5000,\n",
        "                       seed=None):\n",
        "  \"\"\"Add t-SNE embedding to dataframe assuming embedding.\"\"\"\n",
        "  tsne_embedding = (\n",
        "      TSNE(\n",
        "          n_components=2,\n",
        "          perplexity=perplexity,\n",
        "          learning_rate=5,\n",
        "          random_state=seed,\n",
        "          n_iter=n_iter,\n",
        "          n_jobs=32).fit_transform(data_df[range(ndims)].values))\n",
        "  data_df['tsne_x'] = tsne_embedding[:, 0]\n",
        "  data_df['tsne_y'] = tsne_embedding[:, 1]\n",
        "  return data_df\n",
        "\n",
        "\n",
        "def get_subset(data_df, **kwargs):\n",
        "  \"\"\"Subsets dataframe based on column values provided.\"\"\"\n",
        "  subset_df = data_df\n",
        "  for col, val in kwargs.items():\n",
        "    if val is None:\n",
        "      continue\n",
        "    subset_df = subset_df[subset_df[col] == val]\n",
        "  return subset_df\n",
        "\n",
        "\n",
        "def get_pdist_distributions(df,\n",
        "                            group1_kwargs,\n",
        "                            group2_kwargs=None,\n",
        "                            ndims=512,\n",
        "                            groupby_cols=None,\n",
        "                            metric='euclidean',\n",
        "                            exclude_same_cols=None):\n",
        "  \"\"\"Returns pairwise dist between elements of grp 1 and between grps 1 and 2.\n",
        "\n",
        "  Specifically:\n",
        "    1. It uses group1_kwargs / group2_kwargs to filter elements of df.\n",
        "    2. It groups group1 / 2 by `groupby_cols`, averaging the embeddings.\n",
        "    3. It computes `within_group_distances`, which is distance of each element\n",
        "       of group 1 from other elements of group 1 as long as\n",
        "       they don't share the exact same values of cols in `exclude_same_cols`.\n",
        "    4. It computes `between_group_distances`, which is distance of each element\n",
        "       of group 1 from elements of group 2 as long as\n",
        "       they don't share the exact same values of cols in `exclude_same_cols`.\n",
        "\n",
        "  Args:\n",
        "    df: Dataframe containing (1) metadata for each example and (2) columns\n",
        "        named 1...n_dims containing the embeddings for each example.\n",
        "    group1_kwargs: List of column name and values to filter `df` to get group 1.\n",
        "    group2_kwargs: List of column name and values to filter `df` to get group 2.\n",
        "    ndims: Number of embedding dimensions.\n",
        "    groupby_cols: Columns to use to average embeddings.\n",
        "    metric: Metric to use to compute pairwise distances.\n",
        "    exclude_same_cols: Entries that share the same values of `exclude_same_cols`\n",
        "                       will be excluded from the pairwise distance distribution.\n",
        "\n",
        "  Returns:\n",
        "    within_group_distances: Distances between elements of df that are in group 1\n",
        "                            that don't share values of `exclude_same_col`.\n",
        "    between_group_distances: Distances between elements of df that are in\n",
        "                             group 1 and elements of df in group 2 that don't\n",
        "                             share values of `exclude_same_col`.\n",
        "  \"\"\"\n",
        "  group1_elements = get_subset(df, **group1_kwargs)\n",
        "  if group2_kwargs is None:\n",
        "    group2_elements = df\n",
        "  else:\n",
        "    group2_elements = get_subset(df, **group2_kwargs)\n",
        "  # Exclude group 1 from group 2\n",
        "  mask = group2_elements.index.isin(group1_elements.index.values)\n",
        "  group2_elements = group2_elements[~mask]\n",
        "\n",
        "  if groupby_cols is not None:\n",
        "    group1_elements = (\n",
        "        group1_elements.groupby(groupby_cols)[list(\n",
        "            range(ndims))].mean().reset_index())\n",
        "    group2_elements = (\n",
        "        group2_elements.groupby(groupby_cols)[list(\n",
        "            range(ndims))].mean().reset_index())\n",
        "\n",
        "  within_group_distances = squareform(\n",
        "      pdist(group1_elements[list(range(ndims))].values, metric=metric))\n",
        "  exclusion_mask = np.zeros_like(within_group_distances).astype(bool)\n",
        "  for col in exclude_same_cols:\n",
        "    grp1_values = group1_elements[col].values\n",
        "    partial_mask = grp1_values[:, None] == grp1_values[None, :]\n",
        "    exclusion_mask |= partial_mask\n",
        "  within_group_distances = within_group_distances[~exclusion_mask].flatten()\n",
        "\n",
        "  between_group_distances = cdist(group1_elements[list(range(ndims))].values,\n",
        "                                  group2_elements[list(range(ndims))].values,\n",
        "                                  metric=metric)\n",
        "  exclusion_mask = np.zeros_like(between_group_distances).astype(bool)\n",
        "  for col in exclude_same_cols:\n",
        "    grp1_values = group1_elements[col].values[:, None]\n",
        "    grp2_values = group2_elements[col].values[None, :]\n",
        "    partial_mask = grp1_values == grp2_values\n",
        "    exclusion_mask |= partial_mask\n",
        "  between_group_distances = between_group_distances[~exclusion_mask].flatten()\n",
        "  return within_group_distances, between_group_distances"
      ],
      "metadata": {
        "id": "iyZdeLDyZfjF"
      },
      "execution_count": 64,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# constants necessary for running the notebook\n",
        "\n",
        "timepoint_map = {\n",
        "    0: '2 hours',\n",
        "    1: '6 hours',\n",
        "    2: '24 hours',\n",
        "    3: '48 hours',\n",
        "    4: '72 hours'\n",
        "}\n",
        "\n",
        "paper_group_names = {\n",
        "    'DMSO': ['DMSO'],\n",
        "    'pos_con': ['Fenbendazole', 'Etoposide', 'Vorinostat', 'Mitomycin C', 'Vincristine'],\n",
        "    'neg_con': ['human IgG, whole molecule'],\n",
        "    'Herceptin': ['Herceptin'],\n",
        "    'Perjeta': ['Pertuzumab (HER2/HER3dimerization blocker)'],\n",
        "    'Active Degraders': ['Crews Acvite HER2/EGFR degrader (Lapatinib based)',\n",
        "                         'C4T VHL-based active HER2-degrader (Tucatinib based)'],\n",
        "    'Inactive Degraders': ['C4T VHL-based inactive HER2-degrader (Tucatinib based)',\n",
        "                           'Crews inactive HER2/EGFR degrader (Lapatinib based)'],\n",
        "    'PI3K Inhibitor': ['Alpelisib (PI3K inhibitor)'],\n",
        "    'Pan-Akt Inhibitor': ['Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)'],\n",
        "    'Neratinib (Covalent Inhibitor)': ['Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)'],\n",
        "    'BDTX-189 (Covalent Inhibitor)': ['BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)'],\n",
        "    'Head Group Small Molecules': ['Lapatanib (HER2/EGFR selective)',\n",
        "                                   'Tucatinib (Irbinitinib; HER2-selective)'],\n",
        "}\n",
        "\n",
        "paper_group_map = {}\n",
        "for group in paper_group_names:\n",
        "  for compound in paper_group_names[group]:\n",
        "    paper_group_map[compound] = group\n",
        "\n",
        "paper_colour_map = {\n",
        "    'DMSO': '#7f7f7f',\n",
        "    'Herceptin': '#ff7f0e',\n",
        "    'Perjeta': '#8c5626',\n",
        "    'Active Degraders': '#d62728',\n",
        "    'Inactive Degraders': '#bcbd22',\n",
        "    'PI3K Inhibitor': '#9467bd',\n",
        "    'Pan-Akt Inhibitor': '#e377c2',\n",
        "    'Neratinib (Covalent Inhibitor)': '#1f77b4',\n",
        "    'BDTX-189 (Covalent Inhibitor)': '#17becf',\n",
        "    'Head Group Small Molecules': '#2ca02c',\n",
        "}\n",
        "\n",
        "embedding_files = {\n",
        "    'skbr3': 'skbr3_embeddings.parquet.gzip',\n",
        "    'skbr3_noher2': 'skbr3_noher2_embeddings.parquet.gzip',\n",
        "    'skov3': 'skov3_embeddings.parquet.gzip',\n",
        "    'skov3_noher2': 'skov3_noher2_embeddings.parquet.gzip',\n",
        "}\n"
      ],
      "metadata": {
        "id": "HDNaMLj2Fknm"
      },
      "execution_count": 65,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Upload Embeddings Files\n",
        "\n",
        "Run the below cell and upload 1 or more of the embedding parquet files when prompted. These files are included in the repo under the ```embeddings/``` directory and are named as ```*_embeddings.parquet.gzip```. Only embeddings that have been uploaded can be referenced later in the notebook."
      ],
      "metadata": {
        "id": "sVmYd6HhUKcT"
      }
    },
    {
      "cell_type": "code",
      "execution_count": 25,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 74
        },
        "id": "0-qhQhKBIHZQ",
        "outputId": "fbdf2608-cb11-4582-d46d-b0d0fe19dadf"
      },
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "     <input type=\"file\" id=\"files-971c6e7f-c266-48a7-bbf8-aa4ddffbdf60\" name=\"files[]\" multiple disabled\n",
              "        style=\"border:none\" />\n",
              "     <output id=\"result-971c6e7f-c266-48a7-bbf8-aa4ddffbdf60\">\n",
              "      Upload widget is only available when the cell has been executed in the\n",
              "      current browser session. Please rerun this cell to enable.\n",
              "      </output>\n",
              "      <script>// Copyright 2017 Google LLC\n",
              "//\n",
              "// Licensed under the Apache License, Version 2.0 (the \"License\");\n",
              "// you may not use this file except in compliance with the License.\n",
              "// You may obtain a copy of the License at\n",
              "//\n",
              "//      http://www.apache.org/licenses/LICENSE-2.0\n",
              "//\n",
              "// Unless required by applicable law or agreed to in writing, software\n",
              "// distributed under the License is distributed on an \"AS IS\" BASIS,\n",
              "// WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.\n",
              "// See the License for the specific language governing permissions and\n",
              "// limitations under the License.\n",
              "\n",
              "/**\n",
              " * @fileoverview Helpers for google.colab Python module.\n",
              " */\n",
              "(function(scope) {\n",
              "function span(text, styleAttributes = {}) {\n",
              "  const element = document.createElement('span');\n",
              "  element.textContent = text;\n",
              "  for (const key of Object.keys(styleAttributes)) {\n",
              "    element.style[key] = styleAttributes[key];\n",
              "  }\n",
              "  return element;\n",
              "}\n",
              "\n",
              "// Max number of bytes which will be uploaded at a time.\n",
              "const MAX_PAYLOAD_SIZE = 100 * 1024;\n",
              "\n",
              "function _uploadFiles(inputId, outputId) {\n",
              "  const steps = uploadFilesStep(inputId, outputId);\n",
              "  const outputElement = document.getElementById(outputId);\n",
              "  // Cache steps on the outputElement to make it available for the next call\n",
              "  // to uploadFilesContinue from Python.\n",
              "  outputElement.steps = steps;\n",
              "\n",
              "  return _uploadFilesContinue(outputId);\n",
              "}\n",
              "\n",
              "// This is roughly an async generator (not supported in the browser yet),\n",
              "// where there are multiple asynchronous steps and the Python side is going\n",
              "// to poll for completion of each step.\n",
              "// This uses a Promise to block the python side on completion of each step,\n",
              "// then passes the result of the previous step as the input to the next step.\n",
              "function _uploadFilesContinue(outputId) {\n",
              "  const outputElement = document.getElementById(outputId);\n",
              "  const steps = outputElement.steps;\n",
              "\n",
              "  const next = steps.next(outputElement.lastPromiseValue);\n",
              "  return Promise.resolve(next.value.promise).then((value) => {\n",
              "    // Cache the last promise value to make it available to the next\n",
              "    // step of the generator.\n",
              "    outputElement.lastPromiseValue = value;\n",
              "    return next.value.response;\n",
              "  });\n",
              "}\n",
              "\n",
              "/**\n",
              " * Generator function which is called between each async step of the upload\n",
              " * process.\n",
              " * @param {string} inputId Element ID of the input file picker element.\n",
              " * @param {string} outputId Element ID of the output display.\n",
              " * @return {!Iterable<!Object>} Iterable of next steps.\n",
              " */\n",
              "function* uploadFilesStep(inputId, outputId) {\n",
              "  const inputElement = document.getElementById(inputId);\n",
              "  inputElement.disabled = false;\n",
              "\n",
              "  const outputElement = document.getElementById(outputId);\n",
              "  outputElement.innerHTML = '';\n",
              "\n",
              "  const pickedPromise = new Promise((resolve) => {\n",
              "    inputElement.addEventListener('change', (e) => {\n",
              "      resolve(e.target.files);\n",
              "    });\n",
              "  });\n",
              "\n",
              "  const cancel = document.createElement('button');\n",
              "  inputElement.parentElement.appendChild(cancel);\n",
              "  cancel.textContent = 'Cancel upload';\n",
              "  const cancelPromise = new Promise((resolve) => {\n",
              "    cancel.onclick = () => {\n",
              "      resolve(null);\n",
              "    };\n",
              "  });\n",
              "\n",
              "  // Wait for the user to pick the files.\n",
              "  const files = yield {\n",
              "    promise: Promise.race([pickedPromise, cancelPromise]),\n",
              "    response: {\n",
              "      action: 'starting',\n",
              "    }\n",
              "  };\n",
              "\n",
              "  cancel.remove();\n",
              "\n",
              "  // Disable the input element since further picks are not allowed.\n",
              "  inputElement.disabled = true;\n",
              "\n",
              "  if (!files) {\n",
              "    return {\n",
              "      response: {\n",
              "        action: 'complete',\n",
              "      }\n",
              "    };\n",
              "  }\n",
              "\n",
              "  for (const file of files) {\n",
              "    const li = document.createElement('li');\n",
              "    li.append(span(file.name, {fontWeight: 'bold'}));\n",
              "    li.append(span(\n",
              "        `(${file.type || 'n/a'}) - ${file.size} bytes, ` +\n",
              "        `last modified: ${\n",
              "            file.lastModifiedDate ? file.lastModifiedDate.toLocaleDateString() :\n",
              "                                    'n/a'} - `));\n",
              "    const percent = span('0% done');\n",
              "    li.appendChild(percent);\n",
              "\n",
              "    outputElement.appendChild(li);\n",
              "\n",
              "    const fileDataPromise = new Promise((resolve) => {\n",
              "      const reader = new FileReader();\n",
              "      reader.onload = (e) => {\n",
              "        resolve(e.target.result);\n",
              "      };\n",
              "      reader.readAsArrayBuffer(file);\n",
              "    });\n",
              "    // Wait for the data to be ready.\n",
              "    let fileData = yield {\n",
              "      promise: fileDataPromise,\n",
              "      response: {\n",
              "        action: 'continue',\n",
              "      }\n",
              "    };\n",
              "\n",
              "    // Use a chunked sending to avoid message size limits. See b/62115660.\n",
              "    let position = 0;\n",
              "    do {\n",
              "      const length = Math.min(fileData.byteLength - position, MAX_PAYLOAD_SIZE);\n",
              "      const chunk = new Uint8Array(fileData, position, length);\n",
              "      position += length;\n",
              "\n",
              "      const base64 = btoa(String.fromCharCode.apply(null, chunk));\n",
              "      yield {\n",
              "        response: {\n",
              "          action: 'append',\n",
              "          file: file.name,\n",
              "          data: base64,\n",
              "        },\n",
              "      };\n",
              "\n",
              "      let percentDone = fileData.byteLength === 0 ?\n",
              "          100 :\n",
              "          Math.round((position / fileData.byteLength) * 100);\n",
              "      percent.textContent = `${percentDone}% done`;\n",
              "\n",
              "    } while (position < fileData.byteLength);\n",
              "  }\n",
              "\n",
              "  // All done.\n",
              "  yield {\n",
              "    response: {\n",
              "      action: 'complete',\n",
              "    }\n",
              "  };\n",
              "}\n",
              "\n",
              "scope.google = scope.google || {};\n",
              "scope.google.colab = scope.google.colab || {};\n",
              "scope.google.colab._files = {\n",
              "  _uploadFiles,\n",
              "  _uploadFilesContinue,\n",
              "};\n",
              "})(self);\n",
              "</script> "
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Saving skov3_embeddings.parquet.gzip to skov3_embeddings.parquet.gzip\n"
          ]
        }
      ],
      "source": [
        "from google.colab import files\n",
        "files.upload()"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Preprocess Embeddings\n",
        "\n",
        "This cell preprocesses the embeddings by subtracting the average DMSO embedding per plate. A set of embeddings averaging replicates per plate are also created."
      ],
      "metadata": {
        "id": "QfcIoq-_xhBI"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "dfs = {}\n",
        "ndims = 512\n",
        "for name, filename in embedding_files.items():\n",
        "  if not os.path.isfile(filename):\n",
        "    continue\n",
        "  raw_df = pd.read_parquet(filename).rename({str(i): i for i in range(ndims)}, axis=1)\n",
        "  dfs[name] = subtract_dmso(raw_df, ndims)\n",
        "\n",
        "agg_dfs = {}\n",
        "AGG_COLS = ['label', 'compound', 'dose_order', 'timepoint_order', 'group', 'compound_dose', 'plate']\n",
        "for name, df in dfs.items():\n",
        "  agg_data_df = df.groupby(AGG_COLS)[list(range(ndims))].mean().reset_index()\n",
        "  agg_dfs[name] = agg_data_df"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "YsISaLfhOgxi",
        "outputId": "2ef0a263-9b52-4221-978e-f3900a93e270"
      },
      "execution_count": 58,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Dropping 0 rows\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Generate T-SNE Plots\n",
        "\n",
        "This section generates and plots T-SNEs of the data. Due to the stochasticity of the T-SNE algorithm the exact plots will vary from run to run but the general groupings should remain similar. For SKOV3 embeddings a perplexity value of 10 was used whereas for SKBR3 embeddings a perplexity value of 50 was used."
      ],
      "metadata": {
        "id": "ZXT6zdByXZFF"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "embedding_name = 'skov3' # @param [\"skov3\", \"skov3_noher2\", \"skbr3\", \"skbr3_noher2\"]\n",
        "aggregated_df = agg_dfs[embedding_name]\n",
        "\n",
        "timepoints = sorted(aggregated_df['timepoint_order'].unique())\n",
        "aggregated_dfs = []\n",
        "perplexity = 10 #@param\n",
        "for timepoint in timepoints:\n",
        "  timepoint_df = aggregated_df[aggregated_df['timepoint_order'] == timepoint].copy()\n",
        "  timepoint_df = add_tsne_embedding(timepoint_df, perplexity=perplexity)\n",
        "  aggregated_dfs.append((timepoint, timepoint_df))"
      ],
      "metadata": {
        "id": "Yxdlw0QATsjg"
      },
      "execution_count": 47,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "TOOLTIP_VAR = 'compound_dose'\n",
        "SHAPE_VAR = 'Dose Order'\n",
        "COLOR_VAR = 'Compound Group'\n",
        "\n",
        "domain = list(paper_colour_map.keys())\n",
        "range_ = list(paper_colour_map.values())\n",
        "\n",
        "for timepoint, aggregated_df in aggregated_dfs:\n",
        "  aggregated_df['Compound Group'] = aggregated_df['compound'].map(paper_group_map)\n",
        "  aggregated_df = aggregated_df[aggregated_df['Compound Group'].notna()]\n",
        "  aggregated_df = aggregated_df[~aggregated_df['group'].isin(['neg_con', 'pos_con'])]\n",
        "  altair_plot_data = aggregated_df[['tsne_x', 'tsne_y', 'Compound Group'] + AGG_COLS]\n",
        "  altair_plot_data['Dose Order'] = altair_plot_data['dose_order'].astype(str)\n",
        "  chart = (altair.Chart(altair_plot_data, title=f'{embedding_name} Timepoint {timepoint} ({timepoint_map[timepoint]})', height=700, width=700)\n",
        "                .mark_point(size=240, filled=True, stroke='black', strokeWidth=1.5)\n",
        "                .encode(x='tsne_x',\n",
        "                        y='tsne_y',\n",
        "                        tooltip=TOOLTIP_VAR,\n",
        "                        shape=SHAPE_VAR,\n",
        "                        color=altair.Color(COLOR_VAR, scale=altair.Scale(domain=domain, range=range_)),\n",
        "          ))\n",
        "\n",
        "  (chart.configure(background='white')\n",
        "        .configure_axis(labelFontSize=20, titleFontSize=20)\n",
        "        .configure_legend(labelFontSize=20, titleFontSize=20, labelLimit=0)).display()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "3DiuTom2UA_r",
        "outputId": "4205e8d0-e554-44df-c40b-684cb51fbdd2"
      },
      "execution_count": 52,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-52-84172d8d0eec>:13: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  altair_plot_data['Dose Order'] = altair_plot_data['dose_order'].astype(str)\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/html": [
              "\n",
              "<div id=\"altair-viz-6545dc96a18940749e4698011e083a20\"></div>\n",
              "<script type=\"text/javascript\">\n",
              "  var VEGA_DEBUG = (typeof VEGA_DEBUG == \"undefined\") ? {} : VEGA_DEBUG;\n",
              "  (function(spec, embedOpt){\n",
              "    let outputDiv = document.currentScript.previousElementSibling;\n",
              "    if (outputDiv.id !== \"altair-viz-6545dc96a18940749e4698011e083a20\") {\n",
              "      outputDiv = document.getElementById(\"altair-viz-6545dc96a18940749e4698011e083a20\");\n",
              "    }\n",
              "    const paths = {\n",
              "      \"vega\": \"https://cdn.jsdelivr.net/npm//vega@5?noext\",\n",
              "      \"vega-lib\": \"https://cdn.jsdelivr.net/npm//vega-lib?noext\",\n",
              "      \"vega-lite\": \"https://cdn.jsdelivr.net/npm//vega-lite@4.17.0?noext\",\n",
              "      \"vega-embed\": \"https://cdn.jsdelivr.net/npm//vega-embed@6?noext\",\n",
              "    };\n",
              "\n",
              "    function maybeLoadScript(lib, version) {\n",
              "      var key = `${lib.replace(\"-\", \"\")}_version`;\n",
              "      return (VEGA_DEBUG[key] == version) ?\n",
              "        Promise.resolve(paths[lib]) :\n",
              "        new Promise(function(resolve, reject) {\n",
              "          var s = document.createElement('script');\n",
              "          document.getElementsByTagName(\"head\")[0].appendChild(s);\n",
              "          s.async = true;\n",
              "          s.onload = () => {\n",
              "            VEGA_DEBUG[key] = version;\n",
              "            return resolve(paths[lib]);\n",
              "          };\n",
              "          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);\n",
              "          s.src = paths[lib];\n",
              "        });\n",
              "    }\n",
              "\n",
              "    function showError(err) {\n",
              "      outputDiv.innerHTML = `<div class=\"error\" style=\"color:red;\">${err}</div>`;\n",
              "      throw err;\n",
              "    }\n",
              "\n",
              "    function displayChart(vegaEmbed) {\n",
              "      vegaEmbed(outputDiv, spec, embedOpt)\n",
              "        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));\n",
              "    }\n",
              "\n",
              "    if(typeof define === \"function\" && define.amd) {\n",
              "      requirejs.config({paths});\n",
              "      require([\"vega-embed\"], displayChart, err => showError(`Error loading script: ${err.message}`));\n",
              "    } else {\n",
              "      maybeLoadScript(\"vega\", \"5\")\n",
              "        .then(() => maybeLoadScript(\"vega-lite\", \"4.17.0\"))\n",
              "        .then(() => maybeLoadScript(\"vega-embed\", \"6\"))\n",
              "        .catch(showError)\n",
              "        .then(() => displayChart(vegaEmbed));\n",
              "    }\n",
              "  })({\"config\": {\"view\": {\"continuousWidth\": 400, \"continuousHeight\": 300}, \"axis\": {\"labelFontSize\": 20, \"titleFontSize\": 20}, \"background\": \"white\", \"legend\": {\"labelFontSize\": 20, \"labelLimit\": 0, \"titleFontSize\": 20}}, \"data\": {\"name\": \"data-a7a1ea10803e46331b822af90065097f\"}, \"mark\": {\"type\": \"point\", \"filled\": true, \"size\": 240, \"stroke\": \"black\", \"strokeWidth\": 1.5}, \"encoding\": {\"color\": {\"field\": \"Compound Group\", \"scale\": {\"domain\": [\"DMSO\", \"Herceptin\", \"Perjeta\", \"Active Degraders\", \"Inactive Degraders\", \"PI3K Inhibitor\", \"Pan-Akt Inhibitor\", \"Neratinib (Covalent Inhibitor)\", \"BDTX-189 (Covalent Inhibitor)\", \"Head Group Small Molecules\"], \"range\": [\"#7f7f7f\", \"#ff7f0e\", \"#8c5626\", \"#d62728\", \"#bcbd22\", \"#9467bd\", \"#e377c2\", \"#1f77b4\", \"#17becf\", \"#2ca02c\"]}, \"type\": \"nominal\"}, \"shape\": {\"field\": \"Dose Order\", \"type\": \"nominal\"}, \"tooltip\": {\"field\": \"compound_dose\", \"type\": \"nominal\"}, \"x\": {\"field\": \"tsne_x\", \"type\": \"quantitative\"}, \"y\": {\"field\": \"tsne_y\", \"type\": \"quantitative\"}}, \"height\": 700, \"title\": \"SKOV3 No GFP Timepoint 0 (2 hours)\", \"width\": 700, \"$schema\": \"https://vega.github.io/schema/vega-lite/v4.17.0.json\", \"datasets\": {\"data-a7a1ea10803e46331b822af90065097f\": [{\"tsne_x\": 5.421834468841553, \"tsne_y\": 4.521368026733398, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1462\", \"Dose Order\": \"0\"}, {\"tsne_x\": 5.507885932922363, \"tsne_y\": 3.5917036533355713, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1463\", \"Dose Order\": \"0\"}, {\"tsne_x\": 5.825209140777588, \"tsne_y\": 0.8745098114013672, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1880\", \"Dose Order\": \"0\"}, {\"tsne_x\": 4.534212112426758, \"tsne_y\": 3.3134653568267822, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1881\", \"Dose Order\": \"0\"}, {\"tsne_x\": 5.859501838684082, \"tsne_y\": 3.672476053237915, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1882\", \"Dose Order\": \"0\"}, {\"tsne_x\": 4.723519325256348, \"tsne_y\": 3.185631275177002, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1883\", \"Dose Order\": \"0\"}, {\"tsne_x\": 5.853327751159668, \"tsne_y\": 0.8339211940765381, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1924\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.1767616271972656, \"tsne_y\": 6.085784912109375, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1925\", \"Dose Order\": \"0\"}, {\"tsne_x\": 5.8601393699646, \"tsne_y\": 3.5285487174987793, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1926\", \"Dose Order\": \"0\"}, {\"tsne_x\": 4.644901275634766, \"tsne_y\": 3.540102243423462, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1927\", \"Dose Order\": \"0\"}, {\"tsne_x\": 39.99687957763672, \"tsne_y\": 24.80877113342285, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1462\", \"Dose Order\": \"1\"}, {\"tsne_x\": 40.644649505615234, \"tsne_y\": 24.5223388671875, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1463\", \"Dose Order\": \"1\"}, {\"tsne_x\": 38.25816345214844, \"tsne_y\": 26.936840057373047, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1880\", \"Dose Order\": \"1\"}, {\"tsne_x\": 39.2811393737793, \"tsne_y\": 25.532596588134766, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1881\", \"Dose Order\": \"1\"}, {\"tsne_x\": 39.110904693603516, \"tsne_y\": 24.9527645111084, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1882\", \"Dose Order\": \"1\"}, {\"tsne_x\": 39.40757751464844, \"tsne_y\": 25.54289436340332, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1883\", \"Dose Order\": \"1\"}, {\"tsne_x\": 38.323951721191406, \"tsne_y\": 26.792551040649414, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1924\", \"Dose Order\": \"1\"}, {\"tsne_x\": 39.5738525390625, \"tsne_y\": 25.937198638916016, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1925\", \"Dose Order\": \"1\"}, {\"tsne_x\": 39.902156829833984, \"tsne_y\": 26.197599411010742, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1926\", \"Dose Order\": \"1\"}, {\"tsne_x\": 40.09727478027344, \"tsne_y\": 25.999536514282227, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1927\", \"Dose Order\": \"1\"}, {\"tsne_x\": 46.77854537963867, \"tsne_y\": 28.830198287963867, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1462\", \"Dose Order\": \"2\"}, {\"tsne_x\": 48.24068832397461, \"tsne_y\": 29.085420608520508, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1463\", \"Dose Order\": \"2\"}, {\"tsne_x\": 45.14801025390625, \"tsne_y\": 29.518407821655273, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1880\", \"Dose Order\": \"2\"}, {\"tsne_x\": 46.16917419433594, \"tsne_y\": 29.8422794342041, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1881\", \"Dose Order\": \"2\"}, {\"tsne_x\": 46.200801849365234, \"tsne_y\": 29.297561645507812, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1882\", \"Dose Order\": \"2\"}, {\"tsne_x\": 46.7519416809082, \"tsne_y\": 29.67518424987793, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1883\", \"Dose Order\": \"2\"}, {\"tsne_x\": 45.36819839477539, \"tsne_y\": 31.022294998168945, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1924\", \"Dose Order\": \"2\"}, {\"tsne_x\": 45.94913864135742, \"tsne_y\": 30.535491943359375, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1925\", \"Dose Order\": \"2\"}, {\"tsne_x\": 46.27313232421875, \"tsne_y\": 30.2591495513916, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1926\", \"Dose Order\": \"2\"}, {\"tsne_x\": 46.386173248291016, \"tsne_y\": 30.652990341186523, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1927\", \"Dose Order\": \"2\"}, {\"tsne_x\": 51.774044036865234, \"tsne_y\": 30.842483520507812, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1462\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.527164459228516, \"tsne_y\": 30.863962173461914, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1463\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.20247268676758, \"tsne_y\": 33.80777359008789, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1880\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.29633331298828, \"tsne_y\": 32.69040298461914, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1881\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.759300231933594, \"tsne_y\": 32.9300422668457, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1882\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.44590377807617, \"tsne_y\": 32.70600128173828, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1883\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.080997467041016, \"tsne_y\": 34.46650314331055, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1924\", \"Dose Order\": \"3\"}, {\"tsne_x\": 49.423458099365234, \"tsne_y\": 33.99711227416992, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1925\", \"Dose Order\": \"3\"}, {\"tsne_x\": 49.759117126464844, \"tsne_y\": 33.800872802734375, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1926\", \"Dose Order\": \"3\"}, {\"tsne_x\": 49.73818588256836, \"tsne_y\": 33.8836784362793, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1927\", \"Dose Order\": \"3\"}, {\"tsne_x\": 53.97304916381836, \"tsne_y\": 30.83086585998535, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1462\", \"Dose Order\": \"4\"}, {\"tsne_x\": 53.85602951049805, \"tsne_y\": 30.853374481201172, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1463\", \"Dose Order\": \"4\"}, {\"tsne_x\": 55.930870056152344, \"tsne_y\": 34.51280975341797, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1880\", \"Dose Order\": \"4\"}, {\"tsne_x\": 56.3646125793457, \"tsne_y\": 33.468021392822266, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1881\", \"Dose Order\": \"4\"}, {\"tsne_x\": 56.22980499267578, \"tsne_y\": 33.52397155761719, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1882\", \"Dose Order\": \"4\"}, {\"tsne_x\": 55.87339401245117, \"tsne_y\": 33.381168365478516, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1883\", \"Dose Order\": \"4\"}, {\"tsne_x\": 56.80192947387695, \"tsne_y\": 35.43317413330078, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1924\", \"Dose Order\": \"4\"}, {\"tsne_x\": 57.91579055786133, \"tsne_y\": 34.20745086669922, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1925\", \"Dose Order\": \"4\"}, {\"tsne_x\": 58.4167594909668, \"tsne_y\": 33.97425079345703, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1926\", \"Dose Order\": \"4\"}, {\"tsne_x\": 58.01189422607422, \"tsne_y\": 34.13568878173828, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1927\", \"Dose Order\": \"4\"}, {\"tsne_x\": 55.31641387939453, \"tsne_y\": 30.350725173950195, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1462\", \"Dose Order\": \"5\"}, {\"tsne_x\": 55.23129653930664, \"tsne_y\": 30.375574111938477, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1463\", \"Dose Order\": \"5\"}, {\"tsne_x\": 60.026920318603516, \"tsne_y\": 31.561119079589844, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1880\", \"Dose Order\": \"5\"}, {\"tsne_x\": 59.50178146362305, \"tsne_y\": 31.490394592285156, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1881\", \"Dose Order\": \"5\"}, {\"tsne_x\": 59.57879638671875, \"tsne_y\": 31.522491455078125, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1882\", \"Dose Order\": \"5\"}, {\"tsne_x\": 58.89547348022461, \"tsne_y\": 31.14012336730957, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1883\", \"Dose Order\": \"5\"}, {\"tsne_x\": 60.746978759765625, \"tsne_y\": 32.84329605102539, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1924\", \"Dose Order\": \"5\"}, {\"tsne_x\": 60.04454803466797, \"tsne_y\": 32.94086837768555, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1925\", \"Dose Order\": \"5\"}, {\"tsne_x\": 60.02032470703125, \"tsne_y\": 33.26449966430664, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1926\", \"Dose Order\": \"5\"}, {\"tsne_x\": 59.50380325317383, \"tsne_y\": 33.18192672729492, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|0\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1927\", \"Dose Order\": \"5\"}, {\"tsne_x\": 21.006080627441406, \"tsne_y\": -9.875906944274902, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1462\", \"Dose Order\": \"0\"}, {\"tsne_x\": 20.644346237182617, \"tsne_y\": -10.327224731445312, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1463\", \"Dose Order\": \"0\"}, {\"tsne_x\": 20.222265243530273, \"tsne_y\": -12.816580772399902, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1880\", \"Dose Order\": \"0\"}, {\"tsne_x\": 20.7431697845459, \"tsne_y\": -11.722579002380371, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1881\", \"Dose Order\": \"0\"}, {\"tsne_x\": 21.23024559020996, \"tsne_y\": -10.96093463897705, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1882\", \"Dose Order\": \"0\"}, {\"tsne_x\": 20.712953567504883, \"tsne_y\": -11.369038581848145, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1883\", \"Dose Order\": \"0\"}, {\"tsne_x\": 20.331438064575195, \"tsne_y\": -13.376494407653809, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1924\", \"Dose Order\": \"0\"}, {\"tsne_x\": 21.03512954711914, \"tsne_y\": -12.197502136230469, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1925\", \"Dose Order\": \"0\"}, {\"tsne_x\": 21.40130615234375, \"tsne_y\": -11.943584442138672, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1926\", \"Dose Order\": \"0\"}, {\"tsne_x\": 21.417957305908203, \"tsne_y\": -12.272374153137207, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1927\", \"Dose Order\": \"0\"}, {\"tsne_x\": 21.818552017211914, \"tsne_y\": -8.190041542053223, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1462\", \"Dose Order\": \"1\"}, {\"tsne_x\": 22.041261672973633, \"tsne_y\": -7.897130966186523, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1463\", \"Dose Order\": \"1\"}, {\"tsne_x\": 23.969703674316406, \"tsne_y\": -5.798106670379639, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1880\", \"Dose Order\": \"1\"}, {\"tsne_x\": 24.165246963500977, \"tsne_y\": -6.902529716491699, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1881\", \"Dose Order\": \"1\"}, {\"tsne_x\": 23.61983871459961, \"tsne_y\": -7.254969596862793, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1882\", \"Dose Order\": \"1\"}, {\"tsne_x\": 23.88671112060547, \"tsne_y\": -6.975322723388672, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1883\", \"Dose Order\": \"1\"}, {\"tsne_x\": 24.468284606933594, \"tsne_y\": -5.544216156005859, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1924\", \"Dose Order\": \"1\"}, {\"tsne_x\": 25.44056510925293, \"tsne_y\": -6.752579689025879, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1925\", \"Dose Order\": \"1\"}, {\"tsne_x\": 25.59075927734375, \"tsne_y\": -6.874504089355469, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1926\", \"Dose Order\": \"1\"}, {\"tsne_x\": 24.89877700805664, \"tsne_y\": -6.608644008636475, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1927\", \"Dose Order\": \"1\"}, {\"tsne_x\": 5.913186073303223, \"tsne_y\": -30.389625549316406, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1462\", \"Dose Order\": \"2\"}, {\"tsne_x\": 5.885481834411621, \"tsne_y\": -30.418682098388672, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1463\", \"Dose Order\": \"2\"}, {\"tsne_x\": 34.39414978027344, \"tsne_y\": 0.27734968066215515, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1880\", \"Dose Order\": \"2\"}, {\"tsne_x\": 35.18006134033203, \"tsne_y\": 1.1107988357543945, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1881\", \"Dose Order\": \"2\"}, {\"tsne_x\": 35.372962951660156, \"tsne_y\": 1.3829718828201294, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1882\", \"Dose Order\": \"2\"}, {\"tsne_x\": 35.18756103515625, \"tsne_y\": 1.209805965423584, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1883\", \"Dose Order\": \"2\"}, {\"tsne_x\": 34.3449821472168, \"tsne_y\": -0.2930413484573364, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1924\", \"Dose Order\": \"2\"}, {\"tsne_x\": 36.986698150634766, \"tsne_y\": -0.10586794465780258, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1925\", \"Dose Order\": \"2\"}, {\"tsne_x\": 36.96929168701172, \"tsne_y\": -0.0634785071015358, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1926\", \"Dose Order\": \"2\"}, {\"tsne_x\": 36.356773376464844, \"tsne_y\": 0.02355446293950081, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1927\", \"Dose Order\": \"2\"}, {\"tsne_x\": 37.285213470458984, \"tsne_y\": 6.97149133682251, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1462\", \"Dose Order\": \"3\"}, {\"tsne_x\": 37.14262771606445, \"tsne_y\": 6.865811347961426, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1463\", \"Dose Order\": \"3\"}, {\"tsne_x\": 35.65279006958008, \"tsne_y\": 4.2410783767700195, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1880\", \"Dose Order\": \"3\"}, {\"tsne_x\": 37.23982238769531, \"tsne_y\": 3.579777479171753, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1881\", \"Dose Order\": \"3\"}, {\"tsne_x\": 36.760658264160156, \"tsne_y\": 3.170821189880371, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1882\", \"Dose Order\": \"3\"}, {\"tsne_x\": 37.09980773925781, \"tsne_y\": 3.464966297149658, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1883\", \"Dose Order\": \"3\"}, {\"tsne_x\": 35.3073616027832, \"tsne_y\": 4.421145439147949, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1924\", \"Dose Order\": \"3\"}, {\"tsne_x\": 38.6993522644043, \"tsne_y\": -0.44775161147117615, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1925\", \"Dose Order\": \"3\"}, {\"tsne_x\": 38.41953659057617, \"tsne_y\": 0.6604577898979187, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1926\", \"Dose Order\": \"3\"}, {\"tsne_x\": 38.546146392822266, \"tsne_y\": 1.008868932723999, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1927\", \"Dose Order\": \"3\"}, {\"tsne_x\": 38.55880355834961, \"tsne_y\": 7.549379825592041, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1462\", \"Dose Order\": \"4\"}, {\"tsne_x\": 38.55352783203125, \"tsne_y\": 7.704449653625488, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1463\", \"Dose Order\": \"4\"}, {\"tsne_x\": 39.310035705566406, \"tsne_y\": 4.820065498352051, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1880\", \"Dose Order\": \"4\"}, {\"tsne_x\": 39.539669036865234, \"tsne_y\": 4.001077651977539, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1881\", \"Dose Order\": \"4\"}, {\"tsne_x\": 40.08170700073242, \"tsne_y\": 4.534329414367676, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1882\", \"Dose Order\": \"4\"}, {\"tsne_x\": 39.62696838378906, \"tsne_y\": 4.433863639831543, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1883\", \"Dose Order\": \"4\"}, {\"tsne_x\": 40.523193359375, \"tsne_y\": 2.268944501876831, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1924\", \"Dose Order\": \"4\"}, {\"tsne_x\": 41.061424255371094, \"tsne_y\": 0.8885290026664734, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1925\", \"Dose Order\": \"4\"}, {\"tsne_x\": 40.398414611816406, \"tsne_y\": 1.1034893989562988, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1926\", \"Dose Order\": \"4\"}, {\"tsne_x\": 40.291744232177734, \"tsne_y\": 1.2235790491104126, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1927\", \"Dose Order\": \"4\"}, {\"tsne_x\": 39.423404693603516, \"tsne_y\": 8.063828468322754, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1462\", \"Dose Order\": \"5\"}, {\"tsne_x\": 39.310546875, \"tsne_y\": 8.092567443847656, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1463\", \"Dose Order\": \"5\"}, {\"tsne_x\": 42.65460205078125, \"tsne_y\": 4.408527851104736, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1880\", \"Dose Order\": \"5\"}, {\"tsne_x\": 42.15822219848633, \"tsne_y\": 4.65228271484375, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1881\", \"Dose Order\": \"5\"}, {\"tsne_x\": 41.84880447387695, \"tsne_y\": 4.658771991729736, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1882\", \"Dose Order\": \"5\"}, {\"tsne_x\": 41.66617965698242, \"tsne_y\": 4.869848251342773, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1883\", \"Dose Order\": \"5\"}, {\"tsne_x\": 43.10295104980469, \"tsne_y\": 2.7863986492156982, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1924\", \"Dose Order\": \"5\"}, {\"tsne_x\": 43.06679153442383, \"tsne_y\": 1.8857433795928955, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1925\", \"Dose Order\": \"5\"}, {\"tsne_x\": 42.84865951538086, \"tsne_y\": 1.9141534566879272, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1926\", \"Dose Order\": \"5\"}, {\"tsne_x\": 42.36896896362305, \"tsne_y\": 1.7962746620178223, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|0\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1927\", \"Dose Order\": \"5\"}, {\"tsne_x\": -2.1864099502563477, \"tsne_y\": -7.907819747924805, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1462\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.2223267555236816, \"tsne_y\": -8.468741416931152, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1463\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.296008825302124, \"tsne_y\": -6.785223484039307, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1880\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.1046462059021, \"tsne_y\": -8.753546714782715, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1881\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.162078380584717, \"tsne_y\": -7.216412544250488, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1882\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.4678285121917725, \"tsne_y\": -7.494913578033447, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1883\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.0651278495788574, \"tsne_y\": -6.181611061096191, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1924\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.6447913646698, \"tsne_y\": -8.287311553955078, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1925\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.546401262283325, \"tsne_y\": -7.870850086212158, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1926\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.652714729309082, \"tsne_y\": -8.04317855834961, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1927\", \"Dose Order\": \"0\"}, {\"tsne_x\": 9.035041809082031, \"tsne_y\": -9.82484245300293, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1462\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.447183609008789, \"tsne_y\": -8.538981437683105, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1463\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.297536373138428, \"tsne_y\": -2.4180638790130615, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1880\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.736995697021484, \"tsne_y\": -9.440845489501953, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1881\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.403120994567871, \"tsne_y\": -7.8425822257995605, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1882\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.298511505126953, \"tsne_y\": -9.31480598449707, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1883\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.453304767608643, \"tsne_y\": -2.2044453620910645, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1924\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.882229328155518, \"tsne_y\": -8.693771362304688, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1925\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.442044734954834, \"tsne_y\": -8.365399360656738, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1926\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.340140342712402, \"tsne_y\": -9.16690731048584, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1927\", \"Dose Order\": \"1\"}, {\"tsne_x\": 32.89926528930664, \"tsne_y\": -31.91855812072754, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1462\", \"Dose Order\": \"2\"}, {\"tsne_x\": 32.324520111083984, \"tsne_y\": -31.077075958251953, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1463\", \"Dose Order\": \"2\"}, {\"tsne_x\": 32.16900634765625, \"tsne_y\": -30.39244270324707, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1880\", \"Dose Order\": \"2\"}, {\"tsne_x\": 31.836389541625977, \"tsne_y\": -32.03703689575195, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1881\", \"Dose Order\": \"2\"}, {\"tsne_x\": 31.522184371948242, \"tsne_y\": -31.83667755126953, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1882\", \"Dose Order\": \"2\"}, {\"tsne_x\": 32.145103454589844, \"tsne_y\": -31.343643188476562, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1883\", \"Dose Order\": \"2\"}, {\"tsne_x\": 31.31199836730957, \"tsne_y\": -30.519990921020508, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1924\", \"Dose Order\": \"2\"}, {\"tsne_x\": 31.870361328125, \"tsne_y\": -33.82337188720703, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1925\", \"Dose Order\": \"2\"}, {\"tsne_x\": 31.90435028076172, \"tsne_y\": -34.02016830444336, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1926\", \"Dose Order\": \"2\"}, {\"tsne_x\": 31.97928237915039, \"tsne_y\": -33.17777633666992, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1927\", \"Dose Order\": \"2\"}, {\"tsne_x\": 52.252986907958984, \"tsne_y\": -30.974409103393555, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1462\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.192752838134766, \"tsne_y\": -31.30214500427246, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1463\", \"Dose Order\": \"3\"}, {\"tsne_x\": 48.66239547729492, \"tsne_y\": -31.423681259155273, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1880\", \"Dose Order\": \"3\"}, {\"tsne_x\": 49.81316375732422, \"tsne_y\": -30.108854293823242, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1881\", \"Dose Order\": \"3\"}, {\"tsne_x\": 49.58503723144531, \"tsne_y\": -30.79625129699707, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1882\", \"Dose Order\": \"3\"}, {\"tsne_x\": 49.658958435058594, \"tsne_y\": -30.59111213684082, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1883\", \"Dose Order\": \"3\"}, {\"tsne_x\": 48.915733337402344, \"tsne_y\": -30.042329788208008, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1924\", \"Dose Order\": \"3\"}, {\"tsne_x\": 48.59990310668945, \"tsne_y\": -24.25373077392578, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1925\", \"Dose Order\": \"3\"}, {\"tsne_x\": 48.58927917480469, \"tsne_y\": -24.175025939941406, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1926\", \"Dose Order\": \"3\"}, {\"tsne_x\": 48.176368713378906, \"tsne_y\": -24.677703857421875, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1927\", \"Dose Order\": \"3\"}, {\"tsne_x\": 69.64640808105469, \"tsne_y\": -23.676025390625, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1462\", \"Dose Order\": \"4\"}, {\"tsne_x\": 69.58867645263672, \"tsne_y\": -24.83970832824707, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1463\", \"Dose Order\": \"4\"}, {\"tsne_x\": 68.5478286743164, \"tsne_y\": -26.16290283203125, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1880\", \"Dose Order\": \"4\"}, {\"tsne_x\": 68.66790771484375, \"tsne_y\": -26.949602127075195, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1881\", \"Dose Order\": \"4\"}, {\"tsne_x\": 68.6585922241211, \"tsne_y\": -26.991361618041992, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1882\", \"Dose Order\": \"4\"}, {\"tsne_x\": 68.69893646240234, \"tsne_y\": -25.802532196044922, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1883\", \"Dose Order\": \"4\"}, {\"tsne_x\": 69.04334259033203, \"tsne_y\": -28.126611709594727, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1924\", \"Dose Order\": \"4\"}, {\"tsne_x\": 69.32673645019531, \"tsne_y\": -28.62828826904297, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1925\", \"Dose Order\": \"4\"}, {\"tsne_x\": 69.13512420654297, \"tsne_y\": -28.865127563476562, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1926\", \"Dose Order\": \"4\"}, {\"tsne_x\": 68.99227905273438, \"tsne_y\": -28.720624923706055, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1927\", \"Dose Order\": \"4\"}, {\"tsne_x\": 70.96417999267578, \"tsne_y\": -24.472381591796875, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1462\", \"Dose Order\": \"5\"}, {\"tsne_x\": 70.89837646484375, \"tsne_y\": -24.58169174194336, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1463\", \"Dose Order\": \"5\"}, {\"tsne_x\": 72.61683654785156, \"tsne_y\": -24.934593200683594, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1880\", \"Dose Order\": \"5\"}, {\"tsne_x\": 72.37570190429688, \"tsne_y\": -26.41526985168457, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1881\", \"Dose Order\": \"5\"}, {\"tsne_x\": 72.29689025878906, \"tsne_y\": -25.260379791259766, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1882\", \"Dose Order\": \"5\"}, {\"tsne_x\": 72.3016357421875, \"tsne_y\": -25.748506546020508, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1883\", \"Dose Order\": \"5\"}, {\"tsne_x\": 73.19902038574219, \"tsne_y\": -28.06716537475586, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1924\", \"Dose Order\": \"5\"}, {\"tsne_x\": 72.54740905761719, \"tsne_y\": -28.034757614135742, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1925\", \"Dose Order\": \"5\"}, {\"tsne_x\": 72.65296936035156, \"tsne_y\": -28.321874618530273, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1926\", \"Dose Order\": \"5\"}, {\"tsne_x\": 72.46907043457031, \"tsne_y\": -28.443967819213867, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1927\", \"Dose Order\": \"5\"}, {\"tsne_x\": -3.7204079627990723, \"tsne_y\": 6.14355993270874, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1462\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.3337607383728027, \"tsne_y\": 7.416961193084717, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1463\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.026689052581787, \"tsne_y\": 5.055588245391846, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1880\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.1161580085754395, \"tsne_y\": 6.708648681640625, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1881\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.504422664642334, \"tsne_y\": 6.729311943054199, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1882\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.289757013320923, \"tsne_y\": 6.209014892578125, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1883\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.216958999633789, \"tsne_y\": 4.6770172119140625, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1924\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.0699201822280884, \"tsne_y\": 6.111645221710205, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1925\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.237562417984009, \"tsne_y\": 6.351479530334473, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1926\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.119333267211914, \"tsne_y\": 6.164406776428223, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1927\", \"Dose Order\": \"0\"}, {\"tsne_x\": -36.17603302001953, \"tsne_y\": 5.774383068084717, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1462\", \"Dose Order\": \"1\"}, {\"tsne_x\": -36.931888580322266, \"tsne_y\": 5.7963337898254395, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1463\", \"Dose Order\": \"1\"}, {\"tsne_x\": -37.569671630859375, \"tsne_y\": 3.548308849334717, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1880\", \"Dose Order\": \"1\"}, {\"tsne_x\": -37.00289535522461, \"tsne_y\": 4.950698375701904, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1881\", \"Dose Order\": \"1\"}, {\"tsne_x\": -35.76893615722656, \"tsne_y\": 5.346028804779053, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1882\", \"Dose Order\": \"1\"}, {\"tsne_x\": -36.97905731201172, \"tsne_y\": 5.050896644592285, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1883\", \"Dose Order\": \"1\"}, {\"tsne_x\": -36.522945404052734, \"tsne_y\": 3.112041473388672, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1924\", \"Dose Order\": \"1\"}, {\"tsne_x\": -36.445064544677734, \"tsne_y\": 4.3547139167785645, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1925\", \"Dose Order\": \"1\"}, {\"tsne_x\": -36.285606384277344, \"tsne_y\": 4.522331714630127, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1926\", \"Dose Order\": \"1\"}, {\"tsne_x\": -35.97730255126953, \"tsne_y\": 4.293165683746338, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1927\", \"Dose Order\": \"1\"}, {\"tsne_x\": -50.219444274902344, \"tsne_y\": 13.893731117248535, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1462\", \"Dose Order\": \"2\"}, {\"tsne_x\": -50.072364807128906, \"tsne_y\": 12.190381050109863, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1463\", \"Dose Order\": \"2\"}, {\"tsne_x\": -47.75080871582031, \"tsne_y\": 12.201249122619629, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1880\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.36557388305664, \"tsne_y\": 12.04150390625, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1881\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.791019439697266, \"tsne_y\": 12.973045349121094, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1882\", \"Dose Order\": \"2\"}, {\"tsne_x\": -50.02516555786133, \"tsne_y\": 11.655548095703125, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1883\", \"Dose Order\": \"2\"}, {\"tsne_x\": -48.15224075317383, \"tsne_y\": 12.43588924407959, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1924\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.03956604003906, \"tsne_y\": 11.784693717956543, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1925\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.36578369140625, \"tsne_y\": 12.930989265441895, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1926\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.35609436035156, \"tsne_y\": 12.150032997131348, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1927\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.067787170410156, \"tsne_y\": 16.980215072631836, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1462\", \"Dose Order\": \"3\"}, {\"tsne_x\": -56.4771728515625, \"tsne_y\": 18.10203742980957, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1463\", \"Dose Order\": \"3\"}, {\"tsne_x\": -57.13766098022461, \"tsne_y\": 15.438112258911133, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1880\", \"Dose Order\": \"3\"}, {\"tsne_x\": -57.29200744628906, \"tsne_y\": 17.179109573364258, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1881\", \"Dose Order\": \"3\"}, {\"tsne_x\": -56.854000091552734, \"tsne_y\": 16.638065338134766, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1882\", \"Dose Order\": \"3\"}, {\"tsne_x\": -56.74757385253906, \"tsne_y\": 17.0019588470459, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1883\", \"Dose Order\": \"3\"}, {\"tsne_x\": -57.39066696166992, \"tsne_y\": 15.503387451171875, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1924\", \"Dose Order\": \"3\"}, {\"tsne_x\": -57.886497497558594, \"tsne_y\": 17.337427139282227, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1925\", \"Dose Order\": \"3\"}, {\"tsne_x\": -57.98347854614258, \"tsne_y\": 17.473039627075195, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1926\", \"Dose Order\": \"3\"}, {\"tsne_x\": -57.79207229614258, \"tsne_y\": 17.062576293945312, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1927\", \"Dose Order\": \"3\"}, {\"tsne_x\": -61.31724166870117, \"tsne_y\": 19.431467056274414, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1462\", \"Dose Order\": \"4\"}, {\"tsne_x\": -61.55474853515625, \"tsne_y\": 18.996131896972656, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1463\", \"Dose Order\": \"4\"}, {\"tsne_x\": -60.46384048461914, \"tsne_y\": 21.25452995300293, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1880\", \"Dose Order\": \"4\"}, {\"tsne_x\": -60.164146423339844, \"tsne_y\": 19.644855499267578, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1881\", \"Dose Order\": \"4\"}, {\"tsne_x\": -61.02971649169922, \"tsne_y\": 19.89348030090332, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1882\", \"Dose Order\": \"4\"}, {\"tsne_x\": -60.78018569946289, \"tsne_y\": 19.852893829345703, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1883\", \"Dose Order\": \"4\"}, {\"tsne_x\": -60.78350067138672, \"tsne_y\": 22.025226593017578, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1924\", \"Dose Order\": \"4\"}, {\"tsne_x\": -62.26921081542969, \"tsne_y\": 21.89449119567871, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1925\", \"Dose Order\": \"4\"}, {\"tsne_x\": -62.547813415527344, \"tsne_y\": 22.241971969604492, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1926\", \"Dose Order\": \"4\"}, {\"tsne_x\": -62.17552185058594, \"tsne_y\": 21.859169006347656, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1927\", \"Dose Order\": \"4\"}, {\"tsne_x\": -64.41015625, \"tsne_y\": 19.92792510986328, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1462\", \"Dose Order\": \"5\"}, {\"tsne_x\": -64.36253356933594, \"tsne_y\": 19.869985580444336, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1463\", \"Dose Order\": \"5\"}, {\"tsne_x\": -65.74217987060547, \"tsne_y\": 21.892778396606445, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1880\", \"Dose Order\": \"5\"}, {\"tsne_x\": -64.74903869628906, \"tsne_y\": 22.01094627380371, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1881\", \"Dose Order\": \"5\"}, {\"tsne_x\": -64.72454071044922, \"tsne_y\": 21.888317108154297, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1882\", \"Dose Order\": \"5\"}, {\"tsne_x\": -65.0776138305664, \"tsne_y\": 21.80922508239746, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1883\", \"Dose Order\": \"5\"}, {\"tsne_x\": -63.435546875, \"tsne_y\": 23.730093002319336, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1924\", \"Dose Order\": \"5\"}, {\"tsne_x\": -65.10211181640625, \"tsne_y\": 23.934743881225586, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1925\", \"Dose Order\": \"5\"}, {\"tsne_x\": -64.31658172607422, \"tsne_y\": 23.129375457763672, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1926\", \"Dose Order\": \"5\"}, {\"tsne_x\": -64.47332000732422, \"tsne_y\": 23.33761978149414, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|0\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1927\", \"Dose Order\": \"5\"}, {\"tsne_x\": 13.866171836853027, \"tsne_y\": -18.38475799560547, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1462\", \"Dose Order\": \"0\"}, {\"tsne_x\": 13.483436584472656, \"tsne_y\": -19.95139503479004, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1463\", \"Dose Order\": \"0\"}, {\"tsne_x\": 14.553542137145996, \"tsne_y\": -21.40826988220215, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1880\", \"Dose Order\": \"0\"}, {\"tsne_x\": 14.476649284362793, \"tsne_y\": -19.984947204589844, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1881\", \"Dose Order\": \"0\"}, {\"tsne_x\": 14.361767768859863, \"tsne_y\": -19.426055908203125, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1882\", \"Dose Order\": \"0\"}, {\"tsne_x\": 14.225553512573242, \"tsne_y\": -19.944324493408203, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1883\", \"Dose Order\": \"0\"}, {\"tsne_x\": 14.669036865234375, \"tsne_y\": -21.561687469482422, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1924\", \"Dose Order\": \"0\"}, {\"tsne_x\": 15.502521514892578, \"tsne_y\": -20.101032257080078, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1925\", \"Dose Order\": \"0\"}, {\"tsne_x\": 16.355009078979492, \"tsne_y\": -19.75381088256836, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1926\", \"Dose Order\": \"0\"}, {\"tsne_x\": 14.989684104919434, \"tsne_y\": -20.088125228881836, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1927\", \"Dose Order\": \"0\"}, {\"tsne_x\": 27.018474578857422, \"tsne_y\": -36.93531036376953, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1462\", \"Dose Order\": \"1\"}, {\"tsne_x\": 26.905080795288086, \"tsne_y\": -36.85704803466797, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1463\", \"Dose Order\": \"1\"}, {\"tsne_x\": 28.16411781311035, \"tsne_y\": -37.40362548828125, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1880\", \"Dose Order\": \"1\"}, {\"tsne_x\": 28.11161231994629, \"tsne_y\": -36.13529968261719, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1881\", \"Dose Order\": \"1\"}, {\"tsne_x\": 28.04180145263672, \"tsne_y\": -36.370208740234375, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1882\", \"Dose Order\": \"1\"}, {\"tsne_x\": 27.580280303955078, \"tsne_y\": -36.11625671386719, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1883\", \"Dose Order\": \"1\"}, {\"tsne_x\": 29.71500587463379, \"tsne_y\": -37.231468200683594, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1924\", \"Dose Order\": \"1\"}, {\"tsne_x\": 30.113636016845703, \"tsne_y\": -35.9356803894043, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1925\", \"Dose Order\": \"1\"}, {\"tsne_x\": 30.331012725830078, \"tsne_y\": -36.00547409057617, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1926\", \"Dose Order\": \"1\"}, {\"tsne_x\": 29.51000213623047, \"tsne_y\": -36.05786895751953, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1927\", \"Dose Order\": \"1\"}, {\"tsne_x\": 51.67735290527344, \"tsne_y\": -30.00803565979004, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1462\", \"Dose Order\": \"2\"}, {\"tsne_x\": 50.945343017578125, \"tsne_y\": -31.896656036376953, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1463\", \"Dose Order\": \"2\"}, {\"tsne_x\": 51.992008209228516, \"tsne_y\": -29.001750946044922, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1880\", \"Dose Order\": \"2\"}, {\"tsne_x\": 51.278076171875, \"tsne_y\": -28.758678436279297, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1881\", \"Dose Order\": \"2\"}, {\"tsne_x\": 51.43698501586914, \"tsne_y\": -28.31092071533203, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1882\", \"Dose Order\": \"2\"}, {\"tsne_x\": 50.88547897338867, \"tsne_y\": -28.954999923706055, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1883\", \"Dose Order\": \"2\"}, {\"tsne_x\": 49.52751159667969, \"tsne_y\": -27.48015022277832, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1924\", \"Dose Order\": \"2\"}, {\"tsne_x\": 49.69409942626953, \"tsne_y\": -23.562410354614258, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1925\", \"Dose Order\": \"2\"}, {\"tsne_x\": 49.52571105957031, \"tsne_y\": -23.74602699279785, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1926\", \"Dose Order\": \"2\"}, {\"tsne_x\": 49.171531677246094, \"tsne_y\": -23.433124542236328, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1927\", \"Dose Order\": \"2\"}, {\"tsne_x\": 33.47694778442383, \"tsne_y\": -38.16999053955078, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1462\", \"Dose Order\": \"3\"}, {\"tsne_x\": 34.6038932800293, \"tsne_y\": -39.22600555419922, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1463\", \"Dose Order\": \"3\"}, {\"tsne_x\": 35.774391174316406, \"tsne_y\": -37.69028091430664, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1880\", \"Dose Order\": \"3\"}, {\"tsne_x\": 34.54190444946289, \"tsne_y\": -38.191322326660156, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1881\", \"Dose Order\": \"3\"}, {\"tsne_x\": 34.444732666015625, \"tsne_y\": -38.5560417175293, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1882\", \"Dose Order\": \"3\"}, {\"tsne_x\": 34.55363082885742, \"tsne_y\": -38.43465805053711, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1883\", \"Dose Order\": \"3\"}, {\"tsne_x\": 35.965049743652344, \"tsne_y\": -37.512210845947266, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1924\", \"Dose Order\": \"3\"}, {\"tsne_x\": 48.30892562866211, \"tsne_y\": -26.666351318359375, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1925\", \"Dose Order\": \"3\"}, {\"tsne_x\": 33.875972747802734, \"tsne_y\": -36.64691162109375, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1926\", \"Dose Order\": \"3\"}, {\"tsne_x\": 33.8013916015625, \"tsne_y\": -36.88774108886719, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1927\", \"Dose Order\": \"3\"}, {\"tsne_x\": 53.86957550048828, \"tsne_y\": -29.792640686035156, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1462\", \"Dose Order\": \"4\"}, {\"tsne_x\": 54.278560638427734, \"tsne_y\": -29.420610427856445, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1463\", \"Dose Order\": \"4\"}, {\"tsne_x\": 54.33000946044922, \"tsne_y\": -27.734891891479492, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1880\", \"Dose Order\": \"4\"}, {\"tsne_x\": 53.81942367553711, \"tsne_y\": -27.87847328186035, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1881\", \"Dose Order\": \"4\"}, {\"tsne_x\": 53.78679275512695, \"tsne_y\": -28.350927352905273, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1882\", \"Dose Order\": \"4\"}, {\"tsne_x\": 53.719451904296875, \"tsne_y\": -28.58251190185547, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1883\", \"Dose Order\": \"4\"}, {\"tsne_x\": 52.96660614013672, \"tsne_y\": -23.796525955200195, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1924\", \"Dose Order\": \"4\"}, {\"tsne_x\": 52.3143196105957, \"tsne_y\": -23.119918823242188, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1925\", \"Dose Order\": \"4\"}, {\"tsne_x\": 52.17117691040039, \"tsne_y\": -23.070615768432617, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1926\", \"Dose Order\": \"4\"}, {\"tsne_x\": 52.37400436401367, \"tsne_y\": -22.993486404418945, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1927\", \"Dose Order\": \"4\"}, {\"tsne_x\": 56.664894104003906, \"tsne_y\": -30.177722930908203, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1462\", \"Dose Order\": \"5\"}, {\"tsne_x\": 56.72732162475586, \"tsne_y\": -30.188241958618164, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1463\", \"Dose Order\": \"5\"}, {\"tsne_x\": 64.51809692382812, \"tsne_y\": -30.74634552001953, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1880\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.48298645019531, \"tsne_y\": -30.76448631286621, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1881\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.78518676757812, \"tsne_y\": -30.85975456237793, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1882\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.37010192871094, \"tsne_y\": -30.84688377380371, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1883\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.02896118164062, \"tsne_y\": -31.76570701599121, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1924\", \"Dose Order\": \"5\"}, {\"tsne_x\": 66.73187255859375, \"tsne_y\": -32.05909729003906, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1925\", \"Dose Order\": \"5\"}, {\"tsne_x\": 66.5782699584961, \"tsne_y\": -32.00624084472656, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1926\", \"Dose Order\": \"5\"}, {\"tsne_x\": 66.71565246582031, \"tsne_y\": -32.0382194519043, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1927\", \"Dose Order\": \"5\"}, {\"tsne_x\": -6.857764720916748, \"tsne_y\": -16.321199417114258, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1462\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.284348964691162, \"tsne_y\": -16.722824096679688, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1463\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.626001358032227, \"tsne_y\": -16.587230682373047, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1880\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.188465118408203, \"tsne_y\": -15.943804740905762, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1881\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.143082141876221, \"tsne_y\": -15.449585914611816, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1882\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.937962055206299, \"tsne_y\": -15.926421165466309, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1883\", \"Dose Order\": \"0\"}, {\"tsne_x\": -9.090036392211914, \"tsne_y\": -16.2912540435791, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1924\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.952459812164307, \"tsne_y\": -15.271126747131348, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1925\", \"Dose Order\": \"0\"}, {\"tsne_x\": -6.671424865722656, \"tsne_y\": -14.832534790039062, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1926\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.382784843444824, \"tsne_y\": -15.33557415008545, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1927\", \"Dose Order\": \"0\"}, {\"tsne_x\": -33.85387420654297, \"tsne_y\": -5.415557861328125, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1462\", \"Dose Order\": \"1\"}, {\"tsne_x\": -34.392616271972656, \"tsne_y\": -6.462799072265625, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1463\", \"Dose Order\": \"1\"}, {\"tsne_x\": -34.586612701416016, \"tsne_y\": -4.00100040435791, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1880\", \"Dose Order\": \"1\"}, {\"tsne_x\": -35.052120208740234, \"tsne_y\": -6.007397174835205, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1881\", \"Dose Order\": \"1\"}, {\"tsne_x\": -35.783206939697266, \"tsne_y\": -5.7635040283203125, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1882\", \"Dose Order\": \"1\"}, {\"tsne_x\": -34.10127639770508, \"tsne_y\": -6.018929481506348, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1883\", \"Dose Order\": \"1\"}, {\"tsne_x\": -34.52028274536133, \"tsne_y\": -3.4574685096740723, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1924\", \"Dose Order\": \"1\"}, {\"tsne_x\": -34.70750045776367, \"tsne_y\": -5.424275875091553, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1925\", \"Dose Order\": \"1\"}, {\"tsne_x\": -35.15595626831055, \"tsne_y\": -5.480454444885254, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1926\", \"Dose Order\": \"1\"}, {\"tsne_x\": -34.37200927734375, \"tsne_y\": -5.624180316925049, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1927\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.31235885620117, \"tsne_y\": -5.928934097290039, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1462\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.965431213378906, \"tsne_y\": -4.866265773773193, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1463\", \"Dose Order\": \"2\"}, {\"tsne_x\": -55.97221374511719, \"tsne_y\": -3.3635683059692383, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1880\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.21355056762695, \"tsne_y\": -5.252192974090576, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1881\", \"Dose Order\": \"2\"}, {\"tsne_x\": -55.98994445800781, \"tsne_y\": -4.672939777374268, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1882\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.072715759277344, \"tsne_y\": -4.33470344543457, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1883\", \"Dose Order\": \"2\"}, {\"tsne_x\": -54.82032775878906, \"tsne_y\": -3.6222755908966064, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1924\", \"Dose Order\": \"2\"}, {\"tsne_x\": -55.60391616821289, \"tsne_y\": -4.717855930328369, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1925\", \"Dose Order\": \"2\"}, {\"tsne_x\": -55.31758499145508, \"tsne_y\": -5.108638286590576, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1926\", \"Dose Order\": \"2\"}, {\"tsne_x\": -55.40333557128906, \"tsne_y\": -4.745326995849609, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1927\", \"Dose Order\": \"2\"}, {\"tsne_x\": -65.69010925292969, \"tsne_y\": -3.0116634368896484, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1462\", \"Dose Order\": \"3\"}, {\"tsne_x\": -66.37360382080078, \"tsne_y\": -4.897751808166504, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1463\", \"Dose Order\": \"3\"}, {\"tsne_x\": -67.8666000366211, \"tsne_y\": -4.1075358390808105, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1880\", \"Dose Order\": \"3\"}, {\"tsne_x\": -65.66178131103516, \"tsne_y\": -4.260107040405273, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1881\", \"Dose Order\": \"3\"}, {\"tsne_x\": -66.86920166015625, \"tsne_y\": -3.037811279296875, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1882\", \"Dose Order\": \"3\"}, {\"tsne_x\": -66.31745147705078, \"tsne_y\": -4.206032752990723, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1883\", \"Dose Order\": \"3\"}, {\"tsne_x\": -67.91827392578125, \"tsne_y\": -4.0195393562316895, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1924\", \"Dose Order\": \"3\"}, {\"tsne_x\": -65.87374114990234, \"tsne_y\": -3.584320545196533, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1925\", \"Dose Order\": \"3\"}, {\"tsne_x\": -66.768798828125, \"tsne_y\": -3.4089770317077637, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1926\", \"Dose Order\": \"3\"}, {\"tsne_x\": -66.20049285888672, \"tsne_y\": -3.8034303188323975, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1927\", \"Dose Order\": \"3\"}, {\"tsne_x\": -74.82052612304688, \"tsne_y\": -4.1482834815979, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1462\", \"Dose Order\": \"4\"}, {\"tsne_x\": -74.20729064941406, \"tsne_y\": -4.452432632446289, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1463\", \"Dose Order\": \"4\"}, {\"tsne_x\": -75.33827209472656, \"tsne_y\": -6.532400131225586, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1880\", \"Dose Order\": \"4\"}, {\"tsne_x\": -75.39370727539062, \"tsne_y\": -4.794119834899902, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1881\", \"Dose Order\": \"4\"}, {\"tsne_x\": -76.28833770751953, \"tsne_y\": -4.301989555358887, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1882\", \"Dose Order\": \"4\"}, {\"tsne_x\": -75.9377212524414, \"tsne_y\": -4.859340667724609, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1883\", \"Dose Order\": \"4\"}, {\"tsne_x\": -75.91617584228516, \"tsne_y\": -6.373711585998535, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1924\", \"Dose Order\": \"4\"}, {\"tsne_x\": -76.77523040771484, \"tsne_y\": -5.612384796142578, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1925\", \"Dose Order\": \"4\"}, {\"tsne_x\": -77.18994903564453, \"tsne_y\": -5.516114711761475, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1926\", \"Dose Order\": \"4\"}, {\"tsne_x\": -76.45477294921875, \"tsne_y\": -5.402310848236084, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1927\", \"Dose Order\": \"4\"}, {\"tsne_x\": -78.23255157470703, \"tsne_y\": -1.8862082958221436, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1462\", \"Dose Order\": \"5\"}, {\"tsne_x\": -78.20964813232422, \"tsne_y\": -1.8831719160079956, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1463\", \"Dose Order\": \"5\"}, {\"tsne_x\": -79.66110229492188, \"tsne_y\": -3.860806465148926, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1880\", \"Dose Order\": \"5\"}, {\"tsne_x\": -78.87773895263672, \"tsne_y\": -3.790803909301758, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1881\", \"Dose Order\": \"5\"}, {\"tsne_x\": -77.75957489013672, \"tsne_y\": -3.8343493938446045, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1882\", \"Dose Order\": \"5\"}, {\"tsne_x\": -78.11927032470703, \"tsne_y\": -3.5032331943511963, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1883\", \"Dose Order\": \"5\"}, {\"tsne_x\": -80.10787963867188, \"tsne_y\": -4.606374740600586, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1924\", \"Dose Order\": \"5\"}, {\"tsne_x\": -79.322021484375, \"tsne_y\": -4.679627418518066, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1925\", \"Dose Order\": \"5\"}, {\"tsne_x\": -78.82518768310547, \"tsne_y\": -5.1765570640563965, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1926\", \"Dose Order\": \"5\"}, {\"tsne_x\": -79.22736358642578, \"tsne_y\": -4.9477434158325195, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|0\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1927\", \"Dose Order\": \"5\"}, {\"tsne_x\": -12.585946083068848, \"tsne_y\": -6.4266133308410645, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|0\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1462\", \"Dose Order\": \"0\"}, {\"tsne_x\": -11.423885345458984, \"tsne_y\": -6.139542102813721, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|0\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1463\", \"Dose Order\": \"0\"}, {\"tsne_x\": -12.285341262817383, \"tsne_y\": -6.075076103210449, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|0\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1880\", \"Dose Order\": \"0\"}, {\"tsne_x\": -12.541165351867676, \"tsne_y\": -6.946541786193848, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|0\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1881\", \"Dose Order\": \"0\"}, {\"tsne_x\": -11.24986743927002, \"tsne_y\": -7.025101661682129, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|0\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1882\", \"Dose Order\": \"0\"}, {\"tsne_x\": -11.834574699401855, \"tsne_y\": -5.903399467468262, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|0\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1883\", \"Dose Order\": \"0\"}, {\"tsne_x\": -12.177377700805664, \"tsne_y\": -7.316296577453613, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|0\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1924\", \"Dose Order\": \"0\"}, {\"tsne_x\": -11.650382995605469, \"tsne_y\": -7.343584060668945, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|0\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1925\", \"Dose Order\": \"0\"}, {\"tsne_x\": -11.878594398498535, \"tsne_y\": -6.695206642150879, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|0\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1926\", \"Dose Order\": \"0\"}, {\"tsne_x\": -11.139530181884766, \"tsne_y\": -6.500102519989014, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|0\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1927\", \"Dose Order\": \"0\"}, {\"tsne_x\": -41.93223190307617, \"tsne_y\": -24.121810913085938, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|0\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1462\", \"Dose Order\": \"0\"}, {\"tsne_x\": -41.38856887817383, \"tsne_y\": -23.594533920288086, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|0\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1463\", \"Dose Order\": \"0\"}, {\"tsne_x\": -41.829410552978516, \"tsne_y\": -22.512535095214844, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|0\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1880\", \"Dose Order\": \"0\"}, {\"tsne_x\": -40.75758361816406, \"tsne_y\": -22.890962600708008, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|0\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1881\", \"Dose Order\": \"0\"}, {\"tsne_x\": -40.789920806884766, \"tsne_y\": -22.517648696899414, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|0\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1882\", \"Dose Order\": \"0\"}, {\"tsne_x\": -40.56914520263672, \"tsne_y\": -23.986574172973633, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|0\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1883\", \"Dose Order\": \"0\"}, {\"tsne_x\": -42.37241744995117, \"tsne_y\": -22.840309143066406, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|0\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1924\", \"Dose Order\": \"0\"}, {\"tsne_x\": -40.31929397583008, \"tsne_y\": -23.190256118774414, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|0\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1925\", \"Dose Order\": \"0\"}, {\"tsne_x\": -40.868194580078125, \"tsne_y\": -23.586959838867188, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|0\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1926\", \"Dose Order\": \"0\"}, {\"tsne_x\": -39.80659484863281, \"tsne_y\": -23.77921485900879, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|0\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1927\", \"Dose Order\": \"0\"}, {\"tsne_x\": -9.046051025390625, \"tsne_y\": -44.844974517822266, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|0\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1462\", \"Dose Order\": \"1\"}, {\"tsne_x\": -7.786628723144531, \"tsne_y\": -44.99480056762695, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|0\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1463\", \"Dose Order\": \"1\"}, {\"tsne_x\": -10.026561737060547, \"tsne_y\": -46.89365005493164, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|0\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1880\", \"Dose Order\": \"1\"}, {\"tsne_x\": -9.75173568725586, \"tsne_y\": -45.72856903076172, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|0\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1881\", \"Dose Order\": \"1\"}, {\"tsne_x\": -8.928653717041016, \"tsne_y\": -46.24405288696289, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|0\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1882\", \"Dose Order\": \"1\"}, {\"tsne_x\": -8.604757308959961, \"tsne_y\": -45.57089614868164, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|0\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1883\", \"Dose Order\": \"1\"}, {\"tsne_x\": -9.45718765258789, \"tsne_y\": -47.240047454833984, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|0\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1924\", \"Dose Order\": \"1\"}, {\"tsne_x\": -9.281094551086426, \"tsne_y\": -46.05999755859375, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|0\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1925\", \"Dose Order\": \"1\"}, {\"tsne_x\": -9.50716781616211, \"tsne_y\": -45.505123138427734, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|0\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1926\", \"Dose Order\": \"1\"}, {\"tsne_x\": -8.526533126831055, \"tsne_y\": -45.87619400024414, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|0\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1927\", \"Dose Order\": \"1\"}, {\"tsne_x\": -34.48643493652344, \"tsne_y\": -18.04351234436035, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|0\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1462\", \"Dose Order\": \"2\"}, {\"tsne_x\": -35.05949783325195, \"tsne_y\": -17.337724685668945, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|0\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1463\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.662384033203125, \"tsne_y\": -16.241201400756836, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|0\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1880\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.36282730102539, \"tsne_y\": -18.120624542236328, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|0\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1881\", \"Dose Order\": \"2\"}, {\"tsne_x\": -34.446346282958984, \"tsne_y\": -17.424362182617188, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|0\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1882\", \"Dose Order\": \"2\"}, {\"tsne_x\": -34.19472885131836, \"tsne_y\": -18.4735164642334, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|0\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1883\", \"Dose Order\": \"2\"}, {\"tsne_x\": -32.977760314941406, \"tsne_y\": -16.355587005615234, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|0\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1924\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.677146911621094, \"tsne_y\": -17.65097427368164, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|0\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1925\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.7830696105957, \"tsne_y\": -17.423612594604492, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|0\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1926\", \"Dose Order\": \"2\"}, {\"tsne_x\": -32.92044448852539, \"tsne_y\": -17.71954345703125, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|0\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1927\", \"Dose Order\": \"2\"}, {\"tsne_x\": -35.286705017089844, \"tsne_y\": -50.05426788330078, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|0\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1462\", \"Dose Order\": \"3\"}, {\"tsne_x\": -31.16905403137207, \"tsne_y\": -45.29376983642578, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|0\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1463\", \"Dose Order\": \"3\"}, {\"tsne_x\": -32.43689727783203, \"tsne_y\": -44.605201721191406, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|0\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1880\", \"Dose Order\": \"3\"}, {\"tsne_x\": -31.693016052246094, \"tsne_y\": -45.540138244628906, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|0\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1881\", \"Dose Order\": \"3\"}, {\"tsne_x\": -32.35432815551758, \"tsne_y\": -45.921871185302734, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|0\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1882\", \"Dose Order\": \"3\"}, {\"tsne_x\": -31.736146926879883, \"tsne_y\": -45.48753356933594, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|0\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1883\", \"Dose Order\": \"3\"}, {\"tsne_x\": -38.30385971069336, \"tsne_y\": -50.0662956237793, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|0\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1924\", \"Dose Order\": \"3\"}, {\"tsne_x\": -39.38597106933594, \"tsne_y\": -52.214576721191406, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|0\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1925\", \"Dose Order\": \"3\"}, {\"tsne_x\": -36.712215423583984, \"tsne_y\": -50.80450439453125, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|0\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1926\", \"Dose Order\": \"3\"}, {\"tsne_x\": -36.25471115112305, \"tsne_y\": -50.575435638427734, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|0\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1927\", \"Dose Order\": \"3\"}, {\"tsne_x\": -29.462139129638672, \"tsne_y\": -44.805381774902344, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|0\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1462\", \"Dose Order\": \"4\"}, {\"tsne_x\": -29.074317932128906, \"tsne_y\": -45.042938232421875, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|0\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1463\", \"Dose Order\": \"4\"}, {\"tsne_x\": -27.71923828125, \"tsne_y\": -45.28776931762695, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|0\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1880\", \"Dose Order\": \"4\"}, {\"tsne_x\": -27.839128494262695, \"tsne_y\": -46.09463882446289, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|0\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1881\", \"Dose Order\": \"4\"}, {\"tsne_x\": -28.352014541625977, \"tsne_y\": -46.65400695800781, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|0\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1882\", \"Dose Order\": \"4\"}, {\"tsne_x\": -28.0010929107666, \"tsne_y\": -45.9624137878418, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|0\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1883\", \"Dose Order\": \"4\"}, {\"tsne_x\": -38.19041442871094, \"tsne_y\": -50.86849594116211, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|0\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1924\", \"Dose Order\": \"4\"}, {\"tsne_x\": -38.87404251098633, \"tsne_y\": -51.95603942871094, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|0\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1925\", \"Dose Order\": \"4\"}, {\"tsne_x\": -38.4595832824707, \"tsne_y\": -52.1968879699707, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|0\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1926\", \"Dose Order\": \"4\"}, {\"tsne_x\": -38.1343879699707, \"tsne_y\": -52.05308151245117, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|0\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1927\", \"Dose Order\": \"4\"}, {\"tsne_x\": -34.08171081542969, \"tsne_y\": -49.6794548034668, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|0\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1462\", \"Dose Order\": \"5\"}, {\"tsne_x\": -31.6712646484375, \"tsne_y\": -48.888484954833984, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|0\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1463\", \"Dose Order\": \"5\"}, {\"tsne_x\": -31.035282135009766, \"tsne_y\": -48.65867614746094, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|0\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1880\", \"Dose Order\": \"5\"}, {\"tsne_x\": -30.792001724243164, \"tsne_y\": -48.112449645996094, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|0\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1881\", \"Dose Order\": \"5\"}, {\"tsne_x\": -30.739641189575195, \"tsne_y\": -48.174617767333984, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|0\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1882\", \"Dose Order\": \"5\"}, {\"tsne_x\": -30.92844009399414, \"tsne_y\": -48.78134536743164, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|0\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1883\", \"Dose Order\": \"5\"}, {\"tsne_x\": -38.867000579833984, \"tsne_y\": -50.778114318847656, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|0\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1924\", \"Dose Order\": \"5\"}, {\"tsne_x\": -39.06814193725586, \"tsne_y\": -52.60254669189453, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|0\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1925\", \"Dose Order\": \"5\"}, {\"tsne_x\": -38.68680191040039, \"tsne_y\": -52.86887741088867, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|0\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1926\", \"Dose Order\": \"5\"}, {\"tsne_x\": -37.680973052978516, \"tsne_y\": -52.26356506347656, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|0\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1927\", \"Dose Order\": \"5\"}, {\"tsne_x\": 30.037588119506836, \"tsne_y\": 41.61751937866211, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1462\", \"Dose Order\": \"0\"}, {\"tsne_x\": 29.891925811767578, \"tsne_y\": 41.955894470214844, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1463\", \"Dose Order\": \"0\"}, {\"tsne_x\": 31.309778213500977, \"tsne_y\": 42.724666595458984, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1880\", \"Dose Order\": \"0\"}, {\"tsne_x\": 28.235382080078125, \"tsne_y\": 41.83428192138672, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1881\", \"Dose Order\": \"0\"}, {\"tsne_x\": 28.644031524658203, \"tsne_y\": 41.31620407104492, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1882\", \"Dose Order\": \"0\"}, {\"tsne_x\": 29.19308090209961, \"tsne_y\": 41.59820556640625, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1883\", \"Dose Order\": \"0\"}, {\"tsne_x\": 29.824909210205078, \"tsne_y\": 44.23153305053711, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1924\", \"Dose Order\": \"0\"}, {\"tsne_x\": 28.51390266418457, \"tsne_y\": 42.07466506958008, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1925\", \"Dose Order\": \"0\"}, {\"tsne_x\": 28.904518127441406, \"tsne_y\": 42.12021255493164, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1926\", \"Dose Order\": \"0\"}, {\"tsne_x\": 28.729007720947266, \"tsne_y\": 42.677734375, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1927\", \"Dose Order\": \"0\"}, {\"tsne_x\": 25.784578323364258, \"tsne_y\": 45.56036376953125, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1462\", \"Dose Order\": \"1\"}, {\"tsne_x\": 26.41839027404785, \"tsne_y\": 46.73827362060547, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1463\", \"Dose Order\": \"1\"}, {\"tsne_x\": 28.566810607910156, \"tsne_y\": 45.90288543701172, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1880\", \"Dose Order\": \"1\"}, {\"tsne_x\": 27.160993576049805, \"tsne_y\": 46.97541427612305, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1881\", \"Dose Order\": \"1\"}, {\"tsne_x\": 27.063335418701172, \"tsne_y\": 45.50136947631836, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1882\", \"Dose Order\": \"1\"}, {\"tsne_x\": 26.89919090270996, \"tsne_y\": 46.199066162109375, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1883\", \"Dose Order\": \"1\"}, {\"tsne_x\": 29.144100189208984, \"tsne_y\": 45.66078567504883, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1924\", \"Dose Order\": \"1\"}, {\"tsne_x\": 27.650131225585938, \"tsne_y\": 46.73493194580078, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1925\", \"Dose Order\": \"1\"}, {\"tsne_x\": 27.47947120666504, \"tsne_y\": 45.58075714111328, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1926\", \"Dose Order\": \"1\"}, {\"tsne_x\": 27.60357666015625, \"tsne_y\": 46.303443908691406, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1927\", \"Dose Order\": \"1\"}, {\"tsne_x\": 30.670717239379883, \"tsne_y\": 55.13963317871094, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1462\", \"Dose Order\": \"2\"}, {\"tsne_x\": 30.441776275634766, \"tsne_y\": 55.72019958496094, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1463\", \"Dose Order\": \"2\"}, {\"tsne_x\": 28.664596557617188, \"tsne_y\": 52.585914611816406, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1880\", \"Dose Order\": \"2\"}, {\"tsne_x\": 28.98933219909668, \"tsne_y\": 54.10517501831055, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1881\", \"Dose Order\": \"2\"}, {\"tsne_x\": 28.489240646362305, \"tsne_y\": 53.33457946777344, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1882\", \"Dose Order\": \"2\"}, {\"tsne_x\": 29.134428024291992, \"tsne_y\": 53.914817810058594, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1883\", \"Dose Order\": \"2\"}, {\"tsne_x\": 27.24028205871582, \"tsne_y\": 54.11537170410156, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1924\", \"Dose Order\": \"2\"}, {\"tsne_x\": 27.616920471191406, \"tsne_y\": 54.537132263183594, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1925\", \"Dose Order\": \"2\"}, {\"tsne_x\": 27.94859504699707, \"tsne_y\": 54.43063735961914, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1926\", \"Dose Order\": \"2\"}, {\"tsne_x\": 27.648441314697266, \"tsne_y\": 54.66322326660156, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1927\", \"Dose Order\": \"2\"}, {\"tsne_x\": 30.85196304321289, \"tsne_y\": 57.32915496826172, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1462\", \"Dose Order\": \"3\"}, {\"tsne_x\": 30.495132446289062, \"tsne_y\": 56.627838134765625, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1463\", \"Dose Order\": \"3\"}, {\"tsne_x\": 28.126773834228516, \"tsne_y\": 59.7449951171875, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1880\", \"Dose Order\": \"3\"}, {\"tsne_x\": 28.548568725585938, \"tsne_y\": 58.26979446411133, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1881\", \"Dose Order\": \"3\"}, {\"tsne_x\": 28.84089469909668, \"tsne_y\": 58.00814437866211, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1882\", \"Dose Order\": \"3\"}, {\"tsne_x\": 28.688289642333984, \"tsne_y\": 58.198829650878906, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1883\", \"Dose Order\": \"3\"}, {\"tsne_x\": 26.827777862548828, \"tsne_y\": 59.62930679321289, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1924\", \"Dose Order\": \"3\"}, {\"tsne_x\": 26.931568145751953, \"tsne_y\": 58.5971565246582, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1925\", \"Dose Order\": \"3\"}, {\"tsne_x\": 26.772022247314453, \"tsne_y\": 58.75028991699219, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1926\", \"Dose Order\": \"3\"}, {\"tsne_x\": 26.78297233581543, \"tsne_y\": 58.44183349609375, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1927\", \"Dose Order\": \"3\"}, {\"tsne_x\": 32.21793746948242, \"tsne_y\": 59.79410934448242, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1462\", \"Dose Order\": \"4\"}, {\"tsne_x\": 32.2352294921875, \"tsne_y\": 59.805419921875, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1463\", \"Dose Order\": \"4\"}, {\"tsne_x\": 28.650278091430664, \"tsne_y\": 61.59511184692383, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1880\", \"Dose Order\": \"4\"}, {\"tsne_x\": 29.65133285522461, \"tsne_y\": 62.18691635131836, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1881\", \"Dose Order\": \"4\"}, {\"tsne_x\": 30.281179428100586, \"tsne_y\": 62.40857696533203, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1882\", \"Dose Order\": \"4\"}, {\"tsne_x\": 29.654678344726562, \"tsne_y\": 62.05363082885742, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1883\", \"Dose Order\": \"4\"}, {\"tsne_x\": 27.326087951660156, \"tsne_y\": 64.14978790283203, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1924\", \"Dose Order\": \"4\"}, {\"tsne_x\": 28.097543716430664, \"tsne_y\": 64.48350524902344, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1925\", \"Dose Order\": \"4\"}, {\"tsne_x\": 28.190959930419922, \"tsne_y\": 64.3944320678711, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1926\", \"Dose Order\": \"4\"}, {\"tsne_x\": 28.22530746459961, \"tsne_y\": 63.91590118408203, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1927\", \"Dose Order\": \"4\"}, {\"tsne_x\": 32.8629035949707, \"tsne_y\": 61.58208465576172, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1462\", \"Dose Order\": \"5\"}, {\"tsne_x\": 32.859859466552734, \"tsne_y\": 61.629669189453125, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1463\", \"Dose Order\": \"5\"}, {\"tsne_x\": 31.778066635131836, \"tsne_y\": 65.24176025390625, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1880\", \"Dose Order\": \"5\"}, {\"tsne_x\": 30.797666549682617, \"tsne_y\": 64.46044921875, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1881\", \"Dose Order\": \"5\"}, {\"tsne_x\": 30.852689743041992, \"tsne_y\": 63.239967346191406, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1882\", \"Dose Order\": \"5\"}, {\"tsne_x\": 30.95572853088379, \"tsne_y\": 63.86294174194336, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1883\", \"Dose Order\": \"5\"}, {\"tsne_x\": 31.343488693237305, \"tsne_y\": 65.97518920898438, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1924\", \"Dose Order\": \"5\"}, {\"tsne_x\": 29.503189086914062, \"tsne_y\": 66.01177978515625, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1925\", \"Dose Order\": \"5\"}, {\"tsne_x\": 29.595314025878906, \"tsne_y\": 65.80685424804688, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1926\", \"Dose Order\": \"5\"}, {\"tsne_x\": 29.620433807373047, \"tsne_y\": 65.55512237548828, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|0\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1927\", \"Dose Order\": \"5\"}, {\"tsne_x\": -34.38633728027344, \"tsne_y\": 48.23012924194336, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1462\", \"Dose Order\": \"0\"}, {\"tsne_x\": -34.7969856262207, \"tsne_y\": 48.640350341796875, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1463\", \"Dose Order\": \"0\"}, {\"tsne_x\": -34.180782318115234, \"tsne_y\": 47.53827667236328, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1880\", \"Dose Order\": \"0\"}, {\"tsne_x\": -33.60483169555664, \"tsne_y\": 48.66864776611328, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1881\", \"Dose Order\": \"0\"}, {\"tsne_x\": -33.390289306640625, \"tsne_y\": 48.72515869140625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1882\", \"Dose Order\": \"0\"}, {\"tsne_x\": -33.575469970703125, \"tsne_y\": 49.17874526977539, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1883\", \"Dose Order\": \"0\"}, {\"tsne_x\": -34.12119674682617, \"tsne_y\": 46.90729904174805, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1924\", \"Dose Order\": \"0\"}, {\"tsne_x\": -32.024383544921875, \"tsne_y\": 47.98003387451172, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1925\", \"Dose Order\": \"0\"}, {\"tsne_x\": -32.108863830566406, \"tsne_y\": 48.34265899658203, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1926\", \"Dose Order\": \"0\"}, {\"tsne_x\": -32.25511169433594, \"tsne_y\": 48.32131576538086, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1927\", \"Dose Order\": \"0\"}, {\"tsne_x\": -33.89356231689453, \"tsne_y\": 56.27106857299805, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1462\", \"Dose Order\": \"1\"}, {\"tsne_x\": -34.107582092285156, \"tsne_y\": 56.07322311401367, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1463\", \"Dose Order\": \"1\"}, {\"tsne_x\": -33.2724723815918, \"tsne_y\": 54.54652786254883, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1880\", \"Dose Order\": \"1\"}, {\"tsne_x\": -33.084205627441406, \"tsne_y\": 55.72492980957031, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1881\", \"Dose Order\": \"1\"}, {\"tsne_x\": -33.00653076171875, \"tsne_y\": 55.96063232421875, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1882\", \"Dose Order\": \"1\"}, {\"tsne_x\": -33.240657806396484, \"tsne_y\": 55.645652770996094, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1883\", \"Dose Order\": \"1\"}, {\"tsne_x\": -31.735353469848633, \"tsne_y\": 54.604862213134766, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1924\", \"Dose Order\": \"1\"}, {\"tsne_x\": -31.28233528137207, \"tsne_y\": 55.6274528503418, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1925\", \"Dose Order\": \"1\"}, {\"tsne_x\": -31.343936920166016, \"tsne_y\": 55.50392532348633, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1926\", \"Dose Order\": \"1\"}, {\"tsne_x\": -31.42302894592285, \"tsne_y\": 55.580406188964844, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1927\", \"Dose Order\": \"1\"}, {\"tsne_x\": -32.80095291137695, \"tsne_y\": 60.71921920776367, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1462\", \"Dose Order\": \"2\"}, {\"tsne_x\": -32.892574310302734, \"tsne_y\": 60.8516845703125, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1463\", \"Dose Order\": \"2\"}, {\"tsne_x\": -30.406538009643555, \"tsne_y\": 61.837913513183594, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1880\", \"Dose Order\": \"2\"}, {\"tsne_x\": -31.713781356811523, \"tsne_y\": 61.093204498291016, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1881\", \"Dose Order\": \"2\"}, {\"tsne_x\": -31.730363845825195, \"tsne_y\": 61.157047271728516, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1882\", \"Dose Order\": \"2\"}, {\"tsne_x\": -31.96149444580078, \"tsne_y\": 61.10121536254883, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1883\", \"Dose Order\": \"2\"}, {\"tsne_x\": -30.010330200195312, \"tsne_y\": 61.98948287963867, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1924\", \"Dose Order\": \"2\"}, {\"tsne_x\": -28.754487991333008, \"tsne_y\": 62.21296691894531, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1925\", \"Dose Order\": \"2\"}, {\"tsne_x\": -28.594724655151367, \"tsne_y\": 62.41074752807617, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1926\", \"Dose Order\": \"2\"}, {\"tsne_x\": -28.832277297973633, \"tsne_y\": 62.18157958984375, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1927\", \"Dose Order\": \"2\"}, {\"tsne_x\": -31.33849334716797, \"tsne_y\": 68.28498840332031, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1462\", \"Dose Order\": \"3\"}, {\"tsne_x\": -31.341753005981445, \"tsne_y\": 68.26531982421875, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1463\", \"Dose Order\": \"3\"}, {\"tsne_x\": -30.359933853149414, \"tsne_y\": 66.0552978515625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1880\", \"Dose Order\": \"3\"}, {\"tsne_x\": -30.73857879638672, \"tsne_y\": 65.40657806396484, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1881\", \"Dose Order\": \"3\"}, {\"tsne_x\": -30.82259178161621, \"tsne_y\": 65.51716613769531, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1882\", \"Dose Order\": \"3\"}, {\"tsne_x\": -31.010698318481445, \"tsne_y\": 65.36854553222656, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1883\", \"Dose Order\": \"3\"}, {\"tsne_x\": -28.99745750427246, \"tsne_y\": 66.37678527832031, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1924\", \"Dose Order\": \"3\"}, {\"tsne_x\": -28.88495635986328, \"tsne_y\": 65.38057708740234, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1925\", \"Dose Order\": \"3\"}, {\"tsne_x\": -28.859649658203125, \"tsne_y\": 65.67489624023438, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1926\", \"Dose Order\": \"3\"}, {\"tsne_x\": -28.96521759033203, \"tsne_y\": 65.24703216552734, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1927\", \"Dose Order\": \"3\"}, {\"tsne_x\": -29.03156280517578, \"tsne_y\": 72.46392059326172, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1462\", \"Dose Order\": \"4\"}, {\"tsne_x\": -28.931577682495117, \"tsne_y\": 72.4811782836914, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1463\", \"Dose Order\": \"4\"}, {\"tsne_x\": -27.64194107055664, \"tsne_y\": 73.4237289428711, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1880\", \"Dose Order\": \"4\"}, {\"tsne_x\": -27.06953239440918, \"tsne_y\": 72.70992279052734, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1881\", \"Dose Order\": \"4\"}, {\"tsne_x\": -27.188581466674805, \"tsne_y\": 72.39191436767578, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1882\", \"Dose Order\": \"4\"}, {\"tsne_x\": -27.273386001586914, \"tsne_y\": 72.7052230834961, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1883\", \"Dose Order\": \"4\"}, {\"tsne_x\": -26.351186752319336, \"tsne_y\": 73.92952728271484, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1924\", \"Dose Order\": \"4\"}, {\"tsne_x\": -25.880884170532227, \"tsne_y\": 73.1072769165039, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1925\", \"Dose Order\": \"4\"}, {\"tsne_x\": -25.909536361694336, \"tsne_y\": 72.77560424804688, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1926\", \"Dose Order\": \"4\"}, {\"tsne_x\": -26.028030395507812, \"tsne_y\": 73.05655670166016, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1927\", \"Dose Order\": \"4\"}, {\"tsne_x\": -8.821329116821289, \"tsne_y\": -2.2161896228790283, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1462\", \"Dose Order\": \"5\"}, {\"tsne_x\": -8.819609642028809, \"tsne_y\": -2.2124288082122803, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1463\", \"Dose Order\": \"5\"}, {\"tsne_x\": -22.210205078125, \"tsne_y\": 77.69656372070312, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1880\", \"Dose Order\": \"5\"}, {\"tsne_x\": -21.531696319580078, \"tsne_y\": 77.50265502929688, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1881\", \"Dose Order\": \"5\"}, {\"tsne_x\": -21.469472885131836, \"tsne_y\": 77.41865539550781, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1882\", \"Dose Order\": \"5\"}, {\"tsne_x\": -21.74406623840332, \"tsne_y\": 77.63016510009766, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1883\", \"Dose Order\": \"5\"}, {\"tsne_x\": -22.36919593811035, \"tsne_y\": 76.28430938720703, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1924\", \"Dose Order\": \"5\"}, {\"tsne_x\": -21.396690368652344, \"tsne_y\": 75.95331573486328, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1925\", \"Dose Order\": \"5\"}, {\"tsne_x\": -21.735536575317383, \"tsne_y\": 76.3326416015625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1926\", \"Dose Order\": \"5\"}, {\"tsne_x\": -21.705310821533203, \"tsne_y\": 76.37718963623047, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|0\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1927\", \"Dose Order\": \"5\"}, {\"tsne_x\": 60.8980598449707, \"tsne_y\": -18.343839645385742, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1462\", \"Dose Order\": \"0\"}, {\"tsne_x\": 61.670291900634766, \"tsne_y\": -17.66225242614746, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1463\", \"Dose Order\": \"0\"}, {\"tsne_x\": 59.373374938964844, \"tsne_y\": -18.433866500854492, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1880\", \"Dose Order\": \"0\"}, {\"tsne_x\": 58.37908935546875, \"tsne_y\": -19.178987503051758, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1881\", \"Dose Order\": \"0\"}, {\"tsne_x\": 58.463680267333984, \"tsne_y\": -19.160507202148438, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1882\", \"Dose Order\": \"0\"}, {\"tsne_x\": 58.43415451049805, \"tsne_y\": -19.407655715942383, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1883\", \"Dose Order\": \"0\"}, {\"tsne_x\": 58.915000915527344, \"tsne_y\": -18.244009017944336, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1924\", \"Dose Order\": \"0\"}, {\"tsne_x\": 56.215641021728516, \"tsne_y\": -16.942913055419922, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1925\", \"Dose Order\": \"0\"}, {\"tsne_x\": 56.13657760620117, \"tsne_y\": -17.002443313598633, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1926\", \"Dose Order\": \"0\"}, {\"tsne_x\": 56.58954620361328, \"tsne_y\": -17.54039764404297, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1927\", \"Dose Order\": \"0\"}, {\"tsne_x\": 62.35764694213867, \"tsne_y\": -16.712541580200195, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1462\", \"Dose Order\": \"1\"}, {\"tsne_x\": 62.26298522949219, \"tsne_y\": -16.919620513916016, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1463\", \"Dose Order\": \"1\"}, {\"tsne_x\": 60.1672477722168, \"tsne_y\": -13.588787078857422, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1880\", \"Dose Order\": \"1\"}, {\"tsne_x\": 59.44441223144531, \"tsne_y\": -14.918180465698242, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1881\", \"Dose Order\": \"1\"}, {\"tsne_x\": 59.74890899658203, \"tsne_y\": -14.805506706237793, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1882\", \"Dose Order\": \"1\"}, {\"tsne_x\": 59.8343620300293, \"tsne_y\": -14.806976318359375, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1883\", \"Dose Order\": \"1\"}, {\"tsne_x\": 59.84772491455078, \"tsne_y\": -13.167789459228516, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1924\", \"Dose Order\": \"1\"}, {\"tsne_x\": 57.50153350830078, \"tsne_y\": -14.46480655670166, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1925\", \"Dose Order\": \"1\"}, {\"tsne_x\": 57.20348358154297, \"tsne_y\": -14.694838523864746, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1926\", \"Dose Order\": \"1\"}, {\"tsne_x\": 57.754695892333984, \"tsne_y\": -14.236225128173828, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1927\", \"Dose Order\": \"1\"}, {\"tsne_x\": 64.012451171875, \"tsne_y\": -14.963134765625, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1462\", \"Dose Order\": \"2\"}, {\"tsne_x\": 63.878944396972656, \"tsne_y\": -15.050518989562988, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1463\", \"Dose Order\": \"2\"}, {\"tsne_x\": 65.34821319580078, \"tsne_y\": -10.751375198364258, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1880\", \"Dose Order\": \"2\"}, {\"tsne_x\": 65.43345642089844, \"tsne_y\": -11.122143745422363, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1881\", \"Dose Order\": \"2\"}, {\"tsne_x\": 65.97822570800781, \"tsne_y\": -11.030543327331543, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1882\", \"Dose Order\": \"2\"}, {\"tsne_x\": 65.87300872802734, \"tsne_y\": -11.365964889526367, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1883\", \"Dose Order\": \"2\"}, {\"tsne_x\": 64.5619888305664, \"tsne_y\": -8.501485824584961, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1924\", \"Dose Order\": \"2\"}, {\"tsne_x\": 64.07254791259766, \"tsne_y\": -7.594037055969238, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1925\", \"Dose Order\": \"2\"}, {\"tsne_x\": 63.936500549316406, \"tsne_y\": -7.940861225128174, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1926\", \"Dose Order\": \"2\"}, {\"tsne_x\": 63.74610900878906, \"tsne_y\": -8.246291160583496, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1927\", \"Dose Order\": \"2\"}, {\"tsne_x\": 4.601191997528076, \"tsne_y\": -32.25531768798828, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1462\", \"Dose Order\": \"3\"}, {\"tsne_x\": 4.539952754974365, \"tsne_y\": -32.17469787597656, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1463\", \"Dose Order\": \"3\"}, {\"tsne_x\": 66.82907104492188, \"tsne_y\": -9.214142799377441, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1880\", \"Dose Order\": \"3\"}, {\"tsne_x\": 66.73416137695312, \"tsne_y\": -10.12309455871582, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1881\", \"Dose Order\": \"3\"}, {\"tsne_x\": 66.9889907836914, \"tsne_y\": -10.438369750976562, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1882\", \"Dose Order\": \"3\"}, {\"tsne_x\": 66.91546630859375, \"tsne_y\": -10.614508628845215, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1883\", \"Dose Order\": \"3\"}, {\"tsne_x\": 66.20547485351562, \"tsne_y\": -8.423323631286621, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1924\", \"Dose Order\": \"3\"}, {\"tsne_x\": 64.8349380493164, \"tsne_y\": -6.902442932128906, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1925\", \"Dose Order\": \"3\"}, {\"tsne_x\": 64.73805236816406, \"tsne_y\": -6.788315296173096, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1926\", \"Dose Order\": \"3\"}, {\"tsne_x\": 64.6617660522461, \"tsne_y\": -6.859971523284912, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1927\", \"Dose Order\": \"3\"}, {\"tsne_x\": 5.201446056365967, \"tsne_y\": -34.231807708740234, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1462\", \"Dose Order\": \"4\"}, {\"tsne_x\": 4.058638572692871, \"tsne_y\": -32.7360725402832, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1463\", \"Dose Order\": \"4\"}, {\"tsne_x\": 71.03245544433594, \"tsne_y\": -1.808539867401123, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1880\", \"Dose Order\": \"4\"}, {\"tsne_x\": 70.82112121582031, \"tsne_y\": -1.0092717409133911, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1881\", \"Dose Order\": \"4\"}, {\"tsne_x\": 70.77779388427734, \"tsne_y\": -0.8080766201019287, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1882\", \"Dose Order\": \"4\"}, {\"tsne_x\": 70.93624114990234, \"tsne_y\": -0.6652021408081055, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1883\", \"Dose Order\": \"4\"}, {\"tsne_x\": 70.37962341308594, \"tsne_y\": -2.2203197479248047, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1924\", \"Dose Order\": \"4\"}, {\"tsne_x\": 69.65052795410156, \"tsne_y\": -1.7154051065444946, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1925\", \"Dose Order\": \"4\"}, {\"tsne_x\": 69.68425750732422, \"tsne_y\": -1.788578987121582, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1926\", \"Dose Order\": \"4\"}, {\"tsne_x\": 69.3102798461914, \"tsne_y\": -1.991528868675232, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1927\", \"Dose Order\": \"4\"}, {\"tsne_x\": 5.189821243286133, \"tsne_y\": -34.40973663330078, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1462\", \"Dose Order\": \"5\"}, {\"tsne_x\": 3.1369309425354004, \"tsne_y\": -34.53385543823242, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1463\", \"Dose Order\": \"5\"}, {\"tsne_x\": 73.31038665771484, \"tsne_y\": 1.9131721258163452, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1880\", \"Dose Order\": \"5\"}, {\"tsne_x\": 72.57233428955078, \"tsne_y\": 1.9812527894973755, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1881\", \"Dose Order\": \"5\"}, {\"tsne_x\": 72.56450653076172, \"tsne_y\": 2.074796438217163, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1882\", \"Dose Order\": \"5\"}, {\"tsne_x\": 72.60798645019531, \"tsne_y\": 1.874825358390808, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1883\", \"Dose Order\": \"5\"}, {\"tsne_x\": 73.81609344482422, \"tsne_y\": 2.9491968154907227, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1924\", \"Dose Order\": \"5\"}, {\"tsne_x\": 73.00060272216797, \"tsne_y\": 3.702479124069214, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1925\", \"Dose Order\": \"5\"}, {\"tsne_x\": 72.89361572265625, \"tsne_y\": 3.3810064792633057, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1926\", \"Dose Order\": \"5\"}, {\"tsne_x\": 72.75104522705078, \"tsne_y\": 3.185577392578125, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|0\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1927\", \"Dose Order\": \"5\"}, {\"tsne_x\": -31.77022933959961, \"tsne_y\": -30.544963836669922, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1462\", \"Dose Order\": \"0\"}, {\"tsne_x\": -29.647218704223633, \"tsne_y\": -32.721099853515625, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1463\", \"Dose Order\": \"0\"}, {\"tsne_x\": -32.18771743774414, \"tsne_y\": -32.6088981628418, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1880\", \"Dose Order\": \"0\"}, {\"tsne_x\": -30.459535598754883, \"tsne_y\": -31.08015251159668, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1881\", \"Dose Order\": \"0\"}, {\"tsne_x\": -30.55961036682129, \"tsne_y\": -32.1051139831543, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1882\", \"Dose Order\": \"0\"}, {\"tsne_x\": -30.958721160888672, \"tsne_y\": -31.15229606628418, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1883\", \"Dose Order\": \"0\"}, {\"tsne_x\": -31.968570709228516, \"tsne_y\": -32.43968200683594, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1924\", \"Dose Order\": \"0\"}, {\"tsne_x\": -30.269920349121094, \"tsne_y\": -31.395429611206055, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1925\", \"Dose Order\": \"0\"}, {\"tsne_x\": -30.55917739868164, \"tsne_y\": -31.864519119262695, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1926\", \"Dose Order\": \"0\"}, {\"tsne_x\": -30.038057327270508, \"tsne_y\": -31.161130905151367, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1927\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.694711685180664, \"tsne_y\": -38.439414978027344, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1462\", \"Dose Order\": \"1\"}, {\"tsne_x\": -20.60748863220215, \"tsne_y\": -38.87925338745117, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1463\", \"Dose Order\": \"1\"}, {\"tsne_x\": -21.610864639282227, \"tsne_y\": -39.4566764831543, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1880\", \"Dose Order\": \"1\"}, {\"tsne_x\": -20.231813430786133, \"tsne_y\": -39.770389556884766, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1881\", \"Dose Order\": \"1\"}, {\"tsne_x\": -20.80976676940918, \"tsne_y\": -40.63663864135742, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1882\", \"Dose Order\": \"1\"}, {\"tsne_x\": -20.09693717956543, \"tsne_y\": -40.82463455200195, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1883\", \"Dose Order\": \"1\"}, {\"tsne_x\": -21.836427688598633, \"tsne_y\": -40.489688873291016, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1924\", \"Dose Order\": \"1\"}, {\"tsne_x\": -19.652090072631836, \"tsne_y\": -40.15514373779297, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1925\", \"Dose Order\": \"1\"}, {\"tsne_x\": -20.24529266357422, \"tsne_y\": -40.52665328979492, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1926\", \"Dose Order\": \"1\"}, {\"tsne_x\": -20.34771728515625, \"tsne_y\": -40.16413497924805, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1927\", \"Dose Order\": \"1\"}, {\"tsne_x\": -2.243858814239502, \"tsne_y\": -26.487041473388672, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1462\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.7804436683654785, \"tsne_y\": -26.928529739379883, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1463\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.877495050430298, \"tsne_y\": -24.553314208984375, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1880\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.7162857055664062, \"tsne_y\": -25.98577308654785, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1881\", \"Dose Order\": \"2\"}, {\"tsne_x\": -4.229604721069336, \"tsne_y\": -25.6756649017334, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1882\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.3456192016601562, \"tsne_y\": -26.90321922302246, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1883\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.7357981204986572, \"tsne_y\": -24.349050521850586, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1924\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.495126724243164, \"tsne_y\": -26.08485984802246, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1925\", \"Dose Order\": \"2\"}, {\"tsne_x\": -4.302952766418457, \"tsne_y\": -26.176830291748047, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1926\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.700854778289795, \"tsne_y\": -26.86517333984375, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1927\", \"Dose Order\": \"2\"}, {\"tsne_x\": -21.46309471130371, \"tsne_y\": -56.40229797363281, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1462\", \"Dose Order\": \"3\"}, {\"tsne_x\": -22.064125061035156, \"tsne_y\": -56.664817810058594, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1463\", \"Dose Order\": \"3\"}, {\"tsne_x\": -21.447792053222656, \"tsne_y\": -57.401756286621094, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1880\", \"Dose Order\": \"3\"}, {\"tsne_x\": -21.72521209716797, \"tsne_y\": -56.64749526977539, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1881\", \"Dose Order\": \"3\"}, {\"tsne_x\": -20.809480667114258, \"tsne_y\": -57.07914733886719, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1882\", \"Dose Order\": \"3\"}, {\"tsne_x\": -21.33928680419922, \"tsne_y\": -56.86526870727539, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1883\", \"Dose Order\": \"3\"}, {\"tsne_x\": -61.8338623046875, \"tsne_y\": -35.095680236816406, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1924\", \"Dose Order\": \"3\"}, {\"tsne_x\": -60.87944030761719, \"tsne_y\": -34.82057189941406, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1925\", \"Dose Order\": \"3\"}, {\"tsne_x\": -59.653770446777344, \"tsne_y\": -34.2709846496582, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1926\", \"Dose Order\": \"3\"}, {\"tsne_x\": -60.666221618652344, \"tsne_y\": -34.41900634765625, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1927\", \"Dose Order\": \"3\"}, {\"tsne_x\": -23.243770599365234, \"tsne_y\": -52.48922348022461, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1462\", \"Dose Order\": \"4\"}, {\"tsne_x\": -17.945114135742188, \"tsne_y\": -52.665958404541016, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1463\", \"Dose Order\": \"4\"}, {\"tsne_x\": -18.681772232055664, \"tsne_y\": -53.582210540771484, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1880\", \"Dose Order\": \"4\"}, {\"tsne_x\": -18.546920776367188, \"tsne_y\": -52.84035110473633, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1881\", \"Dose Order\": \"4\"}, {\"tsne_x\": -18.5472469329834, \"tsne_y\": -53.14040756225586, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1882\", \"Dose Order\": \"4\"}, {\"tsne_x\": -18.63004493713379, \"tsne_y\": -52.3077278137207, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1883\", \"Dose Order\": \"4\"}, {\"tsne_x\": -61.87598419189453, \"tsne_y\": -34.772315979003906, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1924\", \"Dose Order\": \"4\"}, {\"tsne_x\": -61.00129699707031, \"tsne_y\": -34.886016845703125, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1925\", \"Dose Order\": \"4\"}, {\"tsne_x\": -59.71491241455078, \"tsne_y\": -34.430938720703125, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1926\", \"Dose Order\": \"4\"}, {\"tsne_x\": -60.83103561401367, \"tsne_y\": -33.949737548828125, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1927\", \"Dose Order\": \"4\"}, {\"tsne_x\": -23.262025833129883, \"tsne_y\": -52.45048522949219, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1462\", \"Dose Order\": \"5\"}, {\"tsne_x\": -21.07489013671875, \"tsne_y\": -49.01924514770508, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1463\", \"Dose Order\": \"5\"}, {\"tsne_x\": -22.185489654541016, \"tsne_y\": -49.010169982910156, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1880\", \"Dose Order\": \"5\"}, {\"tsne_x\": -21.633323669433594, \"tsne_y\": -49.53672790527344, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1881\", \"Dose Order\": \"5\"}, {\"tsne_x\": -22.0850830078125, \"tsne_y\": -49.5813102722168, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1882\", \"Dose Order\": \"5\"}, {\"tsne_x\": -21.44660186767578, \"tsne_y\": -49.481746673583984, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1883\", \"Dose Order\": \"5\"}, {\"tsne_x\": -60.47176742553711, \"tsne_y\": -36.730167388916016, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1924\", \"Dose Order\": \"5\"}, {\"tsne_x\": -60.448482513427734, \"tsne_y\": -35.5955810546875, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1925\", \"Dose Order\": \"5\"}, {\"tsne_x\": -60.81085205078125, \"tsne_y\": -36.065269470214844, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1926\", \"Dose Order\": \"5\"}, {\"tsne_x\": -59.89929962158203, \"tsne_y\": -35.39299774169922, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|0\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1927\", \"Dose Order\": \"5\"}, {\"tsne_x\": -24.211565017700195, \"tsne_y\": 10.253872871398926, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1462\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.653139114379883, \"tsne_y\": 12.345698356628418, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1463\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.471824645996094, \"tsne_y\": 10.266654014587402, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1880\", \"Dose Order\": \"0\"}, {\"tsne_x\": -24.684263229370117, \"tsne_y\": 11.518691062927246, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1881\", \"Dose Order\": \"0\"}, {\"tsne_x\": -25.055194854736328, \"tsne_y\": 10.810418128967285, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1882\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.109708786010742, \"tsne_y\": 11.011234283447266, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1883\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.677846908569336, \"tsne_y\": 11.343493461608887, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1924\", \"Dose Order\": \"0\"}, {\"tsne_x\": -24.200231552124023, \"tsne_y\": 11.6007661819458, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1925\", \"Dose Order\": \"0\"}, {\"tsne_x\": -24.351177215576172, \"tsne_y\": 11.83845329284668, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1926\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.28143882751465, \"tsne_y\": 11.430827140808105, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1927\", \"Dose Order\": \"0\"}, {\"tsne_x\": -15.645020484924316, \"tsne_y\": 15.651695251464844, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1462\", \"Dose Order\": \"1\"}, {\"tsne_x\": -15.004781723022461, \"tsne_y\": 15.835392951965332, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1463\", \"Dose Order\": \"1\"}, {\"tsne_x\": -13.399853706359863, \"tsne_y\": 16.74781036376953, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1880\", \"Dose Order\": \"1\"}, {\"tsne_x\": -15.951399803161621, \"tsne_y\": 16.29189682006836, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1881\", \"Dose Order\": \"1\"}, {\"tsne_x\": -16.206674575805664, \"tsne_y\": 15.997807502746582, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1882\", \"Dose Order\": \"1\"}, {\"tsne_x\": -15.648323059082031, \"tsne_y\": 16.147449493408203, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1883\", \"Dose Order\": \"1\"}, {\"tsne_x\": -13.387685775756836, \"tsne_y\": 16.767776489257812, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1924\", \"Dose Order\": \"1\"}, {\"tsne_x\": -16.352365493774414, \"tsne_y\": 17.12116050720215, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1925\", \"Dose Order\": \"1\"}, {\"tsne_x\": -15.793571472167969, \"tsne_y\": 17.30756187438965, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1926\", \"Dose Order\": \"1\"}, {\"tsne_x\": -15.659313201904297, \"tsne_y\": 17.390853881835938, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1927\", \"Dose Order\": \"1\"}, {\"tsne_x\": -25.097347259521484, \"tsne_y\": 37.03200149536133, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1462\", \"Dose Order\": \"2\"}, {\"tsne_x\": -25.463783264160156, \"tsne_y\": 36.59596633911133, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1463\", \"Dose Order\": \"2\"}, {\"tsne_x\": -26.462444305419922, \"tsne_y\": 38.50178909301758, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1880\", \"Dose Order\": \"2\"}, {\"tsne_x\": -25.213760375976562, \"tsne_y\": 37.51165771484375, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1881\", \"Dose Order\": \"2\"}, {\"tsne_x\": -24.634645462036133, \"tsne_y\": 36.831058502197266, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1882\", \"Dose Order\": \"2\"}, {\"tsne_x\": -24.755277633666992, \"tsne_y\": 37.618873596191406, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1883\", \"Dose Order\": \"2\"}, {\"tsne_x\": -26.612144470214844, \"tsne_y\": 38.666622161865234, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1924\", \"Dose Order\": \"2\"}, {\"tsne_x\": -24.706377029418945, \"tsne_y\": 38.70313262939453, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1925\", \"Dose Order\": \"2\"}, {\"tsne_x\": -24.58584213256836, \"tsne_y\": 39.04222869873047, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1926\", \"Dose Order\": \"2\"}, {\"tsne_x\": -24.772167205810547, \"tsne_y\": 38.754638671875, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1927\", \"Dose Order\": \"2\"}, {\"tsne_x\": -10.177263259887695, \"tsne_y\": 34.65358352661133, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1462\", \"Dose Order\": \"3\"}, {\"tsne_x\": -12.6878662109375, \"tsne_y\": 32.93036651611328, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1463\", \"Dose Order\": \"3\"}, {\"tsne_x\": -14.793050765991211, \"tsne_y\": 34.45853042602539, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1880\", \"Dose Order\": \"3\"}, {\"tsne_x\": -13.396522521972656, \"tsne_y\": 33.480018615722656, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1881\", \"Dose Order\": \"3\"}, {\"tsne_x\": -13.054703712463379, \"tsne_y\": 33.864498138427734, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1882\", \"Dose Order\": \"3\"}, {\"tsne_x\": -13.41563892364502, \"tsne_y\": 33.61437225341797, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1883\", \"Dose Order\": \"3\"}, {\"tsne_x\": -14.681109428405762, \"tsne_y\": 34.877349853515625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1924\", \"Dose Order\": \"3\"}, {\"tsne_x\": -13.547447204589844, \"tsne_y\": 35.9222412109375, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1925\", \"Dose Order\": \"3\"}, {\"tsne_x\": -13.425542831420898, \"tsne_y\": 35.71624755859375, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1926\", \"Dose Order\": \"3\"}, {\"tsne_x\": -13.50133991241455, \"tsne_y\": 35.635231018066406, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1927\", \"Dose Order\": \"3\"}, {\"tsne_x\": -10.107819557189941, \"tsne_y\": 31.24651527404785, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1462\", \"Dose Order\": \"4\"}, {\"tsne_x\": -10.25269603729248, \"tsne_y\": 31.39476776123047, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1463\", \"Dose Order\": \"4\"}, {\"tsne_x\": -8.333301544189453, \"tsne_y\": 30.849302291870117, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1880\", \"Dose Order\": \"4\"}, {\"tsne_x\": -9.092904090881348, \"tsne_y\": 31.764509201049805, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1881\", \"Dose Order\": \"4\"}, {\"tsne_x\": -9.43657398223877, \"tsne_y\": 32.14250183105469, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1882\", \"Dose Order\": \"4\"}, {\"tsne_x\": -9.04516315460205, \"tsne_y\": 31.550506591796875, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1883\", \"Dose Order\": \"4\"}, {\"tsne_x\": -8.033233642578125, \"tsne_y\": 30.490280151367188, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1924\", \"Dose Order\": \"4\"}, {\"tsne_x\": -9.105389595031738, \"tsne_y\": 38.34537124633789, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1925\", \"Dose Order\": \"4\"}, {\"tsne_x\": -8.97419261932373, \"tsne_y\": 38.20284652709961, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1926\", \"Dose Order\": \"4\"}, {\"tsne_x\": -9.40085506439209, \"tsne_y\": 38.11582565307617, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1927\", \"Dose Order\": \"4\"}, {\"tsne_x\": -9.030111312866211, \"tsne_y\": 34.477081298828125, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1462\", \"Dose Order\": \"5\"}, {\"tsne_x\": -7.991835117340088, \"tsne_y\": 33.9859619140625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1463\", \"Dose Order\": \"5\"}, {\"tsne_x\": -7.014644145965576, \"tsne_y\": 35.119651794433594, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1880\", \"Dose Order\": \"5\"}, {\"tsne_x\": -7.6962714195251465, \"tsne_y\": 34.69480514526367, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1881\", \"Dose Order\": \"5\"}, {\"tsne_x\": -7.990174293518066, \"tsne_y\": 34.6414909362793, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1882\", \"Dose Order\": \"5\"}, {\"tsne_x\": -7.70578670501709, \"tsne_y\": 34.45317459106445, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1883\", \"Dose Order\": \"5\"}, {\"tsne_x\": -6.966007709503174, \"tsne_y\": 36.91261672973633, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1924\", \"Dose Order\": \"5\"}, {\"tsne_x\": -7.5013885498046875, \"tsne_y\": 37.76806640625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1925\", \"Dose Order\": \"5\"}, {\"tsne_x\": -7.536726474761963, \"tsne_y\": 37.70293045043945, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1926\", \"Dose Order\": \"5\"}, {\"tsne_x\": -7.806485176086426, \"tsne_y\": 37.890907287597656, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|0\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 0, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1927\", \"Dose Order\": \"5\"}]}}, {\"mode\": \"vega-lite\"});\n",
              "</script>"
            ],
            "text/plain": [
              "alt.Chart(...)"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-52-84172d8d0eec>:13: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  altair_plot_data['Dose Order'] = altair_plot_data['dose_order'].astype(str)\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/html": [
              "\n",
              "<div id=\"altair-viz-72eac2bc62e441c7a0f687a6cb16953e\"></div>\n",
              "<script type=\"text/javascript\">\n",
              "  var VEGA_DEBUG = (typeof VEGA_DEBUG == \"undefined\") ? {} : VEGA_DEBUG;\n",
              "  (function(spec, embedOpt){\n",
              "    let outputDiv = document.currentScript.previousElementSibling;\n",
              "    if (outputDiv.id !== \"altair-viz-72eac2bc62e441c7a0f687a6cb16953e\") {\n",
              "      outputDiv = document.getElementById(\"altair-viz-72eac2bc62e441c7a0f687a6cb16953e\");\n",
              "    }\n",
              "    const paths = {\n",
              "      \"vega\": \"https://cdn.jsdelivr.net/npm//vega@5?noext\",\n",
              "      \"vega-lib\": \"https://cdn.jsdelivr.net/npm//vega-lib?noext\",\n",
              "      \"vega-lite\": \"https://cdn.jsdelivr.net/npm//vega-lite@4.17.0?noext\",\n",
              "      \"vega-embed\": \"https://cdn.jsdelivr.net/npm//vega-embed@6?noext\",\n",
              "    };\n",
              "\n",
              "    function maybeLoadScript(lib, version) {\n",
              "      var key = `${lib.replace(\"-\", \"\")}_version`;\n",
              "      return (VEGA_DEBUG[key] == version) ?\n",
              "        Promise.resolve(paths[lib]) :\n",
              "        new Promise(function(resolve, reject) {\n",
              "          var s = document.createElement('script');\n",
              "          document.getElementsByTagName(\"head\")[0].appendChild(s);\n",
              "          s.async = true;\n",
              "          s.onload = () => {\n",
              "            VEGA_DEBUG[key] = version;\n",
              "            return resolve(paths[lib]);\n",
              "          };\n",
              "          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);\n",
              "          s.src = paths[lib];\n",
              "        });\n",
              "    }\n",
              "\n",
              "    function showError(err) {\n",
              "      outputDiv.innerHTML = `<div class=\"error\" style=\"color:red;\">${err}</div>`;\n",
              "      throw err;\n",
              "    }\n",
              "\n",
              "    function displayChart(vegaEmbed) {\n",
              "      vegaEmbed(outputDiv, spec, embedOpt)\n",
              "        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));\n",
              "    }\n",
              "\n",
              "    if(typeof define === \"function\" && define.amd) {\n",
              "      requirejs.config({paths});\n",
              "      require([\"vega-embed\"], displayChart, err => showError(`Error loading script: ${err.message}`));\n",
              "    } else {\n",
              "      maybeLoadScript(\"vega\", \"5\")\n",
              "        .then(() => maybeLoadScript(\"vega-lite\", \"4.17.0\"))\n",
              "        .then(() => maybeLoadScript(\"vega-embed\", \"6\"))\n",
              "        .catch(showError)\n",
              "        .then(() => displayChart(vegaEmbed));\n",
              "    }\n",
              "  })({\"config\": {\"view\": {\"continuousWidth\": 400, \"continuousHeight\": 300}, \"axis\": {\"labelFontSize\": 20, \"titleFontSize\": 20}, \"background\": \"white\", \"legend\": {\"labelFontSize\": 20, \"labelLimit\": 0, \"titleFontSize\": 20}}, \"data\": {\"name\": \"data-2366a1329eb8a9fea2de88b5ccebfed5\"}, \"mark\": {\"type\": \"point\", \"filled\": true, \"size\": 240, \"stroke\": \"black\", \"strokeWidth\": 1.5}, \"encoding\": {\"color\": {\"field\": \"Compound Group\", \"scale\": {\"domain\": [\"DMSO\", \"Herceptin\", \"Perjeta\", \"Active Degraders\", \"Inactive Degraders\", \"PI3K Inhibitor\", \"Pan-Akt Inhibitor\", \"Neratinib (Covalent Inhibitor)\", \"BDTX-189 (Covalent Inhibitor)\", \"Head Group Small Molecules\"], \"range\": [\"#7f7f7f\", \"#ff7f0e\", \"#8c5626\", \"#d62728\", \"#bcbd22\", \"#9467bd\", \"#e377c2\", \"#1f77b4\", \"#17becf\", \"#2ca02c\"]}, \"type\": \"nominal\"}, \"shape\": {\"field\": \"Dose Order\", \"type\": \"nominal\"}, \"tooltip\": {\"field\": \"compound_dose\", \"type\": \"nominal\"}, \"x\": {\"field\": \"tsne_x\", \"type\": \"quantitative\"}, \"y\": {\"field\": \"tsne_y\", \"type\": \"quantitative\"}}, \"height\": 700, \"title\": \"SKOV3 No GFP Timepoint 1 (6 hours)\", \"width\": 700, \"$schema\": \"https://vega.github.io/schema/vega-lite/v4.17.0.json\", \"datasets\": {\"data-2366a1329eb8a9fea2de88b5ccebfed5\": [{\"tsne_x\": 8.700977325439453, \"tsne_y\": 17.315473556518555, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1464\", \"Dose Order\": \"0\"}, {\"tsne_x\": 8.795902252197266, \"tsne_y\": 17.272478103637695, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1465\", \"Dose Order\": \"0\"}, {\"tsne_x\": 8.413525581359863, \"tsne_y\": 18.214345932006836, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1466\", \"Dose Order\": \"0\"}, {\"tsne_x\": 8.678033828735352, \"tsne_y\": 17.85062599182129, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1467\", \"Dose Order\": \"0\"}, {\"tsne_x\": 6.181919574737549, \"tsne_y\": 18.30600357055664, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1884\", \"Dose Order\": \"0\"}, {\"tsne_x\": 7.537148475646973, \"tsne_y\": 17.360626220703125, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1885\", \"Dose Order\": \"0\"}, {\"tsne_x\": 8.229166984558105, \"tsne_y\": 18.38935661315918, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1886\", \"Dose Order\": \"0\"}, {\"tsne_x\": 7.5571441650390625, \"tsne_y\": 17.17955207824707, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1887\", \"Dose Order\": \"0\"}, {\"tsne_x\": 6.291645526885986, \"tsne_y\": 18.26982879638672, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1920\", \"Dose Order\": \"0\"}, {\"tsne_x\": 7.15521764755249, \"tsne_y\": 16.284311294555664, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1921\", \"Dose Order\": \"0\"}, {\"tsne_x\": 7.878307342529297, \"tsne_y\": 17.967666625976562, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1922\", \"Dose Order\": \"0\"}, {\"tsne_x\": 7.2259626388549805, \"tsne_y\": 16.652992248535156, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1923\", \"Dose Order\": \"0\"}, {\"tsne_x\": 18.438159942626953, \"tsne_y\": 16.41549301147461, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1464\", \"Dose Order\": \"1\"}, {\"tsne_x\": 18.53534507751465, \"tsne_y\": 16.923879623413086, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1465\", \"Dose Order\": \"1\"}, {\"tsne_x\": 18.014625549316406, \"tsne_y\": 17.037561416625977, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1466\", \"Dose Order\": \"1\"}, {\"tsne_x\": 19.547056198120117, \"tsne_y\": 16.379526138305664, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1467\", \"Dose Order\": \"1\"}, {\"tsne_x\": 19.34944725036621, \"tsne_y\": 18.48427391052246, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1884\", \"Dose Order\": \"1\"}, {\"tsne_x\": 18.50164031982422, \"tsne_y\": 18.025985717773438, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1885\", \"Dose Order\": \"1\"}, {\"tsne_x\": 19.153335571289062, \"tsne_y\": 17.72831916809082, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1886\", \"Dose Order\": \"1\"}, {\"tsne_x\": 19.099668502807617, \"tsne_y\": 17.55287742614746, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1887\", \"Dose Order\": \"1\"}, {\"tsne_x\": 20.366056442260742, \"tsne_y\": 18.41865348815918, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1920\", \"Dose Order\": \"1\"}, {\"tsne_x\": 19.0875301361084, \"tsne_y\": 17.459030151367188, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1921\", \"Dose Order\": \"1\"}, {\"tsne_x\": 18.816007614135742, \"tsne_y\": 18.144872665405273, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1922\", \"Dose Order\": \"1\"}, {\"tsne_x\": 19.65355682373047, \"tsne_y\": 17.25412940979004, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1923\", \"Dose Order\": \"1\"}, {\"tsne_x\": 66.27349090576172, \"tsne_y\": -4.437464237213135, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1464\", \"Dose Order\": \"2\"}, {\"tsne_x\": 65.98778533935547, \"tsne_y\": -4.535567283630371, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1465\", \"Dose Order\": \"2\"}, {\"tsne_x\": 65.41968536376953, \"tsne_y\": -4.446251392364502, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1466\", \"Dose Order\": \"2\"}, {\"tsne_x\": 65.40264129638672, \"tsne_y\": -4.313742637634277, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1467\", \"Dose Order\": \"2\"}, {\"tsne_x\": 64.77374267578125, \"tsne_y\": -6.523268699645996, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1884\", \"Dose Order\": \"2\"}, {\"tsne_x\": 64.98735809326172, \"tsne_y\": -6.321381092071533, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1885\", \"Dose Order\": \"2\"}, {\"tsne_x\": 65.25296783447266, \"tsne_y\": -5.874909400939941, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1886\", \"Dose Order\": \"2\"}, {\"tsne_x\": 65.2114486694336, \"tsne_y\": -5.882778644561768, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1887\", \"Dose Order\": \"2\"}, {\"tsne_x\": 65.60102081298828, \"tsne_y\": -7.21929407119751, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1920\", \"Dose Order\": \"2\"}, {\"tsne_x\": 65.99916076660156, \"tsne_y\": -6.374416828155518, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1921\", \"Dose Order\": \"2\"}, {\"tsne_x\": 66.22113037109375, \"tsne_y\": -6.669200420379639, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1922\", \"Dose Order\": \"2\"}, {\"tsne_x\": 66.08541107177734, \"tsne_y\": -6.604372978210449, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1923\", \"Dose Order\": \"2\"}, {\"tsne_x\": 69.53959655761719, \"tsne_y\": -2.602445602416992, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1464\", \"Dose Order\": \"3\"}, {\"tsne_x\": 69.46583557128906, \"tsne_y\": -2.616847038269043, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1465\", \"Dose Order\": \"3\"}, {\"tsne_x\": 70.12893676757812, \"tsne_y\": -2.6876657009124756, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1466\", \"Dose Order\": \"3\"}, {\"tsne_x\": 70.09668731689453, \"tsne_y\": -2.733173370361328, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1467\", \"Dose Order\": \"3\"}, {\"tsne_x\": 72.16626739501953, \"tsne_y\": -5.1811347007751465, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1884\", \"Dose Order\": \"3\"}, {\"tsne_x\": 70.92189025878906, \"tsne_y\": -4.6975812911987305, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1885\", \"Dose Order\": \"3\"}, {\"tsne_x\": 70.99673461914062, \"tsne_y\": -4.531009197235107, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1886\", \"Dose Order\": \"3\"}, {\"tsne_x\": 70.90597534179688, \"tsne_y\": -4.708119869232178, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1887\", \"Dose Order\": \"3\"}, {\"tsne_x\": 71.33580780029297, \"tsne_y\": -6.258785724639893, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1920\", \"Dose Order\": \"3\"}, {\"tsne_x\": 70.98123931884766, \"tsne_y\": -5.70467472076416, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1921\", \"Dose Order\": \"3\"}, {\"tsne_x\": 70.83956146240234, \"tsne_y\": -6.131556987762451, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1922\", \"Dose Order\": \"3\"}, {\"tsne_x\": 70.86854553222656, \"tsne_y\": -5.936582565307617, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1923\", \"Dose Order\": \"3\"}, {\"tsne_x\": 76.61966705322266, \"tsne_y\": 3.167604446411133, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1464\", \"Dose Order\": \"4\"}, {\"tsne_x\": 76.6420669555664, \"tsne_y\": 3.0505712032318115, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1465\", \"Dose Order\": \"4\"}, {\"tsne_x\": 76.60946655273438, \"tsne_y\": 2.501678466796875, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1466\", \"Dose Order\": \"4\"}, {\"tsne_x\": 76.48963165283203, \"tsne_y\": 2.2851598262786865, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1467\", \"Dose Order\": \"4\"}, {\"tsne_x\": 79.11225128173828, \"tsne_y\": -0.6398546695709229, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1884\", \"Dose Order\": \"4\"}, {\"tsne_x\": 78.94577026367188, \"tsne_y\": 0.31665390729904175, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1885\", \"Dose Order\": \"4\"}, {\"tsne_x\": 78.98138427734375, \"tsne_y\": 0.3792957365512848, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1886\", \"Dose Order\": \"4\"}, {\"tsne_x\": 78.9931869506836, \"tsne_y\": 0.37299787998199463, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1887\", \"Dose Order\": \"4\"}, {\"tsne_x\": 80.31217956542969, \"tsne_y\": -0.3321934938430786, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1920\", \"Dose Order\": \"4\"}, {\"tsne_x\": 80.24656677246094, \"tsne_y\": 0.5378630757331848, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1921\", \"Dose Order\": \"4\"}, {\"tsne_x\": 80.27399444580078, \"tsne_y\": 0.5563883781433105, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1922\", \"Dose Order\": \"4\"}, {\"tsne_x\": 80.30070495605469, \"tsne_y\": 0.5114766955375671, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1923\", \"Dose Order\": \"4\"}, {\"tsne_x\": 76.8927230834961, \"tsne_y\": 4.474131107330322, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1464\", \"Dose Order\": \"5\"}, {\"tsne_x\": 77.20919799804688, \"tsne_y\": 4.399962902069092, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1465\", \"Dose Order\": \"5\"}, {\"tsne_x\": 77.6162338256836, \"tsne_y\": 4.541637420654297, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1466\", \"Dose Order\": \"5\"}, {\"tsne_x\": 77.84103393554688, \"tsne_y\": 4.595435619354248, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1467\", \"Dose Order\": \"5\"}, {\"tsne_x\": 81.44351196289062, \"tsne_y\": 5.448507308959961, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1884\", \"Dose Order\": \"5\"}, {\"tsne_x\": 81.22367858886719, \"tsne_y\": 5.244558811187744, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1885\", \"Dose Order\": \"5\"}, {\"tsne_x\": 81.1453857421875, \"tsne_y\": 5.0867509841918945, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1886\", \"Dose Order\": \"5\"}, {\"tsne_x\": 81.0349349975586, \"tsne_y\": 5.044101238250732, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1887\", \"Dose Order\": \"5\"}, {\"tsne_x\": 81.89612579345703, \"tsne_y\": 4.003729820251465, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1920\", \"Dose Order\": \"5\"}, {\"tsne_x\": 81.62477111816406, \"tsne_y\": 3.67440128326416, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1921\", \"Dose Order\": \"5\"}, {\"tsne_x\": 81.640380859375, \"tsne_y\": 3.647876262664795, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1922\", \"Dose Order\": \"5\"}, {\"tsne_x\": 81.51162719726562, \"tsne_y\": 3.602302074432373, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|1\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1923\", \"Dose Order\": \"5\"}, {\"tsne_x\": 39.42298889160156, \"tsne_y\": 28.115293502807617, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1464\", \"Dose Order\": \"0\"}, {\"tsne_x\": 39.94316101074219, \"tsne_y\": 28.24293327331543, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1465\", \"Dose Order\": \"0\"}, {\"tsne_x\": 39.85932159423828, \"tsne_y\": 28.65009117126465, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1466\", \"Dose Order\": \"0\"}, {\"tsne_x\": 39.68580627441406, \"tsne_y\": 29.14842987060547, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1467\", \"Dose Order\": \"0\"}, {\"tsne_x\": 38.95200729370117, \"tsne_y\": 30.421022415161133, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1884\", \"Dose Order\": \"0\"}, {\"tsne_x\": 39.62989044189453, \"tsne_y\": 29.877782821655273, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1885\", \"Dose Order\": \"0\"}, {\"tsne_x\": 39.90444564819336, \"tsne_y\": 29.9353084564209, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1886\", \"Dose Order\": \"0\"}, {\"tsne_x\": 39.805938720703125, \"tsne_y\": 30.11231803894043, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1887\", \"Dose Order\": \"0\"}, {\"tsne_x\": 38.73988723754883, \"tsne_y\": 30.979507446289062, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1920\", \"Dose Order\": \"0\"}, {\"tsne_x\": 40.232852935791016, \"tsne_y\": 31.081743240356445, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1921\", \"Dose Order\": \"0\"}, {\"tsne_x\": 40.152740478515625, \"tsne_y\": 31.2758846282959, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1922\", \"Dose Order\": \"0\"}, {\"tsne_x\": 39.76637268066406, \"tsne_y\": 31.171939849853516, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1923\", \"Dose Order\": \"0\"}, {\"tsne_x\": 44.716609954833984, \"tsne_y\": 29.68328094482422, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1464\", \"Dose Order\": \"1\"}, {\"tsne_x\": -0.9450258612632751, \"tsne_y\": 54.74296188354492, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1465\", \"Dose Order\": \"1\"}, {\"tsne_x\": 44.59708023071289, \"tsne_y\": 30.174970626831055, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1466\", \"Dose Order\": \"1\"}, {\"tsne_x\": 44.54505157470703, \"tsne_y\": 29.945640563964844, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1467\", \"Dose Order\": \"1\"}, {\"tsne_x\": 44.454345703125, \"tsne_y\": 31.855180740356445, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1884\", \"Dose Order\": \"1\"}, {\"tsne_x\": 43.79851531982422, \"tsne_y\": 31.520700454711914, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1885\", \"Dose Order\": \"1\"}, {\"tsne_x\": 43.730995178222656, \"tsne_y\": 31.065452575683594, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1886\", \"Dose Order\": \"1\"}, {\"tsne_x\": 43.93722152709961, \"tsne_y\": 31.665618896484375, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1887\", \"Dose Order\": \"1\"}, {\"tsne_x\": 43.42094421386719, \"tsne_y\": 33.21852493286133, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1920\", \"Dose Order\": \"1\"}, {\"tsne_x\": 42.9830322265625, \"tsne_y\": 32.71169662475586, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1921\", \"Dose Order\": \"1\"}, {\"tsne_x\": 42.74357223510742, \"tsne_y\": 32.426971435546875, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1922\", \"Dose Order\": \"1\"}, {\"tsne_x\": 42.154239654541016, \"tsne_y\": 32.44601058959961, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1923\", \"Dose Order\": \"1\"}, {\"tsne_x\": 49.5546760559082, \"tsne_y\": 29.252197265625, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1464\", \"Dose Order\": \"2\"}, {\"tsne_x\": 49.670352935791016, \"tsne_y\": 29.16573143005371, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1465\", \"Dose Order\": \"2\"}, {\"tsne_x\": 49.77056884765625, \"tsne_y\": 30.290212631225586, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1466\", \"Dose Order\": \"2\"}, {\"tsne_x\": 49.584686279296875, \"tsne_y\": 29.992786407470703, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1467\", \"Dose Order\": \"2\"}, {\"tsne_x\": 50.84992980957031, \"tsne_y\": 34.6224365234375, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1884\", \"Dose Order\": \"2\"}, {\"tsne_x\": 50.76768112182617, \"tsne_y\": 34.47825622558594, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1885\", \"Dose Order\": \"2\"}, {\"tsne_x\": 50.91042709350586, \"tsne_y\": 34.004852294921875, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1886\", \"Dose Order\": \"2\"}, {\"tsne_x\": 50.85625457763672, \"tsne_y\": 34.52877426147461, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1887\", \"Dose Order\": \"2\"}, {\"tsne_x\": 51.1237678527832, \"tsne_y\": 36.49932098388672, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1920\", \"Dose Order\": \"2\"}, {\"tsne_x\": 51.214569091796875, \"tsne_y\": 36.58031463623047, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1921\", \"Dose Order\": \"2\"}, {\"tsne_x\": 50.80783462524414, \"tsne_y\": 36.992881774902344, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1922\", \"Dose Order\": \"2\"}, {\"tsne_x\": 50.91284942626953, \"tsne_y\": 37.242061614990234, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1923\", \"Dose Order\": \"2\"}, {\"tsne_x\": 51.14889907836914, \"tsne_y\": 28.67617416381836, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1464\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.29122543334961, \"tsne_y\": 28.390676498413086, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1465\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.3497314453125, \"tsne_y\": 29.199337005615234, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1466\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.4511833190918, \"tsne_y\": 29.875953674316406, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1467\", \"Dose Order\": \"3\"}, {\"tsne_x\": 54.50373458862305, \"tsne_y\": 35.97539138793945, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1884\", \"Dose Order\": \"3\"}, {\"tsne_x\": 55.398719787597656, \"tsne_y\": 35.79411315917969, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1885\", \"Dose Order\": \"3\"}, {\"tsne_x\": 55.5899658203125, \"tsne_y\": 35.15189743041992, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1886\", \"Dose Order\": \"3\"}, {\"tsne_x\": 55.48481369018555, \"tsne_y\": 35.7213249206543, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1887\", \"Dose Order\": \"3\"}, {\"tsne_x\": 53.94597625732422, \"tsne_y\": 36.21735382080078, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1920\", \"Dose Order\": \"3\"}, {\"tsne_x\": 53.694549560546875, \"tsne_y\": 37.993099212646484, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1921\", \"Dose Order\": \"3\"}, {\"tsne_x\": 53.57429885864258, \"tsne_y\": 38.55862808227539, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1922\", \"Dose Order\": \"3\"}, {\"tsne_x\": 53.23047637939453, \"tsne_y\": 38.31252670288086, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1923\", \"Dose Order\": \"3\"}, {\"tsne_x\": 53.04270553588867, \"tsne_y\": 26.961503982543945, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1464\", \"Dose Order\": \"4\"}, {\"tsne_x\": 53.5997200012207, \"tsne_y\": 27.69194793701172, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1465\", \"Dose Order\": \"4\"}, {\"tsne_x\": 53.76604461669922, \"tsne_y\": 28.14533042907715, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1466\", \"Dose Order\": \"4\"}, {\"tsne_x\": 53.920772552490234, \"tsne_y\": 28.40040397644043, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1467\", \"Dose Order\": \"4\"}, {\"tsne_x\": 57.94156265258789, \"tsne_y\": 36.34129333496094, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1884\", \"Dose Order\": \"4\"}, {\"tsne_x\": 57.511722564697266, \"tsne_y\": 36.437889099121094, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1885\", \"Dose Order\": \"4\"}, {\"tsne_x\": 57.31196594238281, \"tsne_y\": 36.13718032836914, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1886\", \"Dose Order\": \"4\"}, {\"tsne_x\": 57.06584548950195, \"tsne_y\": 36.339412689208984, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1887\", \"Dose Order\": \"4\"}, {\"tsne_x\": 55.175254821777344, \"tsne_y\": 38.57561492919922, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1920\", \"Dose Order\": \"4\"}, {\"tsne_x\": 54.99034881591797, \"tsne_y\": 38.775001525878906, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1921\", \"Dose Order\": \"4\"}, {\"tsne_x\": 54.42349624633789, \"tsne_y\": 39.43153762817383, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1922\", \"Dose Order\": \"4\"}, {\"tsne_x\": 54.469520568847656, \"tsne_y\": 39.5612678527832, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1923\", \"Dose Order\": \"4\"}, {\"tsne_x\": 54.986263275146484, \"tsne_y\": 27.125701904296875, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1464\", \"Dose Order\": \"5\"}, {\"tsne_x\": 54.816993713378906, \"tsne_y\": 27.255111694335938, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1465\", \"Dose Order\": \"5\"}, {\"tsne_x\": 54.784549713134766, \"tsne_y\": 28.11201286315918, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1466\", \"Dose Order\": \"5\"}, {\"tsne_x\": 54.67488479614258, \"tsne_y\": 28.42009735107422, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1467\", \"Dose Order\": \"5\"}, {\"tsne_x\": 58.984886169433594, \"tsne_y\": 38.48458480834961, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1884\", \"Dose Order\": \"5\"}, {\"tsne_x\": 58.866031646728516, \"tsne_y\": 38.47174072265625, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1885\", \"Dose Order\": \"5\"}, {\"tsne_x\": 58.74815368652344, \"tsne_y\": 38.53126525878906, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1886\", \"Dose Order\": \"5\"}, {\"tsne_x\": 58.56601333618164, \"tsne_y\": 38.43250274658203, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1887\", \"Dose Order\": \"5\"}, {\"tsne_x\": 57.09275817871094, \"tsne_y\": 39.934757232666016, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1920\", \"Dose Order\": \"5\"}, {\"tsne_x\": 56.77077865600586, \"tsne_y\": 40.00749969482422, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1921\", \"Dose Order\": \"5\"}, {\"tsne_x\": 56.55678176879883, \"tsne_y\": 40.38724899291992, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1922\", \"Dose Order\": \"5\"}, {\"tsne_x\": 56.39316177368164, \"tsne_y\": 40.405364990234375, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|1\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1923\", \"Dose Order\": \"5\"}, {\"tsne_x\": -7.229650020599365, \"tsne_y\": 14.3731107711792, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1464\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.55255651473999, \"tsne_y\": 14.94836139678955, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1465\", \"Dose Order\": \"0\"}, {\"tsne_x\": -5.984773635864258, \"tsne_y\": 14.585456848144531, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1466\", \"Dose Order\": \"0\"}, {\"tsne_x\": -6.353024482727051, \"tsne_y\": 14.069573402404785, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1467\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.074695587158203, \"tsne_y\": 13.109748840332031, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1884\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.575268745422363, \"tsne_y\": 13.59703540802002, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1885\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.147587776184082, \"tsne_y\": 13.743107795715332, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1886\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.451769828796387, \"tsne_y\": 14.06890869140625, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1887\", \"Dose Order\": \"0\"}, {\"tsne_x\": -6.93795108795166, \"tsne_y\": 12.739798545837402, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1920\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.072240829467773, \"tsne_y\": 13.421330451965332, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1921\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.632431030273438, \"tsne_y\": 14.37299633026123, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1922\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.575469970703125, \"tsne_y\": 14.552574157714844, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1923\", \"Dose Order\": \"0\"}, {\"tsne_x\": -27.098268508911133, \"tsne_y\": 32.72811508178711, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1464\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.400955200195312, \"tsne_y\": 33.06395721435547, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1465\", \"Dose Order\": \"1\"}, {\"tsne_x\": -26.9205265045166, \"tsne_y\": 31.828582763671875, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1466\", \"Dose Order\": \"1\"}, {\"tsne_x\": -26.327390670776367, \"tsne_y\": 32.733123779296875, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1467\", \"Dose Order\": \"1\"}, {\"tsne_x\": -28.304153442382812, \"tsne_y\": 31.346961975097656, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1884\", \"Dose Order\": \"1\"}, {\"tsne_x\": -26.375051498413086, \"tsne_y\": 32.676273345947266, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1885\", \"Dose Order\": \"1\"}, {\"tsne_x\": -25.752025604248047, \"tsne_y\": 32.695518493652344, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1886\", \"Dose Order\": \"1\"}, {\"tsne_x\": -26.69832992553711, \"tsne_y\": 31.498716354370117, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1887\", \"Dose Order\": \"1\"}, {\"tsne_x\": -29.488327026367188, \"tsne_y\": 30.367427825927734, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1920\", \"Dose Order\": \"1\"}, {\"tsne_x\": -26.663284301757812, \"tsne_y\": 33.00590133666992, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1921\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.344268798828125, \"tsne_y\": 32.097900390625, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1922\", \"Dose Order\": \"1\"}, {\"tsne_x\": -26.874313354492188, \"tsne_y\": 33.655799865722656, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1923\", \"Dose Order\": \"1\"}, {\"tsne_x\": -13.518342018127441, \"tsne_y\": 63.269317626953125, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1464\", \"Dose Order\": \"2\"}, {\"tsne_x\": -13.67867660522461, \"tsne_y\": 63.240875244140625, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1465\", \"Dose Order\": \"2\"}, {\"tsne_x\": -12.517513275146484, \"tsne_y\": 63.64448928833008, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1466\", \"Dose Order\": \"2\"}, {\"tsne_x\": -12.618508338928223, \"tsne_y\": 63.6004524230957, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1467\", \"Dose Order\": \"2\"}, {\"tsne_x\": -11.193219184875488, \"tsne_y\": 63.374061584472656, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1884\", \"Dose Order\": \"2\"}, {\"tsne_x\": -12.040205001831055, \"tsne_y\": 64.00691223144531, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1885\", \"Dose Order\": \"2\"}, {\"tsne_x\": -11.89765453338623, \"tsne_y\": 63.31913757324219, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1886\", \"Dose Order\": \"2\"}, {\"tsne_x\": -12.142982482910156, \"tsne_y\": 63.9415283203125, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1887\", \"Dose Order\": \"2\"}, {\"tsne_x\": -13.454144477844238, \"tsne_y\": 65.89191436767578, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1920\", \"Dose Order\": \"2\"}, {\"tsne_x\": -12.48013687133789, \"tsne_y\": 65.29671478271484, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1921\", \"Dose Order\": \"2\"}, {\"tsne_x\": -12.833062171936035, \"tsne_y\": 66.00214385986328, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1922\", \"Dose Order\": \"2\"}, {\"tsne_x\": -12.603737831115723, \"tsne_y\": 66.04119110107422, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1923\", \"Dose Order\": \"2\"}, {\"tsne_x\": 10.564085006713867, \"tsne_y\": 74.52184295654297, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1464\", \"Dose Order\": \"3\"}, {\"tsne_x\": 10.242006301879883, \"tsne_y\": 74.34309387207031, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1465\", \"Dose Order\": \"3\"}, {\"tsne_x\": 10.428325653076172, \"tsne_y\": 74.02764892578125, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1466\", \"Dose Order\": \"3\"}, {\"tsne_x\": 9.928398132324219, \"tsne_y\": 72.38372039794922, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1467\", \"Dose Order\": \"3\"}, {\"tsne_x\": 8.70821762084961, \"tsne_y\": 71.61392211914062, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1884\", \"Dose Order\": \"3\"}, {\"tsne_x\": 7.693915843963623, \"tsne_y\": 72.28443908691406, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1885\", \"Dose Order\": \"3\"}, {\"tsne_x\": 8.319673538208008, \"tsne_y\": 71.9577407836914, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1886\", \"Dose Order\": \"3\"}, {\"tsne_x\": 8.112017631530762, \"tsne_y\": 72.06317138671875, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1887\", \"Dose Order\": \"3\"}, {\"tsne_x\": 6.157820701599121, \"tsne_y\": 73.42887878417969, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1920\", \"Dose Order\": \"3\"}, {\"tsne_x\": 5.578381538391113, \"tsne_y\": 73.26603698730469, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1921\", \"Dose Order\": \"3\"}, {\"tsne_x\": 5.474477291107178, \"tsne_y\": 72.5354995727539, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1922\", \"Dose Order\": \"3\"}, {\"tsne_x\": 5.386509418487549, \"tsne_y\": 72.6907958984375, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1923\", \"Dose Order\": \"3\"}, {\"tsne_x\": 32.89451599121094, \"tsne_y\": 53.986846923828125, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1464\", \"Dose Order\": \"4\"}, {\"tsne_x\": 33.010196685791016, \"tsne_y\": 54.30495071411133, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1465\", \"Dose Order\": \"4\"}, {\"tsne_x\": 32.461875915527344, \"tsne_y\": 54.5346565246582, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1466\", \"Dose Order\": \"4\"}, {\"tsne_x\": 32.418846130371094, \"tsne_y\": 54.511505126953125, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1467\", \"Dose Order\": \"4\"}, {\"tsne_x\": 30.186500549316406, \"tsne_y\": 55.19480514526367, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1884\", \"Dose Order\": \"4\"}, {\"tsne_x\": 30.324289321899414, \"tsne_y\": 55.8502311706543, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1885\", \"Dose Order\": \"4\"}, {\"tsne_x\": 30.3363094329834, \"tsne_y\": 55.70259094238281, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1886\", \"Dose Order\": \"4\"}, {\"tsne_x\": 30.219892501831055, \"tsne_y\": 55.30870056152344, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1887\", \"Dose Order\": \"4\"}, {\"tsne_x\": 30.941255569458008, \"tsne_y\": 57.36994552612305, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1920\", \"Dose Order\": \"4\"}, {\"tsne_x\": 30.78923797607422, \"tsne_y\": 57.457435607910156, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1921\", \"Dose Order\": \"4\"}, {\"tsne_x\": 30.548076629638672, \"tsne_y\": 57.653656005859375, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1922\", \"Dose Order\": \"4\"}, {\"tsne_x\": 30.380144119262695, \"tsne_y\": 57.70157241821289, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1923\", \"Dose Order\": \"4\"}, {\"tsne_x\": 34.71961212158203, \"tsne_y\": 54.7596549987793, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1464\", \"Dose Order\": \"5\"}, {\"tsne_x\": 34.48809051513672, \"tsne_y\": 54.95336151123047, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1465\", \"Dose Order\": \"5\"}, {\"tsne_x\": 34.497982025146484, \"tsne_y\": 55.38770294189453, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1466\", \"Dose Order\": \"5\"}, {\"tsne_x\": 34.55149841308594, \"tsne_y\": 55.49391555786133, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1467\", \"Dose Order\": \"5\"}, {\"tsne_x\": 35.58771514892578, \"tsne_y\": 57.58480453491211, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1884\", \"Dose Order\": \"5\"}, {\"tsne_x\": 35.26743698120117, \"tsne_y\": 57.592891693115234, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1885\", \"Dose Order\": \"5\"}, {\"tsne_x\": 35.182865142822266, \"tsne_y\": 57.548309326171875, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1886\", \"Dose Order\": \"5\"}, {\"tsne_x\": 35.25768280029297, \"tsne_y\": 57.484798431396484, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1887\", \"Dose Order\": \"5\"}, {\"tsne_x\": 33.7132453918457, \"tsne_y\": 59.1545295715332, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1920\", \"Dose Order\": \"5\"}, {\"tsne_x\": 33.72780227661133, \"tsne_y\": 58.762107849121094, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1921\", \"Dose Order\": \"5\"}, {\"tsne_x\": 33.424991607666016, \"tsne_y\": 58.95466613769531, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1922\", \"Dose Order\": \"5\"}, {\"tsne_x\": 33.32577896118164, \"tsne_y\": 59.0043830871582, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1923\", \"Dose Order\": \"5\"}, {\"tsne_x\": -23.90766716003418, \"tsne_y\": -0.5238454937934875, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1464\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.31378173828125, \"tsne_y\": 0.4677576720714569, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1465\", \"Dose Order\": \"0\"}, {\"tsne_x\": -24.620681762695312, \"tsne_y\": -0.7275602221488953, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1466\", \"Dose Order\": \"0\"}, {\"tsne_x\": -25.291919708251953, \"tsne_y\": -1.061200499534607, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1467\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.528743743896484, \"tsne_y\": -1.588106393814087, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1884\", \"Dose Order\": \"0\"}, {\"tsne_x\": -25.52668571472168, \"tsne_y\": -0.2964019477367401, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1885\", \"Dose Order\": \"0\"}, {\"tsne_x\": -25.23695945739746, \"tsne_y\": 0.2737916111946106, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1886\", \"Dose Order\": \"0\"}, {\"tsne_x\": -24.40495491027832, \"tsne_y\": -0.6548449993133545, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1887\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.181446075439453, \"tsne_y\": -0.8704352378845215, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1920\", \"Dose Order\": \"0\"}, {\"tsne_x\": -24.520435333251953, \"tsne_y\": 0.514776885509491, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1921\", \"Dose Order\": \"0\"}, {\"tsne_x\": -24.325180053710938, \"tsne_y\": -0.1958509385585785, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1922\", \"Dose Order\": \"0\"}, {\"tsne_x\": -24.41683578491211, \"tsne_y\": 0.7030236721038818, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1923\", \"Dose Order\": \"0\"}, {\"tsne_x\": -47.09911346435547, \"tsne_y\": -40.871517181396484, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1464\", \"Dose Order\": \"1\"}, {\"tsne_x\": -46.331825256347656, \"tsne_y\": -40.0850944519043, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1465\", \"Dose Order\": \"1\"}, {\"tsne_x\": -46.92609405517578, \"tsne_y\": -39.9118537902832, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1466\", \"Dose Order\": \"1\"}, {\"tsne_x\": -46.31155776977539, \"tsne_y\": -40.18263626098633, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1467\", \"Dose Order\": \"1\"}, {\"tsne_x\": -44.702178955078125, \"tsne_y\": -40.59007263183594, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1884\", \"Dose Order\": \"1\"}, {\"tsne_x\": -46.3421630859375, \"tsne_y\": -41.15104293823242, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1885\", \"Dose Order\": \"1\"}, {\"tsne_x\": -46.77112579345703, \"tsne_y\": -41.74380111694336, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1886\", \"Dose Order\": \"1\"}, {\"tsne_x\": -45.735260009765625, \"tsne_y\": -40.7783088684082, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1887\", \"Dose Order\": \"1\"}, {\"tsne_x\": -43.49147415161133, \"tsne_y\": -40.290287017822266, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1920\", \"Dose Order\": \"1\"}, {\"tsne_x\": -46.31946563720703, \"tsne_y\": -41.05524444580078, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1921\", \"Dose Order\": \"1\"}, {\"tsne_x\": -45.952396392822266, \"tsne_y\": -42.01011276245117, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1922\", \"Dose Order\": \"1\"}, {\"tsne_x\": -46.452796936035156, \"tsne_y\": -40.77885437011719, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1923\", \"Dose Order\": \"1\"}, {\"tsne_x\": -24.75858497619629, \"tsne_y\": -29.803274154663086, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1464\", \"Dose Order\": \"2\"}, {\"tsne_x\": -25.168922424316406, \"tsne_y\": -30.59922218322754, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1465\", \"Dose Order\": \"2\"}, {\"tsne_x\": -25.275346755981445, \"tsne_y\": -31.070072174072266, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1466\", \"Dose Order\": \"2\"}, {\"tsne_x\": -25.796236038208008, \"tsne_y\": -31.865215301513672, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1467\", \"Dose Order\": \"2\"}, {\"tsne_x\": -25.55099868774414, \"tsne_y\": -29.424753189086914, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1884\", \"Dose Order\": \"2\"}, {\"tsne_x\": -24.594989776611328, \"tsne_y\": -30.152877807617188, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1885\", \"Dose Order\": \"2\"}, {\"tsne_x\": -24.48333740234375, \"tsne_y\": -29.188995361328125, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1886\", \"Dose Order\": \"2\"}, {\"tsne_x\": -25.107223510742188, \"tsne_y\": -29.9685001373291, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1887\", \"Dose Order\": \"2\"}, {\"tsne_x\": -24.97077178955078, \"tsne_y\": -28.742231369018555, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1920\", \"Dose Order\": \"2\"}, {\"tsne_x\": -24.297517776489258, \"tsne_y\": -29.72165298461914, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1921\", \"Dose Order\": \"2\"}, {\"tsne_x\": -23.86282730102539, \"tsne_y\": -30.308034896850586, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1922\", \"Dose Order\": \"2\"}, {\"tsne_x\": -24.312116622924805, \"tsne_y\": -30.664236068725586, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1923\", \"Dose Order\": \"2\"}, {\"tsne_x\": -12.618109703063965, \"tsne_y\": -29.726640701293945, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1464\", \"Dose Order\": \"3\"}, {\"tsne_x\": -12.597895622253418, \"tsne_y\": -29.38397979736328, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1465\", \"Dose Order\": \"3\"}, {\"tsne_x\": -13.759252548217773, \"tsne_y\": -29.705562591552734, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1466\", \"Dose Order\": \"3\"}, {\"tsne_x\": -13.356844902038574, \"tsne_y\": -29.90928840637207, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1467\", \"Dose Order\": \"3\"}, {\"tsne_x\": -13.779437065124512, \"tsne_y\": -27.897314071655273, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1884\", \"Dose Order\": \"3\"}, {\"tsne_x\": -13.435510635375977, \"tsne_y\": -28.76971435546875, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1885\", \"Dose Order\": \"3\"}, {\"tsne_x\": -13.66235637664795, \"tsne_y\": -28.807083129882812, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1886\", \"Dose Order\": \"3\"}, {\"tsne_x\": -12.785539627075195, \"tsne_y\": -28.717174530029297, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1887\", \"Dose Order\": \"3\"}, {\"tsne_x\": -12.729317665100098, \"tsne_y\": -27.690858840942383, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1920\", \"Dose Order\": \"3\"}, {\"tsne_x\": -12.463591575622559, \"tsne_y\": -28.595478057861328, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1921\", \"Dose Order\": \"3\"}, {\"tsne_x\": -12.480624198913574, \"tsne_y\": -28.12683868408203, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1922\", \"Dose Order\": \"3\"}, {\"tsne_x\": -11.884872436523438, \"tsne_y\": -28.414216995239258, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1923\", \"Dose Order\": \"3\"}, {\"tsne_x\": -6.439891815185547, \"tsne_y\": -34.173213958740234, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1464\", \"Dose Order\": \"4\"}, {\"tsne_x\": -6.576607704162598, \"tsne_y\": -34.210208892822266, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1465\", \"Dose Order\": \"4\"}, {\"tsne_x\": -6.788351058959961, \"tsne_y\": -34.817684173583984, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1466\", \"Dose Order\": \"4\"}, {\"tsne_x\": -6.529394149780273, \"tsne_y\": -34.332275390625, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1467\", \"Dose Order\": \"4\"}, {\"tsne_x\": -5.630195617675781, \"tsne_y\": -32.30134582519531, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1884\", \"Dose Order\": \"4\"}, {\"tsne_x\": -5.962750434875488, \"tsne_y\": -32.8426399230957, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1885\", \"Dose Order\": \"4\"}, {\"tsne_x\": -6.199285984039307, \"tsne_y\": -32.824302673339844, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1886\", \"Dose Order\": \"4\"}, {\"tsne_x\": -5.600747108459473, \"tsne_y\": -33.124000549316406, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1887\", \"Dose Order\": \"4\"}, {\"tsne_x\": -3.9476325511932373, \"tsne_y\": -33.103233337402344, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1920\", \"Dose Order\": \"4\"}, {\"tsne_x\": -3.9078431129455566, \"tsne_y\": -33.27964401245117, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1921\", \"Dose Order\": \"4\"}, {\"tsne_x\": -4.295036315917969, \"tsne_y\": -33.062294006347656, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1922\", \"Dose Order\": \"4\"}, {\"tsne_x\": -4.37619686126709, \"tsne_y\": -33.1151237487793, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1923\", \"Dose Order\": \"4\"}, {\"tsne_x\": -3.433865547180176, \"tsne_y\": -36.99209213256836, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1464\", \"Dose Order\": \"5\"}, {\"tsne_x\": -3.5594191551208496, \"tsne_y\": -37.06767272949219, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1465\", \"Dose Order\": \"5\"}, {\"tsne_x\": -3.9215543270111084, \"tsne_y\": -37.21582794189453, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1466\", \"Dose Order\": \"5\"}, {\"tsne_x\": -3.768198251724243, \"tsne_y\": -37.12849426269531, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1467\", \"Dose Order\": \"5\"}, {\"tsne_x\": -0.11078662425279617, \"tsne_y\": -36.53346633911133, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1884\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.2453097105026245, \"tsne_y\": -36.400543212890625, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1885\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.1738638877868652, \"tsne_y\": -36.469398498535156, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1886\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.456871747970581, \"tsne_y\": -36.4140739440918, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1887\", \"Dose Order\": \"5\"}, {\"tsne_x\": -0.7007295489311218, \"tsne_y\": -35.11540603637695, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1920\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.4949852228164673, \"tsne_y\": -35.15397644042969, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1921\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.8520574569702148, \"tsne_y\": -34.822059631347656, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1922\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.853629231452942, \"tsne_y\": -34.90791702270508, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|1\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1923\", \"Dose Order\": \"5\"}, {\"tsne_x\": -21.6180362701416, \"tsne_y\": 43.5910758972168, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1464\", \"Dose Order\": \"0\"}, {\"tsne_x\": -21.186630249023438, \"tsne_y\": 44.324256896972656, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1465\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.726104736328125, \"tsne_y\": 43.00294876098633, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1466\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.024105072021484, \"tsne_y\": 43.66915512084961, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1467\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.172603607177734, \"tsne_y\": 43.41438674926758, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1884\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.97507095336914, \"tsne_y\": 42.96001052856445, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1885\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.464580535888672, \"tsne_y\": 43.61447525024414, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1886\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.433324813842773, \"tsne_y\": 43.37934494018555, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1887\", \"Dose Order\": \"0\"}, {\"tsne_x\": -18.683773040771484, \"tsne_y\": 44.01318359375, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1920\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.29424476623535, \"tsne_y\": 44.19636535644531, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1921\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.1365966796875, \"tsne_y\": 44.72069549560547, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1922\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.1076717376709, \"tsne_y\": 44.85194396972656, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1923\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.19665241241455, \"tsne_y\": 66.47279357910156, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1464\", \"Dose Order\": \"1\"}, {\"tsne_x\": -8.31602668762207, \"tsne_y\": 66.83053588867188, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1465\", \"Dose Order\": \"1\"}, {\"tsne_x\": -8.472293853759766, \"tsne_y\": 67.18592834472656, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1466\", \"Dose Order\": \"1\"}, {\"tsne_x\": -8.47922134399414, \"tsne_y\": 67.41492462158203, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1467\", \"Dose Order\": \"1\"}, {\"tsne_x\": -9.07754898071289, \"tsne_y\": 68.7132797241211, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1884\", \"Dose Order\": \"1\"}, {\"tsne_x\": -9.29393196105957, \"tsne_y\": 67.67582702636719, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1885\", \"Dose Order\": \"1\"}, {\"tsne_x\": -9.079069137573242, \"tsne_y\": 67.61193084716797, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1886\", \"Dose Order\": \"1\"}, {\"tsne_x\": -8.849197387695312, \"tsne_y\": 68.38870239257812, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1887\", \"Dose Order\": \"1\"}, {\"tsne_x\": -10.530624389648438, \"tsne_y\": 69.11576843261719, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1920\", \"Dose Order\": \"1\"}, {\"tsne_x\": -10.688615798950195, \"tsne_y\": 67.58106231689453, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1921\", \"Dose Order\": \"1\"}, {\"tsne_x\": -11.549408912658691, \"tsne_y\": 67.81456756591797, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1922\", \"Dose Order\": \"1\"}, {\"tsne_x\": -11.377197265625, \"tsne_y\": 67.87317657470703, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1923\", \"Dose Order\": \"1\"}, {\"tsne_x\": 11.58666706085205, \"tsne_y\": 74.67578887939453, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1464\", \"Dose Order\": \"2\"}, {\"tsne_x\": 11.704272270202637, \"tsne_y\": 75.12174987792969, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1465\", \"Dose Order\": \"2\"}, {\"tsne_x\": 12.002462387084961, \"tsne_y\": 73.21260070800781, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1466\", \"Dose Order\": \"2\"}, {\"tsne_x\": 11.83957576751709, \"tsne_y\": 73.7181396484375, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1467\", \"Dose Order\": \"2\"}, {\"tsne_x\": 12.905715942382812, \"tsne_y\": 70.46096801757812, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1884\", \"Dose Order\": \"2\"}, {\"tsne_x\": 12.58358097076416, \"tsne_y\": 70.75725555419922, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1885\", \"Dose Order\": \"2\"}, {\"tsne_x\": 12.676322937011719, \"tsne_y\": 70.77554321289062, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1886\", \"Dose Order\": \"2\"}, {\"tsne_x\": 12.1919527053833, \"tsne_y\": 70.72809600830078, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1887\", \"Dose Order\": \"2\"}, {\"tsne_x\": 5.138903617858887, \"tsne_y\": 75.15765380859375, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1920\", \"Dose Order\": \"2\"}, {\"tsne_x\": 4.897613525390625, \"tsne_y\": 75.02078247070312, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1921\", \"Dose Order\": \"2\"}, {\"tsne_x\": 4.783436298370361, \"tsne_y\": 75.28948974609375, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1922\", \"Dose Order\": \"2\"}, {\"tsne_x\": 4.8362956047058105, \"tsne_y\": 75.69206237792969, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1923\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.5765347480773926, \"tsne_y\": 68.91475677490234, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1464\", \"Dose Order\": \"3\"}, {\"tsne_x\": -2.2317521572113037, \"tsne_y\": 69.10237121582031, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1465\", \"Dose Order\": \"3\"}, {\"tsne_x\": -1.9808757305145264, \"tsne_y\": 69.2352523803711, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1466\", \"Dose Order\": \"3\"}, {\"tsne_x\": -1.2339545488357544, \"tsne_y\": 69.37137603759766, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1467\", \"Dose Order\": \"3\"}, {\"tsne_x\": -1.1396584510803223, \"tsne_y\": 70.38214874267578, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1884\", \"Dose Order\": \"3\"}, {\"tsne_x\": -0.8133010268211365, \"tsne_y\": 69.85389709472656, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1885\", \"Dose Order\": \"3\"}, {\"tsne_x\": -0.501560389995575, \"tsne_y\": 70.04966735839844, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1886\", \"Dose Order\": \"3\"}, {\"tsne_x\": -1.1488025188446045, \"tsne_y\": 69.77755737304688, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1887\", \"Dose Order\": \"3\"}, {\"tsne_x\": 2.711421251296997, \"tsne_y\": 73.50384521484375, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1920\", \"Dose Order\": \"3\"}, {\"tsne_x\": 3.665661096572876, \"tsne_y\": 73.64142608642578, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1921\", \"Dose Order\": \"3\"}, {\"tsne_x\": 3.6011555194854736, \"tsne_y\": 73.91178131103516, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1922\", \"Dose Order\": \"3\"}, {\"tsne_x\": 3.428027391433716, \"tsne_y\": 73.41159057617188, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1923\", \"Dose Order\": \"3\"}, {\"tsne_x\": 14.249211311340332, \"tsne_y\": 73.4022216796875, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1464\", \"Dose Order\": \"4\"}, {\"tsne_x\": 11.939905166625977, \"tsne_y\": 75.20653533935547, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1465\", \"Dose Order\": \"4\"}, {\"tsne_x\": 13.927665710449219, \"tsne_y\": 73.26661682128906, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1466\", \"Dose Order\": \"4\"}, {\"tsne_x\": 13.691351890563965, \"tsne_y\": 73.23088073730469, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1467\", \"Dose Order\": \"4\"}, {\"tsne_x\": 15.07652759552002, \"tsne_y\": 70.48820495605469, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1884\", \"Dose Order\": \"4\"}, {\"tsne_x\": 14.91203498840332, \"tsne_y\": 70.59882354736328, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1885\", \"Dose Order\": \"4\"}, {\"tsne_x\": 14.611942291259766, \"tsne_y\": 70.69654846191406, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1886\", \"Dose Order\": \"4\"}, {\"tsne_x\": 15.550134658813477, \"tsne_y\": 70.41275787353516, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1887\", \"Dose Order\": \"4\"}, {\"tsne_x\": 18.624727249145508, \"tsne_y\": 69.54397583007812, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1920\", \"Dose Order\": \"4\"}, {\"tsne_x\": 18.083383560180664, \"tsne_y\": 69.74380493164062, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1921\", \"Dose Order\": \"4\"}, {\"tsne_x\": 17.886991500854492, \"tsne_y\": 69.82725524902344, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1922\", \"Dose Order\": \"4\"}, {\"tsne_x\": 17.81239128112793, \"tsne_y\": 69.86640167236328, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1923\", \"Dose Order\": \"4\"}, {\"tsne_x\": 24.298076629638672, \"tsne_y\": 65.59986877441406, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1464\", \"Dose Order\": \"5\"}, {\"tsne_x\": 24.10684585571289, \"tsne_y\": 65.88029479980469, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1465\", \"Dose Order\": \"5\"}, {\"tsne_x\": 23.877992630004883, \"tsne_y\": 66.15472412109375, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1466\", \"Dose Order\": \"5\"}, {\"tsne_x\": 23.937305450439453, \"tsne_y\": 66.0872802734375, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1467\", \"Dose Order\": \"5\"}, {\"tsne_x\": 23.036380767822266, \"tsne_y\": 68.00455474853516, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1884\", \"Dose Order\": \"5\"}, {\"tsne_x\": 23.010055541992188, \"tsne_y\": 67.75409698486328, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1885\", \"Dose Order\": \"5\"}, {\"tsne_x\": 23.086435317993164, \"tsne_y\": 67.62959289550781, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1886\", \"Dose Order\": \"5\"}, {\"tsne_x\": 23.062496185302734, \"tsne_y\": 67.7457046508789, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1887\", \"Dose Order\": \"5\"}, {\"tsne_x\": 21.425243377685547, \"tsne_y\": 68.58720397949219, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1920\", \"Dose Order\": \"5\"}, {\"tsne_x\": 21.43596649169922, \"tsne_y\": 68.35194396972656, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1921\", \"Dose Order\": \"5\"}, {\"tsne_x\": 21.195892333984375, \"tsne_y\": 68.46670532226562, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1922\", \"Dose Order\": \"5\"}, {\"tsne_x\": 21.048484802246094, \"tsne_y\": 68.5460205078125, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1923\", \"Dose Order\": \"5\"}, {\"tsne_x\": -12.922697067260742, \"tsne_y\": 2.785343647003174, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1464\", \"Dose Order\": \"0\"}, {\"tsne_x\": -12.547904968261719, \"tsne_y\": 2.4924569129943848, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1465\", \"Dose Order\": \"0\"}, {\"tsne_x\": -14.208784103393555, \"tsne_y\": 3.3913087844848633, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1466\", \"Dose Order\": \"0\"}, {\"tsne_x\": -12.112394332885742, \"tsne_y\": 3.008528470993042, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1467\", \"Dose Order\": \"0\"}, {\"tsne_x\": -13.267149925231934, \"tsne_y\": 4.166277885437012, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1884\", \"Dose Order\": \"0\"}, {\"tsne_x\": -12.956138610839844, \"tsne_y\": 3.958967685699463, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1885\", \"Dose Order\": \"0\"}, {\"tsne_x\": -12.081793785095215, \"tsne_y\": 4.69158935546875, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1886\", \"Dose Order\": \"0\"}, {\"tsne_x\": -14.21119213104248, \"tsne_y\": 2.6533632278442383, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1887\", \"Dose Order\": \"0\"}, {\"tsne_x\": -13.860791206359863, \"tsne_y\": 3.3968496322631836, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1920\", \"Dose Order\": \"0\"}, {\"tsne_x\": -13.148314476013184, \"tsne_y\": 3.0213284492492676, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1921\", \"Dose Order\": \"0\"}, {\"tsne_x\": -11.923843383789062, \"tsne_y\": 4.281887531280518, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1922\", \"Dose Order\": \"0\"}, {\"tsne_x\": -13.423233032226562, \"tsne_y\": 4.387916088104248, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1923\", \"Dose Order\": \"0\"}, {\"tsne_x\": -36.84259033203125, \"tsne_y\": -37.345149993896484, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1464\", \"Dose Order\": \"1\"}, {\"tsne_x\": -36.13397216796875, \"tsne_y\": -38.82697296142578, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1465\", \"Dose Order\": \"1\"}, {\"tsne_x\": -35.635009765625, \"tsne_y\": -37.55596923828125, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1466\", \"Dose Order\": \"1\"}, {\"tsne_x\": -36.30682373046875, \"tsne_y\": -37.761348724365234, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1467\", \"Dose Order\": \"1\"}, {\"tsne_x\": -37.90484619140625, \"tsne_y\": -38.72831726074219, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1884\", \"Dose Order\": \"1\"}, {\"tsne_x\": -36.84030532836914, \"tsne_y\": -38.70856857299805, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1885\", \"Dose Order\": \"1\"}, {\"tsne_x\": -37.579437255859375, \"tsne_y\": -37.70237350463867, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1886\", \"Dose Order\": \"1\"}, {\"tsne_x\": -36.81159973144531, \"tsne_y\": -38.3056755065918, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1887\", \"Dose Order\": \"1\"}, {\"tsne_x\": -38.40701675415039, \"tsne_y\": -39.01133346557617, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1920\", \"Dose Order\": \"1\"}, {\"tsne_x\": -36.641754150390625, \"tsne_y\": -38.12388610839844, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1921\", \"Dose Order\": \"1\"}, {\"tsne_x\": -37.096805572509766, \"tsne_y\": -37.70677947998047, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1922\", \"Dose Order\": \"1\"}, {\"tsne_x\": -36.96443557739258, \"tsne_y\": -36.9094352722168, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1923\", \"Dose Order\": \"1\"}, {\"tsne_x\": -3.8517465591430664, \"tsne_y\": -7.0149617195129395, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1464\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.604198455810547, \"tsne_y\": -6.85564661026001, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1465\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.876941442489624, \"tsne_y\": -6.274724006652832, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1466\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.784130334854126, \"tsne_y\": -5.890727519989014, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1467\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.4754886627197266, \"tsne_y\": -5.799474716186523, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1884\", \"Dose Order\": \"2\"}, {\"tsne_x\": -1.9784443378448486, \"tsne_y\": -7.089006423950195, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1885\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.23748779296875, \"tsne_y\": -6.23540735244751, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1886\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.034642457962036, \"tsne_y\": -6.600567817687988, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1887\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.8513855934143066, \"tsne_y\": -5.6221842765808105, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1920\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.036804676055908, \"tsne_y\": -6.999430179595947, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1921\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.108045816421509, \"tsne_y\": -6.072531223297119, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1922\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.2524940967559814, \"tsne_y\": -5.012785911560059, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1923\", \"Dose Order\": \"2\"}, {\"tsne_x\": -7.423924446105957, \"tsne_y\": -12.796395301818848, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1464\", \"Dose Order\": \"3\"}, {\"tsne_x\": -6.774440288543701, \"tsne_y\": -13.636068344116211, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1465\", \"Dose Order\": \"3\"}, {\"tsne_x\": -8.07391357421875, \"tsne_y\": -14.302277565002441, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1466\", \"Dose Order\": \"3\"}, {\"tsne_x\": -6.845704555511475, \"tsne_y\": -13.946756362915039, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1467\", \"Dose Order\": \"3\"}, {\"tsne_x\": -5.795628547668457, \"tsne_y\": -14.995469093322754, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1884\", \"Dose Order\": \"3\"}, {\"tsne_x\": -6.824671745300293, \"tsne_y\": -14.540566444396973, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1885\", \"Dose Order\": \"3\"}, {\"tsne_x\": -5.93096399307251, \"tsne_y\": -13.064852714538574, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1886\", \"Dose Order\": \"3\"}, {\"tsne_x\": -6.671401500701904, \"tsne_y\": -14.006547927856445, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1887\", \"Dose Order\": \"3\"}, {\"tsne_x\": -5.296048641204834, \"tsne_y\": -14.812337875366211, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1920\", \"Dose Order\": \"3\"}, {\"tsne_x\": -5.924955368041992, \"tsne_y\": -14.066513061523438, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1921\", \"Dose Order\": \"3\"}, {\"tsne_x\": -5.1767897605896, \"tsne_y\": -13.92570972442627, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1922\", \"Dose Order\": \"3\"}, {\"tsne_x\": -5.5262651443481445, \"tsne_y\": -14.031515121459961, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1923\", \"Dose Order\": \"3\"}, {\"tsne_x\": 3.152937650680542, \"tsne_y\": -16.806310653686523, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1464\", \"Dose Order\": \"4\"}, {\"tsne_x\": 3.7782862186431885, \"tsne_y\": -16.854732513427734, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1465\", \"Dose Order\": \"4\"}, {\"tsne_x\": 3.1173951625823975, \"tsne_y\": -16.753896713256836, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1466\", \"Dose Order\": \"4\"}, {\"tsne_x\": 3.0181407928466797, \"tsne_y\": -16.75153923034668, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1467\", \"Dose Order\": \"4\"}, {\"tsne_x\": 5.219493865966797, \"tsne_y\": -15.26032543182373, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1884\", \"Dose Order\": \"4\"}, {\"tsne_x\": 5.66508150100708, \"tsne_y\": -16.754375457763672, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1885\", \"Dose Order\": \"4\"}, {\"tsne_x\": 5.484574317932129, \"tsne_y\": -17.237947463989258, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1886\", \"Dose Order\": \"4\"}, {\"tsne_x\": 5.376010417938232, \"tsne_y\": -16.54631996154785, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1887\", \"Dose Order\": \"4\"}, {\"tsne_x\": 5.2263007164001465, \"tsne_y\": -14.626700401306152, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1920\", \"Dose Order\": \"4\"}, {\"tsne_x\": 6.3880133628845215, \"tsne_y\": -16.354026794433594, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1921\", \"Dose Order\": \"4\"}, {\"tsne_x\": 5.81254243850708, \"tsne_y\": -16.208593368530273, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1922\", \"Dose Order\": \"4\"}, {\"tsne_x\": 6.1719841957092285, \"tsne_y\": -16.082454681396484, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1923\", \"Dose Order\": \"4\"}, {\"tsne_x\": 6.184666633605957, \"tsne_y\": -20.46379280090332, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1464\", \"Dose Order\": \"5\"}, {\"tsne_x\": 5.9193434715271, \"tsne_y\": -20.188081741333008, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1465\", \"Dose Order\": \"5\"}, {\"tsne_x\": 5.8670501708984375, \"tsne_y\": -20.056657791137695, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1466\", \"Dose Order\": \"5\"}, {\"tsne_x\": 5.927242279052734, \"tsne_y\": -19.99245834350586, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1467\", \"Dose Order\": \"5\"}, {\"tsne_x\": 8.49786376953125, \"tsne_y\": -18.41775894165039, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1884\", \"Dose Order\": \"5\"}, {\"tsne_x\": 8.220714569091797, \"tsne_y\": -18.5355281829834, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1885\", \"Dose Order\": \"5\"}, {\"tsne_x\": 6.3037919998168945, \"tsne_y\": -18.37053680419922, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1886\", \"Dose Order\": \"5\"}, {\"tsne_x\": 7.984158515930176, \"tsne_y\": -18.389619827270508, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1887\", \"Dose Order\": \"5\"}, {\"tsne_x\": 8.728270530700684, \"tsne_y\": -17.29808235168457, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1920\", \"Dose Order\": \"5\"}, {\"tsne_x\": 8.065410614013672, \"tsne_y\": -17.133464813232422, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1921\", \"Dose Order\": \"5\"}, {\"tsne_x\": 8.454384803771973, \"tsne_y\": -16.60911750793457, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1922\", \"Dose Order\": \"5\"}, {\"tsne_x\": 8.65135383605957, \"tsne_y\": -17.131935119628906, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|1\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1923\", \"Dose Order\": \"5\"}, {\"tsne_x\": -20.049896240234375, \"tsne_y\": 8.953709602355957, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|1\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1464\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.112131118774414, \"tsne_y\": 10.889922142028809, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|1\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1465\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.002887725830078, \"tsne_y\": 10.015345573425293, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|1\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1466\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.5068416595459, \"tsne_y\": 10.889100074768066, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|1\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1467\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.400596618652344, \"tsne_y\": 10.339825630187988, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|1\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1884\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.847848892211914, \"tsne_y\": 9.44844913482666, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|1\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1885\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.31742286682129, \"tsne_y\": 9.981413841247559, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|1\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1886\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.277021408081055, \"tsne_y\": 10.4321928024292, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|1\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1887\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.352720260620117, \"tsne_y\": 10.006781578063965, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|1\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1920\", \"Dose Order\": \"0\"}, {\"tsne_x\": -18.563447952270508, \"tsne_y\": 9.879549980163574, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|1\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1921\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.066232681274414, \"tsne_y\": 9.176496505737305, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|1\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1922\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.61856460571289, \"tsne_y\": 9.863968849182129, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|1\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1923\", \"Dose Order\": \"0\"}, {\"tsne_x\": -66.61676788330078, \"tsne_y\": 26.5191707611084, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|1\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1464\", \"Dose Order\": \"0\"}, {\"tsne_x\": -67.9524154663086, \"tsne_y\": 26.431596755981445, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|1\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1465\", \"Dose Order\": \"0\"}, {\"tsne_x\": -66.75093078613281, \"tsne_y\": 26.227216720581055, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|1\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1466\", \"Dose Order\": \"0\"}, {\"tsne_x\": -67.90998840332031, \"tsne_y\": 26.410308837890625, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|1\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1467\", \"Dose Order\": \"0\"}, {\"tsne_x\": -67.363525390625, \"tsne_y\": 27.196002960205078, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|1\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1884\", \"Dose Order\": \"0\"}, {\"tsne_x\": -66.67745208740234, \"tsne_y\": 27.277999877929688, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|1\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1885\", \"Dose Order\": \"0\"}, {\"tsne_x\": -66.71772003173828, \"tsne_y\": 27.249267578125, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|1\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1886\", \"Dose Order\": \"0\"}, {\"tsne_x\": -67.06410217285156, \"tsne_y\": 28.00732421875, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|1\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1887\", \"Dose Order\": \"0\"}, {\"tsne_x\": -64.77899169921875, \"tsne_y\": 27.966875076293945, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|1\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1920\", \"Dose Order\": \"0\"}, {\"tsne_x\": -65.36937713623047, \"tsne_y\": 27.741954803466797, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|1\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1921\", \"Dose Order\": \"0\"}, {\"tsne_x\": -66.11522674560547, \"tsne_y\": 27.38738441467285, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|1\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1922\", \"Dose Order\": \"0\"}, {\"tsne_x\": -66.76980590820312, \"tsne_y\": 27.969276428222656, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|1\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1923\", \"Dose Order\": \"0\"}, {\"tsne_x\": -55.426597595214844, \"tsne_y\": 32.59956741333008, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|1\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1464\", \"Dose Order\": \"1\"}, {\"tsne_x\": -54.409297943115234, \"tsne_y\": 32.24600601196289, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|1\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1465\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.263084411621094, \"tsne_y\": 32.2834587097168, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|1\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1466\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.2476806640625, \"tsne_y\": 32.07463455200195, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|1\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1467\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.38990020751953, \"tsne_y\": 31.341543197631836, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|1\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1884\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.40902328491211, \"tsne_y\": 31.37837791442871, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|1\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1885\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.18796920776367, \"tsne_y\": 31.28239631652832, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|1\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1886\", \"Dose Order\": \"1\"}, {\"tsne_x\": -56.06996536254883, \"tsne_y\": 31.775272369384766, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|1\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1887\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.89644241333008, \"tsne_y\": 30.28984260559082, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|1\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1920\", \"Dose Order\": \"1\"}, {\"tsne_x\": -56.20408248901367, \"tsne_y\": 29.374706268310547, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|1\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1921\", \"Dose Order\": \"1\"}, {\"tsne_x\": -56.138214111328125, \"tsne_y\": 29.604507446289062, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|1\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1922\", \"Dose Order\": \"1\"}, {\"tsne_x\": -56.51117706298828, \"tsne_y\": 32.234130859375, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|1\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1923\", \"Dose Order\": \"1\"}, {\"tsne_x\": -56.31983947753906, \"tsne_y\": 22.779253005981445, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|1\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1464\", \"Dose Order\": \"2\"}, {\"tsne_x\": -55.8227653503418, \"tsne_y\": 24.305625915527344, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|1\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1465\", \"Dose Order\": \"2\"}, {\"tsne_x\": -55.405677795410156, \"tsne_y\": 23.75798797607422, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|1\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1466\", \"Dose Order\": \"2\"}, {\"tsne_x\": -55.316707611083984, \"tsne_y\": 24.28546142578125, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|1\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1467\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.435203552246094, \"tsne_y\": 24.386117935180664, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|1\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1884\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.437068939208984, \"tsne_y\": 25.129920959472656, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|1\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1885\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.79660415649414, \"tsne_y\": 24.68109893798828, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|1\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1886\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.32101058959961, \"tsne_y\": 23.739927291870117, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|1\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1887\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.301231384277344, \"tsne_y\": 23.572553634643555, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|1\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1920\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.51581573486328, \"tsne_y\": 27.267234802246094, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|1\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1921\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.52689743041992, \"tsne_y\": 26.009784698486328, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|1\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1922\", \"Dose Order\": \"2\"}, {\"tsne_x\": -57.27976608276367, \"tsne_y\": 23.91442108154297, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|1\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1923\", \"Dose Order\": \"2\"}, {\"tsne_x\": -40.13714599609375, \"tsne_y\": 54.16735076904297, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|1\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1464\", \"Dose Order\": \"3\"}, {\"tsne_x\": -40.38603973388672, \"tsne_y\": 52.83258056640625, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|1\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1465\", \"Dose Order\": \"3\"}, {\"tsne_x\": -40.030574798583984, \"tsne_y\": 53.580810546875, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|1\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1466\", \"Dose Order\": \"3\"}, {\"tsne_x\": -44.31269073486328, \"tsne_y\": 49.48709487915039, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|1\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1467\", \"Dose Order\": \"3\"}, {\"tsne_x\": -45.80126953125, \"tsne_y\": 52.18933868408203, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|1\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1884\", \"Dose Order\": \"3\"}, {\"tsne_x\": -44.99091339111328, \"tsne_y\": 51.92382049560547, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|1\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1885\", \"Dose Order\": \"3\"}, {\"tsne_x\": -44.9272346496582, \"tsne_y\": 51.06128692626953, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|1\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1886\", \"Dose Order\": \"3\"}, {\"tsne_x\": -44.89866638183594, \"tsne_y\": 50.03038787841797, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|1\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1887\", \"Dose Order\": \"3\"}, {\"tsne_x\": -48.28883743286133, \"tsne_y\": 48.82831954956055, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|1\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1920\", \"Dose Order\": \"3\"}, {\"tsne_x\": -48.7082405090332, \"tsne_y\": 47.46698760986328, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|1\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1921\", \"Dose Order\": \"3\"}, {\"tsne_x\": -46.655189514160156, \"tsne_y\": 49.382225036621094, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|1\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1922\", \"Dose Order\": \"3\"}, {\"tsne_x\": -45.699825286865234, \"tsne_y\": 49.66233825683594, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|1\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1923\", \"Dose Order\": \"3\"}, {\"tsne_x\": -40.08442687988281, \"tsne_y\": 54.82757568359375, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|1\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1464\", \"Dose Order\": \"4\"}, {\"tsne_x\": -40.59454345703125, \"tsne_y\": 52.232967376708984, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|1\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1465\", \"Dose Order\": \"4\"}, {\"tsne_x\": -42.448368072509766, \"tsne_y\": 50.313663482666016, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|1\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1466\", \"Dose Order\": \"4\"}, {\"tsne_x\": -42.54907989501953, \"tsne_y\": 49.87256622314453, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|1\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1467\", \"Dose Order\": \"4\"}, {\"tsne_x\": -45.43992614746094, \"tsne_y\": 53.200347900390625, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|1\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1884\", \"Dose Order\": \"4\"}, {\"tsne_x\": -43.324039459228516, \"tsne_y\": 51.54786682128906, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|1\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1885\", \"Dose Order\": \"4\"}, {\"tsne_x\": -43.967777252197266, \"tsne_y\": 51.84355545043945, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|1\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1886\", \"Dose Order\": \"4\"}, {\"tsne_x\": -43.320316314697266, \"tsne_y\": 51.9786376953125, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|1\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1887\", \"Dose Order\": \"4\"}, {\"tsne_x\": -48.73093032836914, \"tsne_y\": 48.64411163330078, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|1\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1920\", \"Dose Order\": \"4\"}, {\"tsne_x\": -49.25191116333008, \"tsne_y\": 47.455867767333984, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|1\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1921\", \"Dose Order\": \"4\"}, {\"tsne_x\": -50.247920989990234, \"tsne_y\": 47.3734130859375, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|1\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1922\", \"Dose Order\": \"4\"}, {\"tsne_x\": -50.46909713745117, \"tsne_y\": 47.03678894042969, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|1\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1923\", \"Dose Order\": \"4\"}, {\"tsne_x\": -41.00641632080078, \"tsne_y\": 54.387916564941406, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|1\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1464\", \"Dose Order\": \"5\"}, {\"tsne_x\": -40.87025833129883, \"tsne_y\": 54.05767822265625, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|1\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1465\", \"Dose Order\": \"5\"}, {\"tsne_x\": -41.63190841674805, \"tsne_y\": 54.219810485839844, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|1\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1466\", \"Dose Order\": \"5\"}, {\"tsne_x\": -42.030033111572266, \"tsne_y\": 54.227752685546875, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|1\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1467\", \"Dose Order\": \"5\"}, {\"tsne_x\": -45.28474044799805, \"tsne_y\": 53.489845275878906, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|1\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1884\", \"Dose Order\": \"5\"}, {\"tsne_x\": -44.31424331665039, \"tsne_y\": 52.92255401611328, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|1\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1885\", \"Dose Order\": \"5\"}, {\"tsne_x\": -44.08511734008789, \"tsne_y\": 52.278533935546875, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|1\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1886\", \"Dose Order\": \"5\"}, {\"tsne_x\": -43.63539505004883, \"tsne_y\": 52.66596984863281, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|1\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1887\", \"Dose Order\": \"5\"}, {\"tsne_x\": -49.152217864990234, \"tsne_y\": 48.817684173583984, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|1\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1920\", \"Dose Order\": \"5\"}, {\"tsne_x\": -49.322998046875, \"tsne_y\": 47.77861404418945, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|1\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1921\", \"Dose Order\": \"5\"}, {\"tsne_x\": -50.25440216064453, \"tsne_y\": 47.836036682128906, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|1\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1922\", \"Dose Order\": \"5\"}, {\"tsne_x\": -50.48374938964844, \"tsne_y\": 47.79120635986328, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|1\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1923\", \"Dose Order\": \"5\"}, {\"tsne_x\": 20.980144500732422, \"tsne_y\": -3.991806983947754, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1464\", \"Dose Order\": \"0\"}, {\"tsne_x\": 20.485675811767578, \"tsne_y\": -4.069916725158691, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1465\", \"Dose Order\": \"0\"}, {\"tsne_x\": 21.051301956176758, \"tsne_y\": -4.7444868087768555, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1466\", \"Dose Order\": \"0\"}, {\"tsne_x\": 21.047731399536133, \"tsne_y\": -4.648623943328857, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1467\", \"Dose Order\": \"0\"}, {\"tsne_x\": 18.536325454711914, \"tsne_y\": -4.059105396270752, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1884\", \"Dose Order\": \"0\"}, {\"tsne_x\": 20.110260009765625, \"tsne_y\": -4.722842216491699, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1885\", \"Dose Order\": \"0\"}, {\"tsne_x\": 19.992130279541016, \"tsne_y\": -3.2134222984313965, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1886\", \"Dose Order\": \"0\"}, {\"tsne_x\": 19.723670959472656, \"tsne_y\": -4.44386100769043, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1887\", \"Dose Order\": \"0\"}, {\"tsne_x\": 19.480562210083008, \"tsne_y\": -2.2851574420928955, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1920\", \"Dose Order\": \"0\"}, {\"tsne_x\": 19.50735855102539, \"tsne_y\": -4.047393321990967, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1921\", \"Dose Order\": \"0\"}, {\"tsne_x\": 20.042579650878906, \"tsne_y\": -3.644077777862549, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1922\", \"Dose Order\": \"0\"}, {\"tsne_x\": 19.799945831298828, \"tsne_y\": -3.2234878540039062, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1923\", \"Dose Order\": \"0\"}, {\"tsne_x\": 25.825878143310547, \"tsne_y\": 0.736545205116272, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1464\", \"Dose Order\": \"1\"}, {\"tsne_x\": 25.22662925720215, \"tsne_y\": 1.059779405593872, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1465\", \"Dose Order\": \"1\"}, {\"tsne_x\": 26.077341079711914, \"tsne_y\": 0.12274416536092758, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1466\", \"Dose Order\": \"1\"}, {\"tsne_x\": 25.688634872436523, \"tsne_y\": 0.09759559482336044, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1467\", \"Dose Order\": \"1\"}, {\"tsne_x\": 24.3136043548584, \"tsne_y\": 0.15360406041145325, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1884\", \"Dose Order\": \"1\"}, {\"tsne_x\": 24.71381187438965, \"tsne_y\": -0.05704321339726448, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1885\", \"Dose Order\": \"1\"}, {\"tsne_x\": 23.437313079833984, \"tsne_y\": 0.6918051242828369, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1886\", \"Dose Order\": \"1\"}, {\"tsne_x\": 24.342933654785156, \"tsne_y\": 0.468955397605896, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1887\", \"Dose Order\": \"1\"}, {\"tsne_x\": 24.693466186523438, \"tsne_y\": 1.9627097845077515, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1920\", \"Dose Order\": \"1\"}, {\"tsne_x\": 24.665651321411133, \"tsne_y\": 0.6776966452598572, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1921\", \"Dose Order\": \"1\"}, {\"tsne_x\": 24.009328842163086, \"tsne_y\": 1.6672577857971191, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1922\", \"Dose Order\": \"1\"}, {\"tsne_x\": 24.43743324279785, \"tsne_y\": 1.5142091512680054, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1923\", \"Dose Order\": \"1\"}, {\"tsne_x\": 37.006656646728516, \"tsne_y\": 3.2049946784973145, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1464\", \"Dose Order\": \"2\"}, {\"tsne_x\": 37.26987075805664, \"tsne_y\": 3.507474660873413, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1465\", \"Dose Order\": \"2\"}, {\"tsne_x\": 36.62929916381836, \"tsne_y\": 3.5091936588287354, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1466\", \"Dose Order\": \"2\"}, {\"tsne_x\": 36.293331146240234, \"tsne_y\": 3.7128732204437256, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1467\", \"Dose Order\": \"2\"}, {\"tsne_x\": 34.19124984741211, \"tsne_y\": 4.666409492492676, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1884\", \"Dose Order\": \"2\"}, {\"tsne_x\": 34.673519134521484, \"tsne_y\": 4.639690399169922, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1885\", \"Dose Order\": \"2\"}, {\"tsne_x\": 34.525108337402344, \"tsne_y\": 4.0278496742248535, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1886\", \"Dose Order\": \"2\"}, {\"tsne_x\": 34.54719161987305, \"tsne_y\": 4.738380432128906, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1887\", \"Dose Order\": \"2\"}, {\"tsne_x\": 33.727394104003906, \"tsne_y\": 3.547239065170288, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1920\", \"Dose Order\": \"2\"}, {\"tsne_x\": 33.42558670043945, \"tsne_y\": 4.099376678466797, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1921\", \"Dose Order\": \"2\"}, {\"tsne_x\": 34.19418716430664, \"tsne_y\": 3.6245436668395996, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1922\", \"Dose Order\": \"2\"}, {\"tsne_x\": 34.11425018310547, \"tsne_y\": 3.3462061882019043, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1923\", \"Dose Order\": \"2\"}, {\"tsne_x\": 40.17674255371094, \"tsne_y\": 3.7213714122772217, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1464\", \"Dose Order\": \"3\"}, {\"tsne_x\": 38.959144592285156, \"tsne_y\": 3.9357378482818604, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1465\", \"Dose Order\": \"3\"}, {\"tsne_x\": 39.54988098144531, \"tsne_y\": 4.528934001922607, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1466\", \"Dose Order\": \"3\"}, {\"tsne_x\": 39.44225311279297, \"tsne_y\": 4.680186748504639, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1467\", \"Dose Order\": \"3\"}, {\"tsne_x\": 39.59959411621094, \"tsne_y\": 7.5780816078186035, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1884\", \"Dose Order\": \"3\"}, {\"tsne_x\": 39.7756462097168, \"tsne_y\": 7.129576683044434, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1885\", \"Dose Order\": \"3\"}, {\"tsne_x\": 40.05278015136719, \"tsne_y\": 6.923268795013428, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1886\", \"Dose Order\": \"3\"}, {\"tsne_x\": 39.75253677368164, \"tsne_y\": 6.979274272918701, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1887\", \"Dose Order\": \"3\"}, {\"tsne_x\": 39.850975036621094, \"tsne_y\": 8.492330551147461, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1920\", \"Dose Order\": \"3\"}, {\"tsne_x\": 40.838706970214844, \"tsne_y\": 8.078744888305664, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1921\", \"Dose Order\": \"3\"}, {\"tsne_x\": 40.83462905883789, \"tsne_y\": 7.9866743087768555, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1922\", \"Dose Order\": \"3\"}, {\"tsne_x\": 41.068878173828125, \"tsne_y\": 8.179229736328125, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1923\", \"Dose Order\": \"3\"}, {\"tsne_x\": 42.6834716796875, \"tsne_y\": 3.2901077270507812, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1464\", \"Dose Order\": \"4\"}, {\"tsne_x\": 42.58668518066406, \"tsne_y\": 3.2799606323242188, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1465\", \"Dose Order\": \"4\"}, {\"tsne_x\": 43.263946533203125, \"tsne_y\": 3.688833475112915, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1466\", \"Dose Order\": \"4\"}, {\"tsne_x\": 43.33480453491211, \"tsne_y\": 3.73433780670166, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1467\", \"Dose Order\": \"4\"}, {\"tsne_x\": 44.4960823059082, \"tsne_y\": 7.690553188323975, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1884\", \"Dose Order\": \"4\"}, {\"tsne_x\": 45.012916564941406, \"tsne_y\": 7.503230571746826, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1885\", \"Dose Order\": \"4\"}, {\"tsne_x\": 45.18489074707031, \"tsne_y\": 7.42609977722168, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1886\", \"Dose Order\": \"4\"}, {\"tsne_x\": 45.0698356628418, \"tsne_y\": 7.470351696014404, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1887\", \"Dose Order\": \"4\"}, {\"tsne_x\": 44.168209075927734, \"tsne_y\": 8.903656959533691, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1920\", \"Dose Order\": \"4\"}, {\"tsne_x\": 44.943233489990234, \"tsne_y\": 8.746153831481934, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1921\", \"Dose Order\": \"4\"}, {\"tsne_x\": 45.134666442871094, \"tsne_y\": 8.952448844909668, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1922\", \"Dose Order\": \"4\"}, {\"tsne_x\": 45.10790252685547, \"tsne_y\": 9.136500358581543, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1923\", \"Dose Order\": \"4\"}, {\"tsne_x\": 45.87706756591797, \"tsne_y\": 2.601243495941162, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1464\", \"Dose Order\": \"5\"}, {\"tsne_x\": 45.89793395996094, \"tsne_y\": 2.7015247344970703, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1465\", \"Dose Order\": \"5\"}, {\"tsne_x\": 46.12177658081055, \"tsne_y\": 2.959526777267456, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1466\", \"Dose Order\": \"5\"}, {\"tsne_x\": 46.147132873535156, \"tsne_y\": 2.905029535293579, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1467\", \"Dose Order\": \"5\"}, {\"tsne_x\": 49.04329299926758, \"tsne_y\": 7.591670036315918, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1884\", \"Dose Order\": \"5\"}, {\"tsne_x\": 48.66624450683594, \"tsne_y\": 7.273128509521484, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1885\", \"Dose Order\": \"5\"}, {\"tsne_x\": 48.48567199707031, \"tsne_y\": 7.04022741317749, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1886\", \"Dose Order\": \"5\"}, {\"tsne_x\": 48.51725387573242, \"tsne_y\": 7.057124614715576, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1887\", \"Dose Order\": \"5\"}, {\"tsne_x\": 49.01811981201172, \"tsne_y\": 9.04279613494873, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1920\", \"Dose Order\": \"5\"}, {\"tsne_x\": 48.42523193359375, \"tsne_y\": 8.611984252929688, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1921\", \"Dose Order\": \"5\"}, {\"tsne_x\": 48.392921447753906, \"tsne_y\": 8.618795394897461, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1922\", \"Dose Order\": \"5\"}, {\"tsne_x\": 48.251373291015625, \"tsne_y\": 8.953520774841309, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|1\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1923\", \"Dose Order\": \"5\"}, {\"tsne_x\": 37.51573181152344, \"tsne_y\": -58.36288833618164, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1464\", \"Dose Order\": \"0\"}, {\"tsne_x\": 37.26716995239258, \"tsne_y\": -58.09023666381836, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1465\", \"Dose Order\": \"0\"}, {\"tsne_x\": 38.122310638427734, \"tsne_y\": -58.21000289916992, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1466\", \"Dose Order\": \"0\"}, {\"tsne_x\": 38.2943000793457, \"tsne_y\": -58.63212203979492, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1467\", \"Dose Order\": \"0\"}, {\"tsne_x\": 37.87662887573242, \"tsne_y\": -61.075897216796875, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1884\", \"Dose Order\": \"0\"}, {\"tsne_x\": 38.34808349609375, \"tsne_y\": -60.496646881103516, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1885\", \"Dose Order\": \"0\"}, {\"tsne_x\": 38.706478118896484, \"tsne_y\": -60.42348861694336, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1886\", \"Dose Order\": \"0\"}, {\"tsne_x\": 38.15034484863281, \"tsne_y\": -60.13737869262695, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1887\", \"Dose Order\": \"0\"}, {\"tsne_x\": 36.57729721069336, \"tsne_y\": -61.01747512817383, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1920\", \"Dose Order\": \"0\"}, {\"tsne_x\": 37.28508758544922, \"tsne_y\": -60.4066162109375, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1921\", \"Dose Order\": \"0\"}, {\"tsne_x\": 37.042972564697266, \"tsne_y\": -60.06159591674805, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1922\", \"Dose Order\": \"0\"}, {\"tsne_x\": 36.73046112060547, \"tsne_y\": -59.90323257446289, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1923\", \"Dose Order\": \"0\"}, {\"tsne_x\": 40.520111083984375, \"tsne_y\": -57.41219711303711, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1464\", \"Dose Order\": \"1\"}, {\"tsne_x\": 40.502986907958984, \"tsne_y\": -57.31562805175781, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1465\", \"Dose Order\": \"1\"}, {\"tsne_x\": 39.679710388183594, \"tsne_y\": -57.16848373413086, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1466\", \"Dose Order\": \"1\"}, {\"tsne_x\": 40.02544021606445, \"tsne_y\": -57.895240783691406, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1467\", \"Dose Order\": \"1\"}, {\"tsne_x\": 41.87041091918945, \"tsne_y\": -58.710479736328125, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1884\", \"Dose Order\": \"1\"}, {\"tsne_x\": 41.70871353149414, \"tsne_y\": -58.763023376464844, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1885\", \"Dose Order\": \"1\"}, {\"tsne_x\": 40.99523162841797, \"tsne_y\": -59.621456146240234, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1886\", \"Dose Order\": \"1\"}, {\"tsne_x\": 41.86030197143555, \"tsne_y\": -58.38140869140625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1887\", \"Dose Order\": \"1\"}, {\"tsne_x\": 42.791934967041016, \"tsne_y\": -59.65178680419922, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1920\", \"Dose Order\": \"1\"}, {\"tsne_x\": 42.22798156738281, \"tsne_y\": -59.813560485839844, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1921\", \"Dose Order\": \"1\"}, {\"tsne_x\": 42.34107971191406, \"tsne_y\": -59.46994400024414, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1922\", \"Dose Order\": \"1\"}, {\"tsne_x\": 42.57249450683594, \"tsne_y\": -60.10700607299805, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1923\", \"Dose Order\": \"1\"}, {\"tsne_x\": 48.178043365478516, \"tsne_y\": -51.43902587890625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1464\", \"Dose Order\": \"2\"}, {\"tsne_x\": 48.09588623046875, \"tsne_y\": -50.98481750488281, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1465\", \"Dose Order\": \"2\"}, {\"tsne_x\": 48.07994842529297, \"tsne_y\": -51.03384017944336, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1466\", \"Dose Order\": \"2\"}, {\"tsne_x\": 48.175933837890625, \"tsne_y\": -50.94877624511719, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1467\", \"Dose Order\": \"2\"}, {\"tsne_x\": 50.943519592285156, \"tsne_y\": -49.95521545410156, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1884\", \"Dose Order\": \"2\"}, {\"tsne_x\": 49.97429275512695, \"tsne_y\": -49.83787155151367, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1885\", \"Dose Order\": \"2\"}, {\"tsne_x\": 49.98341369628906, \"tsne_y\": -49.87447738647461, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1886\", \"Dose Order\": \"2\"}, {\"tsne_x\": 50.214630126953125, \"tsne_y\": -49.99752426147461, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1887\", \"Dose Order\": \"2\"}, {\"tsne_x\": 51.49602127075195, \"tsne_y\": -50.35015106201172, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1920\", \"Dose Order\": \"2\"}, {\"tsne_x\": 50.747596740722656, \"tsne_y\": -51.116458892822266, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1921\", \"Dose Order\": \"2\"}, {\"tsne_x\": 50.85002899169922, \"tsne_y\": -50.9869384765625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1922\", \"Dose Order\": \"2\"}, {\"tsne_x\": 50.65978240966797, \"tsne_y\": -51.02798080444336, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1923\", \"Dose Order\": \"2\"}, {\"tsne_x\": 51.615779876708984, \"tsne_y\": -44.100868225097656, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1464\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.69395065307617, \"tsne_y\": -44.06101608276367, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1465\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.89426040649414, \"tsne_y\": -44.02640151977539, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1466\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.88621139526367, \"tsne_y\": -43.97275161743164, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1467\", \"Dose Order\": \"3\"}, {\"tsne_x\": 53.404972076416016, \"tsne_y\": -46.67585372924805, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1884\", \"Dose Order\": \"3\"}, {\"tsne_x\": 52.996978759765625, \"tsne_y\": -46.32698059082031, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1885\", \"Dose Order\": \"3\"}, {\"tsne_x\": 52.67634582519531, \"tsne_y\": -46.53031921386719, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1886\", \"Dose Order\": \"3\"}, {\"tsne_x\": 52.6795539855957, \"tsne_y\": -46.343624114990234, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1887\", \"Dose Order\": \"3\"}, {\"tsne_x\": 54.25909423828125, \"tsne_y\": -46.34065246582031, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1920\", \"Dose Order\": \"3\"}, {\"tsne_x\": 53.81703567504883, \"tsne_y\": -45.61182403564453, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1921\", \"Dose Order\": \"3\"}, {\"tsne_x\": 53.95711135864258, \"tsne_y\": -45.79237365722656, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1922\", \"Dose Order\": \"3\"}, {\"tsne_x\": 53.6584587097168, \"tsne_y\": -45.45383834838867, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1923\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.61284255981445, \"tsne_y\": -28.14983367919922, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1464\", \"Dose Order\": \"4\"}, {\"tsne_x\": 51.727210998535156, \"tsne_y\": -28.261980056762695, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1465\", \"Dose Order\": \"4\"}, {\"tsne_x\": 50.83706283569336, \"tsne_y\": -28.147451400756836, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1466\", \"Dose Order\": \"4\"}, {\"tsne_x\": 51.139739990234375, \"tsne_y\": -28.174877166748047, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1467\", \"Dose Order\": \"4\"}, {\"tsne_x\": 50.31757736206055, \"tsne_y\": -25.796485900878906, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1884\", \"Dose Order\": \"4\"}, {\"tsne_x\": 50.12572479248047, \"tsne_y\": -26.402311325073242, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1885\", \"Dose Order\": \"4\"}, {\"tsne_x\": 50.12278747558594, \"tsne_y\": -26.55372428894043, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1886\", \"Dose Order\": \"4\"}, {\"tsne_x\": 50.07059860229492, \"tsne_y\": -26.684267044067383, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1887\", \"Dose Order\": \"4\"}, {\"tsne_x\": 51.016387939453125, \"tsne_y\": -25.719783782958984, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1920\", \"Dose Order\": \"4\"}, {\"tsne_x\": 51.1805305480957, \"tsne_y\": -26.485944747924805, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1921\", \"Dose Order\": \"4\"}, {\"tsne_x\": 51.218284606933594, \"tsne_y\": -26.360401153564453, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1922\", \"Dose Order\": \"4\"}, {\"tsne_x\": 51.154296875, \"tsne_y\": -26.401649475097656, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1923\", \"Dose Order\": \"4\"}, {\"tsne_x\": 44.784000396728516, \"tsne_y\": -17.501094818115234, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1464\", \"Dose Order\": \"5\"}, {\"tsne_x\": 44.23054122924805, \"tsne_y\": -16.965497970581055, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1465\", \"Dose Order\": \"5\"}, {\"tsne_x\": 44.11296081542969, \"tsne_y\": -16.833698272705078, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1466\", \"Dose Order\": \"5\"}, {\"tsne_x\": 44.14640426635742, \"tsne_y\": -16.873289108276367, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1467\", \"Dose Order\": \"5\"}, {\"tsne_x\": 45.938751220703125, \"tsne_y\": -19.937824249267578, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1884\", \"Dose Order\": \"5\"}, {\"tsne_x\": 46.145694732666016, \"tsne_y\": -20.332674026489258, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1885\", \"Dose Order\": \"5\"}, {\"tsne_x\": 46.2298469543457, \"tsne_y\": -20.339365005493164, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1886\", \"Dose Order\": \"5\"}, {\"tsne_x\": 46.74593734741211, \"tsne_y\": -20.452587127685547, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1887\", \"Dose Order\": \"5\"}, {\"tsne_x\": 46.25258255004883, \"tsne_y\": -19.003694534301758, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1920\", \"Dose Order\": \"5\"}, {\"tsne_x\": 46.759613037109375, \"tsne_y\": -19.386796951293945, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1921\", \"Dose Order\": \"5\"}, {\"tsne_x\": 46.58723449707031, \"tsne_y\": -19.376310348510742, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1922\", \"Dose Order\": \"5\"}, {\"tsne_x\": 46.99517822265625, \"tsne_y\": -19.707033157348633, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|1\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1923\", \"Dose Order\": \"5\"}, {\"tsne_x\": 16.175691604614258, \"tsne_y\": 41.314151763916016, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1464\", \"Dose Order\": \"0\"}, {\"tsne_x\": 16.318172454833984, \"tsne_y\": 41.184879302978516, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1465\", \"Dose Order\": \"0\"}, {\"tsne_x\": 15.802363395690918, \"tsne_y\": 41.17080307006836, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1466\", \"Dose Order\": \"0\"}, {\"tsne_x\": 15.65269947052002, \"tsne_y\": 41.21479034423828, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1467\", \"Dose Order\": \"0\"}, {\"tsne_x\": 13.796242713928223, \"tsne_y\": 43.083465576171875, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1884\", \"Dose Order\": \"0\"}, {\"tsne_x\": 14.051371574401855, \"tsne_y\": 43.41228103637695, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1885\", \"Dose Order\": \"0\"}, {\"tsne_x\": 13.984766006469727, \"tsne_y\": 43.546295166015625, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1886\", \"Dose Order\": \"0\"}, {\"tsne_x\": 14.067821502685547, \"tsne_y\": 43.59807205200195, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1887\", \"Dose Order\": \"0\"}, {\"tsne_x\": 12.850767135620117, \"tsne_y\": 44.574615478515625, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1920\", \"Dose Order\": \"0\"}, {\"tsne_x\": 13.12840747833252, \"tsne_y\": 44.75770568847656, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1921\", \"Dose Order\": \"0\"}, {\"tsne_x\": 13.241288185119629, \"tsne_y\": 45.15681838989258, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1922\", \"Dose Order\": \"0\"}, {\"tsne_x\": 13.248276710510254, \"tsne_y\": 45.13048553466797, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1923\", \"Dose Order\": \"0\"}, {\"tsne_x\": 16.024389266967773, \"tsne_y\": 38.35226821899414, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1464\", \"Dose Order\": \"1\"}, {\"tsne_x\": 16.110116958618164, \"tsne_y\": 38.73316192626953, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1465\", \"Dose Order\": \"1\"}, {\"tsne_x\": 15.223934173583984, \"tsne_y\": 38.94395446777344, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1466\", \"Dose Order\": \"1\"}, {\"tsne_x\": 15.104854583740234, \"tsne_y\": 39.14375305175781, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1467\", \"Dose Order\": \"1\"}, {\"tsne_x\": 11.045811653137207, \"tsne_y\": 39.24202346801758, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1884\", \"Dose Order\": \"1\"}, {\"tsne_x\": 11.41591739654541, \"tsne_y\": 39.78826141357422, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1885\", \"Dose Order\": \"1\"}, {\"tsne_x\": 11.463614463806152, \"tsne_y\": 39.8519401550293, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1886\", \"Dose Order\": \"1\"}, {\"tsne_x\": 11.434309959411621, \"tsne_y\": 39.69847869873047, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1887\", \"Dose Order\": \"1\"}, {\"tsne_x\": 9.280844688415527, \"tsne_y\": 40.09162521362305, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1920\", \"Dose Order\": \"1\"}, {\"tsne_x\": 9.058103561401367, \"tsne_y\": 40.02729797363281, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1921\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.580745697021484, \"tsne_y\": 39.99018859863281, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1922\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.732687950134277, \"tsne_y\": 40.11502456665039, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1923\", \"Dose Order\": \"1\"}, {\"tsne_x\": 15.963281631469727, \"tsne_y\": 37.60783767700195, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1464\", \"Dose Order\": \"2\"}, {\"tsne_x\": 15.655583381652832, \"tsne_y\": 37.383094787597656, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1465\", \"Dose Order\": \"2\"}, {\"tsne_x\": 15.216084480285645, \"tsne_y\": 37.18386459350586, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1466\", \"Dose Order\": \"2\"}, {\"tsne_x\": 15.055970191955566, \"tsne_y\": 37.03459167480469, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1467\", \"Dose Order\": \"2\"}, {\"tsne_x\": 8.641037940979004, \"tsne_y\": 35.06549072265625, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1884\", \"Dose Order\": \"2\"}, {\"tsne_x\": 8.678925514221191, \"tsne_y\": 35.452999114990234, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1885\", \"Dose Order\": \"2\"}, {\"tsne_x\": 8.725675582885742, \"tsne_y\": 35.61027908325195, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1886\", \"Dose Order\": \"2\"}, {\"tsne_x\": 8.684176445007324, \"tsne_y\": 35.4929313659668, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1887\", \"Dose Order\": \"2\"}, {\"tsne_x\": 7.271642684936523, \"tsne_y\": 37.56488800048828, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1920\", \"Dose Order\": \"2\"}, {\"tsne_x\": 6.909677028656006, \"tsne_y\": 37.4163818359375, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1921\", \"Dose Order\": \"2\"}, {\"tsne_x\": 6.500609397888184, \"tsne_y\": 37.53767395019531, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1922\", \"Dose Order\": \"2\"}, {\"tsne_x\": 6.209458351135254, \"tsne_y\": 37.47434616088867, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1923\", \"Dose Order\": \"2\"}, {\"tsne_x\": -17.190881729125977, \"tsne_y\": 15.40638542175293, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1464\", \"Dose Order\": \"3\"}, {\"tsne_x\": -17.257986068725586, \"tsne_y\": 15.533354759216309, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1465\", \"Dose Order\": \"3\"}, {\"tsne_x\": -17.227819442749023, \"tsne_y\": 15.442647933959961, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1466\", \"Dose Order\": \"3\"}, {\"tsne_x\": -16.842100143432617, \"tsne_y\": 14.658490180969238, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1467\", \"Dose Order\": \"3\"}, {\"tsne_x\": 6.929925918579102, \"tsne_y\": 33.88306427001953, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1884\", \"Dose Order\": \"3\"}, {\"tsne_x\": 6.588925838470459, \"tsne_y\": 34.3446159362793, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1885\", \"Dose Order\": \"3\"}, {\"tsne_x\": 6.338922500610352, \"tsne_y\": 34.50214385986328, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1886\", \"Dose Order\": \"3\"}, {\"tsne_x\": 6.54959774017334, \"tsne_y\": 34.40311813354492, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1887\", \"Dose Order\": \"3\"}, {\"tsne_x\": 5.498018264770508, \"tsne_y\": 35.92188262939453, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1920\", \"Dose Order\": \"3\"}, {\"tsne_x\": 5.759312152862549, \"tsne_y\": 36.20151901245117, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1921\", \"Dose Order\": \"3\"}, {\"tsne_x\": 5.599287033081055, \"tsne_y\": 36.797420501708984, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1922\", \"Dose Order\": \"3\"}, {\"tsne_x\": 5.49860954284668, \"tsne_y\": 36.72257614135742, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1923\", \"Dose Order\": \"3\"}, {\"tsne_x\": -18.25796890258789, \"tsne_y\": 17.324922561645508, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1464\", \"Dose Order\": \"4\"}, {\"tsne_x\": -18.212905883789062, \"tsne_y\": 17.20407485961914, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1465\", \"Dose Order\": \"4\"}, {\"tsne_x\": -18.43624496459961, \"tsne_y\": 16.9644775390625, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1466\", \"Dose Order\": \"4\"}, {\"tsne_x\": -18.149499893188477, \"tsne_y\": 17.62435531616211, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1467\", \"Dose Order\": \"4\"}, {\"tsne_x\": -5.831863880157471, \"tsne_y\": 30.495771408081055, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1884\", \"Dose Order\": \"4\"}, {\"tsne_x\": -5.844876289367676, \"tsne_y\": 30.663633346557617, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1885\", \"Dose Order\": \"4\"}, {\"tsne_x\": -5.817533016204834, \"tsne_y\": 30.71236801147461, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1886\", \"Dose Order\": \"4\"}, {\"tsne_x\": -5.751256942749023, \"tsne_y\": 30.913562774658203, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1887\", \"Dose Order\": \"4\"}, {\"tsne_x\": -4.173690319061279, \"tsne_y\": 31.38155174255371, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1920\", \"Dose Order\": \"4\"}, {\"tsne_x\": -4.401439666748047, \"tsne_y\": 31.302860260009766, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1921\", \"Dose Order\": \"4\"}, {\"tsne_x\": -4.377407073974609, \"tsne_y\": 31.45975685119629, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1922\", \"Dose Order\": \"4\"}, {\"tsne_x\": -4.428657054901123, \"tsne_y\": 31.642240524291992, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1923\", \"Dose Order\": \"4\"}, {\"tsne_x\": -22.31648826599121, \"tsne_y\": 16.4848575592041, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1464\", \"Dose Order\": \"5\"}, {\"tsne_x\": -22.410066604614258, \"tsne_y\": 16.70313835144043, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1465\", \"Dose Order\": \"5\"}, {\"tsne_x\": -22.27311897277832, \"tsne_y\": 16.500391006469727, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1466\", \"Dose Order\": \"5\"}, {\"tsne_x\": -22.30142593383789, \"tsne_y\": 16.498865127563477, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1467\", \"Dose Order\": \"5\"}, {\"tsne_x\": -8.530763626098633, \"tsne_y\": 29.827972412109375, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1884\", \"Dose Order\": \"5\"}, {\"tsne_x\": -8.857404708862305, \"tsne_y\": 29.844839096069336, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1885\", \"Dose Order\": \"5\"}, {\"tsne_x\": -8.777152061462402, \"tsne_y\": 29.872730255126953, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1886\", \"Dose Order\": \"5\"}, {\"tsne_x\": -8.687986373901367, \"tsne_y\": 29.868284225463867, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1887\", \"Dose Order\": \"5\"}, {\"tsne_x\": -10.778587341308594, \"tsne_y\": 28.98413848876953, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1920\", \"Dose Order\": \"5\"}, {\"tsne_x\": -10.367450714111328, \"tsne_y\": 29.260709762573242, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1921\", \"Dose Order\": \"5\"}, {\"tsne_x\": -10.417189598083496, \"tsne_y\": 29.288108825683594, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1922\", \"Dose Order\": \"5\"}, {\"tsne_x\": -10.41032600402832, \"tsne_y\": 29.306541442871094, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|1\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1923\", \"Dose Order\": \"5\"}, {\"tsne_x\": -54.63847351074219, \"tsne_y\": -0.5171191096305847, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1464\", \"Dose Order\": \"0\"}, {\"tsne_x\": -54.340553283691406, \"tsne_y\": -0.49678507447242737, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1465\", \"Dose Order\": \"0\"}, {\"tsne_x\": -55.53364562988281, \"tsne_y\": -0.06212294474244118, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1466\", \"Dose Order\": \"0\"}, {\"tsne_x\": -55.22522735595703, \"tsne_y\": 1.271087884902954, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1467\", \"Dose Order\": \"0\"}, {\"tsne_x\": -53.34418869018555, \"tsne_y\": -0.9045745134353638, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1884\", \"Dose Order\": \"0\"}, {\"tsne_x\": -54.441471099853516, \"tsne_y\": 0.5142881274223328, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1885\", \"Dose Order\": \"0\"}, {\"tsne_x\": -54.01869583129883, \"tsne_y\": 0.6953268647193909, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1886\", \"Dose Order\": \"0\"}, {\"tsne_x\": -54.425662994384766, \"tsne_y\": 0.1994965821504593, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1887\", \"Dose Order\": \"0\"}, {\"tsne_x\": -54.48103713989258, \"tsne_y\": -10.282632827758789, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1920\", \"Dose Order\": \"0\"}, {\"tsne_x\": -53.98334884643555, \"tsne_y\": 0.0587061271071434, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1921\", \"Dose Order\": \"0\"}, {\"tsne_x\": -54.460514068603516, \"tsne_y\": -10.292095184326172, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1922\", \"Dose Order\": \"0\"}, {\"tsne_x\": -53.97564697265625, \"tsne_y\": 0.18902626633644104, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1923\", \"Dose Order\": \"0\"}, {\"tsne_x\": -55.34593200683594, \"tsne_y\": -5.69948148727417, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1464\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.37290573120117, \"tsne_y\": -6.0362043380737305, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1465\", \"Dose Order\": \"1\"}, {\"tsne_x\": -56.13843536376953, \"tsne_y\": -6.036108493804932, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1466\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.35822296142578, \"tsne_y\": -6.651662349700928, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1467\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.04243469238281, \"tsne_y\": -5.000938892364502, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1884\", \"Dose Order\": \"1\"}, {\"tsne_x\": -54.785072326660156, \"tsne_y\": -5.778109073638916, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1885\", \"Dose Order\": \"1\"}, {\"tsne_x\": -54.249969482421875, \"tsne_y\": -5.4102463722229, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1886\", \"Dose Order\": \"1\"}, {\"tsne_x\": -54.671966552734375, \"tsne_y\": -5.887712478637695, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1887\", \"Dose Order\": \"1\"}, {\"tsne_x\": -54.67182922363281, \"tsne_y\": -8.960735321044922, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1920\", \"Dose Order\": \"1\"}, {\"tsne_x\": -54.82920837402344, \"tsne_y\": -7.52740478515625, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1921\", \"Dose Order\": \"1\"}, {\"tsne_x\": -54.7885627746582, \"tsne_y\": -8.44878101348877, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1922\", \"Dose Order\": \"1\"}, {\"tsne_x\": -54.69661331176758, \"tsne_y\": -7.511090278625488, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1923\", \"Dose Order\": \"1\"}, {\"tsne_x\": -49.346370697021484, \"tsne_y\": -6.706183433532715, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1464\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.36832046508789, \"tsne_y\": -6.739470958709717, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1465\", \"Dose Order\": \"2\"}, {\"tsne_x\": -48.75166320800781, \"tsne_y\": -6.934835433959961, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1466\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.06841278076172, \"tsne_y\": -7.3323974609375, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1467\", \"Dose Order\": \"2\"}, {\"tsne_x\": -50.110042572021484, \"tsne_y\": -8.929000854492188, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1884\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.863182067871094, \"tsne_y\": -8.477397918701172, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1885\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.710838317871094, \"tsne_y\": -6.344353199005127, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1886\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.61048889160156, \"tsne_y\": -7.094456672668457, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1887\", \"Dose Order\": \"2\"}, {\"tsne_x\": -50.67227554321289, \"tsne_y\": -9.824324607849121, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1920\", \"Dose Order\": \"2\"}, {\"tsne_x\": -51.053348541259766, \"tsne_y\": -16.195642471313477, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1921\", \"Dose Order\": \"2\"}, {\"tsne_x\": -51.42955780029297, \"tsne_y\": -15.053985595703125, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1922\", \"Dose Order\": \"2\"}, {\"tsne_x\": -50.168209075927734, \"tsne_y\": -8.927630424499512, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1923\", \"Dose Order\": \"2\"}, {\"tsne_x\": -41.18545913696289, \"tsne_y\": -15.26879596710205, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1464\", \"Dose Order\": \"3\"}, {\"tsne_x\": -41.455631256103516, \"tsne_y\": -14.437135696411133, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1465\", \"Dose Order\": \"3\"}, {\"tsne_x\": -43.872737884521484, \"tsne_y\": -11.617059707641602, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1466\", \"Dose Order\": \"3\"}, {\"tsne_x\": -43.935760498046875, \"tsne_y\": -11.443655967712402, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1467\", \"Dose Order\": \"3\"}, {\"tsne_x\": -44.80622482299805, \"tsne_y\": -19.96066665649414, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1884\", \"Dose Order\": \"3\"}, {\"tsne_x\": -44.372379302978516, \"tsne_y\": -20.708173751831055, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1885\", \"Dose Order\": \"3\"}, {\"tsne_x\": -43.974388122558594, \"tsne_y\": -11.421513557434082, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1886\", \"Dose Order\": \"3\"}, {\"tsne_x\": -44.17543029785156, \"tsne_y\": -20.992982864379883, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1887\", \"Dose Order\": \"3\"}, {\"tsne_x\": -49.79785919189453, \"tsne_y\": -17.279634475708008, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1920\", \"Dose Order\": \"3\"}, {\"tsne_x\": -50.449928283691406, \"tsne_y\": -17.468292236328125, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1921\", \"Dose Order\": \"3\"}, {\"tsne_x\": -51.41539001464844, \"tsne_y\": -18.197566986083984, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1922\", \"Dose Order\": \"3\"}, {\"tsne_x\": -50.825714111328125, \"tsne_y\": -18.94649887084961, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1923\", \"Dose Order\": \"3\"}, {\"tsne_x\": -42.5391731262207, \"tsne_y\": -14.39654541015625, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1464\", \"Dose Order\": \"4\"}, {\"tsne_x\": -42.500484466552734, \"tsne_y\": -14.376399993896484, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1465\", \"Dose Order\": \"4\"}, {\"tsne_x\": -43.13345718383789, \"tsne_y\": -13.313931465148926, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1466\", \"Dose Order\": \"4\"}, {\"tsne_x\": -43.03428268432617, \"tsne_y\": -14.795265197753906, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1467\", \"Dose Order\": \"4\"}, {\"tsne_x\": -44.880775451660156, \"tsne_y\": -19.12313461303711, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1884\", \"Dose Order\": \"4\"}, {\"tsne_x\": -43.811580657958984, \"tsne_y\": -20.76058006286621, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1885\", \"Dose Order\": \"4\"}, {\"tsne_x\": -43.382938385009766, \"tsne_y\": -20.19394302368164, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1886\", \"Dose Order\": \"4\"}, {\"tsne_x\": -43.128726959228516, \"tsne_y\": -20.264684677124023, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1887\", \"Dose Order\": \"4\"}, {\"tsne_x\": -49.145904541015625, \"tsne_y\": -17.782190322875977, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1920\", \"Dose Order\": \"4\"}, {\"tsne_x\": -49.96097946166992, \"tsne_y\": -18.200851440429688, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1921\", \"Dose Order\": \"4\"}, {\"tsne_x\": -50.70702362060547, \"tsne_y\": -18.593843460083008, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1922\", \"Dose Order\": \"4\"}, {\"tsne_x\": -50.565181732177734, \"tsne_y\": -19.11431121826172, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1923\", \"Dose Order\": \"4\"}, {\"tsne_x\": -41.65479278564453, \"tsne_y\": -15.872501373291016, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1464\", \"Dose Order\": \"5\"}, {\"tsne_x\": -41.477474212646484, \"tsne_y\": -15.787444114685059, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1465\", \"Dose Order\": \"5\"}, {\"tsne_x\": -41.94675064086914, \"tsne_y\": -16.437835693359375, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1466\", \"Dose Order\": \"5\"}, {\"tsne_x\": -42.45063400268555, \"tsne_y\": -16.477581024169922, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1467\", \"Dose Order\": \"5\"}, {\"tsne_x\": -44.21625900268555, \"tsne_y\": -18.435604095458984, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1884\", \"Dose Order\": \"5\"}, {\"tsne_x\": -43.738258361816406, \"tsne_y\": -18.70461654663086, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1885\", \"Dose Order\": \"5\"}, {\"tsne_x\": -43.160282135009766, \"tsne_y\": -19.147457122802734, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1886\", \"Dose Order\": \"5\"}, {\"tsne_x\": -43.38443374633789, \"tsne_y\": -18.80256462097168, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1887\", \"Dose Order\": \"5\"}, {\"tsne_x\": -48.7382926940918, \"tsne_y\": -17.99359893798828, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1920\", \"Dose Order\": \"5\"}, {\"tsne_x\": -49.362449645996094, \"tsne_y\": -18.671323776245117, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1921\", \"Dose Order\": \"5\"}, {\"tsne_x\": -49.47810745239258, \"tsne_y\": -19.848608016967773, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1922\", \"Dose Order\": \"5\"}, {\"tsne_x\": -49.99897766113281, \"tsne_y\": -19.41242790222168, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|1\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1923\", \"Dose Order\": \"5\"}, {\"tsne_x\": -18.30010223388672, \"tsne_y\": -45.842586517333984, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1464\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.274518966674805, \"tsne_y\": -46.79670333862305, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1465\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.44333839416504, \"tsne_y\": -46.56281661987305, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1466\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.425256729125977, \"tsne_y\": -45.82302474975586, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1467\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.493927001953125, \"tsne_y\": -47.733524322509766, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1884\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.34523582458496, \"tsne_y\": -48.097198486328125, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1885\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.72290802001953, \"tsne_y\": -48.033626556396484, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1886\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.12332534790039, \"tsne_y\": -46.984806060791016, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1887\", \"Dose Order\": \"0\"}, {\"tsne_x\": -21.47962188720703, \"tsne_y\": -47.74623489379883, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1920\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.503040313720703, \"tsne_y\": -47.23644256591797, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1921\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.087711334228516, \"tsne_y\": -47.41254425048828, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1922\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.582353591918945, \"tsne_y\": -47.010536193847656, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1923\", \"Dose Order\": \"0\"}, {\"tsne_x\": -16.006242752075195, \"tsne_y\": -58.53000259399414, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1464\", \"Dose Order\": \"1\"}, {\"tsne_x\": -16.339458465576172, \"tsne_y\": -59.30369567871094, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1465\", \"Dose Order\": \"1\"}, {\"tsne_x\": -16.722576141357422, \"tsne_y\": -58.15304183959961, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1466\", \"Dose Order\": \"1\"}, {\"tsne_x\": -16.82052993774414, \"tsne_y\": -58.3049430847168, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1467\", \"Dose Order\": \"1\"}, {\"tsne_x\": -14.05839729309082, \"tsne_y\": -58.824466705322266, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1884\", \"Dose Order\": \"1\"}, {\"tsne_x\": -15.9581880569458, \"tsne_y\": -59.43094253540039, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1885\", \"Dose Order\": \"1\"}, {\"tsne_x\": -15.633220672607422, \"tsne_y\": -57.46160125732422, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1886\", \"Dose Order\": \"1\"}, {\"tsne_x\": -15.414070129394531, \"tsne_y\": -58.941532135009766, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1887\", \"Dose Order\": \"1\"}, {\"tsne_x\": -13.798516273498535, \"tsne_y\": -58.875892639160156, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1920\", \"Dose Order\": \"1\"}, {\"tsne_x\": -15.59164047241211, \"tsne_y\": -58.490386962890625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1921\", \"Dose Order\": \"1\"}, {\"tsne_x\": -15.697026252746582, \"tsne_y\": -58.13054275512695, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1922\", \"Dose Order\": \"1\"}, {\"tsne_x\": -15.713967323303223, \"tsne_y\": -58.6676139831543, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1923\", \"Dose Order\": \"1\"}, {\"tsne_x\": -2.59584379196167, \"tsne_y\": -73.04966735839844, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1464\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.473763942718506, \"tsne_y\": -72.68048095703125, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1465\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.675121784210205, \"tsne_y\": -73.27098083496094, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1466\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.4981112480163574, \"tsne_y\": -72.71056365966797, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1467\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.8077731132507324, \"tsne_y\": -70.87598419189453, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1884\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.250863552093506, \"tsne_y\": -71.98802947998047, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1885\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.5664079189300537, \"tsne_y\": -71.79000854492188, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1886\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.8759565353393555, \"tsne_y\": -71.74174499511719, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1887\", \"Dose Order\": \"2\"}, {\"tsne_x\": -1.7504034042358398, \"tsne_y\": -70.71112060546875, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1920\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.023885488510132, \"tsne_y\": -71.81464385986328, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1921\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.29544997215271, \"tsne_y\": -71.89498138427734, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1922\", \"Dose Order\": \"2\"}, {\"tsne_x\": -1.7676854133605957, \"tsne_y\": -71.78060913085938, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1923\", \"Dose Order\": \"2\"}, {\"tsne_x\": 12.479302406311035, \"tsne_y\": -79.00821685791016, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1464\", \"Dose Order\": \"3\"}, {\"tsne_x\": 12.873013496398926, \"tsne_y\": -78.5755844116211, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1465\", \"Dose Order\": \"3\"}, {\"tsne_x\": 13.268899917602539, \"tsne_y\": -78.2712173461914, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1466\", \"Dose Order\": \"3\"}, {\"tsne_x\": 12.747550964355469, \"tsne_y\": -78.51521301269531, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1467\", \"Dose Order\": \"3\"}, {\"tsne_x\": 10.726507186889648, \"tsne_y\": -78.26435852050781, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1884\", \"Dose Order\": \"3\"}, {\"tsne_x\": 11.191718101501465, \"tsne_y\": -78.94019317626953, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1885\", \"Dose Order\": \"3\"}, {\"tsne_x\": 11.593236923217773, \"tsne_y\": -78.77208709716797, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1886\", \"Dose Order\": \"3\"}, {\"tsne_x\": 11.348113059997559, \"tsne_y\": -79.13957977294922, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1887\", \"Dose Order\": \"3\"}, {\"tsne_x\": 9.880919456481934, \"tsne_y\": -79.55665588378906, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1920\", \"Dose Order\": \"3\"}, {\"tsne_x\": 10.886621475219727, \"tsne_y\": -80.24872589111328, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1921\", \"Dose Order\": \"3\"}, {\"tsne_x\": 11.015796661376953, \"tsne_y\": -80.08697509765625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1922\", \"Dose Order\": \"3\"}, {\"tsne_x\": 11.076701164245605, \"tsne_y\": -80.26686096191406, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1923\", \"Dose Order\": \"3\"}, {\"tsne_x\": 16.942354202270508, \"tsne_y\": -81.36965942382812, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1464\", \"Dose Order\": \"4\"}, {\"tsne_x\": 16.348308563232422, \"tsne_y\": -81.39852142333984, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1465\", \"Dose Order\": \"4\"}, {\"tsne_x\": 16.151765823364258, \"tsne_y\": -81.78711700439453, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1466\", \"Dose Order\": \"4\"}, {\"tsne_x\": 16.14173698425293, \"tsne_y\": -81.65800476074219, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1467\", \"Dose Order\": \"4\"}, {\"tsne_x\": 15.399040222167969, \"tsne_y\": -84.78681182861328, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1884\", \"Dose Order\": \"4\"}, {\"tsne_x\": 14.46634292602539, \"tsne_y\": -83.89119720458984, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1885\", \"Dose Order\": \"4\"}, {\"tsne_x\": 14.396459579467773, \"tsne_y\": -83.44284057617188, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1886\", \"Dose Order\": \"4\"}, {\"tsne_x\": 14.529219627380371, \"tsne_y\": -83.97480010986328, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1887\", \"Dose Order\": \"4\"}, {\"tsne_x\": 13.783072471618652, \"tsne_y\": -85.99082946777344, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1920\", \"Dose Order\": \"4\"}, {\"tsne_x\": 14.00102710723877, \"tsne_y\": -85.02027893066406, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1921\", \"Dose Order\": \"4\"}, {\"tsne_x\": 13.967949867248535, \"tsne_y\": -85.18746948242188, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1922\", \"Dose Order\": \"4\"}, {\"tsne_x\": 13.147444725036621, \"tsne_y\": -84.67649841308594, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1923\", \"Dose Order\": \"4\"}, {\"tsne_x\": 18.452350616455078, \"tsne_y\": -83.05422973632812, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1464\", \"Dose Order\": \"5\"}, {\"tsne_x\": 17.978235244750977, \"tsne_y\": -82.90365600585938, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1465\", \"Dose Order\": \"5\"}, {\"tsne_x\": 17.67523193359375, \"tsne_y\": -82.78076171875, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1466\", \"Dose Order\": \"5\"}, {\"tsne_x\": 17.96514129638672, \"tsne_y\": -83.02005767822266, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1467\", \"Dose Order\": \"5\"}, {\"tsne_x\": 16.839824676513672, \"tsne_y\": -85.82603454589844, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1884\", \"Dose Order\": \"5\"}, {\"tsne_x\": 17.09585189819336, \"tsne_y\": -86.01447296142578, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1885\", \"Dose Order\": \"5\"}, {\"tsne_x\": 17.510528564453125, \"tsne_y\": -85.86106872558594, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1886\", \"Dose Order\": \"5\"}, {\"tsne_x\": 16.838159561157227, \"tsne_y\": -86.42032623291016, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1887\", \"Dose Order\": \"5\"}, {\"tsne_x\": 16.14093780517578, \"tsne_y\": -87.17132568359375, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1920\", \"Dose Order\": \"5\"}, {\"tsne_x\": 15.968517303466797, \"tsne_y\": -87.0325698852539, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1921\", \"Dose Order\": \"5\"}, {\"tsne_x\": 15.744673728942871, \"tsne_y\": -86.95182037353516, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1922\", \"Dose Order\": \"5\"}, {\"tsne_x\": 15.450547218322754, \"tsne_y\": -87.04508209228516, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|1\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 1, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1923\", \"Dose Order\": \"5\"}]}}, {\"mode\": \"vega-lite\"});\n",
              "</script>"
            ],
            "text/plain": [
              "alt.Chart(...)"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-52-84172d8d0eec>:13: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  altair_plot_data['Dose Order'] = altair_plot_data['dose_order'].astype(str)\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/html": [
              "\n",
              "<div id=\"altair-viz-f29bceb81fd7490086e539ce4b958ad3\"></div>\n",
              "<script type=\"text/javascript\">\n",
              "  var VEGA_DEBUG = (typeof VEGA_DEBUG == \"undefined\") ? {} : VEGA_DEBUG;\n",
              "  (function(spec, embedOpt){\n",
              "    let outputDiv = document.currentScript.previousElementSibling;\n",
              "    if (outputDiv.id !== \"altair-viz-f29bceb81fd7490086e539ce4b958ad3\") {\n",
              "      outputDiv = document.getElementById(\"altair-viz-f29bceb81fd7490086e539ce4b958ad3\");\n",
              "    }\n",
              "    const paths = {\n",
              "      \"vega\": \"https://cdn.jsdelivr.net/npm//vega@5?noext\",\n",
              "      \"vega-lib\": \"https://cdn.jsdelivr.net/npm//vega-lib?noext\",\n",
              "      \"vega-lite\": \"https://cdn.jsdelivr.net/npm//vega-lite@4.17.0?noext\",\n",
              "      \"vega-embed\": \"https://cdn.jsdelivr.net/npm//vega-embed@6?noext\",\n",
              "    };\n",
              "\n",
              "    function maybeLoadScript(lib, version) {\n",
              "      var key = `${lib.replace(\"-\", \"\")}_version`;\n",
              "      return (VEGA_DEBUG[key] == version) ?\n",
              "        Promise.resolve(paths[lib]) :\n",
              "        new Promise(function(resolve, reject) {\n",
              "          var s = document.createElement('script');\n",
              "          document.getElementsByTagName(\"head\")[0].appendChild(s);\n",
              "          s.async = true;\n",
              "          s.onload = () => {\n",
              "            VEGA_DEBUG[key] = version;\n",
              "            return resolve(paths[lib]);\n",
              "          };\n",
              "          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);\n",
              "          s.src = paths[lib];\n",
              "        });\n",
              "    }\n",
              "\n",
              "    function showError(err) {\n",
              "      outputDiv.innerHTML = `<div class=\"error\" style=\"color:red;\">${err}</div>`;\n",
              "      throw err;\n",
              "    }\n",
              "\n",
              "    function displayChart(vegaEmbed) {\n",
              "      vegaEmbed(outputDiv, spec, embedOpt)\n",
              "        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));\n",
              "    }\n",
              "\n",
              "    if(typeof define === \"function\" && define.amd) {\n",
              "      requirejs.config({paths});\n",
              "      require([\"vega-embed\"], displayChart, err => showError(`Error loading script: ${err.message}`));\n",
              "    } else {\n",
              "      maybeLoadScript(\"vega\", \"5\")\n",
              "        .then(() => maybeLoadScript(\"vega-lite\", \"4.17.0\"))\n",
              "        .then(() => maybeLoadScript(\"vega-embed\", \"6\"))\n",
              "        .catch(showError)\n",
              "        .then(() => displayChart(vegaEmbed));\n",
              "    }\n",
              "  })({\"config\": {\"view\": {\"continuousWidth\": 400, \"continuousHeight\": 300}, \"axis\": {\"labelFontSize\": 20, \"titleFontSize\": 20}, \"background\": \"white\", \"legend\": {\"labelFontSize\": 20, \"labelLimit\": 0, \"titleFontSize\": 20}}, \"data\": {\"name\": \"data-87f620788b51d456bb8569018cd61866\"}, \"mark\": {\"type\": \"point\", \"filled\": true, \"size\": 240, \"stroke\": \"black\", \"strokeWidth\": 1.5}, \"encoding\": {\"color\": {\"field\": \"Compound Group\", \"scale\": {\"domain\": [\"DMSO\", \"Herceptin\", \"Perjeta\", \"Active Degraders\", \"Inactive Degraders\", \"PI3K Inhibitor\", \"Pan-Akt Inhibitor\", \"Neratinib (Covalent Inhibitor)\", \"BDTX-189 (Covalent Inhibitor)\", \"Head Group Small Molecules\"], \"range\": [\"#7f7f7f\", \"#ff7f0e\", \"#8c5626\", \"#d62728\", \"#bcbd22\", \"#9467bd\", \"#e377c2\", \"#1f77b4\", \"#17becf\", \"#2ca02c\"]}, \"type\": \"nominal\"}, \"shape\": {\"field\": \"Dose Order\", \"type\": \"nominal\"}, \"tooltip\": {\"field\": \"compound_dose\", \"type\": \"nominal\"}, \"x\": {\"field\": \"tsne_x\", \"type\": \"quantitative\"}, \"y\": {\"field\": \"tsne_y\", \"type\": \"quantitative\"}}, \"height\": 700, \"title\": \"SKOV3 No GFP Timepoint 2 (24 hours)\", \"width\": 700, \"$schema\": \"https://vega.github.io/schema/vega-lite/v4.17.0.json\", \"datasets\": {\"data-87f620788b51d456bb8569018cd61866\": [{\"tsne_x\": 9.9508695602417, \"tsne_y\": 7.768763542175293, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1468\", \"Dose Order\": \"0\"}, {\"tsne_x\": 11.461974143981934, \"tsne_y\": 8.834405899047852, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1469\", \"Dose Order\": \"0\"}, {\"tsne_x\": 11.119850158691406, \"tsne_y\": 8.051785469055176, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1470\", \"Dose Order\": \"0\"}, {\"tsne_x\": 11.429689407348633, \"tsne_y\": 7.744870185852051, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1471\", \"Dose Order\": \"0\"}, {\"tsne_x\": 11.133516311645508, \"tsne_y\": 6.818475723266602, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1888\", \"Dose Order\": \"0\"}, {\"tsne_x\": 11.234013557434082, \"tsne_y\": 7.263581275939941, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1889\", \"Dose Order\": \"0\"}, {\"tsne_x\": 12.118548393249512, \"tsne_y\": 7.277163982391357, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1890\", \"Dose Order\": \"0\"}, {\"tsne_x\": 10.971099853515625, \"tsne_y\": 6.939157485961914, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1891\", \"Dose Order\": \"0\"}, {\"tsne_x\": 5.85811710357666, \"tsne_y\": 6.732569217681885, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1928\", \"Dose Order\": \"0\"}, {\"tsne_x\": 10.631298065185547, \"tsne_y\": 6.284419059753418, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1929\", \"Dose Order\": \"0\"}, {\"tsne_x\": 11.73332405090332, \"tsne_y\": 6.988128185272217, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1930\", \"Dose Order\": \"0\"}, {\"tsne_x\": 11.868234634399414, \"tsne_y\": 5.567323684692383, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1931\", \"Dose Order\": \"0\"}, {\"tsne_x\": 32.366233825683594, \"tsne_y\": 11.3898286819458, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1468\", \"Dose Order\": \"1\"}, {\"tsne_x\": 33.782981872558594, \"tsne_y\": 10.407882690429688, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1469\", \"Dose Order\": \"1\"}, {\"tsne_x\": 33.38941955566406, \"tsne_y\": 11.065320014953613, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1470\", \"Dose Order\": \"1\"}, {\"tsne_x\": 33.15735626220703, \"tsne_y\": 10.126408576965332, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1471\", \"Dose Order\": \"1\"}, {\"tsne_x\": 34.350318908691406, \"tsne_y\": 11.613994598388672, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1888\", \"Dose Order\": \"1\"}, {\"tsne_x\": 33.54270935058594, \"tsne_y\": 11.65794563293457, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1889\", \"Dose Order\": \"1\"}, {\"tsne_x\": 34.42919158935547, \"tsne_y\": 11.618948936462402, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1890\", \"Dose Order\": \"1\"}, {\"tsne_x\": 34.34679412841797, \"tsne_y\": 11.300760269165039, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1891\", \"Dose Order\": \"1\"}, {\"tsne_x\": 32.60670852661133, \"tsne_y\": 13.081923484802246, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1928\", \"Dose Order\": \"1\"}, {\"tsne_x\": 33.2589225769043, \"tsne_y\": 12.240775108337402, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1929\", \"Dose Order\": \"1\"}, {\"tsne_x\": 34.08180236816406, \"tsne_y\": 12.261974334716797, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1930\", \"Dose Order\": \"1\"}, {\"tsne_x\": 33.90087127685547, \"tsne_y\": 12.459406852722168, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1931\", \"Dose Order\": \"1\"}, {\"tsne_x\": 45.99488067626953, \"tsne_y\": 11.265071868896484, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1468\", \"Dose Order\": \"2\"}, {\"tsne_x\": 46.147727966308594, \"tsne_y\": 10.662590980529785, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1469\", \"Dose Order\": \"2\"}, {\"tsne_x\": 45.740535736083984, \"tsne_y\": 10.540093421936035, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1470\", \"Dose Order\": \"2\"}, {\"tsne_x\": 45.58388137817383, \"tsne_y\": 9.973530769348145, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1471\", \"Dose Order\": \"2\"}, {\"tsne_x\": 44.7355842590332, \"tsne_y\": 11.539589881896973, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1888\", \"Dose Order\": \"2\"}, {\"tsne_x\": 44.77133560180664, \"tsne_y\": 11.792466163635254, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1889\", \"Dose Order\": \"2\"}, {\"tsne_x\": 44.131324768066406, \"tsne_y\": 11.71462631225586, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1890\", \"Dose Order\": \"2\"}, {\"tsne_x\": 44.421592712402344, \"tsne_y\": 11.260597229003906, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1891\", \"Dose Order\": \"2\"}, {\"tsne_x\": 44.8525276184082, \"tsne_y\": 13.689260482788086, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1928\", \"Dose Order\": \"2\"}, {\"tsne_x\": 44.98104476928711, \"tsne_y\": 12.834757804870605, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1929\", \"Dose Order\": \"2\"}, {\"tsne_x\": 44.806121826171875, \"tsne_y\": 12.895404815673828, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1930\", \"Dose Order\": \"2\"}, {\"tsne_x\": 45.0081901550293, \"tsne_y\": 13.234469413757324, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1931\", \"Dose Order\": \"2\"}, {\"tsne_x\": 50.07696533203125, \"tsne_y\": 10.811942100524902, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1468\", \"Dose Order\": \"3\"}, {\"tsne_x\": 49.59474182128906, \"tsne_y\": 11.307817459106445, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1469\", \"Dose Order\": \"3\"}, {\"tsne_x\": 49.63966751098633, \"tsne_y\": 11.573319435119629, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1470\", \"Dose Order\": \"3\"}, {\"tsne_x\": 49.66661071777344, \"tsne_y\": 11.656332969665527, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1471\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.41659927368164, \"tsne_y\": 13.300089836120605, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1888\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.509437561035156, \"tsne_y\": 13.270991325378418, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1889\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.13436508178711, \"tsne_y\": 13.016966819763184, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1890\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.0437126159668, \"tsne_y\": 12.897826194763184, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1891\", \"Dose Order\": \"3\"}, {\"tsne_x\": 49.72224807739258, \"tsne_y\": 15.244300842285156, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1928\", \"Dose Order\": \"3\"}, {\"tsne_x\": 49.49137878417969, \"tsne_y\": 13.76041030883789, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1929\", \"Dose Order\": \"3\"}, {\"tsne_x\": 49.67136001586914, \"tsne_y\": 14.438003540039062, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1930\", \"Dose Order\": \"3\"}, {\"tsne_x\": 49.64524459838867, \"tsne_y\": 14.493026733398438, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1931\", \"Dose Order\": \"3\"}, {\"tsne_x\": 58.83094024658203, \"tsne_y\": 16.92560577392578, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1468\", \"Dose Order\": \"4\"}, {\"tsne_x\": 58.515777587890625, \"tsne_y\": 17.21821403503418, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1469\", \"Dose Order\": \"4\"}, {\"tsne_x\": 58.39289474487305, \"tsne_y\": 17.450897216796875, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1470\", \"Dose Order\": \"4\"}, {\"tsne_x\": 58.33692932128906, \"tsne_y\": 17.463560104370117, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1471\", \"Dose Order\": \"4\"}, {\"tsne_x\": 59.54439163208008, \"tsne_y\": 14.719332695007324, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1888\", \"Dose Order\": \"4\"}, {\"tsne_x\": 59.55008316040039, \"tsne_y\": 14.559226036071777, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1889\", \"Dose Order\": \"4\"}, {\"tsne_x\": 59.14039611816406, \"tsne_y\": 14.764373779296875, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1890\", \"Dose Order\": \"4\"}, {\"tsne_x\": 59.20026779174805, \"tsne_y\": 14.888334274291992, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1891\", \"Dose Order\": \"4\"}, {\"tsne_x\": 60.69292068481445, \"tsne_y\": 13.034783363342285, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1928\", \"Dose Order\": \"4\"}, {\"tsne_x\": 60.82233810424805, \"tsne_y\": 14.095945358276367, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1929\", \"Dose Order\": \"4\"}, {\"tsne_x\": 60.97598648071289, \"tsne_y\": 14.044754981994629, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1930\", \"Dose Order\": \"4\"}, {\"tsne_x\": 60.949764251708984, \"tsne_y\": 13.967591285705566, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1931\", \"Dose Order\": \"4\"}, {\"tsne_x\": 63.128196716308594, \"tsne_y\": 18.649627685546875, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1468\", \"Dose Order\": \"5\"}, {\"tsne_x\": 62.53567123413086, \"tsne_y\": 19.47635841369629, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1469\", \"Dose Order\": \"5\"}, {\"tsne_x\": 62.785133361816406, \"tsne_y\": 18.95994758605957, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1470\", \"Dose Order\": \"5\"}, {\"tsne_x\": 62.87258529663086, \"tsne_y\": 18.88226890563965, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1471\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.51434326171875, \"tsne_y\": 17.561138153076172, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1888\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.39342498779297, \"tsne_y\": 17.1348876953125, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1889\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.40441131591797, \"tsne_y\": 17.204011917114258, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1890\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.17453002929688, \"tsne_y\": 17.723337173461914, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1891\", \"Dose Order\": \"5\"}, {\"tsne_x\": 64.28314208984375, \"tsne_y\": 15.851987838745117, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1928\", \"Dose Order\": \"5\"}, {\"tsne_x\": 64.17814636230469, \"tsne_y\": 15.803977966308594, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1929\", \"Dose Order\": \"5\"}, {\"tsne_x\": 64.41233825683594, \"tsne_y\": 15.860411643981934, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1930\", \"Dose Order\": \"5\"}, {\"tsne_x\": 64.71476745605469, \"tsne_y\": 15.81705093383789, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|2\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1931\", \"Dose Order\": \"5\"}, {\"tsne_x\": -25.987943649291992, \"tsne_y\": 52.80173873901367, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1468\", \"Dose Order\": \"0\"}, {\"tsne_x\": -26.341638565063477, \"tsne_y\": 53.622711181640625, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1469\", \"Dose Order\": \"0\"}, {\"tsne_x\": -26.65464210510254, \"tsne_y\": 53.599327087402344, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1470\", \"Dose Order\": \"0\"}, {\"tsne_x\": -26.362024307250977, \"tsne_y\": 53.44893264770508, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1471\", \"Dose Order\": \"0\"}, {\"tsne_x\": -22.365360260009766, \"tsne_y\": 54.97568130493164, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1888\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.349565505981445, \"tsne_y\": 55.17240905761719, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1889\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.48503303527832, \"tsne_y\": 54.86906051635742, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1890\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.456483840942383, \"tsne_y\": 55.557613372802734, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1891\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.166887283325195, \"tsne_y\": 52.901092529296875, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1928\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.794803619384766, \"tsne_y\": 53.594085693359375, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1929\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.418933868408203, \"tsne_y\": 53.61215591430664, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1930\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.42432975769043, \"tsne_y\": 53.65913009643555, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1931\", \"Dose Order\": \"0\"}, {\"tsne_x\": -27.29060173034668, \"tsne_y\": 57.018768310546875, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1468\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.34248161315918, \"tsne_y\": 55.58237838745117, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1469\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.764944076538086, \"tsne_y\": 56.02496337890625, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1470\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.573036193847656, \"tsne_y\": 56.172828674316406, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1471\", \"Dose Order\": \"1\"}, {\"tsne_x\": -23.651592254638672, \"tsne_y\": 57.35696029663086, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1888\", \"Dose Order\": \"1\"}, {\"tsne_x\": -24.13863754272461, \"tsne_y\": 57.32866287231445, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1889\", \"Dose Order\": \"1\"}, {\"tsne_x\": -24.132532119750977, \"tsne_y\": 57.343170166015625, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1890\", \"Dose Order\": \"1\"}, {\"tsne_x\": -23.76698875427246, \"tsne_y\": 56.72478485107422, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1891\", \"Dose Order\": \"1\"}, {\"tsne_x\": -24.9031982421875, \"tsne_y\": 59.456356048583984, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1928\", \"Dose Order\": \"1\"}, {\"tsne_x\": -25.153404235839844, \"tsne_y\": 58.69992446899414, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1929\", \"Dose Order\": \"1\"}, {\"tsne_x\": -25.208581924438477, \"tsne_y\": 59.072994232177734, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1930\", \"Dose Order\": \"1\"}, {\"tsne_x\": -25.13518714904785, \"tsne_y\": 59.04071807861328, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1931\", \"Dose Order\": \"1\"}, {\"tsne_x\": -32.47100830078125, \"tsne_y\": 55.370582580566406, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1468\", \"Dose Order\": \"2\"}, {\"tsne_x\": -31.770063400268555, \"tsne_y\": 55.45195007324219, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1469\", \"Dose Order\": \"2\"}, {\"tsne_x\": -31.69593048095703, \"tsne_y\": 55.34268569946289, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1470\", \"Dose Order\": \"2\"}, {\"tsne_x\": -31.5433349609375, \"tsne_y\": 55.059383392333984, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1471\", \"Dose Order\": \"2\"}, {\"tsne_x\": -27.608657836914062, \"tsne_y\": 63.69741439819336, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1888\", \"Dose Order\": \"2\"}, {\"tsne_x\": -27.954317092895508, \"tsne_y\": 63.31997299194336, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1889\", \"Dose Order\": \"2\"}, {\"tsne_x\": -28.18596839904785, \"tsne_y\": 63.18146514892578, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1890\", \"Dose Order\": \"2\"}, {\"tsne_x\": -28.21595573425293, \"tsne_y\": 62.869747161865234, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1891\", \"Dose Order\": \"2\"}, {\"tsne_x\": -25.053176879882812, \"tsne_y\": 62.570091247558594, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1928\", \"Dose Order\": \"2\"}, {\"tsne_x\": -25.760526657104492, \"tsne_y\": 62.5463752746582, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1929\", \"Dose Order\": \"2\"}, {\"tsne_x\": -25.632183074951172, \"tsne_y\": 62.48357391357422, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1930\", \"Dose Order\": \"2\"}, {\"tsne_x\": -25.614431381225586, \"tsne_y\": 62.6045036315918, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1931\", \"Dose Order\": \"2\"}, {\"tsne_x\": -31.6265869140625, \"tsne_y\": 58.913116455078125, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1468\", \"Dose Order\": \"3\"}, {\"tsne_x\": -32.335205078125, \"tsne_y\": 58.555137634277344, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1469\", \"Dose Order\": \"3\"}, {\"tsne_x\": -32.301544189453125, \"tsne_y\": 58.20282745361328, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1470\", \"Dose Order\": \"3\"}, {\"tsne_x\": -32.37510299682617, \"tsne_y\": 58.66426467895508, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1471\", \"Dose Order\": \"3\"}, {\"tsne_x\": -28.88712501525879, \"tsne_y\": 66.00997161865234, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1888\", \"Dose Order\": \"3\"}, {\"tsne_x\": -29.2022647857666, \"tsne_y\": 66.10941314697266, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1889\", \"Dose Order\": \"3\"}, {\"tsne_x\": -29.482091903686523, \"tsne_y\": 66.11434173583984, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1890\", \"Dose Order\": \"3\"}, {\"tsne_x\": -29.438053131103516, \"tsne_y\": 65.72740173339844, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1891\", \"Dose Order\": \"3\"}, {\"tsne_x\": -27.65448760986328, \"tsne_y\": 68.41767883300781, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1928\", \"Dose Order\": \"3\"}, {\"tsne_x\": -28.64011573791504, \"tsne_y\": 67.80896759033203, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1929\", \"Dose Order\": \"3\"}, {\"tsne_x\": -28.53142738342285, \"tsne_y\": 68.03355407714844, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1930\", \"Dose Order\": \"3\"}, {\"tsne_x\": -28.610130310058594, \"tsne_y\": 67.91647338867188, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1931\", \"Dose Order\": \"3\"}, {\"tsne_x\": -34.99223709106445, \"tsne_y\": 56.503814697265625, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1468\", \"Dose Order\": \"4\"}, {\"tsne_x\": -35.21924591064453, \"tsne_y\": 58.21505355834961, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1469\", \"Dose Order\": \"4\"}, {\"tsne_x\": -35.31833267211914, \"tsne_y\": 58.227474212646484, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1470\", \"Dose Order\": \"4\"}, {\"tsne_x\": -35.40453338623047, \"tsne_y\": 58.48583984375, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1471\", \"Dose Order\": \"4\"}, {\"tsne_x\": -35.0217170715332, \"tsne_y\": 72.45523834228516, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1888\", \"Dose Order\": \"4\"}, {\"tsne_x\": -34.93932342529297, \"tsne_y\": 72.44507598876953, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1889\", \"Dose Order\": \"4\"}, {\"tsne_x\": -35.41688537597656, \"tsne_y\": 72.6151351928711, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1890\", \"Dose Order\": \"4\"}, {\"tsne_x\": -35.12162780761719, \"tsne_y\": 72.29150390625, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1891\", \"Dose Order\": \"4\"}, {\"tsne_x\": -32.4662971496582, \"tsne_y\": 73.98881530761719, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1928\", \"Dose Order\": \"4\"}, {\"tsne_x\": -33.13020324707031, \"tsne_y\": 74.06086730957031, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1929\", \"Dose Order\": \"4\"}, {\"tsne_x\": -33.247798919677734, \"tsne_y\": 74.25047302246094, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1930\", \"Dose Order\": \"4\"}, {\"tsne_x\": -33.205406188964844, \"tsne_y\": 74.18872833251953, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1931\", \"Dose Order\": \"4\"}, {\"tsne_x\": -37.105525970458984, \"tsne_y\": 58.357852935791016, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1468\", \"Dose Order\": \"5\"}, {\"tsne_x\": -36.8015022277832, \"tsne_y\": 58.942665100097656, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1469\", \"Dose Order\": \"5\"}, {\"tsne_x\": -36.98773956298828, \"tsne_y\": 58.893409729003906, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1470\", \"Dose Order\": \"5\"}, {\"tsne_x\": -36.84479522705078, \"tsne_y\": 58.976627349853516, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1471\", \"Dose Order\": \"5\"}, {\"tsne_x\": -36.4901237487793, \"tsne_y\": 75.05023956298828, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1888\", \"Dose Order\": \"5\"}, {\"tsne_x\": -36.406124114990234, \"tsne_y\": 74.76010131835938, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1889\", \"Dose Order\": \"5\"}, {\"tsne_x\": -36.61888885498047, \"tsne_y\": 74.57351684570312, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1890\", \"Dose Order\": \"5\"}, {\"tsne_x\": -36.576560974121094, \"tsne_y\": 74.71979522705078, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1891\", \"Dose Order\": \"5\"}, {\"tsne_x\": -34.86354064941406, \"tsne_y\": 76.31632995605469, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1928\", \"Dose Order\": \"5\"}, {\"tsne_x\": -34.718265533447266, \"tsne_y\": 75.95191192626953, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1929\", \"Dose Order\": \"5\"}, {\"tsne_x\": -34.61927795410156, \"tsne_y\": 75.84464263916016, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1930\", \"Dose Order\": \"5\"}, {\"tsne_x\": -34.45598602294922, \"tsne_y\": 75.7186050415039, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|2\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1931\", \"Dose Order\": \"5\"}, {\"tsne_x\": -2.6731770038604736, \"tsne_y\": 17.70633888244629, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1468\", \"Dose Order\": \"0\"}, {\"tsne_x\": -1.9133821725845337, \"tsne_y\": 16.72571563720703, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1469\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.6927242279052734, \"tsne_y\": 16.328285217285156, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1470\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.959285020828247, \"tsne_y\": 17.154512405395508, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1471\", \"Dose Order\": \"0\"}, {\"tsne_x\": -1.904640793800354, \"tsne_y\": 15.425851821899414, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1888\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.0621349811553955, \"tsne_y\": 16.440155029296875, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1889\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.1371819972991943, \"tsne_y\": 15.536544799804688, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1890\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.8607611656188965, \"tsne_y\": 15.849600791931152, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1891\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.8387198448181152, \"tsne_y\": 14.361015319824219, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1928\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.120161771774292, \"tsne_y\": 15.90038776397705, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1929\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.19301176071167, \"tsne_y\": 15.630243301391602, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1930\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.2220842838287354, \"tsne_y\": 15.515174865722656, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1931\", \"Dose Order\": \"0\"}, {\"tsne_x\": -12.330667495727539, \"tsne_y\": 13.573569297790527, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1468\", \"Dose Order\": \"1\"}, {\"tsne_x\": -13.82827377319336, \"tsne_y\": 16.09650421142578, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1469\", \"Dose Order\": \"1\"}, {\"tsne_x\": -13.270462036132812, \"tsne_y\": 15.672038078308105, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1470\", \"Dose Order\": \"1\"}, {\"tsne_x\": -13.297436714172363, \"tsne_y\": 16.17328643798828, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1471\", \"Dose Order\": \"1\"}, {\"tsne_x\": -12.013130187988281, \"tsne_y\": 14.713712692260742, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1888\", \"Dose Order\": \"1\"}, {\"tsne_x\": -12.16403865814209, \"tsne_y\": 15.112374305725098, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1889\", \"Dose Order\": \"1\"}, {\"tsne_x\": -13.212876319885254, \"tsne_y\": 14.615337371826172, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1890\", \"Dose Order\": \"1\"}, {\"tsne_x\": -11.849547386169434, \"tsne_y\": 14.996370315551758, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1891\", \"Dose Order\": \"1\"}, {\"tsne_x\": -13.713007926940918, \"tsne_y\": 12.43581485748291, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1928\", \"Dose Order\": \"1\"}, {\"tsne_x\": -12.281607627868652, \"tsne_y\": 15.556803703308105, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1929\", \"Dose Order\": \"1\"}, {\"tsne_x\": -12.943615913391113, \"tsne_y\": 14.46589469909668, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1930\", \"Dose Order\": \"1\"}, {\"tsne_x\": -11.428783416748047, \"tsne_y\": 15.855731010437012, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1931\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.112621307373047, \"tsne_y\": 38.911407470703125, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1468\", \"Dose Order\": \"2\"}, {\"tsne_x\": -30.97561264038086, \"tsne_y\": 40.31148910522461, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1469\", \"Dose Order\": \"2\"}, {\"tsne_x\": -31.256261825561523, \"tsne_y\": 39.76095199584961, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1470\", \"Dose Order\": \"2\"}, {\"tsne_x\": -31.485919952392578, \"tsne_y\": 39.633235931396484, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1471\", \"Dose Order\": \"2\"}, {\"tsne_x\": -31.303483963012695, \"tsne_y\": 37.27375411987305, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1888\", \"Dose Order\": \"2\"}, {\"tsne_x\": -32.093326568603516, \"tsne_y\": 37.976863861083984, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1889\", \"Dose Order\": \"2\"}, {\"tsne_x\": -32.27791976928711, \"tsne_y\": 37.98519515991211, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1890\", \"Dose Order\": \"2\"}, {\"tsne_x\": -32.10158157348633, \"tsne_y\": 38.05801773071289, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1891\", \"Dose Order\": \"2\"}, {\"tsne_x\": -32.58894348144531, \"tsne_y\": 36.373619079589844, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1928\", \"Dose Order\": \"2\"}, {\"tsne_x\": -32.78083038330078, \"tsne_y\": 37.23457717895508, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1929\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.732357025146484, \"tsne_y\": 36.46999740600586, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1930\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.624908447265625, \"tsne_y\": 36.489315032958984, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1931\", \"Dose Order\": \"2\"}, {\"tsne_x\": 3.220475435256958, \"tsne_y\": 70.45660400390625, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1468\", \"Dose Order\": \"3\"}, {\"tsne_x\": 3.7750449180603027, \"tsne_y\": 67.76569366455078, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1469\", \"Dose Order\": \"3\"}, {\"tsne_x\": 3.825958013534546, \"tsne_y\": 67.18656158447266, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1470\", \"Dose Order\": \"3\"}, {\"tsne_x\": 4.008181095123291, \"tsne_y\": 66.87531280517578, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1471\", \"Dose Order\": \"3\"}, {\"tsne_x\": 0.28126421570777893, \"tsne_y\": 71.64691925048828, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1888\", \"Dose Order\": \"3\"}, {\"tsne_x\": 0.16866075992584229, \"tsne_y\": 71.40947723388672, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1889\", \"Dose Order\": \"3\"}, {\"tsne_x\": 0.21932215988636017, \"tsne_y\": 71.03099060058594, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1890\", \"Dose Order\": \"3\"}, {\"tsne_x\": 0.21448086202144623, \"tsne_y\": 70.89156341552734, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1891\", \"Dose Order\": \"3\"}, {\"tsne_x\": -1.8151441812515259, \"tsne_y\": 71.90898895263672, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1928\", \"Dose Order\": \"3\"}, {\"tsne_x\": -1.4456610679626465, \"tsne_y\": 72.49518585205078, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1929\", \"Dose Order\": \"3\"}, {\"tsne_x\": -1.370562195777893, \"tsne_y\": 73.0179443359375, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1930\", \"Dose Order\": \"3\"}, {\"tsne_x\": -1.3542195558547974, \"tsne_y\": 73.35196685791016, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1931\", \"Dose Order\": \"3\"}, {\"tsne_x\": 22.734012603759766, \"tsne_y\": 63.56037521362305, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1468\", \"Dose Order\": \"4\"}, {\"tsne_x\": 21.735918045043945, \"tsne_y\": 64.37409210205078, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1469\", \"Dose Order\": \"4\"}, {\"tsne_x\": 21.84951400756836, \"tsne_y\": 64.13996887207031, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1470\", \"Dose Order\": \"4\"}, {\"tsne_x\": 21.616680145263672, \"tsne_y\": 64.0119400024414, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1471\", \"Dose Order\": \"4\"}, {\"tsne_x\": 25.284507751464844, \"tsne_y\": 63.26341247558594, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1888\", \"Dose Order\": \"4\"}, {\"tsne_x\": 25.232776641845703, \"tsne_y\": 63.153831481933594, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1889\", \"Dose Order\": \"4\"}, {\"tsne_x\": 25.87692642211914, \"tsne_y\": 63.179931640625, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1890\", \"Dose Order\": \"4\"}, {\"tsne_x\": 25.803274154663086, \"tsne_y\": 63.32194137573242, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1891\", \"Dose Order\": \"4\"}, {\"tsne_x\": 26.017471313476562, \"tsne_y\": 65.1344985961914, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1928\", \"Dose Order\": \"4\"}, {\"tsne_x\": 25.013574600219727, \"tsne_y\": 64.72769165039062, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1929\", \"Dose Order\": \"4\"}, {\"tsne_x\": 25.362516403198242, \"tsne_y\": 64.71238708496094, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1930\", \"Dose Order\": \"4\"}, {\"tsne_x\": 25.33824920654297, \"tsne_y\": 64.72631072998047, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1931\", \"Dose Order\": \"4\"}, {\"tsne_x\": 21.483694076538086, \"tsne_y\": 66.62722778320312, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1468\", \"Dose Order\": \"5\"}, {\"tsne_x\": 21.320825576782227, \"tsne_y\": 65.99217987060547, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1469\", \"Dose Order\": \"5\"}, {\"tsne_x\": 20.997173309326172, \"tsne_y\": 65.62898254394531, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1470\", \"Dose Order\": \"5\"}, {\"tsne_x\": 20.733949661254883, \"tsne_y\": 65.49701690673828, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1471\", \"Dose Order\": \"5\"}, {\"tsne_x\": 24.41044807434082, \"tsne_y\": 69.62761688232422, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1888\", \"Dose Order\": \"5\"}, {\"tsne_x\": 24.332517623901367, \"tsne_y\": 69.39002227783203, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1889\", \"Dose Order\": \"5\"}, {\"tsne_x\": 24.13274574279785, \"tsne_y\": 68.58258056640625, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1890\", \"Dose Order\": \"5\"}, {\"tsne_x\": 24.211902618408203, \"tsne_y\": 68.67385864257812, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1891\", \"Dose Order\": \"5\"}, {\"tsne_x\": 22.252582550048828, \"tsne_y\": 69.5258560180664, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1928\", \"Dose Order\": \"5\"}, {\"tsne_x\": 22.859752655029297, \"tsne_y\": 69.012451171875, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1929\", \"Dose Order\": \"5\"}, {\"tsne_x\": 22.654491424560547, \"tsne_y\": 69.12428283691406, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1930\", \"Dose Order\": \"5\"}, {\"tsne_x\": 22.717103958129883, \"tsne_y\": 69.0845718383789, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1931\", \"Dose Order\": \"5\"}, {\"tsne_x\": -0.35027241706848145, \"tsne_y\": 4.673909664154053, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1468\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.801687240600586, \"tsne_y\": 6.352927207946777, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1469\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.5671330690383911, \"tsne_y\": 5.626357555389404, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1470\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.2817213833332062, \"tsne_y\": 5.577768802642822, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1471\", \"Dose Order\": \"0\"}, {\"tsne_x\": 2.2369773387908936, \"tsne_y\": 4.885559558868408, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1888\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.1236395835876465, \"tsne_y\": 5.095866680145264, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1889\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.9693184494972229, \"tsne_y\": 5.098231315612793, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1890\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.5940274000167847, \"tsne_y\": 4.891155242919922, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1891\", \"Dose Order\": \"0\"}, {\"tsne_x\": 5.576317310333252, \"tsne_y\": 6.664727210998535, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1928\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.6311806440353394, \"tsne_y\": 4.550392150878906, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1929\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.4308923482894897, \"tsne_y\": 3.713395118713379, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1930\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.2181434631347656, \"tsne_y\": 4.191352367401123, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1931\", \"Dose Order\": \"0\"}, {\"tsne_x\": 3.7759463787078857, \"tsne_y\": -5.731513500213623, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1468\", \"Dose Order\": \"1\"}, {\"tsne_x\": 4.041919708251953, \"tsne_y\": -7.477604866027832, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1469\", \"Dose Order\": \"1\"}, {\"tsne_x\": 3.636007308959961, \"tsne_y\": -6.997255325317383, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1470\", \"Dose Order\": \"1\"}, {\"tsne_x\": 2.8026769161224365, \"tsne_y\": -7.736015796661377, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1471\", \"Dose Order\": \"1\"}, {\"tsne_x\": 1.708802580833435, \"tsne_y\": -5.570982456207275, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1888\", \"Dose Order\": \"1\"}, {\"tsne_x\": 2.759035587310791, \"tsne_y\": -6.914068698883057, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1889\", \"Dose Order\": \"1\"}, {\"tsne_x\": 2.1596474647521973, \"tsne_y\": -6.908806324005127, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1890\", \"Dose Order\": \"1\"}, {\"tsne_x\": 2.039944648742676, \"tsne_y\": -6.519631385803223, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1891\", \"Dose Order\": \"1\"}, {\"tsne_x\": 0.9828382134437561, \"tsne_y\": -7.45519495010376, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1928\", \"Dose Order\": \"1\"}, {\"tsne_x\": 2.6737563610076904, \"tsne_y\": -5.862109661102295, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1929\", \"Dose Order\": \"1\"}, {\"tsne_x\": 2.2198877334594727, \"tsne_y\": -6.30338716506958, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1930\", \"Dose Order\": \"1\"}, {\"tsne_x\": 2.1460700035095215, \"tsne_y\": -6.6695685386657715, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1931\", \"Dose Order\": \"1\"}, {\"tsne_x\": -4.830178260803223, \"tsne_y\": -25.934846878051758, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1468\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.469259262084961, \"tsne_y\": -26.64846420288086, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1469\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.794156312942505, \"tsne_y\": -27.117280960083008, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1470\", \"Dose Order\": \"2\"}, {\"tsne_x\": -4.594906806945801, \"tsne_y\": -26.313669204711914, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1471\", \"Dose Order\": \"2\"}, {\"tsne_x\": -5.308475971221924, \"tsne_y\": -27.576810836791992, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1888\", \"Dose Order\": \"2\"}, {\"tsne_x\": -4.349233627319336, \"tsne_y\": -27.856657028198242, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1889\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.8523030281066895, \"tsne_y\": -27.754661560058594, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1890\", \"Dose Order\": \"2\"}, {\"tsne_x\": -4.878718376159668, \"tsne_y\": -29.155967712402344, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1891\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.4892587661743164, \"tsne_y\": -28.654905319213867, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1928\", \"Dose Order\": \"2\"}, {\"tsne_x\": -4.409812927246094, \"tsne_y\": -28.391910552978516, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1929\", \"Dose Order\": \"2\"}, {\"tsne_x\": -4.5731987953186035, \"tsne_y\": -27.830310821533203, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1930\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.8499233722686768, \"tsne_y\": -28.792875289916992, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1931\", \"Dose Order\": \"2\"}, {\"tsne_x\": -3.809936046600342, \"tsne_y\": -39.917415618896484, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1468\", \"Dose Order\": \"3\"}, {\"tsne_x\": -3.15002179145813, \"tsne_y\": -41.20091247558594, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1469\", \"Dose Order\": \"3\"}, {\"tsne_x\": -3.6723272800445557, \"tsne_y\": -40.58073425292969, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1470\", \"Dose Order\": \"3\"}, {\"tsne_x\": -2.51057505607605, \"tsne_y\": -41.30229949951172, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1471\", \"Dose Order\": \"3\"}, {\"tsne_x\": -3.9349350929260254, \"tsne_y\": -41.31682205200195, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1888\", \"Dose Order\": \"3\"}, {\"tsne_x\": -4.3279128074646, \"tsne_y\": -41.584075927734375, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1889\", \"Dose Order\": \"3\"}, {\"tsne_x\": -4.493885040283203, \"tsne_y\": -41.049522399902344, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1890\", \"Dose Order\": \"3\"}, {\"tsne_x\": -4.770670413970947, \"tsne_y\": -41.02235794067383, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1891\", \"Dose Order\": \"3\"}, {\"tsne_x\": -5.937741756439209, \"tsne_y\": -42.582984924316406, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1928\", \"Dose Order\": \"3\"}, {\"tsne_x\": -4.786759853363037, \"tsne_y\": -42.319129943847656, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1929\", \"Dose Order\": \"3\"}, {\"tsne_x\": -5.015298843383789, \"tsne_y\": -42.02229309082031, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1930\", \"Dose Order\": \"3\"}, {\"tsne_x\": -4.928325176239014, \"tsne_y\": -42.776180267333984, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1931\", \"Dose Order\": \"3\"}, {\"tsne_x\": 0.8337010741233826, \"tsne_y\": -42.12980270385742, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1468\", \"Dose Order\": \"4\"}, {\"tsne_x\": 0.3126700818538666, \"tsne_y\": -41.88365936279297, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1469\", \"Dose Order\": \"4\"}, {\"tsne_x\": -0.7352441549301147, \"tsne_y\": -42.390785217285156, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1470\", \"Dose Order\": \"4\"}, {\"tsne_x\": -0.9904415011405945, \"tsne_y\": -42.2520637512207, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1471\", \"Dose Order\": \"4\"}, {\"tsne_x\": 0.40131592750549316, \"tsne_y\": -44.86191940307617, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1888\", \"Dose Order\": \"4\"}, {\"tsne_x\": 0.2198466956615448, \"tsne_y\": -44.86384582519531, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1889\", \"Dose Order\": \"4\"}, {\"tsne_x\": 0.11882120370864868, \"tsne_y\": -44.36195755004883, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1890\", \"Dose Order\": \"4\"}, {\"tsne_x\": 0.0649566799402237, \"tsne_y\": -44.267616271972656, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1891\", \"Dose Order\": \"4\"}, {\"tsne_x\": -0.34200459718704224, \"tsne_y\": -47.527198791503906, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1928\", \"Dose Order\": \"4\"}, {\"tsne_x\": 0.25126394629478455, \"tsne_y\": -46.78776550292969, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1929\", \"Dose Order\": \"4\"}, {\"tsne_x\": 0.17937463521957397, \"tsne_y\": -46.978580474853516, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1930\", \"Dose Order\": \"4\"}, {\"tsne_x\": 0.2514517307281494, \"tsne_y\": -46.8101806640625, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1931\", \"Dose Order\": \"4\"}, {\"tsne_x\": 2.264272689819336, \"tsne_y\": -42.38601303100586, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1468\", \"Dose Order\": \"5\"}, {\"tsne_x\": 2.707878828048706, \"tsne_y\": -42.601806640625, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1469\", \"Dose Order\": \"5\"}, {\"tsne_x\": 3.105886697769165, \"tsne_y\": -42.83622360229492, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1470\", \"Dose Order\": \"5\"}, {\"tsne_x\": 3.021207332611084, \"tsne_y\": -42.904205322265625, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1471\", \"Dose Order\": \"5\"}, {\"tsne_x\": 4.454096794128418, \"tsne_y\": -45.62533187866211, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1888\", \"Dose Order\": \"5\"}, {\"tsne_x\": 3.379676580429077, \"tsne_y\": -45.249446868896484, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1889\", \"Dose Order\": \"5\"}, {\"tsne_x\": 2.982924461364746, \"tsne_y\": -44.971195220947266, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1890\", \"Dose Order\": \"5\"}, {\"tsne_x\": 2.7879512310028076, \"tsne_y\": -44.76611328125, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1891\", \"Dose Order\": \"5\"}, {\"tsne_x\": 7.167377471923828, \"tsne_y\": -45.09304428100586, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1928\", \"Dose Order\": \"5\"}, {\"tsne_x\": 5.986865997314453, \"tsne_y\": -45.46543502807617, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1929\", \"Dose Order\": \"5\"}, {\"tsne_x\": 6.275007247924805, \"tsne_y\": -45.397987365722656, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1930\", \"Dose Order\": \"5\"}, {\"tsne_x\": 6.2375874519348145, \"tsne_y\": -45.40407943725586, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|2\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1931\", \"Dose Order\": \"5\"}, {\"tsne_x\": -18.547950744628906, \"tsne_y\": 28.0032901763916, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1468\", \"Dose Order\": \"0\"}, {\"tsne_x\": -21.279399871826172, \"tsne_y\": 28.885683059692383, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1469\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.849905014038086, \"tsne_y\": 28.487913131713867, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1470\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.808713912963867, \"tsne_y\": 28.983400344848633, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1471\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.920976638793945, \"tsne_y\": 29.897937774658203, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1888\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.55874252319336, \"tsne_y\": 29.275188446044922, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1889\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.1912841796875, \"tsne_y\": 29.436674118041992, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1890\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.174226760864258, \"tsne_y\": 30.213058471679688, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1891\", \"Dose Order\": \"0\"}, {\"tsne_x\": -18.11913299560547, \"tsne_y\": 30.357120513916016, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1928\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.268657684326172, \"tsne_y\": 29.241607666015625, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1929\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.073837280273438, \"tsne_y\": 29.948081970214844, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1930\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.50909423828125, \"tsne_y\": 30.517696380615234, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1931\", \"Dose Order\": \"0\"}, {\"tsne_x\": -29.146236419677734, \"tsne_y\": 38.318565368652344, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1468\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.716407775878906, \"tsne_y\": 38.97290802001953, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1469\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.44321632385254, \"tsne_y\": 39.123008728027344, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1470\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.308576583862305, \"tsne_y\": 39.25856399536133, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1471\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.449392318725586, \"tsne_y\": 36.05698776245117, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1888\", \"Dose Order\": \"1\"}, {\"tsne_x\": -28.35797119140625, \"tsne_y\": 36.436492919921875, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1889\", \"Dose Order\": \"1\"}, {\"tsne_x\": -28.08174705505371, \"tsne_y\": 36.62138366699219, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1890\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.87323570251465, \"tsne_y\": 36.27729797363281, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1891\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.192201614379883, \"tsne_y\": 34.44208908081055, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1928\", \"Dose Order\": \"1\"}, {\"tsne_x\": -29.385133743286133, \"tsne_y\": 35.49380874633789, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1929\", \"Dose Order\": \"1\"}, {\"tsne_x\": -29.49545669555664, \"tsne_y\": 35.11821746826172, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1930\", \"Dose Order\": \"1\"}, {\"tsne_x\": -29.297441482543945, \"tsne_y\": 35.00273132324219, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1931\", \"Dose Order\": \"1\"}, {\"tsne_x\": 3.547254800796509, \"tsne_y\": 70.7225112915039, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1468\", \"Dose Order\": \"2\"}, {\"tsne_x\": 5.217545509338379, \"tsne_y\": 67.3126220703125, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1469\", \"Dose Order\": \"2\"}, {\"tsne_x\": 4.956106662750244, \"tsne_y\": 66.59297943115234, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1470\", \"Dose Order\": \"2\"}, {\"tsne_x\": 4.733354091644287, \"tsne_y\": 66.75638580322266, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1471\", \"Dose Order\": \"2\"}, {\"tsne_x\": 4.19436502456665, \"tsne_y\": 76.6786117553711, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1888\", \"Dose Order\": \"2\"}, {\"tsne_x\": 3.369356155395508, \"tsne_y\": 75.5646743774414, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1889\", \"Dose Order\": \"2\"}, {\"tsne_x\": 4.265457630157471, \"tsne_y\": 75.40861511230469, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1890\", \"Dose Order\": \"2\"}, {\"tsne_x\": 3.7920663356781006, \"tsne_y\": 74.75494384765625, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1891\", \"Dose Order\": \"2\"}, {\"tsne_x\": 0.8446921706199646, \"tsne_y\": 76.94699096679688, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1928\", \"Dose Order\": \"2\"}, {\"tsne_x\": 0.34617820382118225, \"tsne_y\": 76.51069641113281, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1929\", \"Dose Order\": \"2\"}, {\"tsne_x\": -0.31371283531188965, \"tsne_y\": 76.17415618896484, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1930\", \"Dose Order\": \"2\"}, {\"tsne_x\": -0.6523646712303162, \"tsne_y\": 75.51631164550781, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1931\", \"Dose Order\": \"2\"}, {\"tsne_x\": 3.8698368072509766, \"tsne_y\": 70.96607971191406, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1468\", \"Dose Order\": \"3\"}, {\"tsne_x\": 5.827836036682129, \"tsne_y\": 67.68621826171875, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1469\", \"Dose Order\": \"3\"}, {\"tsne_x\": 6.0859150886535645, \"tsne_y\": 67.78706359863281, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1470\", \"Dose Order\": \"3\"}, {\"tsne_x\": -11.039615631103516, \"tsne_y\": 4.593992233276367, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1471\", \"Dose Order\": \"3\"}, {\"tsne_x\": 4.192355155944824, \"tsne_y\": 76.53063201904297, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1888\", \"Dose Order\": \"3\"}, {\"tsne_x\": 3.5342540740966797, \"tsne_y\": 75.70431518554688, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1889\", \"Dose Order\": \"3\"}, {\"tsne_x\": 4.6728386878967285, \"tsne_y\": 75.35016632080078, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1890\", \"Dose Order\": \"3\"}, {\"tsne_x\": 4.161547660827637, \"tsne_y\": 75.17086791992188, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1891\", \"Dose Order\": \"3\"}, {\"tsne_x\": 0.42515698075294495, \"tsne_y\": 77.61009979248047, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1928\", \"Dose Order\": \"3\"}, {\"tsne_x\": 0.2828651964664459, \"tsne_y\": 76.82323455810547, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1929\", \"Dose Order\": \"3\"}, {\"tsne_x\": -0.5066264271736145, \"tsne_y\": 76.59961700439453, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1930\", \"Dose Order\": \"3\"}, {\"tsne_x\": -0.7792890071868896, \"tsne_y\": 75.6688461303711, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1931\", \"Dose Order\": \"3\"}, {\"tsne_x\": 22.3624324798584, \"tsne_y\": 58.7020149230957, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1468\", \"Dose Order\": \"4\"}, {\"tsne_x\": 22.060625076293945, \"tsne_y\": 59.069854736328125, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1469\", \"Dose Order\": \"4\"}, {\"tsne_x\": 22.020906448364258, \"tsne_y\": 59.10637664794922, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1470\", \"Dose Order\": \"4\"}, {\"tsne_x\": -11.22285270690918, \"tsne_y\": 4.67108678817749, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1471\", \"Dose Order\": \"4\"}, {\"tsne_x\": 22.10135269165039, \"tsne_y\": 56.25666427612305, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1888\", \"Dose Order\": \"4\"}, {\"tsne_x\": 22.42687225341797, \"tsne_y\": 56.5582275390625, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1889\", \"Dose Order\": \"4\"}, {\"tsne_x\": 22.527057647705078, \"tsne_y\": 56.24079895019531, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1890\", \"Dose Order\": \"4\"}, {\"tsne_x\": 22.584430694580078, \"tsne_y\": 56.186397552490234, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1891\", \"Dose Order\": \"4\"}, {\"tsne_x\": 24.244306564331055, \"tsne_y\": 56.35050964355469, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1928\", \"Dose Order\": \"4\"}, {\"tsne_x\": 24.034238815307617, \"tsne_y\": 57.10810852050781, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1929\", \"Dose Order\": \"4\"}, {\"tsne_x\": 23.856306076049805, \"tsne_y\": 56.882667541503906, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1930\", \"Dose Order\": \"4\"}, {\"tsne_x\": 23.951475143432617, \"tsne_y\": 56.997093200683594, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1931\", \"Dose Order\": \"4\"}, {\"tsne_x\": 28.892593383789062, \"tsne_y\": 51.4980583190918, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1468\", \"Dose Order\": \"5\"}, {\"tsne_x\": 29.251256942749023, \"tsne_y\": 50.74625778198242, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1469\", \"Dose Order\": \"5\"}, {\"tsne_x\": 29.17402458190918, \"tsne_y\": 50.811180114746094, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1470\", \"Dose Order\": \"5\"}, {\"tsne_x\": -11.424280166625977, \"tsne_y\": 4.773979663848877, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1471\", \"Dose Order\": \"5\"}, {\"tsne_x\": 30.897300720214844, \"tsne_y\": 51.858551025390625, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1888\", \"Dose Order\": \"5\"}, {\"tsne_x\": 30.833192825317383, \"tsne_y\": 52.014095306396484, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1889\", \"Dose Order\": \"5\"}, {\"tsne_x\": 31.556787490844727, \"tsne_y\": 52.48092269897461, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1890\", \"Dose Order\": \"5\"}, {\"tsne_x\": 31.333696365356445, \"tsne_y\": 52.28166961669922, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1891\", \"Dose Order\": \"5\"}, {\"tsne_x\": 30.329051971435547, \"tsne_y\": 53.17697525024414, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1928\", \"Dose Order\": \"5\"}, {\"tsne_x\": 29.85063934326172, \"tsne_y\": 52.58753204345703, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1929\", \"Dose Order\": \"5\"}, {\"tsne_x\": 29.94573211669922, \"tsne_y\": 52.737640380859375, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1930\", \"Dose Order\": \"5\"}, {\"tsne_x\": 30.057802200317383, \"tsne_y\": 52.72624588012695, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1931\", \"Dose Order\": \"5\"}, {\"tsne_x\": -12.537142753601074, \"tsne_y\": -7.804769992828369, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1468\", \"Dose Order\": \"0\"}, {\"tsne_x\": -13.873859405517578, \"tsne_y\": -7.1365132331848145, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1469\", \"Dose Order\": \"0\"}, {\"tsne_x\": -13.639923095703125, \"tsne_y\": -7.555997848510742, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1470\", \"Dose Order\": \"0\"}, {\"tsne_x\": -13.619275093078613, \"tsne_y\": -7.242868900299072, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1471\", \"Dose Order\": \"0\"}, {\"tsne_x\": -12.837615966796875, \"tsne_y\": -6.1351165771484375, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1888\", \"Dose Order\": \"0\"}, {\"tsne_x\": -21.18262481689453, \"tsne_y\": -7.442162036895752, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1889\", \"Dose Order\": \"0\"}, {\"tsne_x\": -12.26504135131836, \"tsne_y\": -5.348342418670654, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1890\", \"Dose Order\": \"0\"}, {\"tsne_x\": -12.721607208251953, \"tsne_y\": -6.407003402709961, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1891\", \"Dose Order\": \"0\"}, {\"tsne_x\": -14.163581848144531, \"tsne_y\": -6.058788299560547, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1928\", \"Dose Order\": \"0\"}, {\"tsne_x\": -12.669845581054688, \"tsne_y\": -6.267031192779541, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1929\", \"Dose Order\": \"0\"}, {\"tsne_x\": -13.241456031799316, \"tsne_y\": -5.163852214813232, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1930\", \"Dose Order\": \"0\"}, {\"tsne_x\": -12.143962860107422, \"tsne_y\": -6.537952423095703, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1931\", \"Dose Order\": \"0\"}, {\"tsne_x\": -5.760517120361328, \"tsne_y\": -15.579071998596191, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1468\", \"Dose Order\": \"1\"}, {\"tsne_x\": -3.4598865509033203, \"tsne_y\": -15.918599128723145, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1469\", \"Dose Order\": \"1\"}, {\"tsne_x\": -4.143138408660889, \"tsne_y\": -16.006677627563477, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1470\", \"Dose Order\": \"1\"}, {\"tsne_x\": -4.272258281707764, \"tsne_y\": -15.479598045349121, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1471\", \"Dose Order\": \"1\"}, {\"tsne_x\": -5.119971752166748, \"tsne_y\": -14.226388931274414, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1888\", \"Dose Order\": \"1\"}, {\"tsne_x\": -4.5155181884765625, \"tsne_y\": -14.560300827026367, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1889\", \"Dose Order\": \"1\"}, {\"tsne_x\": -4.056881427764893, \"tsne_y\": -14.07089900970459, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1890\", \"Dose Order\": \"1\"}, {\"tsne_x\": -4.942426681518555, \"tsne_y\": -14.881438255310059, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1891\", \"Dose Order\": \"1\"}, {\"tsne_x\": -3.157928466796875, \"tsne_y\": -13.82895278930664, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1928\", \"Dose Order\": \"1\"}, {\"tsne_x\": -4.570782661437988, \"tsne_y\": -14.073433876037598, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1929\", \"Dose Order\": \"1\"}, {\"tsne_x\": -4.987479209899902, \"tsne_y\": -13.276632308959961, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1930\", \"Dose Order\": \"1\"}, {\"tsne_x\": -4.9660563468933105, \"tsne_y\": -14.565872192382812, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1931\", \"Dose Order\": \"1\"}, {\"tsne_x\": 15.95474910736084, \"tsne_y\": -9.69471263885498, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1468\", \"Dose Order\": \"2\"}, {\"tsne_x\": 13.91390323638916, \"tsne_y\": -11.590927124023438, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1469\", \"Dose Order\": \"2\"}, {\"tsne_x\": 14.270257949829102, \"tsne_y\": -10.085317611694336, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1470\", \"Dose Order\": \"2\"}, {\"tsne_x\": 14.570805549621582, \"tsne_y\": -10.571136474609375, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1471\", \"Dose Order\": \"2\"}, {\"tsne_x\": 15.18930435180664, \"tsne_y\": -11.074318885803223, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1888\", \"Dose Order\": \"2\"}, {\"tsne_x\": 16.34404754638672, \"tsne_y\": -11.153712272644043, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1889\", \"Dose Order\": \"2\"}, {\"tsne_x\": 14.894598007202148, \"tsne_y\": -11.535270690917969, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1890\", \"Dose Order\": \"2\"}, {\"tsne_x\": 15.400874137878418, \"tsne_y\": -11.32442855834961, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1891\", \"Dose Order\": \"2\"}, {\"tsne_x\": 16.429792404174805, \"tsne_y\": -11.556879043579102, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1928\", \"Dose Order\": \"2\"}, {\"tsne_x\": 15.808460235595703, \"tsne_y\": -12.319924354553223, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1929\", \"Dose Order\": \"2\"}, {\"tsne_x\": 14.985591888427734, \"tsne_y\": -11.73843765258789, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1930\", \"Dose Order\": \"2\"}, {\"tsne_x\": 15.839405059814453, \"tsne_y\": -11.423771858215332, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1931\", \"Dose Order\": \"2\"}, {\"tsne_x\": 17.70354652404785, \"tsne_y\": -21.1557674407959, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1468\", \"Dose Order\": \"3\"}, {\"tsne_x\": 16.12095832824707, \"tsne_y\": -21.076335906982422, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1469\", \"Dose Order\": \"3\"}, {\"tsne_x\": 16.2227783203125, \"tsne_y\": -21.534955978393555, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1470\", \"Dose Order\": \"3\"}, {\"tsne_x\": 16.89984893798828, \"tsne_y\": -20.585580825805664, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1471\", \"Dose Order\": \"3\"}, {\"tsne_x\": 15.177971839904785, \"tsne_y\": -20.169139862060547, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1888\", \"Dose Order\": \"3\"}, {\"tsne_x\": 16.433618545532227, \"tsne_y\": -19.506317138671875, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1889\", \"Dose Order\": \"3\"}, {\"tsne_x\": 16.30659294128418, \"tsne_y\": -20.044649124145508, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1890\", \"Dose Order\": \"3\"}, {\"tsne_x\": 15.676941871643066, \"tsne_y\": -20.089258193969727, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1891\", \"Dose Order\": \"3\"}, {\"tsne_x\": 16.090970993041992, \"tsne_y\": -18.39389991760254, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1928\", \"Dose Order\": \"3\"}, {\"tsne_x\": 16.19434356689453, \"tsne_y\": -19.5594539642334, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1929\", \"Dose Order\": \"3\"}, {\"tsne_x\": 15.101059913635254, \"tsne_y\": -19.277355194091797, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1930\", \"Dose Order\": \"3\"}, {\"tsne_x\": 15.741296768188477, \"tsne_y\": -19.467859268188477, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1931\", \"Dose Order\": \"3\"}, {\"tsne_x\": 15.605238914489746, \"tsne_y\": -25.70969009399414, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1468\", \"Dose Order\": \"4\"}, {\"tsne_x\": 14.562055587768555, \"tsne_y\": -25.824731826782227, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1469\", \"Dose Order\": \"4\"}, {\"tsne_x\": 14.860276222229004, \"tsne_y\": -25.475120544433594, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1470\", \"Dose Order\": \"4\"}, {\"tsne_x\": 14.745037078857422, \"tsne_y\": -25.530658721923828, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1471\", \"Dose Order\": \"4\"}, {\"tsne_x\": 13.9312105178833, \"tsne_y\": -27.48514175415039, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1888\", \"Dose Order\": \"4\"}, {\"tsne_x\": 13.757712364196777, \"tsne_y\": -27.77143096923828, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1889\", \"Dose Order\": \"4\"}, {\"tsne_x\": 14.2175874710083, \"tsne_y\": -28.26690673828125, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1890\", \"Dose Order\": \"4\"}, {\"tsne_x\": 14.404316902160645, \"tsne_y\": -28.575605392456055, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1891\", \"Dose Order\": \"4\"}, {\"tsne_x\": 12.409832954406738, \"tsne_y\": -28.084606170654297, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1928\", \"Dose Order\": \"4\"}, {\"tsne_x\": 13.194592475891113, \"tsne_y\": -28.011737823486328, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1929\", \"Dose Order\": \"4\"}, {\"tsne_x\": 12.898216247558594, \"tsne_y\": -28.73900032043457, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1930\", \"Dose Order\": \"4\"}, {\"tsne_x\": 12.907157897949219, \"tsne_y\": -28.344642639160156, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1931\", \"Dose Order\": \"4\"}, {\"tsne_x\": 15.931893348693848, \"tsne_y\": -36.07151794433594, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1468\", \"Dose Order\": \"5\"}, {\"tsne_x\": 15.811875343322754, \"tsne_y\": -35.859989166259766, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1469\", \"Dose Order\": \"5\"}, {\"tsne_x\": 15.946239471435547, \"tsne_y\": -36.082767486572266, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1470\", \"Dose Order\": \"5\"}, {\"tsne_x\": 15.786787986755371, \"tsne_y\": -35.7924690246582, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1471\", \"Dose Order\": \"5\"}, {\"tsne_x\": 13.780086517333984, \"tsne_y\": -33.147457122802734, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1888\", \"Dose Order\": \"5\"}, {\"tsne_x\": 13.987411499023438, \"tsne_y\": -33.53017807006836, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1889\", \"Dose Order\": \"5\"}, {\"tsne_x\": 14.313158988952637, \"tsne_y\": -33.65972137451172, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1890\", \"Dose Order\": \"5\"}, {\"tsne_x\": 14.400091171264648, \"tsne_y\": -33.563987731933594, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1891\", \"Dose Order\": \"5\"}, {\"tsne_x\": 13.050226211547852, \"tsne_y\": -33.16862869262695, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1928\", \"Dose Order\": \"5\"}, {\"tsne_x\": 13.322220802307129, \"tsne_y\": -32.4915885925293, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1929\", \"Dose Order\": \"5\"}, {\"tsne_x\": 13.128938674926758, \"tsne_y\": -31.789628982543945, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1930\", \"Dose Order\": \"5\"}, {\"tsne_x\": 13.289044380187988, \"tsne_y\": -32.51742935180664, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|2\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1931\", \"Dose Order\": \"5\"}, {\"tsne_x\": -7.273963451385498, \"tsne_y\": 0.729155421257019, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|2\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1468\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.329221725463867, \"tsne_y\": -0.7430575489997864, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|2\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1469\", \"Dose Order\": \"0\"}, {\"tsne_x\": -9.084915161132812, \"tsne_y\": -0.6174750328063965, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|2\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1470\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.9647955894470215, \"tsne_y\": -0.2552946209907532, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|2\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1471\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.450675010681152, \"tsne_y\": 0.49778977036476135, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|2\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1888\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.90676212310791, \"tsne_y\": -0.1364538073539734, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|2\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1889\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.36356258392334, \"tsne_y\": -0.9180788397789001, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|2\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1890\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.31564474105835, \"tsne_y\": -0.2075919508934021, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|2\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1891\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.292848110198975, \"tsne_y\": -1.3971946239471436, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|2\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1928\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.274789810180664, \"tsne_y\": -0.7573955655097961, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|2\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1929\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.772400856018066, \"tsne_y\": 0.028491539880633354, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|2\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1930\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.322837829589844, \"tsne_y\": -1.5351060628890991, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|2\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1931\", \"Dose Order\": \"0\"}, {\"tsne_x\": -63.630828857421875, \"tsne_y\": 12.558249473571777, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|2\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1468\", \"Dose Order\": \"0\"}, {\"tsne_x\": -63.29630661010742, \"tsne_y\": 12.976019859313965, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|2\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1469\", \"Dose Order\": \"0\"}, {\"tsne_x\": -62.58894729614258, \"tsne_y\": 13.159205436706543, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|2\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1470\", \"Dose Order\": \"0\"}, {\"tsne_x\": -62.43560028076172, \"tsne_y\": 11.713906288146973, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|2\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1471\", \"Dose Order\": \"0\"}, {\"tsne_x\": -61.67789840698242, \"tsne_y\": 11.259527206420898, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|2\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1888\", \"Dose Order\": \"0\"}, {\"tsne_x\": -61.576698303222656, \"tsne_y\": 12.012517929077148, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|2\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1889\", \"Dose Order\": \"0\"}, {\"tsne_x\": -60.94628143310547, \"tsne_y\": 11.92585277557373, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|2\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1890\", \"Dose Order\": \"0\"}, {\"tsne_x\": -61.0794563293457, \"tsne_y\": 12.351214408874512, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|2\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1891\", \"Dose Order\": \"0\"}, {\"tsne_x\": -61.92887496948242, \"tsne_y\": 13.386701583862305, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|2\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1928\", \"Dose Order\": \"0\"}, {\"tsne_x\": -61.52712631225586, \"tsne_y\": 12.737354278564453, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|2\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1929\", \"Dose Order\": \"0\"}, {\"tsne_x\": -61.644527435302734, \"tsne_y\": 12.17662525177002, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|2\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1930\", \"Dose Order\": \"0\"}, {\"tsne_x\": -60.6543083190918, \"tsne_y\": 12.897224426269531, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|2\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1931\", \"Dose Order\": \"0\"}, {\"tsne_x\": -56.20756149291992, \"tsne_y\": -0.9460609555244446, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|2\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1468\", \"Dose Order\": \"1\"}, {\"tsne_x\": -53.861236572265625, \"tsne_y\": 1.2590930461883545, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|2\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1469\", \"Dose Order\": \"1\"}, {\"tsne_x\": -53.65525436401367, \"tsne_y\": -0.14481034874916077, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|2\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1470\", \"Dose Order\": \"1\"}, {\"tsne_x\": -54.45647430419922, \"tsne_y\": 0.4666828215122223, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|2\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1471\", \"Dose Order\": \"1\"}, {\"tsne_x\": -54.95806884765625, \"tsne_y\": -0.6838394999504089, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|2\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1888\", \"Dose Order\": \"1\"}, {\"tsne_x\": -54.501861572265625, \"tsne_y\": -0.4377305507659912, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|2\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1889\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.217037200927734, \"tsne_y\": -0.5822051167488098, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|2\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1890\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.13777160644531, \"tsne_y\": 0.19527745246887207, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|2\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1891\", \"Dose Order\": \"1\"}, {\"tsne_x\": -56.361061096191406, \"tsne_y\": -0.024262186139822006, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|2\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1928\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.399993896484375, \"tsne_y\": 0.256869375705719, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|2\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1929\", \"Dose Order\": \"1\"}, {\"tsne_x\": -54.514404296875, \"tsne_y\": -1.7686026096343994, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|2\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1930\", \"Dose Order\": \"1\"}, {\"tsne_x\": -54.54933547973633, \"tsne_y\": -0.6388609409332275, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|2\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1931\", \"Dose Order\": \"1\"}, {\"tsne_x\": -49.359127044677734, \"tsne_y\": 14.94344425201416, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|2\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1468\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.036991119384766, \"tsne_y\": 13.86424446105957, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|2\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1469\", \"Dose Order\": \"2\"}, {\"tsne_x\": -48.90855407714844, \"tsne_y\": 13.34071159362793, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|2\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1470\", \"Dose Order\": \"2\"}, {\"tsne_x\": -48.44881057739258, \"tsne_y\": 12.875819206237793, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|2\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1471\", \"Dose Order\": \"2\"}, {\"tsne_x\": -50.03065872192383, \"tsne_y\": 13.302404403686523, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|2\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1888\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.67080307006836, \"tsne_y\": 12.179683685302734, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|2\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1889\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.94086837768555, \"tsne_y\": 12.900498390197754, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|2\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1890\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.580196380615234, \"tsne_y\": 13.450114250183105, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|2\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1891\", \"Dose Order\": \"2\"}, {\"tsne_x\": -50.1120719909668, \"tsne_y\": 13.997776985168457, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|2\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1928\", \"Dose Order\": \"2\"}, {\"tsne_x\": -50.97840118408203, \"tsne_y\": 12.891810417175293, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|2\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1929\", \"Dose Order\": \"2\"}, {\"tsne_x\": -50.61638259887695, \"tsne_y\": 13.471029281616211, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|2\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1930\", \"Dose Order\": \"2\"}, {\"tsne_x\": -51.04091262817383, \"tsne_y\": 14.367637634277344, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|2\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1931\", \"Dose Order\": \"2\"}, {\"tsne_x\": -84.09972381591797, \"tsne_y\": -5.4828948974609375, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|2\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1468\", \"Dose Order\": \"3\"}, {\"tsne_x\": -69.70382690429688, \"tsne_y\": -8.5020170211792, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|2\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1469\", \"Dose Order\": \"3\"}, {\"tsne_x\": -64.64527130126953, \"tsne_y\": -9.462324142456055, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|2\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1470\", \"Dose Order\": \"3\"}, {\"tsne_x\": -65.62874603271484, \"tsne_y\": -10.51822566986084, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|2\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1471\", \"Dose Order\": \"3\"}, {\"tsne_x\": -65.4626235961914, \"tsne_y\": -9.943140029907227, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|2\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1888\", \"Dose Order\": \"3\"}, {\"tsne_x\": -66.43678283691406, \"tsne_y\": -10.348496437072754, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|2\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1889\", \"Dose Order\": \"3\"}, {\"tsne_x\": -65.92882537841797, \"tsne_y\": -9.774876594543457, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|2\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1890\", \"Dose Order\": \"3\"}, {\"tsne_x\": -65.29653930664062, \"tsne_y\": -10.123343467712402, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|2\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1891\", \"Dose Order\": \"3\"}, {\"tsne_x\": -85.4710464477539, \"tsne_y\": -2.6517140865325928, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|2\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1928\", \"Dose Order\": \"3\"}, {\"tsne_x\": -86.70870208740234, \"tsne_y\": -4.554226875305176, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|2\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1929\", \"Dose Order\": \"3\"}, {\"tsne_x\": -87.73494720458984, \"tsne_y\": -4.511366844177246, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|2\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1930\", \"Dose Order\": \"3\"}, {\"tsne_x\": -86.52031707763672, \"tsne_y\": -3.992297649383545, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|2\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1931\", \"Dose Order\": \"3\"}, {\"tsne_x\": -84.02710723876953, \"tsne_y\": -5.1532745361328125, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|2\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1468\", \"Dose Order\": \"4\"}, {\"tsne_x\": -68.10843658447266, \"tsne_y\": -6.700212478637695, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|2\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1469\", \"Dose Order\": \"4\"}, {\"tsne_x\": -67.17736053466797, \"tsne_y\": -6.519631385803223, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|2\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1470\", \"Dose Order\": \"4\"}, {\"tsne_x\": -67.53085327148438, \"tsne_y\": -6.162735939025879, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|2\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1471\", \"Dose Order\": \"4\"}, {\"tsne_x\": -66.65091705322266, \"tsne_y\": -5.624685287475586, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|2\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1888\", \"Dose Order\": \"4\"}, {\"tsne_x\": -66.60306549072266, \"tsne_y\": -6.232801914215088, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|2\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1889\", \"Dose Order\": \"4\"}, {\"tsne_x\": -66.12590789794922, \"tsne_y\": -6.209929466247559, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|2\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1890\", \"Dose Order\": \"4\"}, {\"tsne_x\": -66.01720428466797, \"tsne_y\": -6.124130725860596, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|2\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1891\", \"Dose Order\": \"4\"}, {\"tsne_x\": -86.75385284423828, \"tsne_y\": -2.6323935985565186, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|2\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1928\", \"Dose Order\": \"4\"}, {\"tsne_x\": -86.07682800292969, \"tsne_y\": -3.6587650775909424, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|2\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1929\", \"Dose Order\": \"4\"}, {\"tsne_x\": -86.88166046142578, \"tsne_y\": -3.529691696166992, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|2\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1930\", \"Dose Order\": \"4\"}, {\"tsne_x\": -87.78315734863281, \"tsne_y\": -3.3192315101623535, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|2\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1931\", \"Dose Order\": \"4\"}, {\"tsne_x\": -84.15735626220703, \"tsne_y\": -5.612229347229004, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|2\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1468\", \"Dose Order\": \"5\"}, {\"tsne_x\": -69.52336120605469, \"tsne_y\": -9.137901306152344, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|2\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1469\", \"Dose Order\": \"5\"}, {\"tsne_x\": -69.32164764404297, \"tsne_y\": -11.015188217163086, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|2\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1470\", \"Dose Order\": \"5\"}, {\"tsne_x\": -68.18020629882812, \"tsne_y\": -11.515512466430664, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|2\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1471\", \"Dose Order\": \"5\"}, {\"tsne_x\": -68.92684936523438, \"tsne_y\": -10.781865119934082, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|2\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1888\", \"Dose Order\": \"5\"}, {\"tsne_x\": -68.20928955078125, \"tsne_y\": -11.007654190063477, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|2\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1889\", \"Dose Order\": \"5\"}, {\"tsne_x\": -68.79004669189453, \"tsne_y\": -11.153608322143555, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|2\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1890\", \"Dose Order\": \"5\"}, {\"tsne_x\": -69.28571319580078, \"tsne_y\": -11.483423233032227, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|2\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1891\", \"Dose Order\": \"5\"}, {\"tsne_x\": -86.9856185913086, \"tsne_y\": -2.316972017288208, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|2\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1928\", \"Dose Order\": \"5\"}, {\"tsne_x\": -86.72604370117188, \"tsne_y\": -4.46405029296875, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|2\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1929\", \"Dose Order\": \"5\"}, {\"tsne_x\": -87.43189239501953, \"tsne_y\": -4.116369247436523, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|2\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1930\", \"Dose Order\": \"5\"}, {\"tsne_x\": -87.68863677978516, \"tsne_y\": -3.5914909839630127, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|2\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1931\", \"Dose Order\": \"5\"}, {\"tsne_x\": 27.70745849609375, \"tsne_y\": 27.678552627563477, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1468\", \"Dose Order\": \"0\"}, {\"tsne_x\": 26.77165985107422, \"tsne_y\": 27.477500915527344, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1469\", \"Dose Order\": \"0\"}, {\"tsne_x\": 26.54985809326172, \"tsne_y\": 28.3841609954834, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1470\", \"Dose Order\": \"0\"}, {\"tsne_x\": 26.096277236938477, \"tsne_y\": 28.59893035888672, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1471\", \"Dose Order\": \"0\"}, {\"tsne_x\": 27.451074600219727, \"tsne_y\": 28.691131591796875, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1888\", \"Dose Order\": \"0\"}, {\"tsne_x\": 26.714309692382812, \"tsne_y\": 29.347829818725586, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1889\", \"Dose Order\": \"0\"}, {\"tsne_x\": 27.233169555664062, \"tsne_y\": 29.451448440551758, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1890\", \"Dose Order\": \"0\"}, {\"tsne_x\": 26.251544952392578, \"tsne_y\": 29.109554290771484, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1891\", \"Dose Order\": \"0\"}, {\"tsne_x\": 25.9879093170166, \"tsne_y\": 31.018871307373047, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1928\", \"Dose Order\": \"0\"}, {\"tsne_x\": 26.05685043334961, \"tsne_y\": 29.769166946411133, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1929\", \"Dose Order\": \"0\"}, {\"tsne_x\": 27.091503143310547, \"tsne_y\": 29.397090911865234, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1930\", \"Dose Order\": \"0\"}, {\"tsne_x\": 27.468355178833008, \"tsne_y\": 30.062549591064453, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1931\", \"Dose Order\": \"0\"}, {\"tsne_x\": 32.290863037109375, \"tsne_y\": 31.26387596130371, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1468\", \"Dose Order\": \"1\"}, {\"tsne_x\": 32.859039306640625, \"tsne_y\": 32.80948257446289, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1469\", \"Dose Order\": \"1\"}, {\"tsne_x\": 32.98534393310547, \"tsne_y\": 32.58138656616211, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1470\", \"Dose Order\": \"1\"}, {\"tsne_x\": 32.97550964355469, \"tsne_y\": 31.87119483947754, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1471\", \"Dose Order\": \"1\"}, {\"tsne_x\": 31.563657760620117, \"tsne_y\": 31.78775978088379, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1888\", \"Dose Order\": \"1\"}, {\"tsne_x\": 31.293874740600586, \"tsne_y\": 31.365779876708984, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1889\", \"Dose Order\": \"1\"}, {\"tsne_x\": 32.1186408996582, \"tsne_y\": 33.39677429199219, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1890\", \"Dose Order\": \"1\"}, {\"tsne_x\": 31.157230377197266, \"tsne_y\": 32.290283203125, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1891\", \"Dose Order\": \"1\"}, {\"tsne_x\": 30.181291580200195, \"tsne_y\": 33.20762634277344, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1928\", \"Dose Order\": \"1\"}, {\"tsne_x\": 31.640012741088867, \"tsne_y\": 32.688751220703125, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1929\", \"Dose Order\": \"1\"}, {\"tsne_x\": 31.432588577270508, \"tsne_y\": 33.454471588134766, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1930\", \"Dose Order\": \"1\"}, {\"tsne_x\": 31.0938720703125, \"tsne_y\": 32.373069763183594, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1931\", \"Dose Order\": \"1\"}, {\"tsne_x\": 44.02107620239258, \"tsne_y\": 36.93783187866211, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1468\", \"Dose Order\": \"2\"}, {\"tsne_x\": 44.06679916381836, \"tsne_y\": 36.45838165283203, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1469\", \"Dose Order\": \"2\"}, {\"tsne_x\": 43.55036163330078, \"tsne_y\": 35.73068618774414, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1470\", \"Dose Order\": \"2\"}, {\"tsne_x\": 43.495853424072266, \"tsne_y\": 35.96025848388672, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1471\", \"Dose Order\": \"2\"}, {\"tsne_x\": 42.31737518310547, \"tsne_y\": 36.91141891479492, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1888\", \"Dose Order\": \"2\"}, {\"tsne_x\": 42.331138610839844, \"tsne_y\": 36.64068603515625, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1889\", \"Dose Order\": \"2\"}, {\"tsne_x\": 42.064273834228516, \"tsne_y\": 36.343101501464844, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1890\", \"Dose Order\": \"2\"}, {\"tsne_x\": 42.46370315551758, \"tsne_y\": 36.43354034423828, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1891\", \"Dose Order\": \"2\"}, {\"tsne_x\": 40.92677307128906, \"tsne_y\": 37.96244430541992, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1928\", \"Dose Order\": \"2\"}, {\"tsne_x\": 41.6192512512207, \"tsne_y\": 37.55498123168945, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1929\", \"Dose Order\": \"2\"}, {\"tsne_x\": 41.3786735534668, \"tsne_y\": 37.236000061035156, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1930\", \"Dose Order\": \"2\"}, {\"tsne_x\": 41.00337600708008, \"tsne_y\": 37.112430572509766, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1931\", \"Dose Order\": \"2\"}, {\"tsne_x\": 50.86940002441406, \"tsne_y\": 37.187164306640625, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1468\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.2851448059082, \"tsne_y\": 37.171180725097656, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1469\", \"Dose Order\": \"3\"}, {\"tsne_x\": 52.227596282958984, \"tsne_y\": 37.06800079345703, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1470\", \"Dose Order\": \"3\"}, {\"tsne_x\": 52.00407028198242, \"tsne_y\": 37.2303466796875, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1471\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.366172790527344, \"tsne_y\": 40.023040771484375, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1888\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.60379409790039, \"tsne_y\": 39.59252166748047, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1889\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.494869232177734, \"tsne_y\": 39.45082092285156, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1890\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.334312438964844, \"tsne_y\": 39.338809967041016, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1891\", \"Dose Order\": \"3\"}, {\"tsne_x\": 52.252750396728516, \"tsne_y\": 40.76513671875, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1928\", \"Dose Order\": \"3\"}, {\"tsne_x\": 52.009883880615234, \"tsne_y\": 40.37225341796875, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1929\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.91426467895508, \"tsne_y\": 40.360111236572266, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1930\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.93796920776367, \"tsne_y\": 40.49760437011719, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1931\", \"Dose Order\": \"3\"}, {\"tsne_x\": 54.57145309448242, \"tsne_y\": 36.953033447265625, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1468\", \"Dose Order\": \"4\"}, {\"tsne_x\": 53.8417854309082, \"tsne_y\": 36.29583740234375, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1469\", \"Dose Order\": \"4\"}, {\"tsne_x\": 53.88227844238281, \"tsne_y\": 35.82292938232422, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1470\", \"Dose Order\": \"4\"}, {\"tsne_x\": 54.02021408081055, \"tsne_y\": 35.356536865234375, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1471\", \"Dose Order\": \"4\"}, {\"tsne_x\": 59.156002044677734, \"tsne_y\": 42.76769256591797, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1888\", \"Dose Order\": \"4\"}, {\"tsne_x\": 59.46500778198242, \"tsne_y\": 42.51073455810547, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1889\", \"Dose Order\": \"4\"}, {\"tsne_x\": 59.71413040161133, \"tsne_y\": 42.734718322753906, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1890\", \"Dose Order\": \"4\"}, {\"tsne_x\": 59.57835006713867, \"tsne_y\": 42.90189743041992, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1891\", \"Dose Order\": \"4\"}, {\"tsne_x\": 58.19831848144531, \"tsne_y\": 40.32029724121094, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1928\", \"Dose Order\": \"4\"}, {\"tsne_x\": 58.57864761352539, \"tsne_y\": 40.52131652832031, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1929\", \"Dose Order\": \"4\"}, {\"tsne_x\": 58.88698196411133, \"tsne_y\": 40.770538330078125, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1930\", \"Dose Order\": \"4\"}, {\"tsne_x\": 58.71298599243164, \"tsne_y\": 40.71645736694336, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1931\", \"Dose Order\": \"4\"}, {\"tsne_x\": 55.83774185180664, \"tsne_y\": 34.82416534423828, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1468\", \"Dose Order\": \"5\"}, {\"tsne_x\": 55.337738037109375, \"tsne_y\": 34.7855224609375, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1469\", \"Dose Order\": \"5\"}, {\"tsne_x\": 55.3372802734375, \"tsne_y\": 34.37022018432617, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1470\", \"Dose Order\": \"5\"}, {\"tsne_x\": 55.1891975402832, \"tsne_y\": 34.498504638671875, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1471\", \"Dose Order\": \"5\"}, {\"tsne_x\": 61.70548629760742, \"tsne_y\": 41.61644744873047, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1888\", \"Dose Order\": \"5\"}, {\"tsne_x\": 61.76566696166992, \"tsne_y\": 41.53311538696289, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1889\", \"Dose Order\": \"5\"}, {\"tsne_x\": 61.94306564331055, \"tsne_y\": 42.112632751464844, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1890\", \"Dose Order\": \"5\"}, {\"tsne_x\": 61.86797332763672, \"tsne_y\": 42.13623046875, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1891\", \"Dose Order\": \"5\"}, {\"tsne_x\": 60.455909729003906, \"tsne_y\": 39.010337829589844, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1928\", \"Dose Order\": \"5\"}, {\"tsne_x\": 61.03707504272461, \"tsne_y\": 39.86703872680664, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1929\", \"Dose Order\": \"5\"}, {\"tsne_x\": 60.91815948486328, \"tsne_y\": 39.824615478515625, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1930\", \"Dose Order\": \"5\"}, {\"tsne_x\": 60.839515686035156, \"tsne_y\": 39.900413513183594, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|2\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1931\", \"Dose Order\": \"5\"}, {\"tsne_x\": 30.618240356445312, \"tsne_y\": -47.55885314941406, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1468\", \"Dose Order\": \"0\"}, {\"tsne_x\": 29.476762771606445, \"tsne_y\": -47.03561782836914, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1469\", \"Dose Order\": \"0\"}, {\"tsne_x\": 29.399784088134766, \"tsne_y\": -47.14778518676758, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1470\", \"Dose Order\": \"0\"}, {\"tsne_x\": 29.608400344848633, \"tsne_y\": -46.7435302734375, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1471\", \"Dose Order\": \"0\"}, {\"tsne_x\": 31.621042251586914, \"tsne_y\": -53.55341720581055, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1888\", \"Dose Order\": \"0\"}, {\"tsne_x\": 32.602745056152344, \"tsne_y\": -52.91151428222656, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1889\", \"Dose Order\": \"0\"}, {\"tsne_x\": 31.595714569091797, \"tsne_y\": -52.982933044433594, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1890\", \"Dose Order\": \"0\"}, {\"tsne_x\": 31.48276710510254, \"tsne_y\": -52.891395568847656, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1891\", \"Dose Order\": \"0\"}, {\"tsne_x\": 31.217918395996094, \"tsne_y\": -50.95035934448242, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1928\", \"Dose Order\": \"0\"}, {\"tsne_x\": 31.150379180908203, \"tsne_y\": -51.06056594848633, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1929\", \"Dose Order\": \"0\"}, {\"tsne_x\": 30.62583351135254, \"tsne_y\": -51.50371170043945, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1930\", \"Dose Order\": \"0\"}, {\"tsne_x\": 30.626914978027344, \"tsne_y\": -51.48554611206055, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1931\", \"Dose Order\": \"0\"}, {\"tsne_x\": 31.34246063232422, \"tsne_y\": -47.09853744506836, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1468\", \"Dose Order\": \"1\"}, {\"tsne_x\": 30.92726707458496, \"tsne_y\": -45.44443893432617, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1469\", \"Dose Order\": \"1\"}, {\"tsne_x\": 31.008785247802734, \"tsne_y\": -45.78709030151367, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1470\", \"Dose Order\": \"1\"}, {\"tsne_x\": 31.015823364257812, \"tsne_y\": -45.83055114746094, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1471\", \"Dose Order\": \"1\"}, {\"tsne_x\": 35.69296646118164, \"tsne_y\": -50.60569381713867, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1888\", \"Dose Order\": \"1\"}, {\"tsne_x\": 35.516422271728516, \"tsne_y\": -50.64540481567383, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1889\", \"Dose Order\": \"1\"}, {\"tsne_x\": 35.662784576416016, \"tsne_y\": -50.334075927734375, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1890\", \"Dose Order\": \"1\"}, {\"tsne_x\": 35.821563720703125, \"tsne_y\": -49.92460632324219, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1891\", \"Dose Order\": \"1\"}, {\"tsne_x\": 32.553062438964844, \"tsne_y\": -49.799598693847656, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1928\", \"Dose Order\": \"1\"}, {\"tsne_x\": 33.2136116027832, \"tsne_y\": -49.601871490478516, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1929\", \"Dose Order\": \"1\"}, {\"tsne_x\": 33.61048126220703, \"tsne_y\": -49.55219650268555, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1930\", \"Dose Order\": \"1\"}, {\"tsne_x\": 33.592041015625, \"tsne_y\": -49.52025604248047, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1931\", \"Dose Order\": \"1\"}, {\"tsne_x\": 38.877952575683594, \"tsne_y\": -28.359031677246094, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1468\", \"Dose Order\": \"2\"}, {\"tsne_x\": 38.28669357299805, \"tsne_y\": -28.925979614257812, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1469\", \"Dose Order\": \"2\"}, {\"tsne_x\": 38.222801208496094, \"tsne_y\": -29.038463592529297, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1470\", \"Dose Order\": \"2\"}, {\"tsne_x\": 38.11665725708008, \"tsne_y\": -29.031980514526367, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1471\", \"Dose Order\": \"2\"}, {\"tsne_x\": 35.289222717285156, \"tsne_y\": -26.26668357849121, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1888\", \"Dose Order\": \"2\"}, {\"tsne_x\": 35.33259582519531, \"tsne_y\": -26.54159927368164, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1889\", \"Dose Order\": \"2\"}, {\"tsne_x\": 35.1380729675293, \"tsne_y\": -26.61854362487793, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1890\", \"Dose Order\": \"2\"}, {\"tsne_x\": 35.099693298339844, \"tsne_y\": -26.37088394165039, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1891\", \"Dose Order\": \"2\"}, {\"tsne_x\": 37.13335037231445, \"tsne_y\": -25.93425178527832, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1928\", \"Dose Order\": \"2\"}, {\"tsne_x\": 37.04056930541992, \"tsne_y\": -25.888408660888672, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1929\", \"Dose Order\": \"2\"}, {\"tsne_x\": 36.78752136230469, \"tsne_y\": -25.627819061279297, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1930\", \"Dose Order\": \"2\"}, {\"tsne_x\": 36.64940643310547, \"tsne_y\": -25.493486404418945, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1931\", \"Dose Order\": \"2\"}, {\"tsne_x\": 40.227500915527344, \"tsne_y\": -20.26919174194336, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1468\", \"Dose Order\": \"3\"}, {\"tsne_x\": 40.76110076904297, \"tsne_y\": -20.2103328704834, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1469\", \"Dose Order\": \"3\"}, {\"tsne_x\": 40.77617645263672, \"tsne_y\": -20.247968673706055, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1470\", \"Dose Order\": \"3\"}, {\"tsne_x\": 40.8638801574707, \"tsne_y\": -20.27422523498535, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1471\", \"Dose Order\": \"3\"}, {\"tsne_x\": 37.33143615722656, \"tsne_y\": -19.909320831298828, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1888\", \"Dose Order\": \"3\"}, {\"tsne_x\": 37.31699752807617, \"tsne_y\": -19.945768356323242, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1889\", \"Dose Order\": \"3\"}, {\"tsne_x\": 36.98292922973633, \"tsne_y\": -19.547590255737305, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1890\", \"Dose Order\": \"3\"}, {\"tsne_x\": 37.291412353515625, \"tsne_y\": -19.644929885864258, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1891\", \"Dose Order\": \"3\"}, {\"tsne_x\": 38.09352493286133, \"tsne_y\": -21.498620986938477, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1928\", \"Dose Order\": \"3\"}, {\"tsne_x\": 38.069541931152344, \"tsne_y\": -21.516813278198242, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1929\", \"Dose Order\": \"3\"}, {\"tsne_x\": 37.58958435058594, \"tsne_y\": -21.546920776367188, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1930\", \"Dose Order\": \"3\"}, {\"tsne_x\": 37.468658447265625, \"tsne_y\": -21.64406394958496, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1931\", \"Dose Order\": \"3\"}, {\"tsne_x\": 42.82810974121094, \"tsne_y\": -13.984312057495117, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1468\", \"Dose Order\": \"4\"}, {\"tsne_x\": 43.37977600097656, \"tsne_y\": -14.231209754943848, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1469\", \"Dose Order\": \"4\"}, {\"tsne_x\": 43.31917190551758, \"tsne_y\": -14.23198413848877, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1470\", \"Dose Order\": \"4\"}, {\"tsne_x\": 43.2913932800293, \"tsne_y\": -14.237669944763184, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1471\", \"Dose Order\": \"4\"}, {\"tsne_x\": 39.26165771484375, \"tsne_y\": -11.985424995422363, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1888\", \"Dose Order\": \"4\"}, {\"tsne_x\": 39.2681770324707, \"tsne_y\": -12.026156425476074, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1889\", \"Dose Order\": \"4\"}, {\"tsne_x\": 38.77617645263672, \"tsne_y\": -11.961409568786621, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1890\", \"Dose Order\": \"4\"}, {\"tsne_x\": 38.77246856689453, \"tsne_y\": -11.975418090820312, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1891\", \"Dose Order\": \"4\"}, {\"tsne_x\": 40.44403076171875, \"tsne_y\": -12.553632736206055, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1928\", \"Dose Order\": \"4\"}, {\"tsne_x\": 40.166908264160156, \"tsne_y\": -12.884733200073242, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1929\", \"Dose Order\": \"4\"}, {\"tsne_x\": 39.76708221435547, \"tsne_y\": -13.185691833496094, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1930\", \"Dose Order\": \"4\"}, {\"tsne_x\": 39.79389190673828, \"tsne_y\": -13.082202911376953, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1931\", \"Dose Order\": \"4\"}, {\"tsne_x\": 52.70223617553711, \"tsne_y\": -6.215691566467285, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1468\", \"Dose Order\": \"5\"}, {\"tsne_x\": 52.887939453125, \"tsne_y\": -5.9992241859436035, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1469\", \"Dose Order\": \"5\"}, {\"tsne_x\": 52.93360900878906, \"tsne_y\": -5.947242736816406, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1470\", \"Dose Order\": \"5\"}, {\"tsne_x\": 52.95016098022461, \"tsne_y\": -5.924071788787842, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1471\", \"Dose Order\": \"5\"}, {\"tsne_x\": 50.66558074951172, \"tsne_y\": -8.61498737335205, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1888\", \"Dose Order\": \"5\"}, {\"tsne_x\": 51.03541946411133, \"tsne_y\": -8.612533569335938, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1889\", \"Dose Order\": \"5\"}, {\"tsne_x\": 50.832584381103516, \"tsne_y\": -8.675614356994629, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1890\", \"Dose Order\": \"5\"}, {\"tsne_x\": 50.8261833190918, \"tsne_y\": -8.588560104370117, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1891\", \"Dose Order\": \"5\"}, {\"tsne_x\": 49.78499221801758, \"tsne_y\": -9.502459526062012, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1928\", \"Dose Order\": \"5\"}, {\"tsne_x\": 49.48908233642578, \"tsne_y\": -9.20386791229248, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1929\", \"Dose Order\": \"5\"}, {\"tsne_x\": 49.14570617675781, \"tsne_y\": -9.170123100280762, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1930\", \"Dose Order\": \"5\"}, {\"tsne_x\": 49.34814453125, \"tsne_y\": -9.13345718383789, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|2\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1931\", \"Dose Order\": \"5\"}, {\"tsne_x\": 5.684264659881592, \"tsne_y\": 59.383094787597656, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1468\", \"Dose Order\": \"0\"}, {\"tsne_x\": 6.626658916473389, \"tsne_y\": 61.1773567199707, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1469\", \"Dose Order\": \"0\"}, {\"tsne_x\": 7.338558673858643, \"tsne_y\": 61.183414459228516, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1470\", \"Dose Order\": \"0\"}, {\"tsne_x\": 7.091989517211914, \"tsne_y\": 60.845802307128906, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1471\", \"Dose Order\": \"0\"}, {\"tsne_x\": -0.43714940547943115, \"tsne_y\": 56.069000244140625, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1888\", \"Dose Order\": \"0\"}, {\"tsne_x\": -0.2611710727214813, \"tsne_y\": 55.83380889892578, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1889\", \"Dose Order\": \"0\"}, {\"tsne_x\": -0.376457542181015, \"tsne_y\": 55.439453125, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1890\", \"Dose Order\": \"0\"}, {\"tsne_x\": -0.5280044674873352, \"tsne_y\": 55.39323425292969, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1891\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.9372692108154297, \"tsne_y\": 57.14641571044922, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1928\", \"Dose Order\": \"0\"}, {\"tsne_x\": 2.4048492908477783, \"tsne_y\": 56.97052001953125, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1929\", \"Dose Order\": \"0\"}, {\"tsne_x\": 2.2921056747436523, \"tsne_y\": 57.38604736328125, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1930\", \"Dose Order\": \"0\"}, {\"tsne_x\": 2.2638940811157227, \"tsne_y\": 57.354305267333984, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1931\", \"Dose Order\": \"0\"}, {\"tsne_x\": 5.791574001312256, \"tsne_y\": 59.16447830200195, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1468\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.055434226989746, \"tsne_y\": 60.531436920166016, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1469\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.176627159118652, \"tsne_y\": 60.52445983886719, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1470\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.71870231628418, \"tsne_y\": 60.119686126708984, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1471\", \"Dose Order\": \"1\"}, {\"tsne_x\": 0.6028507947921753, \"tsne_y\": 53.48353576660156, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1888\", \"Dose Order\": \"1\"}, {\"tsne_x\": 0.44915255904197693, \"tsne_y\": 53.52389907836914, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1889\", \"Dose Order\": \"1\"}, {\"tsne_x\": 0.1845112442970276, \"tsne_y\": 53.927528381347656, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1890\", \"Dose Order\": \"1\"}, {\"tsne_x\": -0.30471140146255493, \"tsne_y\": 54.08933639526367, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1891\", \"Dose Order\": \"1\"}, {\"tsne_x\": 3.5465199947357178, \"tsne_y\": 54.743465423583984, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1928\", \"Dose Order\": \"1\"}, {\"tsne_x\": 2.840846300125122, \"tsne_y\": 54.64469909667969, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1929\", \"Dose Order\": \"1\"}, {\"tsne_x\": 2.580960750579834, \"tsne_y\": 54.30110549926758, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1930\", \"Dose Order\": \"1\"}, {\"tsne_x\": 2.69223690032959, \"tsne_y\": 54.46199035644531, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1931\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.218417167663574, \"tsne_y\": 58.066123962402344, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1468\", \"Dose Order\": \"2\"}, {\"tsne_x\": 8.932655334472656, \"tsne_y\": 58.72509002685547, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1469\", \"Dose Order\": \"2\"}, {\"tsne_x\": 9.221389770507812, \"tsne_y\": 58.75457763671875, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1470\", \"Dose Order\": \"2\"}, {\"tsne_x\": 9.356916427612305, \"tsne_y\": 58.76219940185547, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1471\", \"Dose Order\": \"2\"}, {\"tsne_x\": 3.8741602897644043, \"tsne_y\": 46.721405029296875, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1888\", \"Dose Order\": \"2\"}, {\"tsne_x\": 3.469909906387329, \"tsne_y\": 46.499046325683594, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1889\", \"Dose Order\": \"2\"}, {\"tsne_x\": 3.5657804012298584, \"tsne_y\": 46.122806549072266, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1890\", \"Dose Order\": \"2\"}, {\"tsne_x\": 3.658280611038208, \"tsne_y\": 46.32558822631836, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1891\", \"Dose Order\": \"2\"}, {\"tsne_x\": 1.234660029411316, \"tsne_y\": 46.77128219604492, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1928\", \"Dose Order\": \"2\"}, {\"tsne_x\": 1.789655089378357, \"tsne_y\": 46.56022644042969, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1929\", \"Dose Order\": \"2\"}, {\"tsne_x\": 1.840084433555603, \"tsne_y\": 46.66943359375, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1930\", \"Dose Order\": \"2\"}, {\"tsne_x\": 1.8353769779205322, \"tsne_y\": 46.76421356201172, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1931\", \"Dose Order\": \"2\"}, {\"tsne_x\": -18.11417579650879, \"tsne_y\": 3.469639539718628, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1468\", \"Dose Order\": \"3\"}, {\"tsne_x\": -16.87610626220703, \"tsne_y\": 4.035365581512451, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1469\", \"Dose Order\": \"3\"}, {\"tsne_x\": -16.822216033935547, \"tsne_y\": 4.0657453536987305, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1470\", \"Dose Order\": \"3\"}, {\"tsne_x\": -17.004295349121094, \"tsne_y\": 3.983119487762451, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1471\", \"Dose Order\": \"3\"}, {\"tsne_x\": 2.761141538619995, \"tsne_y\": 42.326011657714844, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1888\", \"Dose Order\": \"3\"}, {\"tsne_x\": 2.57432222366333, \"tsne_y\": 42.22728729248047, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1889\", \"Dose Order\": \"3\"}, {\"tsne_x\": 2.5112526416778564, \"tsne_y\": 41.921016693115234, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1890\", \"Dose Order\": \"3\"}, {\"tsne_x\": 2.6051483154296875, \"tsne_y\": 41.91909408569336, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1891\", \"Dose Order\": \"3\"}, {\"tsne_x\": 0.6121493577957153, \"tsne_y\": 42.161659240722656, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1928\", \"Dose Order\": \"3\"}, {\"tsne_x\": 1.0454009771347046, \"tsne_y\": 42.74247741699219, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1929\", \"Dose Order\": \"3\"}, {\"tsne_x\": 0.9406898617744446, \"tsne_y\": 42.750343322753906, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1930\", \"Dose Order\": \"3\"}, {\"tsne_x\": 1.0579895973205566, \"tsne_y\": 42.65696716308594, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1931\", \"Dose Order\": \"3\"}, {\"tsne_x\": -19.570255279541016, \"tsne_y\": 3.9073734283447266, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1468\", \"Dose Order\": \"4\"}, {\"tsne_x\": -19.906795501708984, \"tsne_y\": 4.826091289520264, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1469\", \"Dose Order\": \"4\"}, {\"tsne_x\": -20.548940658569336, \"tsne_y\": 4.295655727386475, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1470\", \"Dose Order\": \"4\"}, {\"tsne_x\": -19.798934936523438, \"tsne_y\": 4.807673931121826, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1471\", \"Dose Order\": \"4\"}, {\"tsne_x\": -0.5853977799415588, \"tsne_y\": 35.40113830566406, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1888\", \"Dose Order\": \"4\"}, {\"tsne_x\": -1.0761122703552246, \"tsne_y\": 35.40732955932617, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1889\", \"Dose Order\": \"4\"}, {\"tsne_x\": -1.0934606790542603, \"tsne_y\": 34.915191650390625, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1890\", \"Dose Order\": \"4\"}, {\"tsne_x\": -1.1299768686294556, \"tsne_y\": 34.93121337890625, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1891\", \"Dose Order\": \"4\"}, {\"tsne_x\": -1.8454607725143433, \"tsne_y\": 36.60283279418945, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1928\", \"Dose Order\": \"4\"}, {\"tsne_x\": -1.626543641090393, \"tsne_y\": 36.47821044921875, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1929\", \"Dose Order\": \"4\"}, {\"tsne_x\": -1.6991504430770874, \"tsne_y\": 36.381683349609375, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1930\", \"Dose Order\": \"4\"}, {\"tsne_x\": -1.96427321434021, \"tsne_y\": 36.147308349609375, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1931\", \"Dose Order\": \"4\"}, {\"tsne_x\": 39.847904205322266, \"tsne_y\": -35.05887985229492, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1468\", \"Dose Order\": \"5\"}, {\"tsne_x\": -24.255165100097656, \"tsne_y\": 6.9670562744140625, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1469\", \"Dose Order\": \"5\"}, {\"tsne_x\": -24.3079833984375, \"tsne_y\": 6.99705696105957, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1470\", \"Dose Order\": \"5\"}, {\"tsne_x\": -24.52802848815918, \"tsne_y\": 7.152873516082764, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1471\", \"Dose Order\": \"5\"}, {\"tsne_x\": -26.68915367126465, \"tsne_y\": 14.22061538696289, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1888\", \"Dose Order\": \"5\"}, {\"tsne_x\": -26.699995040893555, \"tsne_y\": 14.101235389709473, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1889\", \"Dose Order\": \"5\"}, {\"tsne_x\": -26.12688636779785, \"tsne_y\": 14.544998168945312, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1890\", \"Dose Order\": \"5\"}, {\"tsne_x\": -26.066917419433594, \"tsne_y\": 14.586174964904785, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1891\", \"Dose Order\": \"5\"}, {\"tsne_x\": -26.65841293334961, \"tsne_y\": 12.85861873626709, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1928\", \"Dose Order\": \"5\"}, {\"tsne_x\": -26.314054489135742, \"tsne_y\": 13.35852336883545, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1929\", \"Dose Order\": \"5\"}, {\"tsne_x\": -26.24852180480957, \"tsne_y\": 13.330670356750488, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1930\", \"Dose Order\": \"5\"}, {\"tsne_x\": -26.14352035522461, \"tsne_y\": 13.238150596618652, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|2\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1931\", \"Dose Order\": \"5\"}, {\"tsne_x\": -43.489681243896484, \"tsne_y\": -2.1691489219665527, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1468\", \"Dose Order\": \"0\"}, {\"tsne_x\": -42.268123626708984, \"tsne_y\": -1.2543727159500122, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1469\", \"Dose Order\": \"0\"}, {\"tsne_x\": -42.83975601196289, \"tsne_y\": -0.803600013256073, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1470\", \"Dose Order\": \"0\"}, {\"tsne_x\": -41.92972183227539, \"tsne_y\": -0.428020179271698, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1471\", \"Dose Order\": \"0\"}, {\"tsne_x\": -44.31171417236328, \"tsne_y\": -1.0367276668548584, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1888\", \"Dose Order\": \"0\"}, {\"tsne_x\": -43.14602279663086, \"tsne_y\": -0.8177518248558044, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1889\", \"Dose Order\": \"0\"}, {\"tsne_x\": -43.139251708984375, \"tsne_y\": -1.019984245300293, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1890\", \"Dose Order\": \"0\"}, {\"tsne_x\": -43.29262161254883, \"tsne_y\": -0.08044949173927307, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1891\", \"Dose Order\": \"0\"}, {\"tsne_x\": -42.321224212646484, \"tsne_y\": 0.7083909511566162, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1928\", \"Dose Order\": \"0\"}, {\"tsne_x\": -43.7136116027832, \"tsne_y\": 0.5687130689620972, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1929\", \"Dose Order\": \"0\"}, {\"tsne_x\": -43.95587158203125, \"tsne_y\": 1.0552057027816772, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1930\", \"Dose Order\": \"0\"}, {\"tsne_x\": -43.74998092651367, \"tsne_y\": 0.11871401220560074, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1931\", \"Dose Order\": \"0\"}, {\"tsne_x\": -39.22318649291992, \"tsne_y\": -32.933170318603516, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1468\", \"Dose Order\": \"1\"}, {\"tsne_x\": -39.79997253417969, \"tsne_y\": -33.475791931152344, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1469\", \"Dose Order\": \"1\"}, {\"tsne_x\": -40.849334716796875, \"tsne_y\": -33.14061737060547, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1470\", \"Dose Order\": \"1\"}, {\"tsne_x\": -40.42697525024414, \"tsne_y\": -33.04317855834961, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1471\", \"Dose Order\": \"1\"}, {\"tsne_x\": -40.357547760009766, \"tsne_y\": -34.435523986816406, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1888\", \"Dose Order\": \"1\"}, {\"tsne_x\": -41.151065826416016, \"tsne_y\": -34.141502380371094, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1889\", \"Dose Order\": \"1\"}, {\"tsne_x\": -41.54114532470703, \"tsne_y\": -34.76948928833008, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1890\", \"Dose Order\": \"1\"}, {\"tsne_x\": -40.545650482177734, \"tsne_y\": -34.34552764892578, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1891\", \"Dose Order\": \"1\"}, {\"tsne_x\": -39.85169219970703, \"tsne_y\": -35.748435974121094, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1928\", \"Dose Order\": \"1\"}, {\"tsne_x\": -40.6944465637207, \"tsne_y\": -34.35643005371094, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1929\", \"Dose Order\": \"1\"}, {\"tsne_x\": -39.446075439453125, \"tsne_y\": -34.58771514892578, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1930\", \"Dose Order\": \"1\"}, {\"tsne_x\": -39.29138946533203, \"tsne_y\": -34.5407829284668, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1931\", \"Dose Order\": \"1\"}, {\"tsne_x\": -47.554264068603516, \"tsne_y\": -11.45957088470459, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1468\", \"Dose Order\": \"2\"}, {\"tsne_x\": -48.89014434814453, \"tsne_y\": -10.211488723754883, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1469\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.23705291748047, \"tsne_y\": -10.312901496887207, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1470\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.589698791503906, \"tsne_y\": -11.17245101928711, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1471\", \"Dose Order\": \"2\"}, {\"tsne_x\": -48.71836471557617, \"tsne_y\": -11.859193801879883, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1888\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.282623291015625, \"tsne_y\": -11.810797691345215, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1889\", \"Dose Order\": \"2\"}, {\"tsne_x\": -48.92255783081055, \"tsne_y\": -11.712650299072266, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1890\", \"Dose Order\": \"2\"}, {\"tsne_x\": -50.512794494628906, \"tsne_y\": -11.8460111618042, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1891\", \"Dose Order\": \"2\"}, {\"tsne_x\": -50.86482620239258, \"tsne_y\": -10.489774703979492, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1928\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.593231201171875, \"tsne_y\": -12.16359806060791, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1929\", \"Dose Order\": \"2\"}, {\"tsne_x\": -49.20839309692383, \"tsne_y\": -12.533143043518066, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1930\", \"Dose Order\": \"2\"}, {\"tsne_x\": -50.27996063232422, \"tsne_y\": -11.629449844360352, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1931\", \"Dose Order\": \"2\"}, {\"tsne_x\": -65.49828338623047, \"tsne_y\": -30.180706024169922, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1468\", \"Dose Order\": \"3\"}, {\"tsne_x\": -60.76576614379883, \"tsne_y\": -25.25393295288086, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1469\", \"Dose Order\": \"3\"}, {\"tsne_x\": -60.81338882446289, \"tsne_y\": -25.079490661621094, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1470\", \"Dose Order\": \"3\"}, {\"tsne_x\": -60.383323669433594, \"tsne_y\": -24.780864715576172, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1471\", \"Dose Order\": \"3\"}, {\"tsne_x\": -61.0097770690918, \"tsne_y\": -23.906469345092773, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1888\", \"Dose Order\": \"3\"}, {\"tsne_x\": -61.07175827026367, \"tsne_y\": -24.060728073120117, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1889\", \"Dose Order\": \"3\"}, {\"tsne_x\": -62.0339469909668, \"tsne_y\": -24.551250457763672, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1890\", \"Dose Order\": \"3\"}, {\"tsne_x\": -61.55555725097656, \"tsne_y\": -24.751327514648438, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1891\", \"Dose Order\": \"3\"}, {\"tsne_x\": -68.9074935913086, \"tsne_y\": -36.4981689453125, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1928\", \"Dose Order\": \"3\"}, {\"tsne_x\": -68.26348114013672, \"tsne_y\": -37.28166961669922, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1929\", \"Dose Order\": \"3\"}, {\"tsne_x\": -67.3968276977539, \"tsne_y\": -38.12276077270508, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1930\", \"Dose Order\": \"3\"}, {\"tsne_x\": -67.19792938232422, \"tsne_y\": -37.19764709472656, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1931\", \"Dose Order\": \"3\"}, {\"tsne_x\": -65.81847381591797, \"tsne_y\": -29.940168380737305, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1468\", \"Dose Order\": \"4\"}, {\"tsne_x\": -65.61030578613281, \"tsne_y\": -27.059640884399414, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1469\", \"Dose Order\": \"4\"}, {\"tsne_x\": -65.5811538696289, \"tsne_y\": -25.93808364868164, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1470\", \"Dose Order\": \"4\"}, {\"tsne_x\": -65.46251678466797, \"tsne_y\": -26.16637420654297, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1471\", \"Dose Order\": \"4\"}, {\"tsne_x\": -65.20649719238281, \"tsne_y\": -25.596513748168945, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1888\", \"Dose Order\": \"4\"}, {\"tsne_x\": -21.30000877380371, \"tsne_y\": -7.4807257652282715, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1889\", \"Dose Order\": \"4\"}, {\"tsne_x\": -65.08208465576172, \"tsne_y\": -25.381441116333008, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1890\", \"Dose Order\": \"4\"}, {\"tsne_x\": -65.86034393310547, \"tsne_y\": -25.43667221069336, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1891\", \"Dose Order\": \"4\"}, {\"tsne_x\": -69.27660369873047, \"tsne_y\": -36.80976867675781, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1928\", \"Dose Order\": \"4\"}, {\"tsne_x\": -68.41262817382812, \"tsne_y\": -37.72398376464844, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1929\", \"Dose Order\": \"4\"}, {\"tsne_x\": -67.78002166748047, \"tsne_y\": -37.919761657714844, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1930\", \"Dose Order\": \"4\"}, {\"tsne_x\": -66.85807800292969, \"tsne_y\": -37.494224548339844, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1931\", \"Dose Order\": \"4\"}, {\"tsne_x\": -66.02637481689453, \"tsne_y\": -30.41724395751953, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1468\", \"Dose Order\": \"5\"}, {\"tsne_x\": -66.40518188476562, \"tsne_y\": -30.68926429748535, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1469\", \"Dose Order\": \"5\"}, {\"tsne_x\": -64.6053695678711, \"tsne_y\": -23.1347713470459, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1470\", \"Dose Order\": \"5\"}, {\"tsne_x\": -64.51207733154297, \"tsne_y\": -22.288660049438477, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1471\", \"Dose Order\": \"5\"}, {\"tsne_x\": -63.19568634033203, \"tsne_y\": -22.024288177490234, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1888\", \"Dose Order\": \"5\"}, {\"tsne_x\": -63.61199951171875, \"tsne_y\": -22.384172439575195, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1889\", \"Dose Order\": \"5\"}, {\"tsne_x\": -63.95625305175781, \"tsne_y\": -22.623008728027344, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1890\", \"Dose Order\": \"5\"}, {\"tsne_x\": -63.770347595214844, \"tsne_y\": -22.82598304748535, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1891\", \"Dose Order\": \"5\"}, {\"tsne_x\": -68.37586212158203, \"tsne_y\": -36.0316276550293, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1928\", \"Dose Order\": \"5\"}, {\"tsne_x\": -67.92488098144531, \"tsne_y\": -36.76642608642578, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1929\", \"Dose Order\": \"5\"}, {\"tsne_x\": -67.55371856689453, \"tsne_y\": -36.336753845214844, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1930\", \"Dose Order\": \"5\"}, {\"tsne_x\": -67.2244873046875, \"tsne_y\": -36.523590087890625, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|2\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1931\", \"Dose Order\": \"5\"}, {\"tsne_x\": -3.404783248901367, \"tsne_y\": -77.00504302978516, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1468\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.326727867126465, \"tsne_y\": -76.0141830444336, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1469\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.120763063430786, \"tsne_y\": -74.31848907470703, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1470\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.4679088592529297, \"tsne_y\": -75.06800079345703, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1471\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.9374144077301025, \"tsne_y\": -75.30496978759766, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1888\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.2101891040802, \"tsne_y\": -74.62537384033203, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1889\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.051624298095703, \"tsne_y\": -74.28971099853516, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1890\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.1692910194396973, \"tsne_y\": -74.86559295654297, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1891\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.770904302597046, \"tsne_y\": -75.87747192382812, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1928\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.203378677368164, \"tsne_y\": -75.7753677368164, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1929\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.618178367614746, \"tsne_y\": -75.14818572998047, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1930\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.009976387023926, \"tsne_y\": -74.67847442626953, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1931\", \"Dose Order\": \"0\"}, {\"tsne_x\": 9.478999137878418, \"tsne_y\": -70.6748275756836, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1468\", \"Dose Order\": \"1\"}, {\"tsne_x\": 9.534489631652832, \"tsne_y\": -69.43426513671875, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1469\", \"Dose Order\": \"1\"}, {\"tsne_x\": 9.10208511352539, \"tsne_y\": -69.35470581054688, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1470\", \"Dose Order\": \"1\"}, {\"tsne_x\": 9.881712913513184, \"tsne_y\": -69.2574462890625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1471\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.12413501739502, \"tsne_y\": -70.56507110595703, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1888\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.659779071807861, \"tsne_y\": -70.87516784667969, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1889\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.269881248474121, \"tsne_y\": -70.72691345214844, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1890\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.539657592773438, \"tsne_y\": -70.24554443359375, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1891\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.782737731933594, \"tsne_y\": -71.58390808105469, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1928\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.576039791107178, \"tsne_y\": -69.88230895996094, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1929\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.932907581329346, \"tsne_y\": -70.09688568115234, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1930\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.502368450164795, \"tsne_y\": -69.70049285888672, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1931\", \"Dose Order\": \"1\"}, {\"tsne_x\": 26.266742706298828, \"tsne_y\": -58.84706497192383, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1468\", \"Dose Order\": \"2\"}, {\"tsne_x\": 26.636329650878906, \"tsne_y\": -59.73389434814453, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1469\", \"Dose Order\": \"2\"}, {\"tsne_x\": 26.75371742248535, \"tsne_y\": -59.77760696411133, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1470\", \"Dose Order\": \"2\"}, {\"tsne_x\": 26.026752471923828, \"tsne_y\": -59.930294036865234, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1471\", \"Dose Order\": \"2\"}, {\"tsne_x\": 29.507232666015625, \"tsne_y\": -57.07987594604492, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1888\", \"Dose Order\": \"2\"}, {\"tsne_x\": 29.594144821166992, \"tsne_y\": -57.34774398803711, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1889\", \"Dose Order\": \"2\"}, {\"tsne_x\": 29.97681427001953, \"tsne_y\": -56.2739372253418, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1890\", \"Dose Order\": \"2\"}, {\"tsne_x\": 29.53809356689453, \"tsne_y\": -56.728939056396484, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1891\", \"Dose Order\": \"2\"}, {\"tsne_x\": 27.547765731811523, \"tsne_y\": -56.637916564941406, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1928\", \"Dose Order\": \"2\"}, {\"tsne_x\": 27.86206817626953, \"tsne_y\": -55.89653778076172, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1929\", \"Dose Order\": \"2\"}, {\"tsne_x\": 28.2076416015625, \"tsne_y\": -55.33562469482422, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1930\", \"Dose Order\": \"2\"}, {\"tsne_x\": 28.057065963745117, \"tsne_y\": -55.67906951904297, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1931\", \"Dose Order\": \"2\"}, {\"tsne_x\": 39.20183181762695, \"tsne_y\": -43.15400314331055, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1468\", \"Dose Order\": \"3\"}, {\"tsne_x\": 39.51641082763672, \"tsne_y\": -42.55922317504883, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1469\", \"Dose Order\": \"3\"}, {\"tsne_x\": 39.5839729309082, \"tsne_y\": -42.350154876708984, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1470\", \"Dose Order\": \"3\"}, {\"tsne_x\": 39.98564910888672, \"tsne_y\": -42.39608383178711, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1471\", \"Dose Order\": \"3\"}, {\"tsne_x\": 42.235198974609375, \"tsne_y\": -47.86665725708008, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1888\", \"Dose Order\": \"3\"}, {\"tsne_x\": 41.697383880615234, \"tsne_y\": -48.5564079284668, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1889\", \"Dose Order\": \"3\"}, {\"tsne_x\": 41.771270751953125, \"tsne_y\": -48.59062957763672, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1890\", \"Dose Order\": \"3\"}, {\"tsne_x\": 41.792091369628906, \"tsne_y\": -48.56109619140625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1891\", \"Dose Order\": \"3\"}, {\"tsne_x\": 44.66712188720703, \"tsne_y\": -48.898380279541016, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1928\", \"Dose Order\": \"3\"}, {\"tsne_x\": 44.3170166015625, \"tsne_y\": -49.00135040283203, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1929\", \"Dose Order\": \"3\"}, {\"tsne_x\": 43.906558990478516, \"tsne_y\": -49.1356086730957, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1930\", \"Dose Order\": \"3\"}, {\"tsne_x\": 44.01446533203125, \"tsne_y\": -49.14004898071289, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1931\", \"Dose Order\": \"3\"}, {\"tsne_x\": 41.77748107910156, \"tsne_y\": -41.17506790161133, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1468\", \"Dose Order\": \"4\"}, {\"tsne_x\": 40.57646560668945, \"tsne_y\": -40.9794807434082, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1469\", \"Dose Order\": \"4\"}, {\"tsne_x\": 40.947181701660156, \"tsne_y\": -40.6580924987793, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1470\", \"Dose Order\": \"4\"}, {\"tsne_x\": 41.527191162109375, \"tsne_y\": -40.682861328125, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1471\", \"Dose Order\": \"4\"}, {\"tsne_x\": 46.67735290527344, \"tsne_y\": -43.01765441894531, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1888\", \"Dose Order\": \"4\"}, {\"tsne_x\": 46.64788818359375, \"tsne_y\": -43.114532470703125, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1889\", \"Dose Order\": \"4\"}, {\"tsne_x\": 46.37577438354492, \"tsne_y\": -42.39896774291992, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1890\", \"Dose Order\": \"4\"}, {\"tsne_x\": 46.306007385253906, \"tsne_y\": -42.574954986572266, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1891\", \"Dose Order\": \"4\"}, {\"tsne_x\": 49.26839828491211, \"tsne_y\": -44.291080474853516, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1928\", \"Dose Order\": \"4\"}, {\"tsne_x\": 49.26953887939453, \"tsne_y\": -43.95746994018555, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1929\", \"Dose Order\": \"4\"}, {\"tsne_x\": 49.59514617919922, \"tsne_y\": -43.66443634033203, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1930\", \"Dose Order\": \"4\"}, {\"tsne_x\": 50.14625549316406, \"tsne_y\": -44.575443267822266, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1931\", \"Dose Order\": \"4\"}, {\"tsne_x\": 39.870662689208984, \"tsne_y\": -35.082794189453125, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1468\", \"Dose Order\": \"5\"}, {\"tsne_x\": 41.74086380004883, \"tsne_y\": -39.42633819580078, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1469\", \"Dose Order\": \"5\"}, {\"tsne_x\": 41.783363342285156, \"tsne_y\": -39.5686149597168, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1470\", \"Dose Order\": \"5\"}, {\"tsne_x\": 42.06528091430664, \"tsne_y\": -39.86307144165039, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1471\", \"Dose Order\": \"5\"}, {\"tsne_x\": 47.67597961425781, \"tsne_y\": -41.03411102294922, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1888\", \"Dose Order\": \"5\"}, {\"tsne_x\": 47.60226821899414, \"tsne_y\": -40.96650314331055, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1889\", \"Dose Order\": \"5\"}, {\"tsne_x\": 47.21647644042969, \"tsne_y\": -40.82792282104492, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1890\", \"Dose Order\": \"5\"}, {\"tsne_x\": 47.18238067626953, \"tsne_y\": -40.910888671875, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1891\", \"Dose Order\": \"5\"}, {\"tsne_x\": 50.59684371948242, \"tsne_y\": -41.917030334472656, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1928\", \"Dose Order\": \"5\"}, {\"tsne_x\": 50.17277145385742, \"tsne_y\": -42.25569534301758, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1929\", \"Dose Order\": \"5\"}, {\"tsne_x\": 50.03458786010742, \"tsne_y\": -42.4033317565918, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1930\", \"Dose Order\": \"5\"}, {\"tsne_x\": 50.14487838745117, \"tsne_y\": -42.25713348388672, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|2\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 2, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1931\", \"Dose Order\": \"5\"}]}}, {\"mode\": \"vega-lite\"});\n",
              "</script>"
            ],
            "text/plain": [
              "alt.Chart(...)"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-52-84172d8d0eec>:13: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  altair_plot_data['Dose Order'] = altair_plot_data['dose_order'].astype(str)\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/html": [
              "\n",
              "<div id=\"altair-viz-ad61126e6a804eb6892e403bd8782662\"></div>\n",
              "<script type=\"text/javascript\">\n",
              "  var VEGA_DEBUG = (typeof VEGA_DEBUG == \"undefined\") ? {} : VEGA_DEBUG;\n",
              "  (function(spec, embedOpt){\n",
              "    let outputDiv = document.currentScript.previousElementSibling;\n",
              "    if (outputDiv.id !== \"altair-viz-ad61126e6a804eb6892e403bd8782662\") {\n",
              "      outputDiv = document.getElementById(\"altair-viz-ad61126e6a804eb6892e403bd8782662\");\n",
              "    }\n",
              "    const paths = {\n",
              "      \"vega\": \"https://cdn.jsdelivr.net/npm//vega@5?noext\",\n",
              "      \"vega-lib\": \"https://cdn.jsdelivr.net/npm//vega-lib?noext\",\n",
              "      \"vega-lite\": \"https://cdn.jsdelivr.net/npm//vega-lite@4.17.0?noext\",\n",
              "      \"vega-embed\": \"https://cdn.jsdelivr.net/npm//vega-embed@6?noext\",\n",
              "    };\n",
              "\n",
              "    function maybeLoadScript(lib, version) {\n",
              "      var key = `${lib.replace(\"-\", \"\")}_version`;\n",
              "      return (VEGA_DEBUG[key] == version) ?\n",
              "        Promise.resolve(paths[lib]) :\n",
              "        new Promise(function(resolve, reject) {\n",
              "          var s = document.createElement('script');\n",
              "          document.getElementsByTagName(\"head\")[0].appendChild(s);\n",
              "          s.async = true;\n",
              "          s.onload = () => {\n",
              "            VEGA_DEBUG[key] = version;\n",
              "            return resolve(paths[lib]);\n",
              "          };\n",
              "          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);\n",
              "          s.src = paths[lib];\n",
              "        });\n",
              "    }\n",
              "\n",
              "    function showError(err) {\n",
              "      outputDiv.innerHTML = `<div class=\"error\" style=\"color:red;\">${err}</div>`;\n",
              "      throw err;\n",
              "    }\n",
              "\n",
              "    function displayChart(vegaEmbed) {\n",
              "      vegaEmbed(outputDiv, spec, embedOpt)\n",
              "        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));\n",
              "    }\n",
              "\n",
              "    if(typeof define === \"function\" && define.amd) {\n",
              "      requirejs.config({paths});\n",
              "      require([\"vega-embed\"], displayChart, err => showError(`Error loading script: ${err.message}`));\n",
              "    } else {\n",
              "      maybeLoadScript(\"vega\", \"5\")\n",
              "        .then(() => maybeLoadScript(\"vega-lite\", \"4.17.0\"))\n",
              "        .then(() => maybeLoadScript(\"vega-embed\", \"6\"))\n",
              "        .catch(showError)\n",
              "        .then(() => displayChart(vegaEmbed));\n",
              "    }\n",
              "  })({\"config\": {\"view\": {\"continuousWidth\": 400, \"continuousHeight\": 300}, \"axis\": {\"labelFontSize\": 20, \"titleFontSize\": 20}, \"background\": \"white\", \"legend\": {\"labelFontSize\": 20, \"labelLimit\": 0, \"titleFontSize\": 20}}, \"data\": {\"name\": \"data-209833ee93469e8a9a6005165ea1d377\"}, \"mark\": {\"type\": \"point\", \"filled\": true, \"size\": 240, \"stroke\": \"black\", \"strokeWidth\": 1.5}, \"encoding\": {\"color\": {\"field\": \"Compound Group\", \"scale\": {\"domain\": [\"DMSO\", \"Herceptin\", \"Perjeta\", \"Active Degraders\", \"Inactive Degraders\", \"PI3K Inhibitor\", \"Pan-Akt Inhibitor\", \"Neratinib (Covalent Inhibitor)\", \"BDTX-189 (Covalent Inhibitor)\", \"Head Group Small Molecules\"], \"range\": [\"#7f7f7f\", \"#ff7f0e\", \"#8c5626\", \"#d62728\", \"#bcbd22\", \"#9467bd\", \"#e377c2\", \"#1f77b4\", \"#17becf\", \"#2ca02c\"]}, \"type\": \"nominal\"}, \"shape\": {\"field\": \"Dose Order\", \"type\": \"nominal\"}, \"tooltip\": {\"field\": \"compound_dose\", \"type\": \"nominal\"}, \"x\": {\"field\": \"tsne_x\", \"type\": \"quantitative\"}, \"y\": {\"field\": \"tsne_y\", \"type\": \"quantitative\"}}, \"height\": 700, \"title\": \"SKOV3 No GFP Timepoint 3 (48 hours)\", \"width\": 700, \"$schema\": \"https://vega.github.io/schema/vega-lite/v4.17.0.json\", \"datasets\": {\"data-209833ee93469e8a9a6005165ea1d377\": [{\"tsne_x\": -7.992067813873291, \"tsne_y\": -6.37538480758667, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1473\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.874817848205566, \"tsne_y\": -6.596690654754639, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1474\", \"Dose Order\": \"0\"}, {\"tsne_x\": -6.84301233291626, \"tsne_y\": -6.916341781616211, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1475\", \"Dose Order\": \"0\"}, {\"tsne_x\": -6.784897327423096, \"tsne_y\": -8.028507232666016, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1892\", \"Dose Order\": \"0\"}, {\"tsne_x\": -6.7286224365234375, \"tsne_y\": -7.183262348175049, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1893\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.436715602874756, \"tsne_y\": -7.171960353851318, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1894\", \"Dose Order\": \"0\"}, {\"tsne_x\": -6.220637798309326, \"tsne_y\": -6.451186656951904, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1895\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.205908298492432, \"tsne_y\": -9.198420524597168, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1932\", \"Dose Order\": \"0\"}, {\"tsne_x\": -6.019468307495117, \"tsne_y\": -7.31057071685791, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1933\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.885329246520996, \"tsne_y\": -7.894140243530273, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1934\", \"Dose Order\": \"0\"}, {\"tsne_x\": -6.6969380378723145, \"tsne_y\": -7.826564311981201, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1935\", \"Dose Order\": \"0\"}, {\"tsne_x\": -26.10584831237793, \"tsne_y\": -32.32643508911133, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1473\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.02369499206543, \"tsne_y\": -32.34961700439453, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1474\", \"Dose Order\": \"1\"}, {\"tsne_x\": -26.514232635498047, \"tsne_y\": -31.752614974975586, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1475\", \"Dose Order\": \"1\"}, {\"tsne_x\": -26.652198791503906, \"tsne_y\": -32.87748718261719, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1892\", \"Dose Order\": \"1\"}, {\"tsne_x\": -26.47542953491211, \"tsne_y\": -33.46590042114258, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1893\", \"Dose Order\": \"1\"}, {\"tsne_x\": -26.76810646057129, \"tsne_y\": -33.128021240234375, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1894\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.009647369384766, \"tsne_y\": -33.45919418334961, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1895\", \"Dose Order\": \"1\"}, {\"tsne_x\": -28.601118087768555, \"tsne_y\": -33.18459701538086, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1932\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.487258911132812, \"tsne_y\": -31.43674087524414, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1933\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.865880966186523, \"tsne_y\": -32.31867980957031, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1934\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.69564437866211, \"tsne_y\": -31.945842742919922, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1935\", \"Dose Order\": \"1\"}, {\"tsne_x\": -21.70425796508789, \"tsne_y\": -43.006629943847656, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1473\", \"Dose Order\": \"2\"}, {\"tsne_x\": -21.60622787475586, \"tsne_y\": -43.27992630004883, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1474\", \"Dose Order\": \"2\"}, {\"tsne_x\": -21.13335609436035, \"tsne_y\": -42.55521774291992, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1475\", \"Dose Order\": \"2\"}, {\"tsne_x\": -22.308605194091797, \"tsne_y\": -42.63069534301758, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1892\", \"Dose Order\": \"2\"}, {\"tsne_x\": -22.60848045349121, \"tsne_y\": -41.8166389465332, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1893\", \"Dose Order\": \"2\"}, {\"tsne_x\": -22.638978958129883, \"tsne_y\": -42.19778823852539, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1894\", \"Dose Order\": \"2\"}, {\"tsne_x\": -22.353954315185547, \"tsne_y\": -42.32233810424805, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1895\", \"Dose Order\": \"2\"}, {\"tsne_x\": -21.477659225463867, \"tsne_y\": -41.185508728027344, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1932\", \"Dose Order\": \"2\"}, {\"tsne_x\": -22.621135711669922, \"tsne_y\": -43.70268249511719, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1933\", \"Dose Order\": \"2\"}, {\"tsne_x\": -23.226661682128906, \"tsne_y\": -43.232505798339844, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1934\", \"Dose Order\": \"2\"}, {\"tsne_x\": -23.369644165039062, \"tsne_y\": -43.61094284057617, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1935\", \"Dose Order\": \"2\"}, {\"tsne_x\": -20.29515266418457, \"tsne_y\": -47.159053802490234, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1473\", \"Dose Order\": \"3\"}, {\"tsne_x\": -20.513025283813477, \"tsne_y\": -47.10242462158203, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1474\", \"Dose Order\": \"3\"}, {\"tsne_x\": -20.88176155090332, \"tsne_y\": -47.08473205566406, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1475\", \"Dose Order\": \"3\"}, {\"tsne_x\": -21.12469482421875, \"tsne_y\": -48.67821502685547, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1892\", \"Dose Order\": \"3\"}, {\"tsne_x\": -20.992700576782227, \"tsne_y\": -49.19478225708008, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1893\", \"Dose Order\": \"3\"}, {\"tsne_x\": -21.510835647583008, \"tsne_y\": -48.912654876708984, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1894\", \"Dose Order\": \"3\"}, {\"tsne_x\": -21.1218318939209, \"tsne_y\": -48.865501403808594, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1895\", \"Dose Order\": \"3\"}, {\"tsne_x\": -23.696016311645508, \"tsne_y\": -48.25518035888672, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1932\", \"Dose Order\": \"3\"}, {\"tsne_x\": -22.391971588134766, \"tsne_y\": -47.793216705322266, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1933\", \"Dose Order\": \"3\"}, {\"tsne_x\": -23.098678588867188, \"tsne_y\": -47.7573127746582, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1934\", \"Dose Order\": \"3\"}, {\"tsne_x\": -22.852046966552734, \"tsne_y\": -47.75812911987305, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1935\", \"Dose Order\": \"3\"}, {\"tsne_x\": -19.978954315185547, \"tsne_y\": -55.7058219909668, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1473\", \"Dose Order\": \"4\"}, {\"tsne_x\": -19.97262191772461, \"tsne_y\": -55.67264938354492, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1474\", \"Dose Order\": \"4\"}, {\"tsne_x\": -19.897052764892578, \"tsne_y\": -55.56148147583008, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1475\", \"Dose Order\": \"4\"}, {\"tsne_x\": -18.437021255493164, \"tsne_y\": -54.74222946166992, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1892\", \"Dose Order\": \"4\"}, {\"tsne_x\": -18.483806610107422, \"tsne_y\": -54.261695861816406, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1893\", \"Dose Order\": \"4\"}, {\"tsne_x\": -18.580257415771484, \"tsne_y\": -54.150787353515625, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1894\", \"Dose Order\": \"4\"}, {\"tsne_x\": -18.480995178222656, \"tsne_y\": -54.222923278808594, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1895\", \"Dose Order\": \"4\"}, {\"tsne_x\": -16.29169464111328, \"tsne_y\": -54.2569580078125, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1932\", \"Dose Order\": \"4\"}, {\"tsne_x\": -16.90949821472168, \"tsne_y\": -55.280460357666016, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1933\", \"Dose Order\": \"4\"}, {\"tsne_x\": -16.849000930786133, \"tsne_y\": -54.82620620727539, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1934\", \"Dose Order\": \"4\"}, {\"tsne_x\": -17.043405532836914, \"tsne_y\": -54.85077667236328, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1935\", \"Dose Order\": \"4\"}, {\"tsne_x\": -18.55461883544922, \"tsne_y\": -62.79389190673828, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1473\", \"Dose Order\": \"5\"}, {\"tsne_x\": -18.43433380126953, \"tsne_y\": -62.836578369140625, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1474\", \"Dose Order\": \"5\"}, {\"tsne_x\": -18.35895347595215, \"tsne_y\": -62.87682342529297, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1475\", \"Dose Order\": \"5\"}, {\"tsne_x\": -16.95814323425293, \"tsne_y\": -64.05467987060547, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1892\", \"Dose Order\": \"5\"}, {\"tsne_x\": -17.021482467651367, \"tsne_y\": -64.2961196899414, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1893\", \"Dose Order\": \"5\"}, {\"tsne_x\": -17.139877319335938, \"tsne_y\": -64.07414245605469, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1894\", \"Dose Order\": \"5\"}, {\"tsne_x\": -17.085174560546875, \"tsne_y\": -63.72772216796875, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1895\", \"Dose Order\": \"5\"}, {\"tsne_x\": -16.18233871459961, \"tsne_y\": -62.451019287109375, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1932\", \"Dose Order\": \"5\"}, {\"tsne_x\": -15.841459274291992, \"tsne_y\": -62.68501663208008, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1933\", \"Dose Order\": \"5\"}, {\"tsne_x\": -15.72086238861084, \"tsne_y\": -62.91126251220703, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1934\", \"Dose Order\": \"5\"}, {\"tsne_x\": -15.840253829956055, \"tsne_y\": -62.958106994628906, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|3\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1935\", \"Dose Order\": \"5\"}, {\"tsne_x\": -49.25790023803711, \"tsne_y\": 11.282739639282227, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1473\", \"Dose Order\": \"0\"}, {\"tsne_x\": -49.05630874633789, \"tsne_y\": 11.172688484191895, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1474\", \"Dose Order\": \"0\"}, {\"tsne_x\": -49.32066345214844, \"tsne_y\": 11.944812774658203, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1475\", \"Dose Order\": \"0\"}, {\"tsne_x\": -50.19413757324219, \"tsne_y\": 12.67076301574707, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1892\", \"Dose Order\": \"0\"}, {\"tsne_x\": -50.69398498535156, \"tsne_y\": 11.51469612121582, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1893\", \"Dose Order\": \"0\"}, {\"tsne_x\": -50.86127853393555, \"tsne_y\": 11.455413818359375, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1894\", \"Dose Order\": \"0\"}, {\"tsne_x\": -50.409854888916016, \"tsne_y\": 10.854491233825684, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1895\", \"Dose Order\": \"0\"}, {\"tsne_x\": -50.87259292602539, \"tsne_y\": 13.178476333618164, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1932\", \"Dose Order\": \"0\"}, {\"tsne_x\": -51.14461898803711, \"tsne_y\": 12.284457206726074, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1933\", \"Dose Order\": \"0\"}, {\"tsne_x\": -49.01327896118164, \"tsne_y\": 12.708395957946777, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1934\", \"Dose Order\": \"0\"}, {\"tsne_x\": -49.51642608642578, \"tsne_y\": 12.392829895019531, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1935\", \"Dose Order\": \"0\"}, {\"tsne_x\": -55.33827209472656, \"tsne_y\": 7.253514766693115, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1473\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.581207275390625, \"tsne_y\": 6.666660785675049, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1474\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.406219482421875, \"tsne_y\": 7.312931060791016, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1475\", \"Dose Order\": \"1\"}, {\"tsne_x\": -56.82658767700195, \"tsne_y\": 7.290515899658203, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1892\", \"Dose Order\": \"1\"}, {\"tsne_x\": -57.312530517578125, \"tsne_y\": 7.849472522735596, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1893\", \"Dose Order\": \"1\"}, {\"tsne_x\": -56.994667053222656, \"tsne_y\": 7.323065757751465, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1894\", \"Dose Order\": \"1\"}, {\"tsne_x\": -56.61880874633789, \"tsne_y\": 8.201866149902344, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1895\", \"Dose Order\": \"1\"}, {\"tsne_x\": -56.521846771240234, \"tsne_y\": 9.677278518676758, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1932\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.767539978027344, \"tsne_y\": 9.385650634765625, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1933\", \"Dose Order\": \"1\"}, {\"tsne_x\": -55.33829879760742, \"tsne_y\": 8.225288391113281, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1934\", \"Dose Order\": \"1\"}, {\"tsne_x\": -56.14474868774414, \"tsne_y\": 8.320611000061035, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1935\", \"Dose Order\": \"1\"}, {\"tsne_x\": -60.45684051513672, \"tsne_y\": 3.3661699295043945, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1473\", \"Dose Order\": \"2\"}, {\"tsne_x\": -60.48680877685547, \"tsne_y\": 3.4563727378845215, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1474\", \"Dose Order\": \"2\"}, {\"tsne_x\": -60.640506744384766, \"tsne_y\": 3.642792224884033, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1475\", \"Dose Order\": \"2\"}, {\"tsne_x\": -62.243019104003906, \"tsne_y\": 5.111497402191162, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1892\", \"Dose Order\": \"2\"}, {\"tsne_x\": -62.881980895996094, \"tsne_y\": 4.7040815353393555, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1893\", \"Dose Order\": \"2\"}, {\"tsne_x\": -62.507999420166016, \"tsne_y\": 4.78195858001709, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1894\", \"Dose Order\": \"2\"}, {\"tsne_x\": -62.550201416015625, \"tsne_y\": 5.082985877990723, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1895\", \"Dose Order\": \"2\"}, {\"tsne_x\": -61.73779296875, \"tsne_y\": 8.077108383178711, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1932\", \"Dose Order\": \"2\"}, {\"tsne_x\": -61.612586975097656, \"tsne_y\": 7.673302173614502, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1933\", \"Dose Order\": \"2\"}, {\"tsne_x\": -62.41694259643555, \"tsne_y\": 7.56434440612793, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1934\", \"Dose Order\": \"2\"}, {\"tsne_x\": -62.19637680053711, \"tsne_y\": 7.46746301651001, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1935\", \"Dose Order\": \"2\"}, {\"tsne_x\": -65.04183197021484, \"tsne_y\": 0.9190078377723694, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1473\", \"Dose Order\": \"3\"}, {\"tsne_x\": -65.13105773925781, \"tsne_y\": 0.785183846950531, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1474\", \"Dose Order\": \"3\"}, {\"tsne_x\": -65.1004638671875, \"tsne_y\": 0.7722465991973877, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1475\", \"Dose Order\": \"3\"}, {\"tsne_x\": -65.41289520263672, \"tsne_y\": 3.611330032348633, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1892\", \"Dose Order\": \"3\"}, {\"tsne_x\": -65.32890319824219, \"tsne_y\": 3.901113986968994, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1893\", \"Dose Order\": \"3\"}, {\"tsne_x\": -65.43749237060547, \"tsne_y\": 3.69447922706604, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1894\", \"Dose Order\": \"3\"}, {\"tsne_x\": -65.03135681152344, \"tsne_y\": 3.189345359802246, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1895\", \"Dose Order\": \"3\"}, {\"tsne_x\": -67.03535461425781, \"tsne_y\": 7.708774089813232, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1932\", \"Dose Order\": \"3\"}, {\"tsne_x\": -67.03878784179688, \"tsne_y\": 6.692033767700195, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1933\", \"Dose Order\": \"3\"}, {\"tsne_x\": -67.0963134765625, \"tsne_y\": 6.498229026794434, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1934\", \"Dose Order\": \"3\"}, {\"tsne_x\": -66.89846801757812, \"tsne_y\": 6.792464733123779, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1935\", \"Dose Order\": \"3\"}, {\"tsne_x\": -68.17093658447266, \"tsne_y\": -0.9851082563400269, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1473\", \"Dose Order\": \"4\"}, {\"tsne_x\": -68.18120574951172, \"tsne_y\": -1.0421390533447266, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1474\", \"Dose Order\": \"4\"}, {\"tsne_x\": -68.0841064453125, \"tsne_y\": -0.9736136794090271, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1475\", \"Dose Order\": \"4\"}, {\"tsne_x\": -70.16165161132812, \"tsne_y\": 1.8312369585037231, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1892\", \"Dose Order\": \"4\"}, {\"tsne_x\": -69.84838104248047, \"tsne_y\": 1.8244597911834717, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1893\", \"Dose Order\": \"4\"}, {\"tsne_x\": -70.14381408691406, \"tsne_y\": 1.9036521911621094, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1894\", \"Dose Order\": \"4\"}, {\"tsne_x\": -69.94049835205078, \"tsne_y\": 1.6013379096984863, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1895\", \"Dose Order\": \"4\"}, {\"tsne_x\": -72.84361267089844, \"tsne_y\": 1.9462172985076904, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1932\", \"Dose Order\": \"4\"}, {\"tsne_x\": -72.65495300292969, \"tsne_y\": 2.8047797679901123, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1933\", \"Dose Order\": \"4\"}, {\"tsne_x\": -72.36935424804688, \"tsne_y\": 2.4933559894561768, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1934\", \"Dose Order\": \"4\"}, {\"tsne_x\": -72.53277587890625, \"tsne_y\": 2.408203125, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1935\", \"Dose Order\": \"4\"}, {\"tsne_x\": -69.95710754394531, \"tsne_y\": -2.6473307609558105, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1473\", \"Dose Order\": \"5\"}, {\"tsne_x\": -69.72706604003906, \"tsne_y\": -2.1936001777648926, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1474\", \"Dose Order\": \"5\"}, {\"tsne_x\": -70.03170776367188, \"tsne_y\": -2.5986108779907227, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1475\", \"Dose Order\": \"5\"}, {\"tsne_x\": -72.20420837402344, \"tsne_y\": -4.072697639465332, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1892\", \"Dose Order\": \"5\"}, {\"tsne_x\": -72.38713836669922, \"tsne_y\": -4.356104850769043, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1893\", \"Dose Order\": \"5\"}, {\"tsne_x\": -72.63726806640625, \"tsne_y\": -4.248545169830322, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1894\", \"Dose Order\": \"5\"}, {\"tsne_x\": -72.56105041503906, \"tsne_y\": -4.02275276184082, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1895\", \"Dose Order\": \"5\"}, {\"tsne_x\": -73.50833892822266, \"tsne_y\": -2.346686601638794, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1932\", \"Dose Order\": \"5\"}, {\"tsne_x\": -73.18292236328125, \"tsne_y\": -2.4599690437316895, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1933\", \"Dose Order\": \"5\"}, {\"tsne_x\": -72.89969635009766, \"tsne_y\": -2.524108409881592, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1934\", \"Dose Order\": \"5\"}, {\"tsne_x\": -72.54612731933594, \"tsne_y\": -2.3215463161468506, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|3\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1935\", \"Dose Order\": \"5\"}, {\"tsne_x\": -18.529945373535156, \"tsne_y\": 0.887324869632721, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1473\", \"Dose Order\": \"0\"}, {\"tsne_x\": -18.769906997680664, \"tsne_y\": -0.1473500281572342, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1474\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.012727737426758, \"tsne_y\": -0.11429343372583389, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1475\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.481586456298828, \"tsne_y\": -0.20169265568256378, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1892\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.87858009338379, \"tsne_y\": 0.042853884398937225, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1893\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.506860733032227, \"tsne_y\": 0.3922494947910309, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1894\", \"Dose Order\": \"0\"}, {\"tsne_x\": -18.732704162597656, \"tsne_y\": 0.05382728949189186, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1895\", \"Dose Order\": \"0\"}, {\"tsne_x\": -17.957569122314453, \"tsne_y\": -1.2946817874908447, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1932\", \"Dose Order\": \"0\"}, {\"tsne_x\": -27.955188751220703, \"tsne_y\": -2.2375545501708984, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1933\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.336318969726562, \"tsne_y\": -1.1510233879089355, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1934\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.449594497680664, \"tsne_y\": -0.8238710761070251, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1935\", \"Dose Order\": \"0\"}, {\"tsne_x\": -27.975379943847656, \"tsne_y\": 9.984362602233887, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1473\", \"Dose Order\": \"1\"}, {\"tsne_x\": -28.209022521972656, \"tsne_y\": 10.026118278503418, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1474\", \"Dose Order\": \"1\"}, {\"tsne_x\": -28.57010841369629, \"tsne_y\": 9.768589973449707, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1475\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.624794006347656, \"tsne_y\": 12.087761878967285, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1892\", \"Dose Order\": \"1\"}, {\"tsne_x\": -28.19489288330078, \"tsne_y\": 11.201967239379883, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1893\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.515594482421875, \"tsne_y\": 11.338136672973633, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1894\", \"Dose Order\": \"1\"}, {\"tsne_x\": -28.08835792541504, \"tsne_y\": 11.260429382324219, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1895\", \"Dose Order\": \"1\"}, {\"tsne_x\": -26.398475646972656, \"tsne_y\": 10.38603401184082, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1932\", \"Dose Order\": \"1\"}, {\"tsne_x\": -29.0587158203125, \"tsne_y\": 11.30376148223877, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1933\", \"Dose Order\": \"1\"}, {\"tsne_x\": -26.693912506103516, \"tsne_y\": 11.476304054260254, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1934\", \"Dose Order\": \"1\"}, {\"tsne_x\": -27.467041015625, \"tsne_y\": 11.849379539489746, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1935\", \"Dose Order\": \"1\"}, {\"tsne_x\": -33.05691909790039, \"tsne_y\": -1.1022456884384155, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1473\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.3030891418457, \"tsne_y\": -1.8498013019561768, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1474\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.422176361083984, \"tsne_y\": -2.1459076404571533, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1475\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.201332092285156, \"tsne_y\": -3.210056781768799, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1892\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.93606185913086, \"tsne_y\": -3.452270746231079, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1893\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.71334457397461, \"tsne_y\": -3.6934587955474854, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1894\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.822689056396484, \"tsne_y\": -2.9203453063964844, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1895\", \"Dose Order\": \"2\"}, {\"tsne_x\": -32.28419494628906, \"tsne_y\": -3.915865182876587, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1932\", \"Dose Order\": \"2\"}, {\"tsne_x\": -28.285938262939453, \"tsne_y\": -2.2981386184692383, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1933\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.09616470336914, \"tsne_y\": -4.857845306396484, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1934\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.079219818115234, \"tsne_y\": -4.719448566436768, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1935\", \"Dose Order\": \"2\"}, {\"tsne_x\": 53.52613830566406, \"tsne_y\": -12.413507461547852, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1473\", \"Dose Order\": \"3\"}, {\"tsne_x\": 53.5617790222168, \"tsne_y\": -12.440729141235352, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1474\", \"Dose Order\": \"3\"}, {\"tsne_x\": 53.50410079956055, \"tsne_y\": -12.510139465332031, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1475\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.502140045166016, \"tsne_y\": -11.86038875579834, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1892\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.50738525390625, \"tsne_y\": -11.315362930297852, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1893\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.700927734375, \"tsne_y\": -11.435348510742188, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1894\", \"Dose Order\": \"3\"}, {\"tsne_x\": 51.14017868041992, \"tsne_y\": -11.480674743652344, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1895\", \"Dose Order\": \"3\"}, {\"tsne_x\": 52.00934600830078, \"tsne_y\": -14.334031105041504, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1932\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.91851806640625, \"tsne_y\": -13.800581932067871, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1933\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.627262115478516, \"tsne_y\": -13.785194396972656, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1934\", \"Dose Order\": \"3\"}, {\"tsne_x\": 50.56272888183594, \"tsne_y\": -13.72828483581543, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1935\", \"Dose Order\": \"3\"}, {\"tsne_x\": 77.24738311767578, \"tsne_y\": -3.3720474243164062, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1473\", \"Dose Order\": \"4\"}, {\"tsne_x\": 77.27259063720703, \"tsne_y\": -3.4953553676605225, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1474\", \"Dose Order\": \"4\"}, {\"tsne_x\": 77.09402465820312, \"tsne_y\": -3.756162643432617, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1475\", \"Dose Order\": \"4\"}, {\"tsne_x\": 76.14476776123047, \"tsne_y\": -6.078757286071777, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1892\", \"Dose Order\": \"4\"}, {\"tsne_x\": 76.58687591552734, \"tsne_y\": -5.8440842628479, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1893\", \"Dose Order\": \"4\"}, {\"tsne_x\": 76.49856567382812, \"tsne_y\": -5.976935386657715, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1894\", \"Dose Order\": \"4\"}, {\"tsne_x\": 77.15636444091797, \"tsne_y\": -5.397880554199219, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1895\", \"Dose Order\": \"4\"}, {\"tsne_x\": 78.89816284179688, \"tsne_y\": -6.109340667724609, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1932\", \"Dose Order\": \"4\"}, {\"tsne_x\": 78.10130310058594, \"tsne_y\": -5.913406848907471, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1933\", \"Dose Order\": \"4\"}, {\"tsne_x\": 78.40008544921875, \"tsne_y\": -6.16524076461792, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1934\", \"Dose Order\": \"4\"}, {\"tsne_x\": 78.72711181640625, \"tsne_y\": -7.190593719482422, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1935\", \"Dose Order\": \"4\"}, {\"tsne_x\": 78.81864166259766, \"tsne_y\": -1.674561858177185, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1473\", \"Dose Order\": \"5\"}, {\"tsne_x\": 78.91165161132812, \"tsne_y\": -1.6284047365188599, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1474\", \"Dose Order\": \"5\"}, {\"tsne_x\": 78.74754333496094, \"tsne_y\": -1.6174460649490356, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1475\", \"Dose Order\": \"5\"}, {\"tsne_x\": 80.76866912841797, \"tsne_y\": -2.014193058013916, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1892\", \"Dose Order\": \"5\"}, {\"tsne_x\": 81.14779663085938, \"tsne_y\": -1.347461223602295, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1893\", \"Dose Order\": \"5\"}, {\"tsne_x\": 81.30213165283203, \"tsne_y\": -1.7706533670425415, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1894\", \"Dose Order\": \"5\"}, {\"tsne_x\": 81.09915161132812, \"tsne_y\": -1.2109448909759521, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1895\", \"Dose Order\": \"5\"}, {\"tsne_x\": 82.60911560058594, \"tsne_y\": -3.3369057178497314, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1932\", \"Dose Order\": \"5\"}, {\"tsne_x\": 82.50350189208984, \"tsne_y\": -2.3133022785186768, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1933\", \"Dose Order\": \"5\"}, {\"tsne_x\": 82.63249969482422, \"tsne_y\": -2.494549036026001, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1934\", \"Dose Order\": \"5\"}, {\"tsne_x\": 82.5465316772461, \"tsne_y\": -2.608954429626465, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1935\", \"Dose Order\": \"5\"}, {\"tsne_x\": 1.955311894416809, \"tsne_y\": 0.7381331920623779, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1473\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.0223909616470337, \"tsne_y\": 0.9373655915260315, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1474\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.7410309910774231, \"tsne_y\": 0.9011404514312744, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1475\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.9445682764053345, \"tsne_y\": 0.17803779244422913, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1892\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.09593632817268372, \"tsne_y\": -0.22099508345127106, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1893\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.8708747625350952, \"tsne_y\": 0.2008674591779709, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1894\", \"Dose Order\": \"0\"}, {\"tsne_x\": -0.060369253158569336, \"tsne_y\": 0.5587577819824219, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1895\", \"Dose Order\": \"0\"}, {\"tsne_x\": 2.7201497554779053, \"tsne_y\": 0.2478819042444229, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1932\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.6894336938858032, \"tsne_y\": -1.2230687141418457, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1933\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.3578557968139648, \"tsne_y\": -0.7524270415306091, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1934\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.8504438996315002, \"tsne_y\": -0.5254440307617188, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1935\", \"Dose Order\": \"0\"}, {\"tsne_x\": 19.23883628845215, \"tsne_y\": 15.077957153320312, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1473\", \"Dose Order\": \"1\"}, {\"tsne_x\": 19.121522903442383, \"tsne_y\": 14.710838317871094, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1474\", \"Dose Order\": \"1\"}, {\"tsne_x\": 19.99817657470703, \"tsne_y\": 15.730207443237305, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1475\", \"Dose Order\": \"1\"}, {\"tsne_x\": 19.75303840637207, \"tsne_y\": 16.219873428344727, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1892\", \"Dose Order\": \"1\"}, {\"tsne_x\": 19.00083351135254, \"tsne_y\": 16.428939819335938, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1893\", \"Dose Order\": \"1\"}, {\"tsne_x\": 19.4908390045166, \"tsne_y\": 16.292686462402344, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1894\", \"Dose Order\": \"1\"}, {\"tsne_x\": 19.164278030395508, \"tsne_y\": 16.867290496826172, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1895\", \"Dose Order\": \"1\"}, {\"tsne_x\": 20.897632598876953, \"tsne_y\": 17.482173919677734, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1932\", \"Dose Order\": \"1\"}, {\"tsne_x\": 20.64737319946289, \"tsne_y\": 15.657951354980469, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1933\", \"Dose Order\": \"1\"}, {\"tsne_x\": 20.488697052001953, \"tsne_y\": 16.679641723632812, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1934\", \"Dose Order\": \"1\"}, {\"tsne_x\": 18.808656692504883, \"tsne_y\": 15.847454071044922, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1935\", \"Dose Order\": \"1\"}, {\"tsne_x\": 34.41766357421875, \"tsne_y\": 10.494976997375488, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1473\", \"Dose Order\": \"2\"}, {\"tsne_x\": 34.272552490234375, \"tsne_y\": 10.977426528930664, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1474\", \"Dose Order\": \"2\"}, {\"tsne_x\": 34.00388717651367, \"tsne_y\": 9.47876262664795, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1475\", \"Dose Order\": \"2\"}, {\"tsne_x\": 33.343544006347656, \"tsne_y\": 10.533113479614258, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1892\", \"Dose Order\": \"2\"}, {\"tsne_x\": 33.331539154052734, \"tsne_y\": 10.587050437927246, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1893\", \"Dose Order\": \"2\"}, {\"tsne_x\": 33.47161865234375, \"tsne_y\": 10.886127471923828, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1894\", \"Dose Order\": \"2\"}, {\"tsne_x\": 33.783836364746094, \"tsne_y\": 11.416635513305664, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1895\", \"Dose Order\": \"2\"}, {\"tsne_x\": 34.122013092041016, \"tsne_y\": 12.400696754455566, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1932\", \"Dose Order\": \"2\"}, {\"tsne_x\": 32.29132843017578, \"tsne_y\": 10.166632652282715, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1933\", \"Dose Order\": \"2\"}, {\"tsne_x\": 33.045894622802734, \"tsne_y\": 11.764894485473633, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1934\", \"Dose Order\": \"2\"}, {\"tsne_x\": 32.6907844543457, \"tsne_y\": 11.566112518310547, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1935\", \"Dose Order\": \"2\"}, {\"tsne_x\": 34.71321105957031, \"tsne_y\": 21.276329040527344, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1473\", \"Dose Order\": \"3\"}, {\"tsne_x\": 33.34697341918945, \"tsne_y\": 22.565799713134766, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1474\", \"Dose Order\": \"3\"}, {\"tsne_x\": 32.94145584106445, \"tsne_y\": 22.649232864379883, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1475\", \"Dose Order\": \"3\"}, {\"tsne_x\": 33.70096206665039, \"tsne_y\": 22.256366729736328, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1892\", \"Dose Order\": \"3\"}, {\"tsne_x\": 34.3878173828125, \"tsne_y\": 21.849058151245117, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1893\", \"Dose Order\": \"3\"}, {\"tsne_x\": 34.074642181396484, \"tsne_y\": 21.967464447021484, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1894\", \"Dose Order\": \"3\"}, {\"tsne_x\": 34.75716781616211, \"tsne_y\": 21.875497817993164, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1895\", \"Dose Order\": \"3\"}, {\"tsne_x\": 35.848812103271484, \"tsne_y\": 23.042598724365234, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1932\", \"Dose Order\": \"3\"}, {\"tsne_x\": 33.42486572265625, \"tsne_y\": 23.377527236938477, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1933\", \"Dose Order\": \"3\"}, {\"tsne_x\": 35.00358200073242, \"tsne_y\": 23.165245056152344, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1934\", \"Dose Order\": \"3\"}, {\"tsne_x\": 34.571067810058594, \"tsne_y\": 22.990392684936523, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1935\", \"Dose Order\": \"3\"}, {\"tsne_x\": 45.65165710449219, \"tsne_y\": 17.707950592041016, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1473\", \"Dose Order\": \"4\"}, {\"tsne_x\": 45.19731521606445, \"tsne_y\": 17.894981384277344, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1474\", \"Dose Order\": \"4\"}, {\"tsne_x\": 44.562591552734375, \"tsne_y\": 17.77882194519043, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1475\", \"Dose Order\": \"4\"}, {\"tsne_x\": 46.97412872314453, \"tsne_y\": 19.105836868286133, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1892\", \"Dose Order\": \"4\"}, {\"tsne_x\": 46.67451858520508, \"tsne_y\": 18.79353141784668, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1893\", \"Dose Order\": \"4\"}, {\"tsne_x\": 46.62849426269531, \"tsne_y\": 19.28201675415039, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1894\", \"Dose Order\": \"4\"}, {\"tsne_x\": 46.24251174926758, \"tsne_y\": 19.273826599121094, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1895\", \"Dose Order\": \"4\"}, {\"tsne_x\": 47.630672454833984, \"tsne_y\": 21.355831146240234, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1932\", \"Dose Order\": \"4\"}, {\"tsne_x\": 47.54244613647461, \"tsne_y\": 20.561147689819336, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1933\", \"Dose Order\": \"4\"}, {\"tsne_x\": 47.97734069824219, \"tsne_y\": 20.642080307006836, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1934\", \"Dose Order\": \"4\"}, {\"tsne_x\": 47.465370178222656, \"tsne_y\": 20.178874969482422, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1935\", \"Dose Order\": \"4\"}, {\"tsne_x\": 45.87661361694336, \"tsne_y\": 16.546730041503906, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1473\", \"Dose Order\": \"5\"}, {\"tsne_x\": 45.96047592163086, \"tsne_y\": 16.41262435913086, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1474\", \"Dose Order\": \"5\"}, {\"tsne_x\": 45.599609375, \"tsne_y\": 16.26679229736328, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1475\", \"Dose Order\": \"5\"}, {\"tsne_x\": 49.69367218017578, \"tsne_y\": 17.958633422851562, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1892\", \"Dose Order\": \"5\"}, {\"tsne_x\": 49.653568267822266, \"tsne_y\": 17.752111434936523, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1893\", \"Dose Order\": \"5\"}, {\"tsne_x\": 49.562198638916016, \"tsne_y\": 17.808223724365234, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1894\", \"Dose Order\": \"5\"}, {\"tsne_x\": 48.873268127441406, \"tsne_y\": 17.662887573242188, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1895\", \"Dose Order\": \"5\"}, {\"tsne_x\": 57.71989440917969, \"tsne_y\": 21.723222732543945, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1932\", \"Dose Order\": \"5\"}, {\"tsne_x\": 51.853729248046875, \"tsne_y\": 19.7136287689209, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1933\", \"Dose Order\": \"5\"}, {\"tsne_x\": 51.463134765625, \"tsne_y\": 19.61957550048828, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1934\", \"Dose Order\": \"5\"}, {\"tsne_x\": 51.099483489990234, \"tsne_y\": 19.500869750976562, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|3\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1935\", \"Dose Order\": \"5\"}, {\"tsne_x\": -34.1380615234375, \"tsne_y\": 7.235377788543701, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1473\", \"Dose Order\": \"0\"}, {\"tsne_x\": -34.400577545166016, \"tsne_y\": 7.245544910430908, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1474\", \"Dose Order\": \"0\"}, {\"tsne_x\": -34.09347915649414, \"tsne_y\": 5.785850524902344, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1475\", \"Dose Order\": \"0\"}, {\"tsne_x\": -35.48533248901367, \"tsne_y\": 5.983613014221191, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1892\", \"Dose Order\": \"0\"}, {\"tsne_x\": -35.57997131347656, \"tsne_y\": 5.34874153137207, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1893\", \"Dose Order\": \"0\"}, {\"tsne_x\": -35.5877685546875, \"tsne_y\": 6.031408786773682, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1894\", \"Dose Order\": \"0\"}, {\"tsne_x\": -35.207279205322266, \"tsne_y\": 5.451245307922363, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1895\", \"Dose Order\": \"0\"}, {\"tsne_x\": -36.1313591003418, \"tsne_y\": 7.7439961433410645, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1932\", \"Dose Order\": \"0\"}, {\"tsne_x\": -35.02552795410156, \"tsne_y\": 8.376351356506348, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1933\", \"Dose Order\": \"0\"}, {\"tsne_x\": -35.503639221191406, \"tsne_y\": 7.66136360168457, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1934\", \"Dose Order\": \"0\"}, {\"tsne_x\": -35.37767028808594, \"tsne_y\": 7.374181747436523, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1935\", \"Dose Order\": \"0\"}, {\"tsne_x\": -41.872047424316406, \"tsne_y\": -2.7746996879577637, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1473\", \"Dose Order\": \"1\"}, {\"tsne_x\": -41.73104476928711, \"tsne_y\": -2.241083860397339, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1474\", \"Dose Order\": \"1\"}, {\"tsne_x\": -41.78956604003906, \"tsne_y\": -2.0713255405426025, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1475\", \"Dose Order\": \"1\"}, {\"tsne_x\": -40.051177978515625, \"tsne_y\": -3.507686138153076, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1892\", \"Dose Order\": \"1\"}, {\"tsne_x\": -39.02541732788086, \"tsne_y\": -3.961930990219116, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1893\", \"Dose Order\": \"1\"}, {\"tsne_x\": -39.3531379699707, \"tsne_y\": -3.5712697505950928, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1894\", \"Dose Order\": \"1\"}, {\"tsne_x\": -39.391624450683594, \"tsne_y\": -3.237431049346924, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1895\", \"Dose Order\": \"1\"}, {\"tsne_x\": -39.27695846557617, \"tsne_y\": -0.38436824083328247, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1932\", \"Dose Order\": \"1\"}, {\"tsne_x\": -39.758026123046875, \"tsne_y\": -1.2155002355575562, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1933\", \"Dose Order\": \"1\"}, {\"tsne_x\": -39.22425079345703, \"tsne_y\": -1.4122732877731323, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1934\", \"Dose Order\": \"1\"}, {\"tsne_x\": -39.35758590698242, \"tsne_y\": -1.1808960437774658, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1935\", \"Dose Order\": \"1\"}, {\"tsne_x\": 61.155757904052734, \"tsne_y\": -10.722847938537598, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1473\", \"Dose Order\": \"2\"}, {\"tsne_x\": 60.98750686645508, \"tsne_y\": -10.8284912109375, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1474\", \"Dose Order\": \"2\"}, {\"tsne_x\": 61.48243713378906, \"tsne_y\": -10.564130783081055, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1475\", \"Dose Order\": \"2\"}, {\"tsne_x\": 58.15714645385742, \"tsne_y\": -11.615432739257812, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1892\", \"Dose Order\": \"2\"}, {\"tsne_x\": 57.62209701538086, \"tsne_y\": -12.105586051940918, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1893\", \"Dose Order\": \"2\"}, {\"tsne_x\": 57.641700744628906, \"tsne_y\": -12.032990455627441, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1894\", \"Dose Order\": \"2\"}, {\"tsne_x\": 58.10454559326172, \"tsne_y\": -11.886276245117188, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1895\", \"Dose Order\": \"2\"}, {\"tsne_x\": 57.84262466430664, \"tsne_y\": -5.166866302490234, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1932\", \"Dose Order\": \"2\"}, {\"tsne_x\": 58.75339126586914, \"tsne_y\": -5.1091179847717285, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1933\", \"Dose Order\": \"2\"}, {\"tsne_x\": 58.93661880493164, \"tsne_y\": -5.243378639221191, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1934\", \"Dose Order\": \"2\"}, {\"tsne_x\": 58.814735412597656, \"tsne_y\": -5.187469959259033, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1935\", \"Dose Order\": \"2\"}, {\"tsne_x\": 62.157142639160156, \"tsne_y\": -9.362519264221191, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1473\", \"Dose Order\": \"3\"}, {\"tsne_x\": 62.3432502746582, \"tsne_y\": -9.053275108337402, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1474\", \"Dose Order\": \"3\"}, {\"tsne_x\": 62.251155853271484, \"tsne_y\": -9.420429229736328, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1475\", \"Dose Order\": \"3\"}, {\"tsne_x\": 64.36380767822266, \"tsne_y\": -7.790291786193848, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1892\", \"Dose Order\": \"3\"}, {\"tsne_x\": 64.91067504882812, \"tsne_y\": -7.68327522277832, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1893\", \"Dose Order\": \"3\"}, {\"tsne_x\": 64.90503692626953, \"tsne_y\": -7.62883186340332, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1894\", \"Dose Order\": \"3\"}, {\"tsne_x\": 65.23519897460938, \"tsne_y\": -7.5315351486206055, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1895\", \"Dose Order\": \"3\"}, {\"tsne_x\": 62.8947868347168, \"tsne_y\": -5.641031742095947, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1932\", \"Dose Order\": \"3\"}, {\"tsne_x\": 62.88081741333008, \"tsne_y\": -6.095305919647217, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1933\", \"Dose Order\": \"3\"}, {\"tsne_x\": 62.57778549194336, \"tsne_y\": -6.262429714202881, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1934\", \"Dose Order\": \"3\"}, {\"tsne_x\": 62.49005889892578, \"tsne_y\": -6.407993793487549, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1935\", \"Dose Order\": \"3\"}, {\"tsne_x\": 74.01765441894531, \"tsne_y\": 0.7878458499908447, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1473\", \"Dose Order\": \"4\"}, {\"tsne_x\": 74.34563446044922, \"tsne_y\": 1.0137194395065308, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1474\", \"Dose Order\": \"4\"}, {\"tsne_x\": 74.33612060546875, \"tsne_y\": 1.182863473892212, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1475\", \"Dose Order\": \"4\"}, {\"tsne_x\": 72.14859771728516, \"tsne_y\": 5.392072677612305, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1892\", \"Dose Order\": \"4\"}, {\"tsne_x\": 72.50021362304688, \"tsne_y\": 4.630713939666748, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1893\", \"Dose Order\": \"4\"}, {\"tsne_x\": 72.40924072265625, \"tsne_y\": 4.865185737609863, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1894\", \"Dose Order\": \"4\"}, {\"tsne_x\": 72.43607330322266, \"tsne_y\": 4.6038079261779785, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1895\", \"Dose Order\": \"4\"}, {\"tsne_x\": 70.34203338623047, \"tsne_y\": 4.236870765686035, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1932\", \"Dose Order\": \"4\"}, {\"tsne_x\": 70.78170776367188, \"tsne_y\": 3.9611315727233887, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1933\", \"Dose Order\": \"4\"}, {\"tsne_x\": 70.87765502929688, \"tsne_y\": 4.0141167640686035, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1934\", \"Dose Order\": \"4\"}, {\"tsne_x\": 70.9267807006836, \"tsne_y\": 4.1000800132751465, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1935\", \"Dose Order\": \"4\"}, {\"tsne_x\": 74.81937408447266, \"tsne_y\": 2.0423197746276855, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1473\", \"Dose Order\": \"5\"}, {\"tsne_x\": 75.00064086914062, \"tsne_y\": 1.4306315183639526, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1474\", \"Dose Order\": \"5\"}, {\"tsne_x\": 74.98397064208984, \"tsne_y\": 2.07413387298584, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1475\", \"Dose Order\": \"5\"}, {\"tsne_x\": 69.61656188964844, \"tsne_y\": 12.935574531555176, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1892\", \"Dose Order\": \"5\"}, {\"tsne_x\": 69.2706069946289, \"tsne_y\": 13.17822265625, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1893\", \"Dose Order\": \"5\"}, {\"tsne_x\": 69.09818267822266, \"tsne_y\": 13.524826049804688, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1894\", \"Dose Order\": \"5\"}, {\"tsne_x\": 69.3021240234375, \"tsne_y\": 13.38796329498291, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1895\", \"Dose Order\": \"5\"}, {\"tsne_x\": 68.12220764160156, \"tsne_y\": 14.440469741821289, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1932\", \"Dose Order\": \"5\"}, {\"tsne_x\": 68.4503402709961, \"tsne_y\": 13.751953125, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1933\", \"Dose Order\": \"5\"}, {\"tsne_x\": 68.78655242919922, \"tsne_y\": 12.425089836120605, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1934\", \"Dose Order\": \"5\"}, {\"tsne_x\": 68.28607177734375, \"tsne_y\": 14.234087944030762, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1935\", \"Dose Order\": \"5\"}, {\"tsne_x\": -2.5869622230529785, \"tsne_y\": 13.491008758544922, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1473\", \"Dose Order\": \"0\"}, {\"tsne_x\": -1.722335934638977, \"tsne_y\": 13.338654518127441, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1474\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.884596586227417, \"tsne_y\": 13.144327163696289, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1475\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.1336467266082764, \"tsne_y\": 12.870960235595703, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1892\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.324991226196289, \"tsne_y\": 14.857160568237305, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1893\", \"Dose Order\": \"0\"}, {\"tsne_x\": -1.0927952527999878, \"tsne_y\": 12.850311279296875, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1894\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.1697826385498047, \"tsne_y\": 12.279923439025879, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1895\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.3185434341430664, \"tsne_y\": 11.894906044006348, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1932\", \"Dose Order\": \"0\"}, {\"tsne_x\": -0.6423044204711914, \"tsne_y\": 12.280133247375488, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1933\", \"Dose Order\": \"0\"}, {\"tsne_x\": -1.0294442176818848, \"tsne_y\": 13.526192665100098, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1934\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.0806148052215576, \"tsne_y\": 13.705580711364746, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1935\", \"Dose Order\": \"0\"}, {\"tsne_x\": 9.939287185668945, \"tsne_y\": 14.959859848022461, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1473\", \"Dose Order\": \"1\"}, {\"tsne_x\": 9.24390983581543, \"tsne_y\": 15.67507553100586, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1474\", \"Dose Order\": \"1\"}, {\"tsne_x\": 9.797993659973145, \"tsne_y\": 16.447725296020508, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1475\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.634528160095215, \"tsne_y\": 15.632550239562988, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1892\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.442192077636719, \"tsne_y\": 14.949501037597656, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1893\", \"Dose Order\": \"1\"}, {\"tsne_x\": 9.056742668151855, \"tsne_y\": 15.978114128112793, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1894\", \"Dose Order\": \"1\"}, {\"tsne_x\": 9.99913501739502, \"tsne_y\": 16.49799919128418, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1895\", \"Dose Order\": \"1\"}, {\"tsne_x\": 9.686089515686035, \"tsne_y\": 17.575281143188477, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1932\", \"Dose Order\": \"1\"}, {\"tsne_x\": 9.192054748535156, \"tsne_y\": 14.51634407043457, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1933\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.53832721710205, \"tsne_y\": 16.88102149963379, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1934\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.435431480407715, \"tsne_y\": 16.051250457763672, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1935\", \"Dose Order\": \"1\"}, {\"tsne_x\": 54.88041305541992, \"tsne_y\": 36.46428680419922, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1473\", \"Dose Order\": \"2\"}, {\"tsne_x\": 54.976741790771484, \"tsne_y\": 36.80241012573242, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1474\", \"Dose Order\": \"2\"}, {\"tsne_x\": 54.159141540527344, \"tsne_y\": 36.102149963378906, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1475\", \"Dose Order\": \"2\"}, {\"tsne_x\": 53.84346008300781, \"tsne_y\": 36.865440368652344, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1892\", \"Dose Order\": \"2\"}, {\"tsne_x\": 54.95673370361328, \"tsne_y\": 37.438541412353516, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1893\", \"Dose Order\": \"2\"}, {\"tsne_x\": 54.00949478149414, \"tsne_y\": 37.03445053100586, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1894\", \"Dose Order\": \"2\"}, {\"tsne_x\": 53.46818923950195, \"tsne_y\": 36.78810119628906, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1895\", \"Dose Order\": \"2\"}, {\"tsne_x\": 52.68204116821289, \"tsne_y\": 36.89443588256836, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1932\", \"Dose Order\": \"2\"}, {\"tsne_x\": 53.97309112548828, \"tsne_y\": 38.292449951171875, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1933\", \"Dose Order\": \"2\"}, {\"tsne_x\": 55.56086349487305, \"tsne_y\": 38.37290954589844, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1934\", \"Dose Order\": \"2\"}, {\"tsne_x\": 54.13804626464844, \"tsne_y\": 37.609893798828125, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1935\", \"Dose Order\": \"2\"}, {\"tsne_x\": 58.1712646484375, \"tsne_y\": 32.88324737548828, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1473\", \"Dose Order\": \"3\"}, {\"tsne_x\": 58.60675811767578, \"tsne_y\": 33.491275787353516, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1474\", \"Dose Order\": \"3\"}, {\"tsne_x\": 58.501251220703125, \"tsne_y\": 32.61475372314453, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1475\", \"Dose Order\": \"3\"}, {\"tsne_x\": 59.98551559448242, \"tsne_y\": 33.29055404663086, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1892\", \"Dose Order\": \"3\"}, {\"tsne_x\": 59.638370513916016, \"tsne_y\": 33.49674606323242, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1893\", \"Dose Order\": \"3\"}, {\"tsne_x\": 60.14235305786133, \"tsne_y\": 33.51458740234375, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1894\", \"Dose Order\": \"3\"}, {\"tsne_x\": 60.800048828125, \"tsne_y\": 33.29446792602539, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1895\", \"Dose Order\": \"3\"}, {\"tsne_x\": 60.472476959228516, \"tsne_y\": 35.106361389160156, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1932\", \"Dose Order\": \"3\"}, {\"tsne_x\": 58.816505432128906, \"tsne_y\": 34.3693962097168, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1933\", \"Dose Order\": \"3\"}, {\"tsne_x\": 60.847320556640625, \"tsne_y\": 34.05564880371094, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1934\", \"Dose Order\": \"3\"}, {\"tsne_x\": 59.35598373413086, \"tsne_y\": 34.06321334838867, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1935\", \"Dose Order\": \"3\"}, {\"tsne_x\": 58.303016662597656, \"tsne_y\": 30.892107009887695, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1473\", \"Dose Order\": \"4\"}, {\"tsne_x\": 58.287147521972656, \"tsne_y\": 30.465234756469727, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1474\", \"Dose Order\": \"4\"}, {\"tsne_x\": 58.214359283447266, \"tsne_y\": 30.99010467529297, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1475\", \"Dose Order\": \"4\"}, {\"tsne_x\": 59.83672332763672, \"tsne_y\": 27.147294998168945, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1892\", \"Dose Order\": \"4\"}, {\"tsne_x\": 59.469181060791016, \"tsne_y\": 27.46239471435547, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1893\", \"Dose Order\": \"4\"}, {\"tsne_x\": 64.06813049316406, \"tsne_y\": 21.342605590820312, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1894\", \"Dose Order\": \"4\"}, {\"tsne_x\": 63.912532806396484, \"tsne_y\": 21.42865562438965, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1895\", \"Dose Order\": \"4\"}, {\"tsne_x\": 64.93757629394531, \"tsne_y\": 21.218536376953125, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1932\", \"Dose Order\": \"4\"}, {\"tsne_x\": 60.080772399902344, \"tsne_y\": 27.69637680053711, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1933\", \"Dose Order\": \"4\"}, {\"tsne_x\": 60.124290466308594, \"tsne_y\": 28.126251220703125, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1934\", \"Dose Order\": \"4\"}, {\"tsne_x\": 60.15962219238281, \"tsne_y\": 27.6329402923584, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1935\", \"Dose Order\": \"4\"}, {\"tsne_x\": 59.6292610168457, \"tsne_y\": 22.732067108154297, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1473\", \"Dose Order\": \"5\"}, {\"tsne_x\": 59.83833312988281, \"tsne_y\": 22.730243682861328, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1474\", \"Dose Order\": \"5\"}, {\"tsne_x\": 59.912933349609375, \"tsne_y\": 22.71097755432129, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1475\", \"Dose Order\": \"5\"}, {\"tsne_x\": 61.99052810668945, \"tsne_y\": 23.251373291015625, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1892\", \"Dose Order\": \"5\"}, {\"tsne_x\": 63.834373474121094, \"tsne_y\": 21.291053771972656, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1893\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.2082290649414, \"tsne_y\": 20.042762756347656, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1894\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.31488800048828, \"tsne_y\": 19.86729621887207, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1895\", \"Dose Order\": \"5\"}, {\"tsne_x\": 61.28271484375, \"tsne_y\": 23.193601608276367, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1932\", \"Dose Order\": \"5\"}, {\"tsne_x\": 61.3396110534668, \"tsne_y\": 23.727415084838867, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1933\", \"Dose Order\": \"5\"}, {\"tsne_x\": 60.59848403930664, \"tsne_y\": 25.216693878173828, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1934\", \"Dose Order\": \"5\"}, {\"tsne_x\": 61.20341873168945, \"tsne_y\": 23.500682830810547, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|3\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1935\", \"Dose Order\": \"5\"}, {\"tsne_x\": -6.947577953338623, \"tsne_y\": 5.0491743087768555, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|3\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1473\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.612594604492188, \"tsne_y\": 4.81156063079834, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|3\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1474\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.159311771392822, \"tsne_y\": 5.4988837242126465, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|3\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1475\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.1338210105896, \"tsne_y\": 4.555338382720947, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|3\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1892\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.857314586639404, \"tsne_y\": 5.2153191566467285, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|3\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1893\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.217878341674805, \"tsne_y\": 4.317653656005859, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|3\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1894\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.527641296386719, \"tsne_y\": 5.396269798278809, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|3\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1895\", \"Dose Order\": \"0\"}, {\"tsne_x\": -8.1002836227417, \"tsne_y\": 5.84268856048584, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|3\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1932\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.570394515991211, \"tsne_y\": 4.219074249267578, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|3\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1933\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.516707897186279, \"tsne_y\": 5.836959362030029, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|3\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1934\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.841516017913818, \"tsne_y\": 4.801513671875, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|3\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1935\", \"Dose Order\": \"0\"}, {\"tsne_x\": -36.11007308959961, \"tsne_y\": 40.10373306274414, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|3\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1473\", \"Dose Order\": \"0\"}, {\"tsne_x\": -35.71202850341797, \"tsne_y\": 40.38115692138672, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|3\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1474\", \"Dose Order\": \"0\"}, {\"tsne_x\": -35.591148376464844, \"tsne_y\": 40.61720275878906, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|3\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1475\", \"Dose Order\": \"0\"}, {\"tsne_x\": -32.250282287597656, \"tsne_y\": 43.783729553222656, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|3\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1892\", \"Dose Order\": \"0\"}, {\"tsne_x\": -32.08673858642578, \"tsne_y\": 44.22356414794922, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|3\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1893\", \"Dose Order\": \"0\"}, {\"tsne_x\": -32.00172424316406, \"tsne_y\": 44.13799285888672, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|3\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1894\", \"Dose Order\": \"0\"}, {\"tsne_x\": -31.49444007873535, \"tsne_y\": 44.424251556396484, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|3\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1895\", \"Dose Order\": \"0\"}, {\"tsne_x\": -31.94150733947754, \"tsne_y\": 42.98072814941406, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|3\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1932\", \"Dose Order\": \"0\"}, {\"tsne_x\": -30.847883224487305, \"tsne_y\": 42.82121276855469, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|3\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1933\", \"Dose Order\": \"0\"}, {\"tsne_x\": -30.892019271850586, \"tsne_y\": 43.61109161376953, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|3\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1934\", \"Dose Order\": \"0\"}, {\"tsne_x\": -30.976320266723633, \"tsne_y\": 43.74250030517578, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|3\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1935\", \"Dose Order\": \"0\"}, {\"tsne_x\": -37.631595611572266, \"tsne_y\": 38.2596549987793, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|3\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1473\", \"Dose Order\": \"1\"}, {\"tsne_x\": -37.28199768066406, \"tsne_y\": 37.96977615356445, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|3\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1474\", \"Dose Order\": \"1\"}, {\"tsne_x\": -37.24319839477539, \"tsne_y\": 37.6925163269043, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|3\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1475\", \"Dose Order\": \"1\"}, {\"tsne_x\": -29.448579788208008, \"tsne_y\": 53.81877136230469, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|3\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1892\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.49118995666504, \"tsne_y\": 53.64881134033203, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|3\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1893\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.16745948791504, \"tsne_y\": 53.845027923583984, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|3\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1894\", \"Dose Order\": \"1\"}, {\"tsne_x\": -31.380477905273438, \"tsne_y\": 53.06873321533203, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|3\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1895\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.149316787719727, \"tsne_y\": 55.07876205444336, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|3\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1932\", \"Dose Order\": \"1\"}, {\"tsne_x\": -29.585573196411133, \"tsne_y\": 53.04697036743164, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|3\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1933\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.49410057067871, \"tsne_y\": 54.58221435546875, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|3\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1934\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.86083984375, \"tsne_y\": 54.58797073364258, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|3\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1935\", \"Dose Order\": \"1\"}, {\"tsne_x\": -36.86654281616211, \"tsne_y\": 39.0349006652832, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|3\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1473\", \"Dose Order\": \"2\"}, {\"tsne_x\": -36.133750915527344, \"tsne_y\": 38.23505401611328, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|3\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1474\", \"Dose Order\": \"2\"}, {\"tsne_x\": -36.15024948120117, \"tsne_y\": 38.25987243652344, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|3\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1475\", \"Dose Order\": \"2\"}, {\"tsne_x\": -31.71751594543457, \"tsne_y\": 50.34892272949219, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|3\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1892\", \"Dose Order\": \"2\"}, {\"tsne_x\": -32.38026809692383, \"tsne_y\": 49.64795684814453, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|3\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1893\", \"Dose Order\": \"2\"}, {\"tsne_x\": -32.12229537963867, \"tsne_y\": 49.97146987915039, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|3\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1894\", \"Dose Order\": \"2\"}, {\"tsne_x\": -31.956647872924805, \"tsne_y\": 52.01593780517578, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|3\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1895\", \"Dose Order\": \"2\"}, {\"tsne_x\": -31.585205078125, \"tsne_y\": 50.460235595703125, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|3\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1932\", \"Dose Order\": \"2\"}, {\"tsne_x\": -30.732791900634766, \"tsne_y\": 50.31052017211914, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|3\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1933\", \"Dose Order\": \"2\"}, {\"tsne_x\": -32.12507247924805, \"tsne_y\": 50.749267578125, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|3\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1934\", \"Dose Order\": \"2\"}, {\"tsne_x\": -32.828914642333984, \"tsne_y\": 51.21542739868164, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|3\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1935\", \"Dose Order\": \"2\"}, {\"tsne_x\": -37.28820037841797, \"tsne_y\": 39.49182891845703, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|3\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1473\", \"Dose Order\": \"3\"}, {\"tsne_x\": -39.28096389770508, \"tsne_y\": 48.148521423339844, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|3\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1474\", \"Dose Order\": \"3\"}, {\"tsne_x\": -39.09149932861328, \"tsne_y\": 48.73943328857422, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|3\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1475\", \"Dose Order\": \"3\"}, {\"tsne_x\": -37.85268020629883, \"tsne_y\": 48.72296905517578, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|3\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1892\", \"Dose Order\": \"3\"}, {\"tsne_x\": -38.03324508666992, \"tsne_y\": 49.380767822265625, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|3\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1893\", \"Dose Order\": \"3\"}, {\"tsne_x\": -38.25493240356445, \"tsne_y\": 48.99186706542969, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|3\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1894\", \"Dose Order\": \"3\"}, {\"tsne_x\": -38.85183334350586, \"tsne_y\": 49.41728973388672, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|3\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1895\", \"Dose Order\": \"3\"}, {\"tsne_x\": -49.10814666748047, \"tsne_y\": 51.59720230102539, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|3\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1932\", \"Dose Order\": \"3\"}, {\"tsne_x\": -46.0681037902832, \"tsne_y\": 50.09038162231445, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|3\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1933\", \"Dose Order\": \"3\"}, {\"tsne_x\": -45.4217414855957, \"tsne_y\": 49.70980453491211, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|3\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1934\", \"Dose Order\": \"3\"}, {\"tsne_x\": -46.944061279296875, \"tsne_y\": 50.774696350097656, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|3\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1935\", \"Dose Order\": \"3\"}, {\"tsne_x\": -46.271240234375, \"tsne_y\": 46.8364143371582, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|3\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1473\", \"Dose Order\": \"4\"}, {\"tsne_x\": -46.22451400756836, \"tsne_y\": 46.33525466918945, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|3\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1474\", \"Dose Order\": \"4\"}, {\"tsne_x\": -45.81706619262695, \"tsne_y\": 46.033905029296875, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|3\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1475\", \"Dose Order\": \"4\"}, {\"tsne_x\": -46.489166259765625, \"tsne_y\": 45.462425231933594, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|3\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1892\", \"Dose Order\": \"4\"}, {\"tsne_x\": -45.67091751098633, \"tsne_y\": 45.05513381958008, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|3\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1893\", \"Dose Order\": \"4\"}, {\"tsne_x\": -46.04541778564453, \"tsne_y\": 45.591426849365234, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|3\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1894\", \"Dose Order\": \"4\"}, {\"tsne_x\": -45.556190490722656, \"tsne_y\": 45.75695037841797, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|3\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1895\", \"Dose Order\": \"4\"}, {\"tsne_x\": -49.338680267333984, \"tsne_y\": 50.49847412109375, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|3\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1932\", \"Dose Order\": \"4\"}, {\"tsne_x\": -47.7728157043457, \"tsne_y\": 50.1235466003418, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|3\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1933\", \"Dose Order\": \"4\"}, {\"tsne_x\": -46.152366638183594, \"tsne_y\": 47.583065032958984, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|3\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1934\", \"Dose Order\": \"4\"}, {\"tsne_x\": -47.57588195800781, \"tsne_y\": 50.26405334472656, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|3\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1935\", \"Dose Order\": \"4\"}, {\"tsne_x\": -44.043243408203125, \"tsne_y\": 52.611698150634766, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|3\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1473\", \"Dose Order\": \"5\"}, {\"tsne_x\": -43.293701171875, \"tsne_y\": 52.622310638427734, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|3\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1474\", \"Dose Order\": \"5\"}, {\"tsne_x\": -42.786373138427734, \"tsne_y\": 52.372032165527344, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|3\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1475\", \"Dose Order\": \"5\"}, {\"tsne_x\": -42.04477310180664, \"tsne_y\": 53.231834411621094, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|3\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1892\", \"Dose Order\": \"5\"}, {\"tsne_x\": -42.18739700317383, \"tsne_y\": 52.64555358886719, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|3\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1893\", \"Dose Order\": \"5\"}, {\"tsne_x\": -42.094383239746094, \"tsne_y\": 53.01011276245117, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|3\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1894\", \"Dose Order\": \"5\"}, {\"tsne_x\": -42.019020080566406, \"tsne_y\": 52.10961151123047, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|3\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1895\", \"Dose Order\": \"5\"}, {\"tsne_x\": -48.84271240234375, \"tsne_y\": 51.60062789916992, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|3\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1932\", \"Dose Order\": \"5\"}, {\"tsne_x\": -47.82349395751953, \"tsne_y\": 51.57609558105469, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|3\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1933\", \"Dose Order\": \"5\"}, {\"tsne_x\": -43.887916564941406, \"tsne_y\": 51.96918869018555, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|3\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1934\", \"Dose Order\": \"5\"}, {\"tsne_x\": -47.148216247558594, \"tsne_y\": 51.37740707397461, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|3\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1935\", \"Dose Order\": \"5\"}, {\"tsne_x\": -56.32699966430664, \"tsne_y\": -36.043033599853516, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1473\", \"Dose Order\": \"0\"}, {\"tsne_x\": -57.8460807800293, \"tsne_y\": -36.420711517333984, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1474\", \"Dose Order\": \"0\"}, {\"tsne_x\": -57.7799072265625, \"tsne_y\": -35.56705856323242, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1475\", \"Dose Order\": \"0\"}, {\"tsne_x\": -57.02385330200195, \"tsne_y\": -36.13007354736328, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1892\", \"Dose Order\": \"0\"}, {\"tsne_x\": -56.73482894897461, \"tsne_y\": -35.33700180053711, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1893\", \"Dose Order\": \"0\"}, {\"tsne_x\": -57.79549789428711, \"tsne_y\": -37.00925064086914, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1894\", \"Dose Order\": \"0\"}, {\"tsne_x\": -57.87614440917969, \"tsne_y\": -36.303707122802734, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1895\", \"Dose Order\": \"0\"}, {\"tsne_x\": -59.237144470214844, \"tsne_y\": -36.463233947753906, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1932\", \"Dose Order\": \"0\"}, {\"tsne_x\": -57.82649230957031, \"tsne_y\": -34.991310119628906, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1933\", \"Dose Order\": \"0\"}, {\"tsne_x\": -57.04253005981445, \"tsne_y\": -37.038883209228516, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1934\", \"Dose Order\": \"0\"}, {\"tsne_x\": -57.005252838134766, \"tsne_y\": -36.76045227050781, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1935\", \"Dose Order\": \"0\"}, {\"tsne_x\": -53.5982780456543, \"tsne_y\": -42.33679962158203, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1473\", \"Dose Order\": \"1\"}, {\"tsne_x\": -53.12650680541992, \"tsne_y\": -42.033382415771484, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1474\", \"Dose Order\": \"1\"}, {\"tsne_x\": -53.28855514526367, \"tsne_y\": -41.20830154418945, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1475\", \"Dose Order\": \"1\"}, {\"tsne_x\": -52.754852294921875, \"tsne_y\": -41.92631530761719, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1892\", \"Dose Order\": \"1\"}, {\"tsne_x\": -52.282615661621094, \"tsne_y\": -42.39003372192383, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1893\", \"Dose Order\": \"1\"}, {\"tsne_x\": -52.02529525756836, \"tsne_y\": -41.96427917480469, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1894\", \"Dose Order\": \"1\"}, {\"tsne_x\": -52.588104248046875, \"tsne_y\": -41.24366760253906, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1895\", \"Dose Order\": \"1\"}, {\"tsne_x\": -51.52113342285156, \"tsne_y\": -40.8840217590332, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1932\", \"Dose Order\": \"1\"}, {\"tsne_x\": -52.81169509887695, \"tsne_y\": -43.46322250366211, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1933\", \"Dose Order\": \"1\"}, {\"tsne_x\": -53.898555755615234, \"tsne_y\": -41.341819763183594, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1934\", \"Dose Order\": \"1\"}, {\"tsne_x\": -52.79462432861328, \"tsne_y\": -42.574100494384766, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1935\", \"Dose Order\": \"1\"}, {\"tsne_x\": -46.21630859375, \"tsne_y\": -52.381195068359375, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1473\", \"Dose Order\": \"2\"}, {\"tsne_x\": -46.502410888671875, \"tsne_y\": -51.795654296875, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1474\", \"Dose Order\": \"2\"}, {\"tsne_x\": -46.39896774291992, \"tsne_y\": -51.84378433227539, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1475\", \"Dose Order\": \"2\"}, {\"tsne_x\": -47.80110168457031, \"tsne_y\": -52.898773193359375, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1892\", \"Dose Order\": \"2\"}, {\"tsne_x\": -48.134517669677734, \"tsne_y\": -52.581302642822266, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1893\", \"Dose Order\": \"2\"}, {\"tsne_x\": -47.832759857177734, \"tsne_y\": -52.7850341796875, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1894\", \"Dose Order\": \"2\"}, {\"tsne_x\": -47.58700180053711, \"tsne_y\": -52.87737274169922, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1895\", \"Dose Order\": \"2\"}, {\"tsne_x\": -47.56999588012695, \"tsne_y\": -54.460819244384766, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1932\", \"Dose Order\": \"2\"}, {\"tsne_x\": -47.8807258605957, \"tsne_y\": -54.14094924926758, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1933\", \"Dose Order\": \"2\"}, {\"tsne_x\": -47.00011444091797, \"tsne_y\": -53.93633270263672, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1934\", \"Dose Order\": \"2\"}, {\"tsne_x\": -46.95330810546875, \"tsne_y\": -54.064064025878906, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1935\", \"Dose Order\": \"2\"}, {\"tsne_x\": -40.427608489990234, \"tsne_y\": -61.51376724243164, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1473\", \"Dose Order\": \"3\"}, {\"tsne_x\": -40.417152404785156, \"tsne_y\": -61.5467414855957, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1474\", \"Dose Order\": \"3\"}, {\"tsne_x\": -40.47652053833008, \"tsne_y\": -61.55277633666992, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1475\", \"Dose Order\": \"3\"}, {\"tsne_x\": -42.56440353393555, \"tsne_y\": -62.607444763183594, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1892\", \"Dose Order\": \"3\"}, {\"tsne_x\": -41.961551666259766, \"tsne_y\": -62.697940826416016, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1893\", \"Dose Order\": \"3\"}, {\"tsne_x\": -42.089393615722656, \"tsne_y\": -62.3041877746582, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1894\", \"Dose Order\": \"3\"}, {\"tsne_x\": -42.07834243774414, \"tsne_y\": -62.47812271118164, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1895\", \"Dose Order\": \"3\"}, {\"tsne_x\": -42.95070266723633, \"tsne_y\": -61.02728271484375, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1932\", \"Dose Order\": \"3\"}, {\"tsne_x\": -43.06500244140625, \"tsne_y\": -61.330474853515625, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1933\", \"Dose Order\": \"3\"}, {\"tsne_x\": -43.41466522216797, \"tsne_y\": -61.39651107788086, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1934\", \"Dose Order\": \"3\"}, {\"tsne_x\": -43.376068115234375, \"tsne_y\": -61.629512786865234, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1935\", \"Dose Order\": \"3\"}, {\"tsne_x\": -36.321834564208984, \"tsne_y\": -67.5768814086914, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1473\", \"Dose Order\": \"4\"}, {\"tsne_x\": -36.29582977294922, \"tsne_y\": -67.69699096679688, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1474\", \"Dose Order\": \"4\"}, {\"tsne_x\": -36.241092681884766, \"tsne_y\": -67.70423889160156, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1475\", \"Dose Order\": \"4\"}, {\"tsne_x\": -38.93612289428711, \"tsne_y\": -69.41244506835938, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1892\", \"Dose Order\": \"4\"}, {\"tsne_x\": -38.57386016845703, \"tsne_y\": -69.25506591796875, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1893\", \"Dose Order\": \"4\"}, {\"tsne_x\": -38.268333435058594, \"tsne_y\": -69.24851989746094, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1894\", \"Dose Order\": \"4\"}, {\"tsne_x\": -38.34132385253906, \"tsne_y\": -69.52384948730469, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1895\", \"Dose Order\": \"4\"}, {\"tsne_x\": -38.41473388671875, \"tsne_y\": -71.21337127685547, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1932\", \"Dose Order\": \"4\"}, {\"tsne_x\": -37.83730697631836, \"tsne_y\": -70.89082336425781, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1933\", \"Dose Order\": \"4\"}, {\"tsne_x\": -37.740478515625, \"tsne_y\": -71.0315933227539, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1934\", \"Dose Order\": \"4\"}, {\"tsne_x\": -37.973876953125, \"tsne_y\": -70.93824768066406, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1935\", \"Dose Order\": \"4\"}, {\"tsne_x\": -33.4501838684082, \"tsne_y\": -69.31024169921875, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1473\", \"Dose Order\": \"5\"}, {\"tsne_x\": -33.51456069946289, \"tsne_y\": -69.32476043701172, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1474\", \"Dose Order\": \"5\"}, {\"tsne_x\": -33.41767501831055, \"tsne_y\": -69.45071411132812, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1475\", \"Dose Order\": \"5\"}, {\"tsne_x\": -33.19034957885742, \"tsne_y\": -71.87094116210938, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1892\", \"Dose Order\": \"5\"}, {\"tsne_x\": -33.02412033081055, \"tsne_y\": -71.47747802734375, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1893\", \"Dose Order\": \"5\"}, {\"tsne_x\": -33.26390075683594, \"tsne_y\": -71.57524871826172, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1894\", \"Dose Order\": \"5\"}, {\"tsne_x\": -32.95282745361328, \"tsne_y\": -71.80693054199219, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1895\", \"Dose Order\": \"5\"}, {\"tsne_x\": -34.956729888916016, \"tsne_y\": -71.79480743408203, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1932\", \"Dose Order\": \"5\"}, {\"tsne_x\": -34.44803237915039, \"tsne_y\": -72.31707000732422, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1933\", \"Dose Order\": \"5\"}, {\"tsne_x\": -34.589359283447266, \"tsne_y\": -73.36032104492188, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1934\", \"Dose Order\": \"5\"}, {\"tsne_x\": -34.120872497558594, \"tsne_y\": -72.85662078857422, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|3\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1935\", \"Dose Order\": \"5\"}, {\"tsne_x\": 15.525799751281738, \"tsne_y\": -30.840396881103516, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1473\", \"Dose Order\": \"0\"}, {\"tsne_x\": 15.713805198669434, \"tsne_y\": -30.606616973876953, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1474\", \"Dose Order\": \"0\"}, {\"tsne_x\": 15.899920463562012, \"tsne_y\": -30.081966400146484, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1475\", \"Dose Order\": \"0\"}, {\"tsne_x\": 18.07236671447754, \"tsne_y\": -32.711021423339844, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1892\", \"Dose Order\": \"0\"}, {\"tsne_x\": 18.369035720825195, \"tsne_y\": -32.93843078613281, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1893\", \"Dose Order\": \"0\"}, {\"tsne_x\": 18.65983772277832, \"tsne_y\": -32.64166259765625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1894\", \"Dose Order\": \"0\"}, {\"tsne_x\": 18.94021987915039, \"tsne_y\": -32.38346862792969, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1895\", \"Dose Order\": \"0\"}, {\"tsne_x\": 14.865440368652344, \"tsne_y\": -25.52887725830078, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1932\", \"Dose Order\": \"0\"}, {\"tsne_x\": 15.339884757995605, \"tsne_y\": -23.697710037231445, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1933\", \"Dose Order\": \"0\"}, {\"tsne_x\": 15.552298545837402, \"tsne_y\": -24.289188385009766, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1934\", \"Dose Order\": \"0\"}, {\"tsne_x\": 15.434779167175293, \"tsne_y\": -24.393728256225586, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1935\", \"Dose Order\": \"0\"}, {\"tsne_x\": 13.837178230285645, \"tsne_y\": -31.601442337036133, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1473\", \"Dose Order\": \"1\"}, {\"tsne_x\": 13.736942291259766, \"tsne_y\": -31.60878562927246, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1474\", \"Dose Order\": \"1\"}, {\"tsne_x\": 13.773394584655762, \"tsne_y\": -31.584732055664062, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1475\", \"Dose Order\": \"1\"}, {\"tsne_x\": 15.461260795593262, \"tsne_y\": -36.48970031738281, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1892\", \"Dose Order\": \"1\"}, {\"tsne_x\": 15.829163551330566, \"tsne_y\": -36.42660903930664, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1893\", \"Dose Order\": \"1\"}, {\"tsne_x\": 16.196760177612305, \"tsne_y\": -36.93634796142578, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1894\", \"Dose Order\": \"1\"}, {\"tsne_x\": 15.40962028503418, \"tsne_y\": -36.155452728271484, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1895\", \"Dose Order\": \"1\"}, {\"tsne_x\": 13.364212036132812, \"tsne_y\": -25.612001419067383, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1932\", \"Dose Order\": \"1\"}, {\"tsne_x\": 12.903251647949219, \"tsne_y\": -24.038423538208008, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1933\", \"Dose Order\": \"1\"}, {\"tsne_x\": 13.060284614562988, \"tsne_y\": -24.85819435119629, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1934\", \"Dose Order\": \"1\"}, {\"tsne_x\": 13.113581657409668, \"tsne_y\": -24.798877716064453, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1935\", \"Dose Order\": \"1\"}, {\"tsne_x\": -4.484032154083252, \"tsne_y\": -29.410186767578125, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1473\", \"Dose Order\": \"2\"}, {\"tsne_x\": -4.614686965942383, \"tsne_y\": -29.446123123168945, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1474\", \"Dose Order\": \"2\"}, {\"tsne_x\": -4.769414901733398, \"tsne_y\": -29.530960083007812, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1475\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.5368459224700928, \"tsne_y\": -28.734342575073242, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1892\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.299147129058838, \"tsne_y\": -28.831314086914062, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1893\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.4385480880737305, \"tsne_y\": -28.974760055541992, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1894\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.3018295764923096, \"tsne_y\": -28.713048934936523, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1895\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.6468424797058105, \"tsne_y\": -25.311676025390625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1932\", \"Dose Order\": \"2\"}, {\"tsne_x\": -1.558066964149475, \"tsne_y\": -25.004053115844727, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1933\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.2114360332489014, \"tsne_y\": -25.580474853515625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1934\", \"Dose Order\": \"2\"}, {\"tsne_x\": -2.0246477127075195, \"tsne_y\": -25.33019256591797, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1935\", \"Dose Order\": \"2\"}, {\"tsne_x\": -7.449224948883057, \"tsne_y\": -28.017051696777344, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1473\", \"Dose Order\": \"3\"}, {\"tsne_x\": -7.437999248504639, \"tsne_y\": -28.02213478088379, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1474\", \"Dose Order\": \"3\"}, {\"tsne_x\": -7.536470890045166, \"tsne_y\": -28.023160934448242, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1475\", \"Dose Order\": \"3\"}, {\"tsne_x\": -9.111797332763672, \"tsne_y\": -26.48064422607422, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1892\", \"Dose Order\": \"3\"}, {\"tsne_x\": -9.034464836120605, \"tsne_y\": -26.68134117126465, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1893\", \"Dose Order\": \"3\"}, {\"tsne_x\": -8.832433700561523, \"tsne_y\": -26.39104461669922, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1894\", \"Dose Order\": \"3\"}, {\"tsne_x\": -8.73963451385498, \"tsne_y\": -26.635305404663086, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1895\", \"Dose Order\": \"3\"}, {\"tsne_x\": -7.886688232421875, \"tsne_y\": -24.49631118774414, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1932\", \"Dose Order\": \"3\"}, {\"tsne_x\": 2.444204330444336, \"tsne_y\": -22.80891990661621, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1933\", \"Dose Order\": \"3\"}, {\"tsne_x\": -8.058292388916016, \"tsne_y\": -24.546951293945312, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1934\", \"Dose Order\": \"3\"}, {\"tsne_x\": -8.042553901672363, \"tsne_y\": -24.542274475097656, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1935\", \"Dose Order\": \"3\"}, {\"tsne_x\": -13.985153198242188, \"tsne_y\": -18.71817970275879, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1473\", \"Dose Order\": \"4\"}, {\"tsne_x\": -13.976385116577148, \"tsne_y\": -18.728302001953125, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1474\", \"Dose Order\": \"4\"}, {\"tsne_x\": -14.015915870666504, \"tsne_y\": -18.63451385498047, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1475\", \"Dose Order\": \"4\"}, {\"tsne_x\": -13.57337474822998, \"tsne_y\": -21.497690200805664, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1892\", \"Dose Order\": \"4\"}, {\"tsne_x\": -13.436810493469238, \"tsne_y\": -21.340106964111328, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1893\", \"Dose Order\": \"4\"}, {\"tsne_x\": -13.59593391418457, \"tsne_y\": -21.006811141967773, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1894\", \"Dose Order\": \"4\"}, {\"tsne_x\": -13.379988670349121, \"tsne_y\": -21.115745544433594, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1895\", \"Dose Order\": \"4\"}, {\"tsne_x\": -12.002344131469727, \"tsne_y\": -20.704219818115234, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1932\", \"Dose Order\": \"4\"}, {\"tsne_x\": 2.224177360534668, \"tsne_y\": -22.16189956665039, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1933\", \"Dose Order\": \"4\"}, {\"tsne_x\": -12.188308715820312, \"tsne_y\": -21.1848201751709, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1934\", \"Dose Order\": \"4\"}, {\"tsne_x\": -12.327580451965332, \"tsne_y\": -21.12921714782715, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1935\", \"Dose Order\": \"4\"}, {\"tsne_x\": -13.115508079528809, \"tsne_y\": 15.552823066711426, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1473\", \"Dose Order\": \"5\"}, {\"tsne_x\": -13.136188507080078, \"tsne_y\": 15.583191871643066, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1474\", \"Dose Order\": \"5\"}, {\"tsne_x\": -13.05136775970459, \"tsne_y\": 15.433713912963867, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1475\", \"Dose Order\": \"5\"}, {\"tsne_x\": -13.908452987670898, \"tsne_y\": 18.417152404785156, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1892\", \"Dose Order\": \"5\"}, {\"tsne_x\": -13.753439903259277, \"tsne_y\": 18.733081817626953, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1893\", \"Dose Order\": \"5\"}, {\"tsne_x\": -13.748336791992188, \"tsne_y\": 18.726951599121094, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1894\", \"Dose Order\": \"5\"}, {\"tsne_x\": -13.850040435791016, \"tsne_y\": 18.526987075805664, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1895\", \"Dose Order\": \"5\"}, {\"tsne_x\": -14.822440147399902, \"tsne_y\": 17.14206314086914, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1932\", \"Dose Order\": \"5\"}, {\"tsne_x\": -14.395079612731934, \"tsne_y\": 27.727235794067383, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1933\", \"Dose Order\": \"5\"}, {\"tsne_x\": -14.973834037780762, \"tsne_y\": 16.998889923095703, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1934\", \"Dose Order\": \"5\"}, {\"tsne_x\": -14.954360961914062, \"tsne_y\": 16.97017478942871, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|3\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1935\", \"Dose Order\": \"5\"}, {\"tsne_x\": 62.453651428222656, \"tsne_y\": -13.121063232421875, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1473\", \"Dose Order\": \"0\"}, {\"tsne_x\": 62.4109001159668, \"tsne_y\": -13.149630546569824, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1474\", \"Dose Order\": \"0\"}, {\"tsne_x\": 62.38085174560547, \"tsne_y\": -13.127880096435547, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1475\", \"Dose Order\": \"0\"}, {\"tsne_x\": 59.377403259277344, \"tsne_y\": -15.96435260772705, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1892\", \"Dose Order\": \"0\"}, {\"tsne_x\": 58.778377532958984, \"tsne_y\": -15.293167114257812, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1893\", \"Dose Order\": \"0\"}, {\"tsne_x\": 58.91759490966797, \"tsne_y\": -15.484025001525879, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1894\", \"Dose Order\": \"0\"}, {\"tsne_x\": 58.72714614868164, \"tsne_y\": -15.15798282623291, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1895\", \"Dose Order\": \"0\"}, {\"tsne_x\": 57.24909210205078, \"tsne_y\": -19.17286491394043, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1932\", \"Dose Order\": \"0\"}, {\"tsne_x\": 57.45429992675781, \"tsne_y\": -18.756038665771484, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1933\", \"Dose Order\": \"0\"}, {\"tsne_x\": 57.77463150024414, \"tsne_y\": -18.762571334838867, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1934\", \"Dose Order\": \"0\"}, {\"tsne_x\": 57.65066146850586, \"tsne_y\": -18.55318260192871, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1935\", \"Dose Order\": \"0\"}, {\"tsne_x\": 63.8960075378418, \"tsne_y\": -14.591510772705078, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1473\", \"Dose Order\": \"1\"}, {\"tsne_x\": 64.00617980957031, \"tsne_y\": -14.781116485595703, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1474\", \"Dose Order\": \"1\"}, {\"tsne_x\": 63.96221923828125, \"tsne_y\": -14.738635063171387, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1475\", \"Dose Order\": \"1\"}, {\"tsne_x\": 61.13222885131836, \"tsne_y\": -17.786874771118164, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1892\", \"Dose Order\": \"1\"}, {\"tsne_x\": 61.778472900390625, \"tsne_y\": -18.1904354095459, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1893\", \"Dose Order\": \"1\"}, {\"tsne_x\": 61.554840087890625, \"tsne_y\": -18.019954681396484, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1894\", \"Dose Order\": \"1\"}, {\"tsne_x\": 61.877479553222656, \"tsne_y\": -18.394989013671875, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1895\", \"Dose Order\": \"1\"}, {\"tsne_x\": 58.70528030395508, \"tsne_y\": -20.53887176513672, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1932\", \"Dose Order\": \"1\"}, {\"tsne_x\": 59.97582244873047, \"tsne_y\": -20.330814361572266, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1933\", \"Dose Order\": \"1\"}, {\"tsne_x\": 59.28861618041992, \"tsne_y\": -19.90972328186035, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1934\", \"Dose Order\": \"1\"}, {\"tsne_x\": 59.39501190185547, \"tsne_y\": -19.726417541503906, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1935\", \"Dose Order\": \"1\"}, {\"tsne_x\": 66.98600006103516, \"tsne_y\": -29.742708206176758, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1473\", \"Dose Order\": \"2\"}, {\"tsne_x\": 67.10103607177734, \"tsne_y\": -29.981420516967773, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1474\", \"Dose Order\": \"2\"}, {\"tsne_x\": 67.19217681884766, \"tsne_y\": -29.897525787353516, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1475\", \"Dose Order\": \"2\"}, {\"tsne_x\": 68.99266052246094, \"tsne_y\": -27.76319122314453, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1892\", \"Dose Order\": \"2\"}, {\"tsne_x\": 69.28678894042969, \"tsne_y\": -27.274179458618164, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1893\", \"Dose Order\": \"2\"}, {\"tsne_x\": 69.17562866210938, \"tsne_y\": -27.39446258544922, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1894\", \"Dose Order\": \"2\"}, {\"tsne_x\": 68.8957290649414, \"tsne_y\": -27.499296188354492, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1895\", \"Dose Order\": \"2\"}, {\"tsne_x\": 70.67476654052734, \"tsne_y\": -27.50328254699707, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1932\", \"Dose Order\": \"2\"}, {\"tsne_x\": 70.30757141113281, \"tsne_y\": -28.46157455444336, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1933\", \"Dose Order\": \"2\"}, {\"tsne_x\": 70.15189361572266, \"tsne_y\": -28.90303611755371, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1934\", \"Dose Order\": \"2\"}, {\"tsne_x\": 70.029052734375, \"tsne_y\": -28.717838287353516, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1935\", \"Dose Order\": \"2\"}, {\"tsne_x\": 66.91650390625, \"tsne_y\": -31.63572120666504, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1473\", \"Dose Order\": \"3\"}, {\"tsne_x\": 66.93423461914062, \"tsne_y\": -31.18398666381836, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1474\", \"Dose Order\": \"3\"}, {\"tsne_x\": 67.02388763427734, \"tsne_y\": -31.24622344970703, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1475\", \"Dose Order\": \"3\"}, {\"tsne_x\": 69.5146484375, \"tsne_y\": -34.06636047363281, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1892\", \"Dose Order\": \"3\"}, {\"tsne_x\": 69.74740600585938, \"tsne_y\": -34.818016052246094, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1893\", \"Dose Order\": \"3\"}, {\"tsne_x\": 69.64815521240234, \"tsne_y\": -34.66287612915039, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1894\", \"Dose Order\": \"3\"}, {\"tsne_x\": 69.73926544189453, \"tsne_y\": -34.83140563964844, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1895\", \"Dose Order\": \"3\"}, {\"tsne_x\": 68.52274322509766, \"tsne_y\": -35.34592819213867, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1932\", \"Dose Order\": \"3\"}, {\"tsne_x\": 68.29080963134766, \"tsne_y\": -34.59568405151367, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1933\", \"Dose Order\": \"3\"}, {\"tsne_x\": 68.04228973388672, \"tsne_y\": -34.53028869628906, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1934\", \"Dose Order\": \"3\"}, {\"tsne_x\": 68.23896789550781, \"tsne_y\": -34.59602355957031, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1935\", \"Dose Order\": \"3\"}, {\"tsne_x\": 62.00056838989258, \"tsne_y\": -41.492557525634766, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1473\", \"Dose Order\": \"4\"}, {\"tsne_x\": 62.0001106262207, \"tsne_y\": -41.544551849365234, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1474\", \"Dose Order\": \"4\"}, {\"tsne_x\": 61.96723937988281, \"tsne_y\": -41.45866012573242, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1475\", \"Dose Order\": \"4\"}, {\"tsne_x\": 62.5576286315918, \"tsne_y\": -43.04694747924805, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1892\", \"Dose Order\": \"4\"}, {\"tsne_x\": 62.2791633605957, \"tsne_y\": -43.40595245361328, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1893\", \"Dose Order\": \"4\"}, {\"tsne_x\": 62.0869140625, \"tsne_y\": -43.4495735168457, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1894\", \"Dose Order\": \"4\"}, {\"tsne_x\": 62.182735443115234, \"tsne_y\": -43.71747970581055, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1895\", \"Dose Order\": \"4\"}, {\"tsne_x\": 61.240943908691406, \"tsne_y\": -44.63373565673828, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1932\", \"Dose Order\": \"4\"}, {\"tsne_x\": 60.884334564208984, \"tsne_y\": -43.930030822753906, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1933\", \"Dose Order\": \"4\"}, {\"tsne_x\": 60.80983352661133, \"tsne_y\": -44.06455612182617, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1934\", \"Dose Order\": \"4\"}, {\"tsne_x\": 61.10560989379883, \"tsne_y\": -43.88597869873047, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1935\", \"Dose Order\": \"4\"}, {\"tsne_x\": 55.15141677856445, \"tsne_y\": -53.4955940246582, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1473\", \"Dose Order\": \"5\"}, {\"tsne_x\": 55.110107421875, \"tsne_y\": -53.46589279174805, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1474\", \"Dose Order\": \"5\"}, {\"tsne_x\": 55.003379821777344, \"tsne_y\": -53.36865234375, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1475\", \"Dose Order\": \"5\"}, {\"tsne_x\": 53.34721374511719, \"tsne_y\": -52.81166076660156, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1892\", \"Dose Order\": \"5\"}, {\"tsne_x\": 53.69841766357422, \"tsne_y\": -53.15488052368164, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1893\", \"Dose Order\": \"5\"}, {\"tsne_x\": 53.80119705200195, \"tsne_y\": -52.749305725097656, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1894\", \"Dose Order\": \"5\"}, {\"tsne_x\": 53.89540481567383, \"tsne_y\": -52.8500862121582, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1895\", \"Dose Order\": \"5\"}, {\"tsne_x\": 54.59901809692383, \"tsne_y\": -51.32143020629883, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1932\", \"Dose Order\": \"5\"}, {\"tsne_x\": 53.69731903076172, \"tsne_y\": -51.52565002441406, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1933\", \"Dose Order\": \"5\"}, {\"tsne_x\": 53.8398551940918, \"tsne_y\": -51.350059509277344, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1934\", \"Dose Order\": \"5\"}, {\"tsne_x\": 53.99807357788086, \"tsne_y\": -51.59667205810547, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|3\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1935\", \"Dose Order\": \"5\"}, {\"tsne_x\": 1.1146010160446167, \"tsne_y\": 49.701194763183594, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1473\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.73981773853302, \"tsne_y\": 49.35995864868164, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1474\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.9859528541564941, \"tsne_y\": 51.01961898803711, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1475\", \"Dose Order\": \"0\"}, {\"tsne_x\": 2.031663179397583, \"tsne_y\": 49.750640869140625, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1892\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.26217982172966003, \"tsne_y\": 49.71633529663086, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1893\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.6493576765060425, \"tsne_y\": 50.04130554199219, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1894\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.34071484208106995, \"tsne_y\": 49.45138931274414, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1895\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.03173298388719559, \"tsne_y\": 48.27101135253906, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1932\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.9664636254310608, \"tsne_y\": 50.55811309814453, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1933\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.5292385816574097, \"tsne_y\": 48.567237854003906, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1934\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.253547191619873, \"tsne_y\": 48.98442459106445, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1935\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.781427383422852, \"tsne_y\": 59.060455322265625, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1473\", \"Dose Order\": \"1\"}, {\"tsne_x\": -5.505721092224121, \"tsne_y\": 58.74333572387695, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1474\", \"Dose Order\": \"1\"}, {\"tsne_x\": -5.952915668487549, \"tsne_y\": 58.743080139160156, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1475\", \"Dose Order\": \"1\"}, {\"tsne_x\": -5.215963840484619, \"tsne_y\": 57.742340087890625, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1892\", \"Dose Order\": \"1\"}, {\"tsne_x\": -6.079213619232178, \"tsne_y\": 57.74184036254883, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1893\", \"Dose Order\": \"1\"}, {\"tsne_x\": -5.977986812591553, \"tsne_y\": 57.84244918823242, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1894\", \"Dose Order\": \"1\"}, {\"tsne_x\": -6.910261154174805, \"tsne_y\": 57.375179290771484, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1895\", \"Dose Order\": \"1\"}, {\"tsne_x\": -4.532005310058594, \"tsne_y\": 56.89893341064453, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1932\", \"Dose Order\": \"1\"}, {\"tsne_x\": -6.981709957122803, \"tsne_y\": 58.88397216796875, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1933\", \"Dose Order\": \"1\"}, {\"tsne_x\": -5.549612998962402, \"tsne_y\": 56.877132415771484, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1934\", \"Dose Order\": \"1\"}, {\"tsne_x\": -5.82927131652832, \"tsne_y\": 56.861122131347656, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1935\", \"Dose Order\": \"1\"}, {\"tsne_x\": -17.099040985107422, \"tsne_y\": 30.61140251159668, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1473\", \"Dose Order\": \"2\"}, {\"tsne_x\": -16.610130310058594, \"tsne_y\": 29.838024139404297, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1474\", \"Dose Order\": \"2\"}, {\"tsne_x\": -16.573993682861328, \"tsne_y\": 30.83856201171875, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1475\", \"Dose Order\": \"2\"}, {\"tsne_x\": -16.425317764282227, \"tsne_y\": 31.858274459838867, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1892\", \"Dose Order\": \"2\"}, {\"tsne_x\": -15.517806053161621, \"tsne_y\": 31.314916610717773, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1893\", \"Dose Order\": \"2\"}, {\"tsne_x\": -16.26768684387207, \"tsne_y\": 29.536039352416992, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1894\", \"Dose Order\": \"2\"}, {\"tsne_x\": -15.747074127197266, \"tsne_y\": 30.902807235717773, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1895\", \"Dose Order\": \"2\"}, {\"tsne_x\": -17.999073028564453, \"tsne_y\": 29.814922332763672, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1932\", \"Dose Order\": \"2\"}, {\"tsne_x\": -16.036508560180664, \"tsne_y\": 30.135269165039062, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1933\", \"Dose Order\": \"2\"}, {\"tsne_x\": -17.34433937072754, \"tsne_y\": 31.05207633972168, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1934\", \"Dose Order\": \"2\"}, {\"tsne_x\": -16.3874568939209, \"tsne_y\": 31.76696014404297, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1935\", \"Dose Order\": \"2\"}, {\"tsne_x\": -18.696556091308594, \"tsne_y\": 73.75324249267578, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1473\", \"Dose Order\": \"3\"}, {\"tsne_x\": -17.13118553161621, \"tsne_y\": 76.16276550292969, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1474\", \"Dose Order\": \"3\"}, {\"tsne_x\": -19.057313919067383, \"tsne_y\": 72.52317810058594, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1475\", \"Dose Order\": \"3\"}, {\"tsne_x\": -18.446044921875, \"tsne_y\": 72.77066802978516, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1892\", \"Dose Order\": \"3\"}, {\"tsne_x\": -17.701147079467773, \"tsne_y\": 72.57646179199219, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1893\", \"Dose Order\": \"3\"}, {\"tsne_x\": -18.487863540649414, \"tsne_y\": 72.77969360351562, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1894\", \"Dose Order\": \"3\"}, {\"tsne_x\": -18.886905670166016, \"tsne_y\": 72.86260986328125, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1895\", \"Dose Order\": \"3\"}, {\"tsne_x\": -15.772266387939453, \"tsne_y\": 82.00849151611328, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1932\", \"Dose Order\": \"3\"}, {\"tsne_x\": -16.250823974609375, \"tsne_y\": 81.06379699707031, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1933\", \"Dose Order\": \"3\"}, {\"tsne_x\": -20.03231430053711, \"tsne_y\": 72.80548858642578, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1934\", \"Dose Order\": \"3\"}, {\"tsne_x\": -15.931571006774902, \"tsne_y\": 79.70818328857422, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1935\", \"Dose Order\": \"3\"}, {\"tsne_x\": -15.582771301269531, \"tsne_y\": 76.72843933105469, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1473\", \"Dose Order\": \"4\"}, {\"tsne_x\": -16.092060089111328, \"tsne_y\": 76.67826843261719, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1474\", \"Dose Order\": \"4\"}, {\"tsne_x\": -14.124690055847168, \"tsne_y\": 74.20001983642578, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1475\", \"Dose Order\": \"4\"}, {\"tsne_x\": -13.706926345825195, \"tsne_y\": 73.7428970336914, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1892\", \"Dose Order\": \"4\"}, {\"tsne_x\": -14.6820068359375, \"tsne_y\": 73.20072174072266, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1893\", \"Dose Order\": \"4\"}, {\"tsne_x\": -14.330973625183105, \"tsne_y\": 73.78499603271484, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1894\", \"Dose Order\": \"4\"}, {\"tsne_x\": -14.365211486816406, \"tsne_y\": 73.60011291503906, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1895\", \"Dose Order\": \"4\"}, {\"tsne_x\": -15.35112476348877, \"tsne_y\": 81.81297302246094, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1932\", \"Dose Order\": \"4\"}, {\"tsne_x\": -14.76817512512207, \"tsne_y\": 78.7698745727539, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1933\", \"Dose Order\": \"4\"}, {\"tsne_x\": -15.130716323852539, \"tsne_y\": 78.53759002685547, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1934\", \"Dose Order\": \"4\"}, {\"tsne_x\": -14.69924545288086, \"tsne_y\": 77.7828598022461, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1935\", \"Dose Order\": \"4\"}, {\"tsne_x\": -16.461257934570312, \"tsne_y\": 77.59708404541016, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1473\", \"Dose Order\": \"5\"}, {\"tsne_x\": -17.133699417114258, \"tsne_y\": 77.00311279296875, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1474\", \"Dose Order\": \"5\"}, {\"tsne_x\": -15.152307510375977, \"tsne_y\": 69.22821807861328, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1475\", \"Dose Order\": \"5\"}, {\"tsne_x\": -16.057647705078125, \"tsne_y\": 68.9925308227539, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1892\", \"Dose Order\": \"5\"}, {\"tsne_x\": -16.002187728881836, \"tsne_y\": 69.83193969726562, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1893\", \"Dose Order\": \"5\"}, {\"tsne_x\": -15.915735244750977, \"tsne_y\": 69.52804565429688, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1894\", \"Dose Order\": \"5\"}, {\"tsne_x\": -15.574234008789062, \"tsne_y\": 69.55640411376953, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1895\", \"Dose Order\": \"5\"}, {\"tsne_x\": -15.758306503295898, \"tsne_y\": 81.9948959350586, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1932\", \"Dose Order\": \"5\"}, {\"tsne_x\": -16.28976058959961, \"tsne_y\": 80.78751373291016, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1933\", \"Dose Order\": \"5\"}, {\"tsne_x\": -17.138446807861328, \"tsne_y\": 78.55072021484375, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1934\", \"Dose Order\": \"5\"}, {\"tsne_x\": -16.17611312866211, \"tsne_y\": 79.48262023925781, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|3\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1935\", \"Dose Order\": \"5\"}, {\"tsne_x\": 22.909900665283203, \"tsne_y\": -3.35882568359375, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1473\", \"Dose Order\": \"0\"}, {\"tsne_x\": 23.27525520324707, \"tsne_y\": -4.758020401000977, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1474\", \"Dose Order\": \"0\"}, {\"tsne_x\": 23.155366897583008, \"tsne_y\": -3.409701347351074, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1475\", \"Dose Order\": \"0\"}, {\"tsne_x\": 24.588998794555664, \"tsne_y\": -5.1973161697387695, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1892\", \"Dose Order\": \"0\"}, {\"tsne_x\": 24.723773956298828, \"tsne_y\": -4.614873886108398, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1893\", \"Dose Order\": \"0\"}, {\"tsne_x\": 24.046823501586914, \"tsne_y\": -4.19318962097168, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1894\", \"Dose Order\": \"0\"}, {\"tsne_x\": 24.144948959350586, \"tsne_y\": -4.320273399353027, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1895\", \"Dose Order\": \"0\"}, {\"tsne_x\": 24.250356674194336, \"tsne_y\": -2.5763847827911377, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1932\", \"Dose Order\": \"0\"}, {\"tsne_x\": 21.91607666015625, \"tsne_y\": -6.109095573425293, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1933\", \"Dose Order\": \"0\"}, {\"tsne_x\": 24.078351974487305, \"tsne_y\": -3.6334292888641357, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1934\", \"Dose Order\": \"0\"}, {\"tsne_x\": 23.099428176879883, \"tsne_y\": -5.240631103515625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1935\", \"Dose Order\": \"0\"}, {\"tsne_x\": 19.716556549072266, \"tsne_y\": -10.602892875671387, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1473\", \"Dose Order\": \"1\"}, {\"tsne_x\": 19.814851760864258, \"tsne_y\": -10.20877742767334, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1474\", \"Dose Order\": \"1\"}, {\"tsne_x\": 20.197546005249023, \"tsne_y\": -10.075348854064941, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1475\", \"Dose Order\": \"1\"}, {\"tsne_x\": 20.864601135253906, \"tsne_y\": -11.084054946899414, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1892\", \"Dose Order\": \"1\"}, {\"tsne_x\": 21.014202117919922, \"tsne_y\": -11.209677696228027, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1893\", \"Dose Order\": \"1\"}, {\"tsne_x\": 21.41623306274414, \"tsne_y\": -10.240901947021484, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1894\", \"Dose Order\": \"1\"}, {\"tsne_x\": 21.560810089111328, \"tsne_y\": -10.922450065612793, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1895\", \"Dose Order\": \"1\"}, {\"tsne_x\": 20.199758529663086, \"tsne_y\": -8.453137397766113, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1932\", \"Dose Order\": \"1\"}, {\"tsne_x\": 21.61806297302246, \"tsne_y\": -6.794742584228516, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1933\", \"Dose Order\": \"1\"}, {\"tsne_x\": 21.438676834106445, \"tsne_y\": -8.352433204650879, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1934\", \"Dose Order\": \"1\"}, {\"tsne_x\": 21.275001525878906, \"tsne_y\": -8.411596298217773, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1935\", \"Dose Order\": \"1\"}, {\"tsne_x\": 18.063575744628906, \"tsne_y\": -28.30158233642578, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1473\", \"Dose Order\": \"2\"}, {\"tsne_x\": 18.120180130004883, \"tsne_y\": -28.239713668823242, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1474\", \"Dose Order\": \"2\"}, {\"tsne_x\": 17.677860260009766, \"tsne_y\": -28.496685028076172, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1475\", \"Dose Order\": \"2\"}, {\"tsne_x\": 20.798166275024414, \"tsne_y\": -30.661293029785156, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1892\", \"Dose Order\": \"2\"}, {\"tsne_x\": 21.1490478515625, \"tsne_y\": -31.373458862304688, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1893\", \"Dose Order\": \"2\"}, {\"tsne_x\": 20.95680809020996, \"tsne_y\": -31.525955200195312, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1894\", \"Dose Order\": \"2\"}, {\"tsne_x\": 21.494400024414062, \"tsne_y\": -31.540128707885742, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1895\", \"Dose Order\": \"2\"}, {\"tsne_x\": 19.09114646911621, \"tsne_y\": -24.180635452270508, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1932\", \"Dose Order\": \"2\"}, {\"tsne_x\": 7.085895538330078, \"tsne_y\": -24.812091827392578, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1933\", \"Dose Order\": \"2\"}, {\"tsne_x\": 18.890825271606445, \"tsne_y\": -24.84469223022461, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1934\", \"Dose Order\": \"2\"}, {\"tsne_x\": 18.806163787841797, \"tsne_y\": -24.93198013305664, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1935\", \"Dose Order\": \"2\"}, {\"tsne_x\": 9.494203567504883, \"tsne_y\": -32.574729919433594, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1473\", \"Dose Order\": \"3\"}, {\"tsne_x\": 9.523648262023926, \"tsne_y\": -32.266780853271484, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1474\", \"Dose Order\": \"3\"}, {\"tsne_x\": 9.563949584960938, \"tsne_y\": -32.4581413269043, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1475\", \"Dose Order\": \"3\"}, {\"tsne_x\": 13.188318252563477, \"tsne_y\": -37.55628204345703, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1892\", \"Dose Order\": \"3\"}, {\"tsne_x\": 13.605815887451172, \"tsne_y\": -38.309410095214844, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1893\", \"Dose Order\": \"3\"}, {\"tsne_x\": 13.562910079956055, \"tsne_y\": -38.248348236083984, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1894\", \"Dose Order\": \"3\"}, {\"tsne_x\": 13.660388946533203, \"tsne_y\": -37.79507064819336, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1895\", \"Dose Order\": \"3\"}, {\"tsne_x\": 8.596601486206055, \"tsne_y\": -29.1361083984375, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1932\", \"Dose Order\": \"3\"}, {\"tsne_x\": 6.925654888153076, \"tsne_y\": -27.131103515625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1933\", \"Dose Order\": \"3\"}, {\"tsne_x\": 8.041583061218262, \"tsne_y\": -29.1727352142334, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1934\", \"Dose Order\": \"3\"}, {\"tsne_x\": 7.941812515258789, \"tsne_y\": -28.99594497680664, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1935\", \"Dose Order\": \"3\"}, {\"tsne_x\": 7.037418842315674, \"tsne_y\": -35.21974182128906, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1473\", \"Dose Order\": \"4\"}, {\"tsne_x\": 6.643571853637695, \"tsne_y\": -34.820404052734375, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1474\", \"Dose Order\": \"4\"}, {\"tsne_x\": 6.702237606048584, \"tsne_y\": -35.18896484375, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1475\", \"Dose Order\": \"4\"}, {\"tsne_x\": 4.550333499908447, \"tsne_y\": -40.00571060180664, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1892\", \"Dose Order\": \"4\"}, {\"tsne_x\": 4.5312933921813965, \"tsne_y\": -39.421966552734375, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1893\", \"Dose Order\": \"4\"}, {\"tsne_x\": 4.773196220397949, \"tsne_y\": -39.605743408203125, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1894\", \"Dose Order\": \"4\"}, {\"tsne_x\": 5.095389366149902, \"tsne_y\": -39.577232360839844, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1895\", \"Dose Order\": \"4\"}, {\"tsne_x\": 3.757174015045166, \"tsne_y\": -32.56654357910156, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1932\", \"Dose Order\": \"4\"}, {\"tsne_x\": 6.300530433654785, \"tsne_y\": -25.831623077392578, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1933\", \"Dose Order\": \"4\"}, {\"tsne_x\": 4.273542404174805, \"tsne_y\": -32.55582809448242, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1934\", \"Dose Order\": \"4\"}, {\"tsne_x\": 3.7311081886291504, \"tsne_y\": -33.64073944091797, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1935\", \"Dose Order\": \"4\"}, {\"tsne_x\": 5.729393005371094, \"tsne_y\": -35.8397102355957, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1473\", \"Dose Order\": \"5\"}, {\"tsne_x\": 5.532495498657227, \"tsne_y\": -35.777809143066406, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1474\", \"Dose Order\": \"5\"}, {\"tsne_x\": 5.795245170593262, \"tsne_y\": -35.74098587036133, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1475\", \"Dose Order\": \"5\"}, {\"tsne_x\": 3.2115650177001953, \"tsne_y\": -38.568599700927734, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1892\", \"Dose Order\": \"5\"}, {\"tsne_x\": 3.598484992980957, \"tsne_y\": -38.53593444824219, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1893\", \"Dose Order\": \"5\"}, {\"tsne_x\": 3.4116668701171875, \"tsne_y\": -37.891841888427734, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1894\", \"Dose Order\": \"5\"}, {\"tsne_x\": 3.485426664352417, \"tsne_y\": -38.70877456665039, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1895\", \"Dose Order\": \"5\"}, {\"tsne_x\": 2.759869337081909, \"tsne_y\": -34.88142395019531, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1932\", \"Dose Order\": \"5\"}, {\"tsne_x\": 2.640702247619629, \"tsne_y\": -23.187992095947266, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1933\", \"Dose Order\": \"5\"}, {\"tsne_x\": 3.430659055709839, \"tsne_y\": -34.3890495300293, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1934\", \"Dose Order\": \"5\"}, {\"tsne_x\": 3.405733108520508, \"tsne_y\": -34.52175521850586, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|3\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 3, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1935\", \"Dose Order\": \"5\"}]}}, {\"mode\": \"vega-lite\"});\n",
              "</script>"
            ],
            "text/plain": [
              "alt.Chart(...)"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-52-84172d8d0eec>:13: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  altair_plot_data['Dose Order'] = altair_plot_data['dose_order'].astype(str)\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/html": [
              "\n",
              "<div id=\"altair-viz-d8316a4f8e1949d0afb7f231ac32a715\"></div>\n",
              "<script type=\"text/javascript\">\n",
              "  var VEGA_DEBUG = (typeof VEGA_DEBUG == \"undefined\") ? {} : VEGA_DEBUG;\n",
              "  (function(spec, embedOpt){\n",
              "    let outputDiv = document.currentScript.previousElementSibling;\n",
              "    if (outputDiv.id !== \"altair-viz-d8316a4f8e1949d0afb7f231ac32a715\") {\n",
              "      outputDiv = document.getElementById(\"altair-viz-d8316a4f8e1949d0afb7f231ac32a715\");\n",
              "    }\n",
              "    const paths = {\n",
              "      \"vega\": \"https://cdn.jsdelivr.net/npm//vega@5?noext\",\n",
              "      \"vega-lib\": \"https://cdn.jsdelivr.net/npm//vega-lib?noext\",\n",
              "      \"vega-lite\": \"https://cdn.jsdelivr.net/npm//vega-lite@4.17.0?noext\",\n",
              "      \"vega-embed\": \"https://cdn.jsdelivr.net/npm//vega-embed@6?noext\",\n",
              "    };\n",
              "\n",
              "    function maybeLoadScript(lib, version) {\n",
              "      var key = `${lib.replace(\"-\", \"\")}_version`;\n",
              "      return (VEGA_DEBUG[key] == version) ?\n",
              "        Promise.resolve(paths[lib]) :\n",
              "        new Promise(function(resolve, reject) {\n",
              "          var s = document.createElement('script');\n",
              "          document.getElementsByTagName(\"head\")[0].appendChild(s);\n",
              "          s.async = true;\n",
              "          s.onload = () => {\n",
              "            VEGA_DEBUG[key] = version;\n",
              "            return resolve(paths[lib]);\n",
              "          };\n",
              "          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);\n",
              "          s.src = paths[lib];\n",
              "        });\n",
              "    }\n",
              "\n",
              "    function showError(err) {\n",
              "      outputDiv.innerHTML = `<div class=\"error\" style=\"color:red;\">${err}</div>`;\n",
              "      throw err;\n",
              "    }\n",
              "\n",
              "    function displayChart(vegaEmbed) {\n",
              "      vegaEmbed(outputDiv, spec, embedOpt)\n",
              "        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));\n",
              "    }\n",
              "\n",
              "    if(typeof define === \"function\" && define.amd) {\n",
              "      requirejs.config({paths});\n",
              "      require([\"vega-embed\"], displayChart, err => showError(`Error loading script: ${err.message}`));\n",
              "    } else {\n",
              "      maybeLoadScript(\"vega\", \"5\")\n",
              "        .then(() => maybeLoadScript(\"vega-lite\", \"4.17.0\"))\n",
              "        .then(() => maybeLoadScript(\"vega-embed\", \"6\"))\n",
              "        .catch(showError)\n",
              "        .then(() => displayChart(vegaEmbed));\n",
              "    }\n",
              "  })({\"config\": {\"view\": {\"continuousWidth\": 400, \"continuousHeight\": 300}, \"axis\": {\"labelFontSize\": 20, \"titleFontSize\": 20}, \"background\": \"white\", \"legend\": {\"labelFontSize\": 20, \"labelLimit\": 0, \"titleFontSize\": 20}}, \"data\": {\"name\": \"data-c9ff08564f1a91d502e68923570128fc\"}, \"mark\": {\"type\": \"point\", \"filled\": true, \"size\": 240, \"stroke\": \"black\", \"strokeWidth\": 1.5}, \"encoding\": {\"color\": {\"field\": \"Compound Group\", \"scale\": {\"domain\": [\"DMSO\", \"Herceptin\", \"Perjeta\", \"Active Degraders\", \"Inactive Degraders\", \"PI3K Inhibitor\", \"Pan-Akt Inhibitor\", \"Neratinib (Covalent Inhibitor)\", \"BDTX-189 (Covalent Inhibitor)\", \"Head Group Small Molecules\"], \"range\": [\"#7f7f7f\", \"#ff7f0e\", \"#8c5626\", \"#d62728\", \"#bcbd22\", \"#9467bd\", \"#e377c2\", \"#1f77b4\", \"#17becf\", \"#2ca02c\"]}, \"type\": \"nominal\"}, \"shape\": {\"field\": \"Dose Order\", \"type\": \"nominal\"}, \"tooltip\": {\"field\": \"compound_dose\", \"type\": \"nominal\"}, \"x\": {\"field\": \"tsne_x\", \"type\": \"quantitative\"}, \"y\": {\"field\": \"tsne_y\", \"type\": \"quantitative\"}}, \"height\": 700, \"title\": \"SKOV3 No GFP Timepoint 4 (72 hours)\", \"width\": 700, \"$schema\": \"https://vega.github.io/schema/vega-lite/v4.17.0.json\", \"datasets\": {\"data-c9ff08564f1a91d502e68923570128fc\": [{\"tsne_x\": -18.653501510620117, \"tsne_y\": 3.898404836654663, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1476\", \"Dose Order\": \"0\"}, {\"tsne_x\": -20.922382354736328, \"tsne_y\": 4.965038776397705, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1477\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.61063003540039, \"tsne_y\": 3.572949171066284, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1478\", \"Dose Order\": \"0\"}, {\"tsne_x\": -18.974809646606445, \"tsne_y\": 2.8020992279052734, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1896\", \"Dose Order\": \"0\"}, {\"tsne_x\": -19.118457794189453, \"tsne_y\": 2.631206512451172, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1897\", \"Dose Order\": \"0\"}, {\"tsne_x\": -18.336641311645508, \"tsne_y\": 3.3690073490142822, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1898\", \"Dose Order\": \"0\"}, {\"tsne_x\": -18.37724494934082, \"tsne_y\": 2.6146650314331055, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1899\", \"Dose Order\": \"0\"}, {\"tsne_x\": -16.96491050720215, \"tsne_y\": 3.8264882564544678, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1936\", \"Dose Order\": \"0\"}, {\"tsne_x\": -17.880544662475586, \"tsne_y\": 2.149287700653076, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1937\", \"Dose Order\": \"0\"}, {\"tsne_x\": -17.52409553527832, \"tsne_y\": 2.8119699954986572, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1938\", \"Dose Order\": \"0\"}, {\"tsne_x\": -18.419353485107422, \"tsne_y\": 1.6620575189590454, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|0|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_0\", \"plate\": \"CPP1939\", \"Dose Order\": \"0\"}, {\"tsne_x\": -30.059234619140625, \"tsne_y\": 13.655760765075684, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1476\", \"Dose Order\": \"1\"}, {\"tsne_x\": -28.052026748657227, \"tsne_y\": 11.877114295959473, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1477\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.214197158813477, \"tsne_y\": 13.326077461242676, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1478\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.67449378967285, \"tsne_y\": 12.495698928833008, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1896\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.692873001098633, \"tsne_y\": 12.692876815795898, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1897\", \"Dose Order\": \"1\"}, {\"tsne_x\": -29.656320571899414, \"tsne_y\": 12.744529724121094, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1898\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.101289749145508, \"tsne_y\": 13.12594223022461, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1899\", \"Dose Order\": \"1\"}, {\"tsne_x\": -31.79062843322754, \"tsne_y\": 13.590201377868652, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1936\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.308542251586914, \"tsne_y\": 14.404253005981445, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1937\", \"Dose Order\": \"1\"}, {\"tsne_x\": -29.36798667907715, \"tsne_y\": 13.977294921875, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1938\", \"Dose Order\": \"1\"}, {\"tsne_x\": -31.000225067138672, \"tsne_y\": 13.937215805053711, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|1|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_1\", \"plate\": \"CPP1939\", \"Dose Order\": \"1\"}, {\"tsne_x\": -34.51874542236328, \"tsne_y\": 27.518468856811523, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1476\", \"Dose Order\": \"2\"}, {\"tsne_x\": -36.46025085449219, \"tsne_y\": 29.121225357055664, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1477\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.97288513183594, \"tsne_y\": 27.255212783813477, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1478\", \"Dose Order\": \"2\"}, {\"tsne_x\": -34.30752944946289, \"tsne_y\": 26.448942184448242, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1896\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.1110725402832, \"tsne_y\": 26.652217864990234, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1897\", \"Dose Order\": \"2\"}, {\"tsne_x\": -34.65691375732422, \"tsne_y\": 26.22727394104004, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1898\", \"Dose Order\": \"2\"}, {\"tsne_x\": -34.14982604980469, \"tsne_y\": 26.41451644897461, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1899\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.39192199707031, \"tsne_y\": 25.339954376220703, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1936\", \"Dose Order\": \"2\"}, {\"tsne_x\": -34.438690185546875, \"tsne_y\": 25.10965919494629, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1937\", \"Dose Order\": \"2\"}, {\"tsne_x\": -34.87797164916992, \"tsne_y\": 25.430742263793945, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1938\", \"Dose Order\": \"2\"}, {\"tsne_x\": -33.80816650390625, \"tsne_y\": 25.777374267578125, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|2|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_2\", \"plate\": \"CPP1939\", \"Dose Order\": \"2\"}, {\"tsne_x\": -34.891422271728516, \"tsne_y\": 30.778076171875, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1476\", \"Dose Order\": \"3\"}, {\"tsne_x\": -36.37586212158203, \"tsne_y\": 29.457948684692383, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1477\", \"Dose Order\": \"3\"}, {\"tsne_x\": -35.13094711303711, \"tsne_y\": 31.15837287902832, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1478\", \"Dose Order\": \"3\"}, {\"tsne_x\": -33.15229797363281, \"tsne_y\": 31.086076736450195, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1896\", \"Dose Order\": \"3\"}, {\"tsne_x\": -33.86903381347656, \"tsne_y\": 31.777498245239258, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1897\", \"Dose Order\": \"3\"}, {\"tsne_x\": -33.4747314453125, \"tsne_y\": 32.07088851928711, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1898\", \"Dose Order\": \"3\"}, {\"tsne_x\": -33.526344299316406, \"tsne_y\": 31.709579467773438, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1899\", \"Dose Order\": \"3\"}, {\"tsne_x\": -32.22521209716797, \"tsne_y\": 31.514312744140625, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1936\", \"Dose Order\": \"3\"}, {\"tsne_x\": -31.761194229125977, \"tsne_y\": 32.62127685546875, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1937\", \"Dose Order\": \"3\"}, {\"tsne_x\": -31.807292938232422, \"tsne_y\": 32.593894958496094, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1938\", \"Dose Order\": \"3\"}, {\"tsne_x\": -31.84490203857422, \"tsne_y\": 32.14006042480469, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|3|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_3\", \"plate\": \"CPP1939\", \"Dose Order\": \"3\"}, {\"tsne_x\": -36.88579177856445, \"tsne_y\": 37.22104263305664, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1476\", \"Dose Order\": \"4\"}, {\"tsne_x\": -37.609832763671875, \"tsne_y\": 36.79581069946289, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1477\", \"Dose Order\": \"4\"}, {\"tsne_x\": -37.445194244384766, \"tsne_y\": 36.978607177734375, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1478\", \"Dose Order\": \"4\"}, {\"tsne_x\": -36.60187530517578, \"tsne_y\": 39.3758544921875, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1896\", \"Dose Order\": \"4\"}, {\"tsne_x\": -36.56583023071289, \"tsne_y\": 39.01914596557617, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1897\", \"Dose Order\": \"4\"}, {\"tsne_x\": -36.471649169921875, \"tsne_y\": 38.83642578125, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1898\", \"Dose Order\": \"4\"}, {\"tsne_x\": -36.5274543762207, \"tsne_y\": 38.71582794189453, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1899\", \"Dose Order\": \"4\"}, {\"tsne_x\": -35.691307067871094, \"tsne_y\": 40.194332122802734, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1936\", \"Dose Order\": \"4\"}, {\"tsne_x\": -34.83727264404297, \"tsne_y\": 39.73859786987305, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1937\", \"Dose Order\": \"4\"}, {\"tsne_x\": -34.7729606628418, \"tsne_y\": 39.683292388916016, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1938\", \"Dose Order\": \"4\"}, {\"tsne_x\": -35.24586868286133, \"tsne_y\": 39.65058517456055, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|4|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_4\", \"plate\": \"CPP1939\", \"Dose Order\": \"4\"}, {\"tsne_x\": -42.10416030883789, \"tsne_y\": 46.52732849121094, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1476\", \"Dose Order\": \"5\"}, {\"tsne_x\": -42.561737060546875, \"tsne_y\": 46.414955139160156, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1477\", \"Dose Order\": \"5\"}, {\"tsne_x\": -42.357303619384766, \"tsne_y\": 46.4813232421875, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1478\", \"Dose Order\": \"5\"}, {\"tsne_x\": -39.71509552001953, \"tsne_y\": 46.32030487060547, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1896\", \"Dose Order\": \"5\"}, {\"tsne_x\": -40.09914779663086, \"tsne_y\": 46.14030838012695, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1897\", \"Dose Order\": \"5\"}, {\"tsne_x\": -40.04753112792969, \"tsne_y\": 46.24673080444336, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1898\", \"Dose Order\": \"5\"}, {\"tsne_x\": -40.03033447265625, \"tsne_y\": 46.641056060791016, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1899\", \"Dose Order\": \"5\"}, {\"tsne_x\": -39.775474548339844, \"tsne_y\": 47.55061721801758, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1936\", \"Dose Order\": \"5\"}, {\"tsne_x\": -40.12519073486328, \"tsne_y\": 47.997047424316406, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1937\", \"Dose Order\": \"5\"}, {\"tsne_x\": -40.25800323486328, \"tsne_y\": 47.91121292114258, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1938\", \"Dose Order\": \"5\"}, {\"tsne_x\": -39.6622314453125, \"tsne_y\": 48.45033264160156, \"Compound Group\": \"PI3K Inhibitor\", \"label\": \"Alpelisib (PI3K inhibitor)|5|4\", \"compound\": \"Alpelisib (PI3K inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Alpelisib (PI3K inhibitor)_5\", \"plate\": \"CPP1939\", \"Dose Order\": \"5\"}, {\"tsne_x\": -23.239574432373047, \"tsne_y\": -13.01895523071289, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1476\", \"Dose Order\": \"0\"}, {\"tsne_x\": -28.098602294921875, \"tsne_y\": -13.483084678649902, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1477\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.116064071655273, \"tsne_y\": -12.709932327270508, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1478\", \"Dose Order\": \"0\"}, {\"tsne_x\": -24.000226974487305, \"tsne_y\": -12.149016380310059, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1896\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.001380920410156, \"tsne_y\": -13.223570823669434, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1897\", \"Dose Order\": \"0\"}, {\"tsne_x\": -24.66486167907715, \"tsne_y\": -13.549331665039062, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1898\", \"Dose Order\": \"0\"}, {\"tsne_x\": -24.761117935180664, \"tsne_y\": -13.609509468078613, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1899\", \"Dose Order\": \"0\"}, {\"tsne_x\": -22.937824249267578, \"tsne_y\": -14.192822456359863, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1936\", \"Dose Order\": \"0\"}, {\"tsne_x\": -24.36461639404297, \"tsne_y\": -14.30372428894043, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1937\", \"Dose Order\": \"0\"}, {\"tsne_x\": -24.150636672973633, \"tsne_y\": -14.660911560058594, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1938\", \"Dose Order\": \"0\"}, {\"tsne_x\": -23.57939338684082, \"tsne_y\": -14.412731170654297, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|0|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_0\", \"plate\": \"CPP1939\", \"Dose Order\": \"0\"}, {\"tsne_x\": -30.749019622802734, \"tsne_y\": -18.28297233581543, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1476\", \"Dose Order\": \"1\"}, {\"tsne_x\": -28.62925148010254, \"tsne_y\": -13.806215286254883, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1477\", \"Dose Order\": \"1\"}, {\"tsne_x\": -32.85472869873047, \"tsne_y\": -19.685218811035156, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1478\", \"Dose Order\": \"1\"}, {\"tsne_x\": -29.976421356201172, \"tsne_y\": -17.118593215942383, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1896\", \"Dose Order\": \"1\"}, {\"tsne_x\": -29.582069396972656, \"tsne_y\": -17.047805786132812, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1897\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.009946823120117, \"tsne_y\": -17.012773513793945, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1898\", \"Dose Order\": \"1\"}, {\"tsne_x\": -29.511863708496094, \"tsne_y\": -17.603052139282227, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1899\", \"Dose Order\": \"1\"}, {\"tsne_x\": -28.72554588317871, \"tsne_y\": -18.256839752197266, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1936\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.02138900756836, \"tsne_y\": -18.80735969543457, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1937\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.825546264648438, \"tsne_y\": -17.566692352294922, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1938\", \"Dose Order\": \"1\"}, {\"tsne_x\": -29.45329475402832, \"tsne_y\": -18.359384536743164, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|1|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_1\", \"plate\": \"CPP1939\", \"Dose Order\": \"1\"}, {\"tsne_x\": -41.2879753112793, \"tsne_y\": -17.488727569580078, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1476\", \"Dose Order\": \"2\"}, {\"tsne_x\": -50.36479949951172, \"tsne_y\": -22.87725067138672, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1477\", \"Dose Order\": \"2\"}, {\"tsne_x\": -41.29723358154297, \"tsne_y\": -17.621826171875, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1478\", \"Dose Order\": \"2\"}, {\"tsne_x\": -40.43126678466797, \"tsne_y\": -18.658302307128906, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1896\", \"Dose Order\": \"2\"}, {\"tsne_x\": -40.053306579589844, \"tsne_y\": -18.528888702392578, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1897\", \"Dose Order\": \"2\"}, {\"tsne_x\": -40.41556167602539, \"tsne_y\": -18.082300186157227, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1898\", \"Dose Order\": \"2\"}, {\"tsne_x\": -41.006649017333984, \"tsne_y\": -18.416973114013672, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1899\", \"Dose Order\": \"2\"}, {\"tsne_x\": -41.04618835449219, \"tsne_y\": -16.00457763671875, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1936\", \"Dose Order\": \"2\"}, {\"tsne_x\": -41.198822021484375, \"tsne_y\": -15.516816139221191, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1937\", \"Dose Order\": \"2\"}, {\"tsne_x\": -40.08190155029297, \"tsne_y\": -17.13479232788086, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1938\", \"Dose Order\": \"2\"}, {\"tsne_x\": -40.71470642089844, \"tsne_y\": -16.655588150024414, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|2|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_2\", \"plate\": \"CPP1939\", \"Dose Order\": \"2\"}, {\"tsne_x\": -39.02315139770508, \"tsne_y\": -23.65167999267578, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1476\", \"Dose Order\": \"3\"}, {\"tsne_x\": -50.72886657714844, \"tsne_y\": -22.783432006835938, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1477\", \"Dose Order\": \"3\"}, {\"tsne_x\": -33.341861724853516, \"tsne_y\": -19.97319793701172, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1478\", \"Dose Order\": \"3\"}, {\"tsne_x\": -40.16893768310547, \"tsne_y\": -22.571348190307617, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1896\", \"Dose Order\": \"3\"}, {\"tsne_x\": -39.93727493286133, \"tsne_y\": -22.655385971069336, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1897\", \"Dose Order\": \"3\"}, {\"tsne_x\": -39.66791915893555, \"tsne_y\": -22.579668045043945, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1898\", \"Dose Order\": \"3\"}, {\"tsne_x\": -39.14781951904297, \"tsne_y\": -22.26958465576172, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1899\", \"Dose Order\": \"3\"}, {\"tsne_x\": -38.04134750366211, \"tsne_y\": -25.871814727783203, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1936\", \"Dose Order\": \"3\"}, {\"tsne_x\": -39.60334014892578, \"tsne_y\": -24.71746253967285, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1937\", \"Dose Order\": \"3\"}, {\"tsne_x\": -39.68193817138672, \"tsne_y\": -24.846254348754883, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1938\", \"Dose Order\": \"3\"}, {\"tsne_x\": -39.93519973754883, \"tsne_y\": -25.73271369934082, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|3|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_3\", \"plate\": \"CPP1939\", \"Dose Order\": \"3\"}, {\"tsne_x\": -46.788936614990234, \"tsne_y\": -27.22110939025879, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1476\", \"Dose Order\": \"4\"}, {\"tsne_x\": -50.01015090942383, \"tsne_y\": -23.933412551879883, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1477\", \"Dose Order\": \"4\"}, {\"tsne_x\": -46.849571228027344, \"tsne_y\": -27.274486541748047, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1478\", \"Dose Order\": \"4\"}, {\"tsne_x\": -44.68813705444336, \"tsne_y\": -26.93228530883789, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1896\", \"Dose Order\": \"4\"}, {\"tsne_x\": -44.54856872558594, \"tsne_y\": -26.884735107421875, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1897\", \"Dose Order\": \"4\"}, {\"tsne_x\": -44.25345993041992, \"tsne_y\": -26.565223693847656, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1898\", \"Dose Order\": \"4\"}, {\"tsne_x\": -44.40167236328125, \"tsne_y\": -26.891225814819336, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1899\", \"Dose Order\": \"4\"}, {\"tsne_x\": -42.418495178222656, \"tsne_y\": -27.517398834228516, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1936\", \"Dose Order\": \"4\"}, {\"tsne_x\": -42.04046630859375, \"tsne_y\": -27.43988800048828, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1937\", \"Dose Order\": \"4\"}, {\"tsne_x\": -41.68561553955078, \"tsne_y\": -26.96580696105957, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1938\", \"Dose Order\": \"4\"}, {\"tsne_x\": -42.237613677978516, \"tsne_y\": -27.14255714416504, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|4|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_4\", \"plate\": \"CPP1939\", \"Dose Order\": \"4\"}, {\"tsne_x\": -48.563079833984375, \"tsne_y\": -28.992984771728516, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1476\", \"Dose Order\": \"5\"}, {\"tsne_x\": -49.153541564941406, \"tsne_y\": -28.1158390045166, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1477\", \"Dose Order\": \"5\"}, {\"tsne_x\": -48.71779251098633, \"tsne_y\": -28.92798614501953, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1478\", \"Dose Order\": \"5\"}, {\"tsne_x\": -48.72357940673828, \"tsne_y\": -30.710573196411133, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1896\", \"Dose Order\": \"5\"}, {\"tsne_x\": -48.64994430541992, \"tsne_y\": -30.70654296875, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1897\", \"Dose Order\": \"5\"}, {\"tsne_x\": -49.51643371582031, \"tsne_y\": -30.65839195251465, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1898\", \"Dose Order\": \"5\"}, {\"tsne_x\": -49.156333923339844, \"tsne_y\": -30.645069122314453, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1899\", \"Dose Order\": \"5\"}, {\"tsne_x\": -48.619300842285156, \"tsne_y\": -32.57752990722656, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1936\", \"Dose Order\": \"5\"}, {\"tsne_x\": -48.13081359863281, \"tsne_y\": -32.60863494873047, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1937\", \"Dose Order\": \"5\"}, {\"tsne_x\": -48.06037521362305, \"tsne_y\": -32.366695404052734, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1938\", \"Dose Order\": \"5\"}, {\"tsne_x\": -48.31026840209961, \"tsne_y\": -31.90937614440918, \"Compound Group\": \"BDTX-189 (Covalent Inhibitor)\", \"label\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)|5|4\", \"compound\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"BDTX-189 (covalent EGFR/HER2 allosteric inhibitor)_5\", \"plate\": \"CPP1939\", \"Dose Order\": \"5\"}, {\"tsne_x\": -13.962520599365234, \"tsne_y\": -9.380208969116211, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1476\", \"Dose Order\": \"0\"}, {\"tsne_x\": -11.807198524475098, \"tsne_y\": -9.19469928741455, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1477\", \"Dose Order\": \"0\"}, {\"tsne_x\": -13.08254337310791, \"tsne_y\": -9.944551467895508, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1478\", \"Dose Order\": \"0\"}, {\"tsne_x\": -12.852628707885742, \"tsne_y\": -11.901747703552246, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1896\", \"Dose Order\": \"0\"}, {\"tsne_x\": -13.443426132202148, \"tsne_y\": -11.494791030883789, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1897\", \"Dose Order\": \"0\"}, {\"tsne_x\": -13.711116790771484, \"tsne_y\": -10.49112606048584, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1898\", \"Dose Order\": \"0\"}, {\"tsne_x\": -13.752668380737305, \"tsne_y\": -11.33438777923584, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1899\", \"Dose Order\": \"0\"}, {\"tsne_x\": -14.856231689453125, \"tsne_y\": -11.872650146484375, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1936\", \"Dose Order\": \"0\"}, {\"tsne_x\": -14.67929744720459, \"tsne_y\": -10.164644241333008, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1937\", \"Dose Order\": \"0\"}, {\"tsne_x\": -13.9107666015625, \"tsne_y\": -10.551955223083496, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1938\", \"Dose Order\": \"0\"}, {\"tsne_x\": -14.410991668701172, \"tsne_y\": -10.936332702636719, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1939\", \"Dose Order\": \"0\"}, {\"tsne_x\": -14.081485748291016, \"tsne_y\": -22.97942352294922, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1476\", \"Dose Order\": \"1\"}, {\"tsne_x\": -30.156192779541016, \"tsne_y\": -11.392630577087402, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1477\", \"Dose Order\": \"1\"}, {\"tsne_x\": -14.386214256286621, \"tsne_y\": -22.081533432006836, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1478\", \"Dose Order\": \"1\"}, {\"tsne_x\": -13.895033836364746, \"tsne_y\": -20.928020477294922, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1896\", \"Dose Order\": \"1\"}, {\"tsne_x\": -15.56963062286377, \"tsne_y\": -21.603960037231445, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1897\", \"Dose Order\": \"1\"}, {\"tsne_x\": -14.256150245666504, \"tsne_y\": -21.358274459838867, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1898\", \"Dose Order\": \"1\"}, {\"tsne_x\": -14.953896522521973, \"tsne_y\": -21.512632369995117, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1899\", \"Dose Order\": \"1\"}, {\"tsne_x\": -15.552796363830566, \"tsne_y\": -23.978504180908203, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1936\", \"Dose Order\": \"1\"}, {\"tsne_x\": -14.923480987548828, \"tsne_y\": -22.179155349731445, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1937\", \"Dose Order\": \"1\"}, {\"tsne_x\": -13.693387985229492, \"tsne_y\": -22.231101989746094, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1938\", \"Dose Order\": \"1\"}, {\"tsne_x\": -15.206783294677734, \"tsne_y\": -22.240924835205078, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1939\", \"Dose Order\": \"1\"}, {\"tsne_x\": -57.20467758178711, \"tsne_y\": -5.596280097961426, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1476\", \"Dose Order\": \"2\"}, {\"tsne_x\": -52.55168151855469, \"tsne_y\": -19.84552574157715, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1477\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.579349517822266, \"tsne_y\": -5.329240798950195, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1478\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.25653076171875, \"tsne_y\": -3.676999568939209, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1896\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.778446197509766, \"tsne_y\": -5.030794143676758, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1897\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.852622985839844, \"tsne_y\": -4.369197368621826, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1898\", \"Dose Order\": \"2\"}, {\"tsne_x\": -56.60238265991211, \"tsne_y\": -4.01286506652832, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1899\", \"Dose Order\": \"2\"}, {\"tsne_x\": -58.133453369140625, \"tsne_y\": -4.272024154663086, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1936\", \"Dose Order\": \"2\"}, {\"tsne_x\": -57.978118896484375, \"tsne_y\": -5.147635459899902, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1937\", \"Dose Order\": \"2\"}, {\"tsne_x\": -59.00951385498047, \"tsne_y\": -4.465054512023926, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1938\", \"Dose Order\": \"2\"}, {\"tsne_x\": -58.73786163330078, \"tsne_y\": -4.7296648025512695, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1939\", \"Dose Order\": \"2\"}, {\"tsne_x\": 56.303627014160156, \"tsne_y\": 6.879575252532959, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1476\", \"Dose Order\": \"3\"}, {\"tsne_x\": 56.97218322753906, \"tsne_y\": 5.756481647491455, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1477\", \"Dose Order\": \"3\"}, {\"tsne_x\": 56.61734390258789, \"tsne_y\": 6.43479061126709, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1478\", \"Dose Order\": \"3\"}, {\"tsne_x\": 53.578147888183594, \"tsne_y\": 8.04134464263916, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1896\", \"Dose Order\": \"3\"}, {\"tsne_x\": 54.066184997558594, \"tsne_y\": 8.187264442443848, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1897\", \"Dose Order\": \"3\"}, {\"tsne_x\": 54.14728927612305, \"tsne_y\": 8.308484077453613, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1898\", \"Dose Order\": \"3\"}, {\"tsne_x\": 54.132022857666016, \"tsne_y\": 8.21741008758545, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1899\", \"Dose Order\": \"3\"}, {\"tsne_x\": 54.743194580078125, \"tsne_y\": 9.690072059631348, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1936\", \"Dose Order\": \"3\"}, {\"tsne_x\": 55.29152297973633, \"tsne_y\": 9.668546676635742, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1937\", \"Dose Order\": \"3\"}, {\"tsne_x\": 55.40991973876953, \"tsne_y\": 10.007769584655762, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1938\", \"Dose Order\": \"3\"}, {\"tsne_x\": 55.62361526489258, \"tsne_y\": 9.624039649963379, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1939\", \"Dose Order\": \"3\"}, {\"tsne_x\": 65.67755126953125, \"tsne_y\": -9.736145973205566, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1476\", \"Dose Order\": \"4\"}, {\"tsne_x\": 63.344852447509766, \"tsne_y\": -9.647476196289062, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1477\", \"Dose Order\": \"4\"}, {\"tsne_x\": 64.89981079101562, \"tsne_y\": -9.96558666229248, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1478\", \"Dose Order\": \"4\"}, {\"tsne_x\": 67.53618621826172, \"tsne_y\": -9.878329277038574, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1896\", \"Dose Order\": \"4\"}, {\"tsne_x\": 67.60340118408203, \"tsne_y\": -9.23692512512207, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1897\", \"Dose Order\": \"4\"}, {\"tsne_x\": 67.52179718017578, \"tsne_y\": -9.206708908081055, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1898\", \"Dose Order\": \"4\"}, {\"tsne_x\": 67.29000091552734, \"tsne_y\": -9.407983779907227, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1899\", \"Dose Order\": \"4\"}, {\"tsne_x\": 69.24677276611328, \"tsne_y\": -8.787964820861816, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1936\", \"Dose Order\": \"4\"}, {\"tsne_x\": 69.03607940673828, \"tsne_y\": -8.088544845581055, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1937\", \"Dose Order\": \"4\"}, {\"tsne_x\": 68.96540069580078, \"tsne_y\": -8.00718879699707, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1938\", \"Dose Order\": \"4\"}, {\"tsne_x\": 69.3235092163086, \"tsne_y\": -8.394482612609863, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1939\", \"Dose Order\": \"4\"}, {\"tsne_x\": 63.31239700317383, \"tsne_y\": -12.968148231506348, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1476\", \"Dose Order\": \"5\"}, {\"tsne_x\": 62.971309661865234, \"tsne_y\": -10.945266723632812, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1477\", \"Dose Order\": \"5\"}, {\"tsne_x\": 63.85879898071289, \"tsne_y\": -11.363043785095215, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1478\", \"Dose Order\": \"5\"}, {\"tsne_x\": 66.19672393798828, \"tsne_y\": -14.290325164794922, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1896\", \"Dose Order\": \"5\"}, {\"tsne_x\": 66.01953125, \"tsne_y\": -14.84009075164795, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1897\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.922119140625, \"tsne_y\": -14.547815322875977, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1898\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.94078063964844, \"tsne_y\": -14.674111366271973, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1899\", \"Dose Order\": \"5\"}, {\"tsne_x\": 67.35759735107422, \"tsne_y\": -15.757733345031738, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1936\", \"Dose Order\": \"5\"}, {\"tsne_x\": 66.5895004272461, \"tsne_y\": -16.471887588500977, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1937\", \"Dose Order\": \"5\"}, {\"tsne_x\": 66.72786712646484, \"tsne_y\": -16.442968368530273, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1938\", \"Dose Order\": \"5\"}, {\"tsne_x\": 67.05783081054688, \"tsne_y\": -16.500446319580078, \"Compound Group\": \"Active Degraders\", \"label\": \"C4T VHL-based active HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based active HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"C4T VHL-based active HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1939\", \"Dose Order\": \"5\"}, {\"tsne_x\": -2.1508610248565674, \"tsne_y\": -4.383923053741455, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1476\", \"Dose Order\": \"0\"}, {\"tsne_x\": 15.385099411010742, \"tsne_y\": -9.26358699798584, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1477\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.089411497116089, \"tsne_y\": -4.265368938446045, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1478\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.391847610473633, \"tsne_y\": -4.259666919708252, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1896\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.8343095779418945, \"tsne_y\": -4.451408386230469, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1897\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.5240604877471924, \"tsne_y\": -3.7776546478271484, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1898\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.7592713832855225, \"tsne_y\": -3.7537660598754883, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1899\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.8569517135620117, \"tsne_y\": -2.2175986766815186, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1936\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.7685980796813965, \"tsne_y\": -2.2325079441070557, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1937\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.218748092651367, \"tsne_y\": -2.943925619125366, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1938\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.3983712196350098, \"tsne_y\": -3.1993911266326904, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|0|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_0\", \"plate\": \"CPP1939\", \"Dose Order\": \"0\"}, {\"tsne_x\": 7.609994888305664, \"tsne_y\": -10.129586219787598, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1476\", \"Dose Order\": \"1\"}, {\"tsne_x\": 5.635806083679199, \"tsne_y\": -11.50045108795166, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1477\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.845100402832031, \"tsne_y\": -9.793737411499023, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1478\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.376001834869385, \"tsne_y\": -8.700166702270508, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1896\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.37169075012207, \"tsne_y\": -8.807730674743652, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1897\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.591734409332275, \"tsne_y\": -9.165213584899902, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1898\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.438294887542725, \"tsne_y\": -8.966045379638672, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1899\", \"Dose Order\": \"1\"}, {\"tsne_x\": 5.805256366729736, \"tsne_y\": -8.207243919372559, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1936\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.95182466506958, \"tsne_y\": -7.594894886016846, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1937\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.837520122528076, \"tsne_y\": -7.729925632476807, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1938\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.631823539733887, \"tsne_y\": -8.145340919494629, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|1|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_1\", \"plate\": \"CPP1939\", \"Dose Order\": \"1\"}, {\"tsne_x\": 19.060726165771484, \"tsne_y\": -13.359811782836914, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1476\", \"Dose Order\": \"2\"}, {\"tsne_x\": 16.224090576171875, \"tsne_y\": -8.88483715057373, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1477\", \"Dose Order\": \"2\"}, {\"tsne_x\": 19.679616928100586, \"tsne_y\": -14.018072128295898, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1478\", \"Dose Order\": \"2\"}, {\"tsne_x\": 19.433303833007812, \"tsne_y\": -14.364795684814453, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1896\", \"Dose Order\": \"2\"}, {\"tsne_x\": 20.500141143798828, \"tsne_y\": -13.942214012145996, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1897\", \"Dose Order\": \"2\"}, {\"tsne_x\": 19.71577262878418, \"tsne_y\": -14.663640975952148, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1898\", \"Dose Order\": \"2\"}, {\"tsne_x\": 19.89386558532715, \"tsne_y\": -14.998091697692871, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1899\", \"Dose Order\": \"2\"}, {\"tsne_x\": 19.474943161010742, \"tsne_y\": -16.34296989440918, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1936\", \"Dose Order\": \"2\"}, {\"tsne_x\": 18.908002853393555, \"tsne_y\": -15.136528015136719, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1937\", \"Dose Order\": \"2\"}, {\"tsne_x\": 18.761531829833984, \"tsne_y\": -14.455414772033691, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1938\", \"Dose Order\": \"2\"}, {\"tsne_x\": 18.76476287841797, \"tsne_y\": -15.62336540222168, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|2|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_2\", \"plate\": \"CPP1939\", \"Dose Order\": \"2\"}, {\"tsne_x\": 16.05582046508789, \"tsne_y\": -1.3917373418807983, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1476\", \"Dose Order\": \"3\"}, {\"tsne_x\": 17.076963424682617, \"tsne_y\": -6.743765830993652, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1477\", \"Dose Order\": \"3\"}, {\"tsne_x\": 16.881500244140625, \"tsne_y\": -1.1584757566452026, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1478\", \"Dose Order\": \"3\"}, {\"tsne_x\": 18.173858642578125, \"tsne_y\": -1.6210598945617676, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1896\", \"Dose Order\": \"3\"}, {\"tsne_x\": 17.108970642089844, \"tsne_y\": -1.2438218593597412, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1897\", \"Dose Order\": \"3\"}, {\"tsne_x\": 17.755470275878906, \"tsne_y\": -1.3937879800796509, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1898\", \"Dose Order\": \"3\"}, {\"tsne_x\": 17.447580337524414, \"tsne_y\": -1.0010217428207397, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1899\", \"Dose Order\": \"3\"}, {\"tsne_x\": 16.657718658447266, \"tsne_y\": 0.12736180424690247, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1936\", \"Dose Order\": \"3\"}, {\"tsne_x\": 17.78122901916504, \"tsne_y\": -0.30573105812072754, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1937\", \"Dose Order\": \"3\"}, {\"tsne_x\": 18.310394287109375, \"tsne_y\": -0.6778638958930969, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1938\", \"Dose Order\": \"3\"}, {\"tsne_x\": 18.329057693481445, \"tsne_y\": 0.6258831024169922, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|3|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_3\", \"plate\": \"CPP1939\", \"Dose Order\": \"3\"}, {\"tsne_x\": 24.84487533569336, \"tsne_y\": -5.181253910064697, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1476\", \"Dose Order\": \"4\"}, {\"tsne_x\": 17.179040908813477, \"tsne_y\": -7.596224784851074, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1477\", \"Dose Order\": \"4\"}, {\"tsne_x\": 24.38227653503418, \"tsne_y\": -5.276459217071533, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1478\", \"Dose Order\": \"4\"}, {\"tsne_x\": 25.59699249267578, \"tsne_y\": -4.345633029937744, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1896\", \"Dose Order\": \"4\"}, {\"tsne_x\": 25.844079971313477, \"tsne_y\": -4.415019512176514, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1897\", \"Dose Order\": \"4\"}, {\"tsne_x\": 26.17388343811035, \"tsne_y\": -4.859370231628418, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1898\", \"Dose Order\": \"4\"}, {\"tsne_x\": 25.4578857421875, \"tsne_y\": -4.900466442108154, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1899\", \"Dose Order\": \"4\"}, {\"tsne_x\": 26.789363861083984, \"tsne_y\": -3.1509816646575928, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1936\", \"Dose Order\": \"4\"}, {\"tsne_x\": 27.11261749267578, \"tsne_y\": -3.0268657207489014, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1937\", \"Dose Order\": \"4\"}, {\"tsne_x\": 27.381792068481445, \"tsne_y\": -3.8424108028411865, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1938\", \"Dose Order\": \"4\"}, {\"tsne_x\": 26.666818618774414, \"tsne_y\": -3.411780595779419, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|4|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_4\", \"plate\": \"CPP1939\", \"Dose Order\": \"4\"}, {\"tsne_x\": 25.768695831298828, \"tsne_y\": -7.169040679931641, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1476\", \"Dose Order\": \"5\"}, {\"tsne_x\": 17.36685562133789, \"tsne_y\": -7.848135471343994, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1477\", \"Dose Order\": \"5\"}, {\"tsne_x\": 25.62412452697754, \"tsne_y\": -7.165071487426758, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1478\", \"Dose Order\": \"5\"}, {\"tsne_x\": 29.388513565063477, \"tsne_y\": -7.105267524719238, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1896\", \"Dose Order\": \"5\"}, {\"tsne_x\": 28.818166732788086, \"tsne_y\": -6.892111778259277, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1897\", \"Dose Order\": \"5\"}, {\"tsne_x\": 28.84339141845703, \"tsne_y\": -7.012757778167725, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1898\", \"Dose Order\": \"5\"}, {\"tsne_x\": 29.080904006958008, \"tsne_y\": -7.07127571105957, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1899\", \"Dose Order\": \"5\"}, {\"tsne_x\": 30.930158615112305, \"tsne_y\": -5.212163925170898, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1936\", \"Dose Order\": \"5\"}, {\"tsne_x\": 30.85478973388672, \"tsne_y\": -5.131411075592041, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1937\", \"Dose Order\": \"5\"}, {\"tsne_x\": 30.656864166259766, \"tsne_y\": -5.095675468444824, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1938\", \"Dose Order\": \"5\"}, {\"tsne_x\": 30.589344024658203, \"tsne_y\": -4.247279167175293, \"Compound Group\": \"Inactive Degraders\", \"label\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)|5|4\", \"compound\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"C4T VHL-based inactive HER2-degrader (Tucatinib based)_5\", \"plate\": \"CPP1939\", \"Dose Order\": \"5\"}, {\"tsne_x\": -41.423973083496094, \"tsne_y\": -3.3698596954345703, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1476\", \"Dose Order\": \"0\"}, {\"tsne_x\": -30.28171730041504, \"tsne_y\": -11.316690444946289, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1477\", \"Dose Order\": \"0\"}, {\"tsne_x\": -41.89570999145508, \"tsne_y\": -2.835219383239746, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1478\", \"Dose Order\": \"0\"}, {\"tsne_x\": -42.97737503051758, \"tsne_y\": -2.8263533115386963, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1896\", \"Dose Order\": \"0\"}, {\"tsne_x\": -42.954837799072266, \"tsne_y\": -2.9741580486297607, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1897\", \"Dose Order\": \"0\"}, {\"tsne_x\": -42.41263961791992, \"tsne_y\": -2.2999541759490967, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1898\", \"Dose Order\": \"0\"}, {\"tsne_x\": -42.74057388305664, \"tsne_y\": -2.3145663738250732, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1899\", \"Dose Order\": \"0\"}, {\"tsne_x\": -42.56106948852539, \"tsne_y\": -0.7598152756690979, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1936\", \"Dose Order\": \"0\"}, {\"tsne_x\": -41.516265869140625, \"tsne_y\": -2.363710403442383, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1937\", \"Dose Order\": \"0\"}, {\"tsne_x\": -41.20084762573242, \"tsne_y\": -2.0356245040893555, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1938\", \"Dose Order\": \"0\"}, {\"tsne_x\": -41.95689392089844, \"tsne_y\": -1.4157273769378662, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1939\", \"Dose Order\": \"0\"}, {\"tsne_x\": -51.618045806884766, \"tsne_y\": -12.472960472106934, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1476\", \"Dose Order\": \"1\"}, {\"tsne_x\": -52.050533294677734, \"tsne_y\": -21.113269805908203, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1477\", \"Dose Order\": \"1\"}, {\"tsne_x\": -51.59297561645508, \"tsne_y\": -11.93824291229248, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1478\", \"Dose Order\": \"1\"}, {\"tsne_x\": -53.04536819458008, \"tsne_y\": -12.807723045349121, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1896\", \"Dose Order\": \"1\"}, {\"tsne_x\": -52.635581970214844, \"tsne_y\": -11.526409149169922, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1897\", \"Dose Order\": \"1\"}, {\"tsne_x\": -53.10200500488281, \"tsne_y\": -11.759587287902832, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1898\", \"Dose Order\": \"1\"}, {\"tsne_x\": -53.00423049926758, \"tsne_y\": -11.727361679077148, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1899\", \"Dose Order\": \"1\"}, {\"tsne_x\": -50.3931770324707, \"tsne_y\": -9.895100593566895, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1936\", \"Dose Order\": \"1\"}, {\"tsne_x\": -50.7766227722168, \"tsne_y\": -10.055761337280273, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1937\", \"Dose Order\": \"1\"}, {\"tsne_x\": -51.608543395996094, \"tsne_y\": -10.546340942382812, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1938\", \"Dose Order\": \"1\"}, {\"tsne_x\": -51.17572784423828, \"tsne_y\": -11.41001033782959, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1939\", \"Dose Order\": \"1\"}, {\"tsne_x\": 58.896453857421875, \"tsne_y\": 0.8809893727302551, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1476\", \"Dose Order\": \"2\"}, {\"tsne_x\": 60.91657638549805, \"tsne_y\": -0.24164694547653198, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1477\", \"Dose Order\": \"2\"}, {\"tsne_x\": 59.57651138305664, \"tsne_y\": 1.8322854042053223, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1478\", \"Dose Order\": \"2\"}, {\"tsne_x\": 56.32666778564453, \"tsne_y\": 2.75895619392395, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1896\", \"Dose Order\": \"2\"}, {\"tsne_x\": 56.48213577270508, \"tsne_y\": 1.801755666732788, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1897\", \"Dose Order\": \"2\"}, {\"tsne_x\": 56.543338775634766, \"tsne_y\": 2.031496286392212, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1898\", \"Dose Order\": \"2\"}, {\"tsne_x\": 56.51797103881836, \"tsne_y\": 2.3769168853759766, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1899\", \"Dose Order\": \"2\"}, {\"tsne_x\": 54.65948486328125, \"tsne_y\": 0.19838939607143402, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1936\", \"Dose Order\": \"2\"}, {\"tsne_x\": 54.063499450683594, \"tsne_y\": -0.6721324920654297, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1937\", \"Dose Order\": \"2\"}, {\"tsne_x\": 54.279911041259766, \"tsne_y\": -0.5421314835548401, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1938\", \"Dose Order\": \"2\"}, {\"tsne_x\": 54.171207427978516, \"tsne_y\": -0.5223965048789978, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1939\", \"Dose Order\": \"2\"}, {\"tsne_x\": 58.972782135009766, \"tsne_y\": 0.5804803967475891, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1476\", \"Dose Order\": \"3\"}, {\"tsne_x\": 61.614837646484375, \"tsne_y\": -0.6264906525611877, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1477\", \"Dose Order\": \"3\"}, {\"tsne_x\": 63.542476654052734, \"tsne_y\": -1.9067960977554321, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1478\", \"Dose Order\": \"3\"}, {\"tsne_x\": 66.45275115966797, \"tsne_y\": -2.8791728019714355, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1896\", \"Dose Order\": \"3\"}, {\"tsne_x\": 66.35420989990234, \"tsne_y\": -3.016976833343506, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1897\", \"Dose Order\": \"3\"}, {\"tsne_x\": 66.20661926269531, \"tsne_y\": -3.2075424194335938, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1898\", \"Dose Order\": \"3\"}, {\"tsne_x\": 66.45901489257812, \"tsne_y\": -2.944993019104004, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1899\", \"Dose Order\": \"3\"}, {\"tsne_x\": 68.79560089111328, \"tsne_y\": -3.49816632270813, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1936\", \"Dose Order\": \"3\"}, {\"tsne_x\": 68.8443832397461, \"tsne_y\": -4.352242946624756, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1937\", \"Dose Order\": \"3\"}, {\"tsne_x\": 68.82506561279297, \"tsne_y\": -4.1903228759765625, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1938\", \"Dose Order\": \"3\"}, {\"tsne_x\": 68.73590087890625, \"tsne_y\": -4.117663860321045, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1939\", \"Dose Order\": \"3\"}, {\"tsne_x\": 62.51207733154297, \"tsne_y\": -12.941449165344238, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1476\", \"Dose Order\": \"4\"}, {\"tsne_x\": 62.342079162597656, \"tsne_y\": -11.267683982849121, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1477\", \"Dose Order\": \"4\"}, {\"tsne_x\": 62.29950714111328, \"tsne_y\": -12.00556755065918, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1478\", \"Dose Order\": \"4\"}, {\"tsne_x\": 59.454925537109375, \"tsne_y\": -14.576515197753906, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1896\", \"Dose Order\": \"4\"}, {\"tsne_x\": 59.42644500732422, \"tsne_y\": -14.848551750183105, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1897\", \"Dose Order\": \"4\"}, {\"tsne_x\": 58.98751449584961, \"tsne_y\": -14.700014114379883, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1898\", \"Dose Order\": \"4\"}, {\"tsne_x\": 59.47112274169922, \"tsne_y\": -14.649911880493164, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1899\", \"Dose Order\": \"4\"}, {\"tsne_x\": 59.31593322753906, \"tsne_y\": -16.962961196899414, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1936\", \"Dose Order\": \"4\"}, {\"tsne_x\": 58.562889099121094, \"tsne_y\": -16.56338119506836, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1937\", \"Dose Order\": \"4\"}, {\"tsne_x\": 58.38436508178711, \"tsne_y\": -16.769914627075195, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1938\", \"Dose Order\": \"4\"}, {\"tsne_x\": 58.747169494628906, \"tsne_y\": -16.703588485717773, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1939\", \"Dose Order\": \"4\"}, {\"tsne_x\": 55.00159454345703, \"tsne_y\": -18.85930824279785, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1476\", \"Dose Order\": \"5\"}, {\"tsne_x\": 54.88352584838867, \"tsne_y\": -18.887624740600586, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1477\", \"Dose Order\": \"5\"}, {\"tsne_x\": 53.085140228271484, \"tsne_y\": -19.686851501464844, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1478\", \"Dose Order\": \"5\"}, {\"tsne_x\": 52.54216384887695, \"tsne_y\": -21.53989028930664, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1896\", \"Dose Order\": \"5\"}, {\"tsne_x\": 52.334476470947266, \"tsne_y\": -21.407190322875977, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1897\", \"Dose Order\": \"5\"}, {\"tsne_x\": 53.38551712036133, \"tsne_y\": -21.120607376098633, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1898\", \"Dose Order\": \"5\"}, {\"tsne_x\": 53.720462799072266, \"tsne_y\": -21.019882202148438, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1899\", \"Dose Order\": \"5\"}, {\"tsne_x\": 51.06663513183594, \"tsne_y\": -22.168363571166992, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1936\", \"Dose Order\": \"5\"}, {\"tsne_x\": 52.77729797363281, \"tsne_y\": -20.5361385345459, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1937\", \"Dose Order\": \"5\"}, {\"tsne_x\": 56.438655853271484, \"tsne_y\": -18.059446334838867, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1938\", \"Dose Order\": \"5\"}, {\"tsne_x\": 53.381874084472656, \"tsne_y\": -20.349472045898438, \"Compound Group\": \"Active Degraders\", \"label\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"active_degraders\", \"compound_dose\": \"Crews Acvite HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1939\", \"Dose Order\": \"5\"}, {\"tsne_x\": 1.3490548133850098, \"tsne_y\": -15.677206039428711, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1476\", \"Dose Order\": \"0\"}, {\"tsne_x\": 4.905964374542236, \"tsne_y\": -12.449601173400879, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1477\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.8177913427352905, \"tsne_y\": -16.123592376708984, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1478\", \"Dose Order\": \"0\"}, {\"tsne_x\": 2.0920913219451904, \"tsne_y\": -15.932038307189941, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1896\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.704272747039795, \"tsne_y\": -15.447977066040039, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1897\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.2936144471168518, \"tsne_y\": -15.830780982971191, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1898\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.6249721050262451, \"tsne_y\": -16.746784210205078, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1899\", \"Dose Order\": \"0\"}, {\"tsne_x\": -0.3861982226371765, \"tsne_y\": -17.478601455688477, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1936\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.6561563014984131, \"tsne_y\": -16.54039764404297, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1937\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.05028193071484566, \"tsne_y\": -15.825127601623535, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1938\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.0906187295913696, \"tsne_y\": -17.3060302734375, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|0|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_0\", \"plate\": \"CPP1939\", \"Dose Order\": \"0\"}, {\"tsne_x\": 10.82738971710205, \"tsne_y\": -23.932931900024414, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1476\", \"Dose Order\": \"1\"}, {\"tsne_x\": 23.134628295898438, \"tsne_y\": -23.928083419799805, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1477\", \"Dose Order\": \"1\"}, {\"tsne_x\": 11.375515937805176, \"tsne_y\": -25.03385353088379, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1478\", \"Dose Order\": \"1\"}, {\"tsne_x\": 10.167288780212402, \"tsne_y\": -22.948108673095703, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1896\", \"Dose Order\": \"1\"}, {\"tsne_x\": 9.838160514831543, \"tsne_y\": -23.026350021362305, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1897\", \"Dose Order\": \"1\"}, {\"tsne_x\": 9.991978645324707, \"tsne_y\": -23.683910369873047, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1898\", \"Dose Order\": \"1\"}, {\"tsne_x\": 9.751553535461426, \"tsne_y\": -24.369802474975586, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1899\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.98098087310791, \"tsne_y\": -23.397743225097656, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1936\", \"Dose Order\": \"1\"}, {\"tsne_x\": 10.828039169311523, \"tsne_y\": -23.985584259033203, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1937\", \"Dose Order\": \"1\"}, {\"tsne_x\": 11.025397300720215, \"tsne_y\": -22.10276222229004, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1938\", \"Dose Order\": \"1\"}, {\"tsne_x\": 10.940789222717285, \"tsne_y\": -22.827388763427734, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|1|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_1\", \"plate\": \"CPP1939\", \"Dose Order\": \"1\"}, {\"tsne_x\": 25.452083587646484, \"tsne_y\": -25.249767303466797, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1476\", \"Dose Order\": \"2\"}, {\"tsne_x\": 23.940643310546875, \"tsne_y\": -24.374221801757812, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1477\", \"Dose Order\": \"2\"}, {\"tsne_x\": 25.465373992919922, \"tsne_y\": -25.213010787963867, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1478\", \"Dose Order\": \"2\"}, {\"tsne_x\": 25.852331161499023, \"tsne_y\": -26.70045280456543, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1896\", \"Dose Order\": \"2\"}, {\"tsne_x\": 25.30575942993164, \"tsne_y\": -26.26345443725586, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1897\", \"Dose Order\": \"2\"}, {\"tsne_x\": 26.110309600830078, \"tsne_y\": -26.76656723022461, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1898\", \"Dose Order\": \"2\"}, {\"tsne_x\": 25.79264259338379, \"tsne_y\": -26.624786376953125, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1899\", \"Dose Order\": \"2\"}, {\"tsne_x\": 27.42125129699707, \"tsne_y\": -27.194965362548828, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1936\", \"Dose Order\": \"2\"}, {\"tsne_x\": 26.73584747314453, \"tsne_y\": -25.534212112426758, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1937\", \"Dose Order\": \"2\"}, {\"tsne_x\": 27.041898727416992, \"tsne_y\": -26.3405704498291, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1938\", \"Dose Order\": \"2\"}, {\"tsne_x\": 26.902692794799805, \"tsne_y\": -27.007877349853516, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|2|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_2\", \"plate\": \"CPP1939\", \"Dose Order\": \"2\"}, {\"tsne_x\": 33.10989761352539, \"tsne_y\": -25.069477081298828, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1476\", \"Dose Order\": \"3\"}, {\"tsne_x\": 36.395503997802734, \"tsne_y\": -24.59560775756836, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1477\", \"Dose Order\": \"3\"}, {\"tsne_x\": 33.46731185913086, \"tsne_y\": -25.514808654785156, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1478\", \"Dose Order\": \"3\"}, {\"tsne_x\": 34.62460708618164, \"tsne_y\": -26.41514015197754, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1896\", \"Dose Order\": \"3\"}, {\"tsne_x\": 34.639774322509766, \"tsne_y\": -25.84483528137207, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1897\", \"Dose Order\": \"3\"}, {\"tsne_x\": 34.585872650146484, \"tsne_y\": -26.448352813720703, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1898\", \"Dose Order\": \"3\"}, {\"tsne_x\": 35.191654205322266, \"tsne_y\": -26.57704734802246, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1899\", \"Dose Order\": \"3\"}, {\"tsne_x\": 34.71730422973633, \"tsne_y\": -27.51011848449707, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1936\", \"Dose Order\": \"3\"}, {\"tsne_x\": 33.63057327270508, \"tsne_y\": -26.03961181640625, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1937\", \"Dose Order\": \"3\"}, {\"tsne_x\": 33.58039093017578, \"tsne_y\": -27.29132080078125, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1938\", \"Dose Order\": \"3\"}, {\"tsne_x\": 33.253414154052734, \"tsne_y\": -27.315990447998047, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|3|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_3\", \"plate\": \"CPP1939\", \"Dose Order\": \"3\"}, {\"tsne_x\": 38.47038650512695, \"tsne_y\": -23.911020278930664, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1476\", \"Dose Order\": \"4\"}, {\"tsne_x\": 37.67416000366211, \"tsne_y\": -24.190998077392578, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1477\", \"Dose Order\": \"4\"}, {\"tsne_x\": 38.42721176147461, \"tsne_y\": -23.93582534790039, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1478\", \"Dose Order\": \"4\"}, {\"tsne_x\": 50.22733688354492, \"tsne_y\": -26.00263023376465, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1896\", \"Dose Order\": \"4\"}, {\"tsne_x\": 50.157901763916016, \"tsne_y\": -25.881757736206055, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1897\", \"Dose Order\": \"4\"}, {\"tsne_x\": 49.996795654296875, \"tsne_y\": -25.66101837158203, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1898\", \"Dose Order\": \"4\"}, {\"tsne_x\": 49.933692932128906, \"tsne_y\": -25.550790786743164, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1899\", \"Dose Order\": \"4\"}, {\"tsne_x\": 40.587074279785156, \"tsne_y\": -24.41950035095215, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1936\", \"Dose Order\": \"4\"}, {\"tsne_x\": 41.08219528198242, \"tsne_y\": -24.656604766845703, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1937\", \"Dose Order\": \"4\"}, {\"tsne_x\": 40.64851760864258, \"tsne_y\": -24.196996688842773, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1938\", \"Dose Order\": \"4\"}, {\"tsne_x\": 41.14033126831055, \"tsne_y\": -24.74748420715332, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|4|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_4\", \"plate\": \"CPP1939\", \"Dose Order\": \"4\"}, {\"tsne_x\": 46.56599807739258, \"tsne_y\": -22.89844512939453, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1476\", \"Dose Order\": \"5\"}, {\"tsne_x\": 45.75990295410156, \"tsne_y\": -22.850019454956055, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1477\", \"Dose Order\": \"5\"}, {\"tsne_x\": 45.63205337524414, \"tsne_y\": -22.928579330444336, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1478\", \"Dose Order\": \"5\"}, {\"tsne_x\": 51.784061431884766, \"tsne_y\": -28.60835838317871, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1896\", \"Dose Order\": \"5\"}, {\"tsne_x\": 51.49253845214844, \"tsne_y\": -28.115720748901367, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1897\", \"Dose Order\": \"5\"}, {\"tsne_x\": 51.43733596801758, \"tsne_y\": -28.022899627685547, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1898\", \"Dose Order\": \"5\"}, {\"tsne_x\": 51.11319351196289, \"tsne_y\": -27.48294448852539, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1899\", \"Dose Order\": \"5\"}, {\"tsne_x\": 46.48036193847656, \"tsne_y\": -23.234189987182617, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1936\", \"Dose Order\": \"5\"}, {\"tsne_x\": 47.13777160644531, \"tsne_y\": -23.22958755493164, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1937\", \"Dose Order\": \"5\"}, {\"tsne_x\": 41.597843170166016, \"tsne_y\": -23.919296264648438, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1938\", \"Dose Order\": \"5\"}, {\"tsne_x\": 47.89559555053711, \"tsne_y\": -23.29817771911621, \"Compound Group\": \"Inactive Degraders\", \"label\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)|5|4\", \"compound\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"inactive_degraders\", \"compound_dose\": \"Crews inactive HER2/EGFR degrader (Lapatinib based)_5\", \"plate\": \"CPP1939\", \"Dose Order\": \"5\"}, {\"tsne_x\": -5.450206756591797, \"tsne_y\": -11.56082534790039, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|4\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1476\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.898311138153076, \"tsne_y\": -11.437285423278809, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|4\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1477\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.151488780975342, \"tsne_y\": -12.297866821289062, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|4\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1478\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.362693786621094, \"tsne_y\": -12.8636474609375, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|4\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1896\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.922220706939697, \"tsne_y\": -13.192606925964355, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|4\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1897\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.892573356628418, \"tsne_y\": -12.13835620880127, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|4\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1898\", \"Dose Order\": \"0\"}, {\"tsne_x\": -5.784446716308594, \"tsne_y\": -11.979077339172363, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|4\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1899\", \"Dose Order\": \"0\"}, {\"tsne_x\": -5.838831424713135, \"tsne_y\": -12.498528480529785, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|4\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1936\", \"Dose Order\": \"0\"}, {\"tsne_x\": -4.341156959533691, \"tsne_y\": -11.682666778564453, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|4\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1937\", \"Dose Order\": \"0\"}, {\"tsne_x\": -5.047900199890137, \"tsne_y\": -12.524977684020996, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|4\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1938\", \"Dose Order\": \"0\"}, {\"tsne_x\": -5.542715549468994, \"tsne_y\": -13.00802230834961, \"Compound Group\": \"DMSO\", \"label\": \"DMSO|0|4\", \"compound\": \"DMSO\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"DMSO\", \"compound_dose\": \"DMSO_0\", \"plate\": \"CPP1939\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.6096620559692383, \"tsne_y\": -39.96284103393555, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|4\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1476\", \"Dose Order\": \"0\"}, {\"tsne_x\": -9.183902740478516, \"tsne_y\": -67.71814727783203, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|4\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1477\", \"Dose Order\": \"0\"}, {\"tsne_x\": -3.081609010696411, \"tsne_y\": -38.9310302734375, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|4\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1478\", \"Dose Order\": \"0\"}, {\"tsne_x\": -1.8775174617767334, \"tsne_y\": -40.929046630859375, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|4\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1896\", \"Dose Order\": \"0\"}, {\"tsne_x\": -2.078246831893921, \"tsne_y\": -40.01841735839844, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|4\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1897\", \"Dose Order\": \"0\"}, {\"tsne_x\": -1.5791648626327515, \"tsne_y\": -40.306758880615234, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|4\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1898\", \"Dose Order\": \"0\"}, {\"tsne_x\": -1.3231734037399292, \"tsne_y\": -39.72270965576172, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|4\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1899\", \"Dose Order\": \"0\"}, {\"tsne_x\": -1.5118482112884521, \"tsne_y\": -39.019187927246094, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|4\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1936\", \"Dose Order\": \"0\"}, {\"tsne_x\": -0.5161502957344055, \"tsne_y\": -40.00027084350586, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|4\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1937\", \"Dose Order\": \"0\"}, {\"tsne_x\": -0.8181671500205994, \"tsne_y\": -40.47746658325195, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|4\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1938\", \"Dose Order\": \"0\"}, {\"tsne_x\": 0.0409574881196022, \"tsne_y\": -39.68379211425781, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|0|4\", \"compound\": \"Herceptin\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_0\", \"plate\": \"CPP1939\", \"Dose Order\": \"0\"}, {\"tsne_x\": 7.351721286773682, \"tsne_y\": -43.74529266357422, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|4\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1476\", \"Dose Order\": \"1\"}, {\"tsne_x\": -7.550446510314941, \"tsne_y\": -65.9913330078125, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|4\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1477\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.281637191772461, \"tsne_y\": -43.7581901550293, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|4\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1478\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.382096767425537, \"tsne_y\": -43.31715393066406, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|4\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1896\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.404282569885254, \"tsne_y\": -42.771934509277344, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|4\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1897\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.5733747482299805, \"tsne_y\": -44.19408416748047, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|4\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1898\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.948823928833008, \"tsne_y\": -42.923606872558594, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|4\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1899\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.428843975067139, \"tsne_y\": -41.738529205322266, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|4\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1936\", \"Dose Order\": \"1\"}, {\"tsne_x\": 8.231975555419922, \"tsne_y\": -43.24989318847656, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|4\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1937\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.906274318695068, \"tsne_y\": -44.35630416870117, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|4\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1938\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.956357479095459, \"tsne_y\": -42.703155517578125, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|1|4\", \"compound\": \"Herceptin\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_1\", \"plate\": \"CPP1939\", \"Dose Order\": \"1\"}, {\"tsne_x\": -14.794084548950195, \"tsne_y\": -53.66728210449219, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|4\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1476\", \"Dose Order\": \"2\"}, {\"tsne_x\": -9.448258399963379, \"tsne_y\": -66.80411529541016, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|4\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1477\", \"Dose Order\": \"2\"}, {\"tsne_x\": -7.3032546043396, \"tsne_y\": -46.29131317138672, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|4\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1478\", \"Dose Order\": \"2\"}, {\"tsne_x\": -6.631545543670654, \"tsne_y\": -46.165924072265625, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|4\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1896\", \"Dose Order\": \"2\"}, {\"tsne_x\": -6.386447906494141, \"tsne_y\": -45.38712692260742, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|4\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1897\", \"Dose Order\": \"2\"}, {\"tsne_x\": -6.971599578857422, \"tsne_y\": -45.65546798706055, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|4\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1898\", \"Dose Order\": \"2\"}, {\"tsne_x\": -6.994585037231445, \"tsne_y\": -45.50874328613281, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|4\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1899\", \"Dose Order\": \"2\"}, {\"tsne_x\": -8.311087608337402, \"tsne_y\": -44.836307525634766, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|4\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1936\", \"Dose Order\": \"2\"}, {\"tsne_x\": -8.578105926513672, \"tsne_y\": -46.29795455932617, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|4\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1937\", \"Dose Order\": \"2\"}, {\"tsne_x\": -6.540858268737793, \"tsne_y\": -44.512115478515625, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|4\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1938\", \"Dose Order\": \"2\"}, {\"tsne_x\": -7.692489147186279, \"tsne_y\": -44.97798538208008, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|2|4\", \"compound\": \"Herceptin\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_2\", \"plate\": \"CPP1939\", \"Dose Order\": \"2\"}, {\"tsne_x\": -18.830801010131836, \"tsne_y\": -73.79402923583984, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|4\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1476\", \"Dose Order\": \"3\"}, {\"tsne_x\": -10.11638069152832, \"tsne_y\": -71.73644256591797, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|4\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1477\", \"Dose Order\": \"3\"}, {\"tsne_x\": -18.627656936645508, \"tsne_y\": -73.6011734008789, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|4\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1478\", \"Dose Order\": \"3\"}, {\"tsne_x\": -17.6632080078125, \"tsne_y\": -73.53118896484375, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|4\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1896\", \"Dose Order\": \"3\"}, {\"tsne_x\": -18.8398494720459, \"tsne_y\": -72.15386199951172, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|4\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1897\", \"Dose Order\": \"3\"}, {\"tsne_x\": -18.00470733642578, \"tsne_y\": -72.43362426757812, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|4\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1898\", \"Dose Order\": \"3\"}, {\"tsne_x\": -18.064422607421875, \"tsne_y\": -72.43978881835938, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|4\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1899\", \"Dose Order\": \"3\"}, {\"tsne_x\": -22.855037689208984, \"tsne_y\": -76.01165008544922, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|4\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1936\", \"Dose Order\": \"3\"}, {\"tsne_x\": -20.564104080200195, \"tsne_y\": -74.55701446533203, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|4\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1937\", \"Dose Order\": \"3\"}, {\"tsne_x\": -23.081796646118164, \"tsne_y\": -76.5437240600586, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|4\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1938\", \"Dose Order\": \"3\"}, {\"tsne_x\": -22.735225677490234, \"tsne_y\": -75.79817199707031, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|3|4\", \"compound\": \"Herceptin\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_3\", \"plate\": \"CPP1939\", \"Dose Order\": \"3\"}, {\"tsne_x\": -24.587514877319336, \"tsne_y\": -69.58808898925781, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|4\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1476\", \"Dose Order\": \"4\"}, {\"tsne_x\": -10.140342712402344, \"tsne_y\": -72.02803802490234, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|4\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1477\", \"Dose Order\": \"4\"}, {\"tsne_x\": -24.19515609741211, \"tsne_y\": -69.43374633789062, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|4\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1478\", \"Dose Order\": \"4\"}, {\"tsne_x\": -23.301027297973633, \"tsne_y\": -70.0621337890625, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|4\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1896\", \"Dose Order\": \"4\"}, {\"tsne_x\": -23.72150421142578, \"tsne_y\": -70.22640228271484, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|4\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1897\", \"Dose Order\": \"4\"}, {\"tsne_x\": -23.316242218017578, \"tsne_y\": -70.46520233154297, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|4\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1898\", \"Dose Order\": \"4\"}, {\"tsne_x\": -23.600385665893555, \"tsne_y\": -70.43247985839844, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|4\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1899\", \"Dose Order\": \"4\"}, {\"tsne_x\": -23.896116256713867, \"tsne_y\": -72.1810073852539, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|4\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1936\", \"Dose Order\": \"4\"}, {\"tsne_x\": -23.746936798095703, \"tsne_y\": -73.80480194091797, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|4\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1937\", \"Dose Order\": \"4\"}, {\"tsne_x\": -24.506576538085938, \"tsne_y\": -74.62178039550781, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|4\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1938\", \"Dose Order\": \"4\"}, {\"tsne_x\": -24.168489456176758, \"tsne_y\": -74.92118072509766, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|4|4\", \"compound\": \"Herceptin\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_4\", \"plate\": \"CPP1939\", \"Dose Order\": \"4\"}, {\"tsne_x\": -15.330981254577637, \"tsne_y\": -70.56532287597656, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|4\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1476\", \"Dose Order\": \"5\"}, {\"tsne_x\": -10.430452346801758, \"tsne_y\": -71.51641845703125, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|4\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1477\", \"Dose Order\": \"5\"}, {\"tsne_x\": -15.46311092376709, \"tsne_y\": -70.56012725830078, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|4\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1478\", \"Dose Order\": \"5\"}, {\"tsne_x\": -16.376157760620117, \"tsne_y\": -70.04557037353516, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|4\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1896\", \"Dose Order\": \"5\"}, {\"tsne_x\": -15.826849937438965, \"tsne_y\": -70.25335693359375, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|4\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1897\", \"Dose Order\": \"5\"}, {\"tsne_x\": -16.74151039123535, \"tsne_y\": -71.13260650634766, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|4\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1898\", \"Dose Order\": \"5\"}, {\"tsne_x\": -16.531391143798828, \"tsne_y\": -70.31600189208984, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|4\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1899\", \"Dose Order\": \"5\"}, {\"tsne_x\": -24.17494773864746, \"tsne_y\": -76.4736328125, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|4\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1936\", \"Dose Order\": \"5\"}, {\"tsne_x\": -24.23138427734375, \"tsne_y\": -76.5040054321289, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|4\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1937\", \"Dose Order\": \"5\"}, {\"tsne_x\": -23.540475845336914, \"tsne_y\": -77.26387786865234, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|4\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1938\", \"Dose Order\": \"5\"}, {\"tsne_x\": -24.353893280029297, \"tsne_y\": -75.85176849365234, \"Compound Group\": \"Herceptin\", \"label\": \"Herceptin|5|4\", \"compound\": \"Herceptin\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Herceptin_5\", \"plate\": \"CPP1939\", \"Dose Order\": \"5\"}, {\"tsne_x\": -56.11128234863281, \"tsne_y\": 14.261844635009766, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1476\", \"Dose Order\": \"0\"}, {\"tsne_x\": -56.33917999267578, \"tsne_y\": 19.206403732299805, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1477\", \"Dose Order\": \"0\"}, {\"tsne_x\": -57.28049087524414, \"tsne_y\": 15.175293922424316, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1478\", \"Dose Order\": \"0\"}, {\"tsne_x\": -58.37556457519531, \"tsne_y\": 15.831039428710938, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1896\", \"Dose Order\": \"0\"}, {\"tsne_x\": -57.116004943847656, \"tsne_y\": 15.299985885620117, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1897\", \"Dose Order\": \"0\"}, {\"tsne_x\": -57.781700134277344, \"tsne_y\": 16.227563858032227, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1898\", \"Dose Order\": \"0\"}, {\"tsne_x\": -57.99699020385742, \"tsne_y\": 15.55781078338623, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1899\", \"Dose Order\": \"0\"}, {\"tsne_x\": -58.00957107543945, \"tsne_y\": 13.390613555908203, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1936\", \"Dose Order\": \"0\"}, {\"tsne_x\": -57.47307586669922, \"tsne_y\": 14.360344886779785, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1937\", \"Dose Order\": \"0\"}, {\"tsne_x\": -56.752540588378906, \"tsne_y\": 16.317811965942383, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1938\", \"Dose Order\": \"0\"}, {\"tsne_x\": -57.99540710449219, \"tsne_y\": 14.697911262512207, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|0|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_0\", \"plate\": \"CPP1939\", \"Dose Order\": \"0\"}, {\"tsne_x\": -61.0850830078125, \"tsne_y\": 18.985023498535156, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1476\", \"Dose Order\": \"1\"}, {\"tsne_x\": -56.545963287353516, \"tsne_y\": 19.414583206176758, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1477\", \"Dose Order\": \"1\"}, {\"tsne_x\": -60.78678512573242, \"tsne_y\": 19.145456314086914, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1478\", \"Dose Order\": \"1\"}, {\"tsne_x\": -59.96086883544922, \"tsne_y\": 17.70142936706543, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1896\", \"Dose Order\": \"1\"}, {\"tsne_x\": -60.48393249511719, \"tsne_y\": 17.86269760131836, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1897\", \"Dose Order\": \"1\"}, {\"tsne_x\": -59.67120361328125, \"tsne_y\": 18.72688865661621, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1898\", \"Dose Order\": \"1\"}, {\"tsne_x\": -60.29399871826172, \"tsne_y\": 17.618587493896484, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1899\", \"Dose Order\": \"1\"}, {\"tsne_x\": -61.68767547607422, \"tsne_y\": 17.64845085144043, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1936\", \"Dose Order\": \"1\"}, {\"tsne_x\": -59.869197845458984, \"tsne_y\": 19.512256622314453, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1937\", \"Dose Order\": \"1\"}, {\"tsne_x\": -58.730560302734375, \"tsne_y\": 19.076980590820312, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1938\", \"Dose Order\": \"1\"}, {\"tsne_x\": -59.64604187011719, \"tsne_y\": 18.560373306274414, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|1|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_1\", \"plate\": \"CPP1939\", \"Dose Order\": \"1\"}, {\"tsne_x\": -57.84083938598633, \"tsne_y\": 27.194942474365234, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1476\", \"Dose Order\": \"2\"}, {\"tsne_x\": -57.33790588378906, \"tsne_y\": 25.93353843688965, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1477\", \"Dose Order\": \"2\"}, {\"tsne_x\": -57.40886688232422, \"tsne_y\": 27.212459564208984, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1478\", \"Dose Order\": \"2\"}, {\"tsne_x\": -59.05426788330078, \"tsne_y\": 26.271203994750977, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1896\", \"Dose Order\": \"2\"}, {\"tsne_x\": -58.6571044921875, \"tsne_y\": 26.465593338012695, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1897\", \"Dose Order\": \"2\"}, {\"tsne_x\": -60.36991500854492, \"tsne_y\": 25.903215408325195, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1898\", \"Dose Order\": \"2\"}, {\"tsne_x\": -59.24980926513672, \"tsne_y\": 26.529369354248047, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1899\", \"Dose Order\": \"2\"}, {\"tsne_x\": -58.94176483154297, \"tsne_y\": 27.222158432006836, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1936\", \"Dose Order\": \"2\"}, {\"tsne_x\": -59.85818099975586, \"tsne_y\": 27.691619873046875, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1937\", \"Dose Order\": \"2\"}, {\"tsne_x\": -59.590972900390625, \"tsne_y\": 27.775732040405273, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1938\", \"Dose Order\": \"2\"}, {\"tsne_x\": -59.256675720214844, \"tsne_y\": 27.81964111328125, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|2|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_2\", \"plate\": \"CPP1939\", \"Dose Order\": \"2\"}, {\"tsne_x\": -55.307090759277344, \"tsne_y\": 37.439029693603516, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1476\", \"Dose Order\": \"3\"}, {\"tsne_x\": -55.257808685302734, \"tsne_y\": 37.762386322021484, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1477\", \"Dose Order\": \"3\"}, {\"tsne_x\": -53.81718826293945, \"tsne_y\": 42.452796936035156, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1478\", \"Dose Order\": \"3\"}, {\"tsne_x\": -56.178932189941406, \"tsne_y\": 35.88092041015625, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1896\", \"Dose Order\": \"3\"}, {\"tsne_x\": -56.107887268066406, \"tsne_y\": 36.17170715332031, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1897\", \"Dose Order\": \"3\"}, {\"tsne_x\": -56.093109130859375, \"tsne_y\": 35.85530471801758, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1898\", \"Dose Order\": \"3\"}, {\"tsne_x\": -55.717403411865234, \"tsne_y\": 36.210548400878906, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1899\", \"Dose Order\": \"3\"}, {\"tsne_x\": -55.162841796875, \"tsne_y\": 35.134071350097656, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1936\", \"Dose Order\": \"3\"}, {\"tsne_x\": -54.71308135986328, \"tsne_y\": 35.584102630615234, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1937\", \"Dose Order\": \"3\"}, {\"tsne_x\": -54.29142379760742, \"tsne_y\": 34.727195739746094, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1938\", \"Dose Order\": \"3\"}, {\"tsne_x\": -54.71696472167969, \"tsne_y\": 35.130157470703125, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|3|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_3\", \"plate\": \"CPP1939\", \"Dose Order\": \"3\"}, {\"tsne_x\": -56.0782356262207, \"tsne_y\": 43.75411605834961, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1476\", \"Dose Order\": \"4\"}, {\"tsne_x\": -54.64264678955078, \"tsne_y\": 43.587867736816406, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1477\", \"Dose Order\": \"4\"}, {\"tsne_x\": -54.02908706665039, \"tsne_y\": 43.0856819152832, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1478\", \"Dose Order\": \"4\"}, {\"tsne_x\": -57.5864143371582, \"tsne_y\": 43.79944610595703, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1896\", \"Dose Order\": \"4\"}, {\"tsne_x\": -58.2708854675293, \"tsne_y\": 43.891082763671875, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1897\", \"Dose Order\": \"4\"}, {\"tsne_x\": -58.00754165649414, \"tsne_y\": 44.025123596191406, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1898\", \"Dose Order\": \"4\"}, {\"tsne_x\": -58.1089973449707, \"tsne_y\": 44.218875885009766, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1899\", \"Dose Order\": \"4\"}, {\"tsne_x\": -59.11064910888672, \"tsne_y\": 45.307411193847656, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1936\", \"Dose Order\": \"4\"}, {\"tsne_x\": -58.429412841796875, \"tsne_y\": 45.71334457397461, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1937\", \"Dose Order\": \"4\"}, {\"tsne_x\": -58.36835479736328, \"tsne_y\": 45.86598205566406, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1938\", \"Dose Order\": \"4\"}, {\"tsne_x\": -58.415771484375, \"tsne_y\": 45.70827865600586, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|4|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_4\", \"plate\": \"CPP1939\", \"Dose Order\": \"4\"}, {\"tsne_x\": -53.76783752441406, \"tsne_y\": 45.44700622558594, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1476\", \"Dose Order\": \"5\"}, {\"tsne_x\": -53.612815856933594, \"tsne_y\": 45.06807327270508, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1477\", \"Dose Order\": \"5\"}, {\"tsne_x\": -53.42605209350586, \"tsne_y\": 44.863922119140625, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1478\", \"Dose Order\": \"5\"}, {\"tsne_x\": -53.84223175048828, \"tsne_y\": 48.43448257446289, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1896\", \"Dose Order\": \"5\"}, {\"tsne_x\": -53.66323471069336, \"tsne_y\": 49.04573440551758, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1897\", \"Dose Order\": \"5\"}, {\"tsne_x\": -53.619781494140625, \"tsne_y\": 48.481544494628906, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1898\", \"Dose Order\": \"5\"}, {\"tsne_x\": -53.94349670410156, \"tsne_y\": 48.69728469848633, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1899\", \"Dose Order\": \"5\"}, {\"tsne_x\": -55.61636734008789, \"tsne_y\": 48.19261169433594, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1936\", \"Dose Order\": \"5\"}, {\"tsne_x\": -55.51493835449219, \"tsne_y\": 48.83489227294922, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1937\", \"Dose Order\": \"5\"}, {\"tsne_x\": -55.713348388671875, \"tsne_y\": 48.966392517089844, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1938\", \"Dose Order\": \"5\"}, {\"tsne_x\": -55.580718994140625, \"tsne_y\": 48.66768264770508, \"Compound Group\": \"Pan-Akt Inhibitor\", \"label\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)|5|4\", \"compound\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_pi3k_akt\", \"compound_dose\": \"Ipatasertib (pan Akt inhibior; tested in clinic for HER2+ BC)_5\", \"plate\": \"CPP1939\", \"Dose Order\": \"5\"}, {\"tsne_x\": 23.730844497680664, \"tsne_y\": 41.09637451171875, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1476\", \"Dose Order\": \"0\"}, {\"tsne_x\": 21.422487258911133, \"tsne_y\": 40.21568298339844, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1477\", \"Dose Order\": \"0\"}, {\"tsne_x\": 24.003684997558594, \"tsne_y\": 40.9187126159668, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1478\", \"Dose Order\": \"0\"}, {\"tsne_x\": 26.24829864501953, \"tsne_y\": 39.38764190673828, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1896\", \"Dose Order\": \"0\"}, {\"tsne_x\": 25.800016403198242, \"tsne_y\": 40.21681594848633, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1897\", \"Dose Order\": \"0\"}, {\"tsne_x\": 26.12883758544922, \"tsne_y\": 40.1765251159668, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1898\", \"Dose Order\": \"0\"}, {\"tsne_x\": 26.384916305541992, \"tsne_y\": 39.909664154052734, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1899\", \"Dose Order\": \"0\"}, {\"tsne_x\": 28.9757022857666, \"tsne_y\": 40.62732696533203, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1936\", \"Dose Order\": \"0\"}, {\"tsne_x\": 27.89316749572754, \"tsne_y\": 41.10679626464844, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1937\", \"Dose Order\": \"0\"}, {\"tsne_x\": 27.75541877746582, \"tsne_y\": 41.07035827636719, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1938\", \"Dose Order\": \"0\"}, {\"tsne_x\": 27.911998748779297, \"tsne_y\": 40.99192810058594, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|0|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_0\", \"plate\": \"CPP1939\", \"Dose Order\": \"0\"}, {\"tsne_x\": 22.10984992980957, \"tsne_y\": 41.941768646240234, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1476\", \"Dose Order\": \"1\"}, {\"tsne_x\": 21.532970428466797, \"tsne_y\": 40.8487548828125, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1477\", \"Dose Order\": \"1\"}, {\"tsne_x\": 20.39471435546875, \"tsne_y\": 42.79271697998047, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1478\", \"Dose Order\": \"1\"}, {\"tsne_x\": 22.968225479125977, \"tsne_y\": 45.91334915161133, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1896\", \"Dose Order\": \"1\"}, {\"tsne_x\": 23.21923065185547, \"tsne_y\": 45.347999572753906, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1897\", \"Dose Order\": \"1\"}, {\"tsne_x\": 23.36396598815918, \"tsne_y\": 45.88505172729492, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1898\", \"Dose Order\": \"1\"}, {\"tsne_x\": 23.351158142089844, \"tsne_y\": 46.179603576660156, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1899\", \"Dose Order\": \"1\"}, {\"tsne_x\": 25.074464797973633, \"tsne_y\": 46.9578742980957, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1936\", \"Dose Order\": \"1\"}, {\"tsne_x\": 25.13616943359375, \"tsne_y\": 47.56102752685547, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1937\", \"Dose Order\": \"1\"}, {\"tsne_x\": 24.47646141052246, \"tsne_y\": 47.487518310546875, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1938\", \"Dose Order\": \"1\"}, {\"tsne_x\": 24.795700073242188, \"tsne_y\": 47.07098388671875, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|1|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_1\", \"plate\": \"CPP1939\", \"Dose Order\": \"1\"}, {\"tsne_x\": 32.15762710571289, \"tsne_y\": 57.704036712646484, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1476\", \"Dose Order\": \"2\"}, {\"tsne_x\": 32.74769973754883, \"tsne_y\": 58.297916412353516, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1477\", \"Dose Order\": \"2\"}, {\"tsne_x\": 31.735431671142578, \"tsne_y\": 57.75608444213867, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1478\", \"Dose Order\": \"2\"}, {\"tsne_x\": 31.612462997436523, \"tsne_y\": 55.768585205078125, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1896\", \"Dose Order\": \"2\"}, {\"tsne_x\": 31.671876907348633, \"tsne_y\": 55.90520095825195, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1897\", \"Dose Order\": \"2\"}, {\"tsne_x\": 30.642650604248047, \"tsne_y\": 54.88021469116211, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1898\", \"Dose Order\": \"2\"}, {\"tsne_x\": 31.55036163330078, \"tsne_y\": 55.67509841918945, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1899\", \"Dose Order\": \"2\"}, {\"tsne_x\": 29.494367599487305, \"tsne_y\": 56.9459114074707, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1936\", \"Dose Order\": \"2\"}, {\"tsne_x\": 29.46896743774414, \"tsne_y\": 56.39053726196289, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1937\", \"Dose Order\": \"2\"}, {\"tsne_x\": 29.565202713012695, \"tsne_y\": 55.99263000488281, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1938\", \"Dose Order\": \"2\"}, {\"tsne_x\": 29.518775939941406, \"tsne_y\": 56.54231262207031, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|2|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_2\", \"plate\": \"CPP1939\", \"Dose Order\": \"2\"}, {\"tsne_x\": 34.21107864379883, \"tsne_y\": 59.786197662353516, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1476\", \"Dose Order\": \"3\"}, {\"tsne_x\": 33.82495880126953, \"tsne_y\": 59.37620162963867, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1477\", \"Dose Order\": \"3\"}, {\"tsne_x\": 34.34386444091797, \"tsne_y\": 59.848487854003906, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1478\", \"Dose Order\": \"3\"}, {\"tsne_x\": 36.012847900390625, \"tsne_y\": 62.586055755615234, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1896\", \"Dose Order\": \"3\"}, {\"tsne_x\": 35.84076690673828, \"tsne_y\": 62.13880920410156, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1897\", \"Dose Order\": \"3\"}, {\"tsne_x\": 35.725093841552734, \"tsne_y\": 62.281822204589844, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1898\", \"Dose Order\": \"3\"}, {\"tsne_x\": 35.49522018432617, \"tsne_y\": 62.36420440673828, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1899\", \"Dose Order\": \"3\"}, {\"tsne_x\": 37.31173324584961, \"tsne_y\": 60.52993392944336, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1936\", \"Dose Order\": \"3\"}, {\"tsne_x\": 36.86725997924805, \"tsne_y\": 60.71225357055664, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1937\", \"Dose Order\": \"3\"}, {\"tsne_x\": 36.82034683227539, \"tsne_y\": 61.00084686279297, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1938\", \"Dose Order\": \"3\"}, {\"tsne_x\": 36.842559814453125, \"tsne_y\": 60.89086151123047, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|3|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_3\", \"plate\": \"CPP1939\", \"Dose Order\": \"3\"}, {\"tsne_x\": 43.833797454833984, \"tsne_y\": 61.88574981689453, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1476\", \"Dose Order\": \"4\"}, {\"tsne_x\": 43.83904266357422, \"tsne_y\": 61.66094970703125, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1477\", \"Dose Order\": \"4\"}, {\"tsne_x\": 43.82986068725586, \"tsne_y\": 61.79350662231445, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1478\", \"Dose Order\": \"4\"}, {\"tsne_x\": 43.96420669555664, \"tsne_y\": 66.00637817382812, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1896\", \"Dose Order\": \"4\"}, {\"tsne_x\": 43.781070709228516, \"tsne_y\": 65.88748168945312, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1897\", \"Dose Order\": \"4\"}, {\"tsne_x\": 44.07774353027344, \"tsne_y\": 65.51677703857422, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1898\", \"Dose Order\": \"4\"}, {\"tsne_x\": 44.159393310546875, \"tsne_y\": 65.49555206298828, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1899\", \"Dose Order\": \"4\"}, {\"tsne_x\": 42.9002571105957, \"tsne_y\": 64.3573226928711, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1936\", \"Dose Order\": \"4\"}, {\"tsne_x\": 43.31168746948242, \"tsne_y\": 64.26177215576172, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1937\", \"Dose Order\": \"4\"}, {\"tsne_x\": 43.54439163208008, \"tsne_y\": 64.23571014404297, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1938\", \"Dose Order\": \"4\"}, {\"tsne_x\": 43.19491958618164, \"tsne_y\": 64.21990203857422, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|4|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_4\", \"plate\": \"CPP1939\", \"Dose Order\": \"4\"}, {\"tsne_x\": -1.859696865081787, \"tsne_y\": 13.271214485168457, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1476\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.8800708055496216, \"tsne_y\": 13.313050270080566, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1477\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.8810181617736816, \"tsne_y\": 13.252614974975586, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1478\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.2464855909347534, \"tsne_y\": 8.861176490783691, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1896\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.1863373517990112, \"tsne_y\": 9.084385871887207, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1897\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.0334242582321167, \"tsne_y\": 8.996451377868652, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1898\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.1502528190612793, \"tsne_y\": 9.263045310974121, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1899\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.0980433225631714, \"tsne_y\": 10.862131118774414, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1936\", \"Dose Order\": \"5\"}, {\"tsne_x\": -0.6967931985855103, \"tsne_y\": 11.031606674194336, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1937\", \"Dose Order\": \"5\"}, {\"tsne_x\": -0.5654229521751404, \"tsne_y\": 10.97293758392334, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1938\", \"Dose Order\": \"5\"}, {\"tsne_x\": -0.8012936115264893, \"tsne_y\": 11.160964012145996, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Lapatanib (HER2/EGFR selective)|5|4\", \"compound\": \"Lapatanib (HER2/EGFR selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Lapatanib (HER2/EGFR selective)_5\", \"plate\": \"CPP1939\", \"Dose Order\": \"5\"}, {\"tsne_x\": 60.80650329589844, \"tsne_y\": 2.7508394718170166, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1476\", \"Dose Order\": \"0\"}, {\"tsne_x\": 61.13381576538086, \"tsne_y\": 0.7894566655158997, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1477\", \"Dose Order\": \"0\"}, {\"tsne_x\": 60.78153991699219, \"tsne_y\": 2.2936952114105225, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1478\", \"Dose Order\": \"0\"}, {\"tsne_x\": 60.79820251464844, \"tsne_y\": 5.933774471282959, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1896\", \"Dose Order\": \"0\"}, {\"tsne_x\": 61.06489944458008, \"tsne_y\": 5.7289958000183105, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1897\", \"Dose Order\": \"0\"}, {\"tsne_x\": 60.346946716308594, \"tsne_y\": 5.786219120025635, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1898\", \"Dose Order\": \"0\"}, {\"tsne_x\": 60.662498474121094, \"tsne_y\": 6.011833667755127, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1899\", \"Dose Order\": \"0\"}, {\"tsne_x\": 62.99495315551758, \"tsne_y\": 7.546099662780762, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1936\", \"Dose Order\": \"0\"}, {\"tsne_x\": 62.45920944213867, \"tsne_y\": 7.642457962036133, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1937\", \"Dose Order\": \"0\"}, {\"tsne_x\": 62.19593811035156, \"tsne_y\": 8.348718643188477, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1938\", \"Dose Order\": \"0\"}, {\"tsne_x\": 62.529720306396484, \"tsne_y\": 7.850278854370117, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|0|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_0\", \"plate\": \"CPP1939\", \"Dose Order\": \"0\"}, {\"tsne_x\": 62.88713455200195, \"tsne_y\": 2.5193867683410645, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1476\", \"Dose Order\": \"1\"}, {\"tsne_x\": 61.70186996459961, \"tsne_y\": 0.19304846227169037, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1477\", \"Dose Order\": \"1\"}, {\"tsne_x\": 62.55172348022461, \"tsne_y\": 1.8106893301010132, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1478\", \"Dose Order\": \"1\"}, {\"tsne_x\": 66.26209259033203, \"tsne_y\": 3.878892421722412, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1896\", \"Dose Order\": \"1\"}, {\"tsne_x\": 66.06871032714844, \"tsne_y\": 3.6512339115142822, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1897\", \"Dose Order\": \"1\"}, {\"tsne_x\": 66.00685119628906, \"tsne_y\": 3.4792773723602295, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1898\", \"Dose Order\": \"1\"}, {\"tsne_x\": 65.8512191772461, \"tsne_y\": 3.593562126159668, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1899\", \"Dose Order\": \"1\"}, {\"tsne_x\": 66.0864028930664, \"tsne_y\": 6.106632232666016, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1936\", \"Dose Order\": \"1\"}, {\"tsne_x\": 66.67767333984375, \"tsne_y\": 6.083945274353027, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1937\", \"Dose Order\": \"1\"}, {\"tsne_x\": 66.52529907226562, \"tsne_y\": 6.146368980407715, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1938\", \"Dose Order\": \"1\"}, {\"tsne_x\": 67.19487762451172, \"tsne_y\": 5.996128559112549, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|1|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_1\", \"plate\": \"CPP1939\", \"Dose Order\": \"1\"}, {\"tsne_x\": 72.80335235595703, \"tsne_y\": 12.891057968139648, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1476\", \"Dose Order\": \"2\"}, {\"tsne_x\": 72.07719421386719, \"tsne_y\": 13.532259941101074, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1477\", \"Dose Order\": \"2\"}, {\"tsne_x\": 73.03780364990234, \"tsne_y\": 12.86998176574707, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1478\", \"Dose Order\": \"2\"}, {\"tsne_x\": 75.27827453613281, \"tsne_y\": 11.098305702209473, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1896\", \"Dose Order\": \"2\"}, {\"tsne_x\": 74.62788391113281, \"tsne_y\": 11.16075611114502, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1897\", \"Dose Order\": \"2\"}, {\"tsne_x\": 74.766357421875, \"tsne_y\": 11.067163467407227, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1898\", \"Dose Order\": \"2\"}, {\"tsne_x\": 74.81623077392578, \"tsne_y\": 10.850456237792969, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1899\", \"Dose Order\": \"2\"}, {\"tsne_x\": 73.62726593017578, \"tsne_y\": 10.020296096801758, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1936\", \"Dose Order\": \"2\"}, {\"tsne_x\": 74.09552764892578, \"tsne_y\": 9.747514724731445, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1937\", \"Dose Order\": \"2\"}, {\"tsne_x\": 73.99828338623047, \"tsne_y\": 9.577713012695312, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1938\", \"Dose Order\": \"2\"}, {\"tsne_x\": 74.39514923095703, \"tsne_y\": 9.52098274230957, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|2|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_2\", \"plate\": \"CPP1939\", \"Dose Order\": \"2\"}, {\"tsne_x\": 73.01583862304688, \"tsne_y\": 15.67066478729248, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1476\", \"Dose Order\": \"3\"}, {\"tsne_x\": 72.80644989013672, \"tsne_y\": 15.48123550415039, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1477\", \"Dose Order\": \"3\"}, {\"tsne_x\": 73.24161529541016, \"tsne_y\": 15.618117332458496, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1478\", \"Dose Order\": \"3\"}, {\"tsne_x\": 73.38996124267578, \"tsne_y\": 19.184629440307617, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1896\", \"Dose Order\": \"3\"}, {\"tsne_x\": 73.52759552001953, \"tsne_y\": 18.924362182617188, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1897\", \"Dose Order\": \"3\"}, {\"tsne_x\": 73.45899963378906, \"tsne_y\": 18.480121612548828, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1898\", \"Dose Order\": \"3\"}, {\"tsne_x\": 73.45348358154297, \"tsne_y\": 18.416627883911133, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1899\", \"Dose Order\": \"3\"}, {\"tsne_x\": 74.3414306640625, \"tsne_y\": 17.645421981811523, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1936\", \"Dose Order\": \"3\"}, {\"tsne_x\": 74.79828643798828, \"tsne_y\": 18.492387771606445, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1937\", \"Dose Order\": \"3\"}, {\"tsne_x\": 74.88096618652344, \"tsne_y\": 18.29674530029297, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1938\", \"Dose Order\": \"3\"}, {\"tsne_x\": 74.73774719238281, \"tsne_y\": 18.836376190185547, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|3|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_3\", \"plate\": \"CPP1939\", \"Dose Order\": \"3\"}, {\"tsne_x\": 69.88875579833984, \"tsne_y\": 31.32526969909668, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1476\", \"Dose Order\": \"4\"}, {\"tsne_x\": 70.7099838256836, \"tsne_y\": 31.24435806274414, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1477\", \"Dose Order\": \"4\"}, {\"tsne_x\": 70.63229370117188, \"tsne_y\": 31.230777740478516, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1478\", \"Dose Order\": \"4\"}, {\"tsne_x\": 68.4631118774414, \"tsne_y\": 30.197423934936523, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1896\", \"Dose Order\": \"4\"}, {\"tsne_x\": 68.215087890625, \"tsne_y\": 30.316818237304688, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1897\", \"Dose Order\": \"4\"}, {\"tsne_x\": 68.14678192138672, \"tsne_y\": 30.12516212463379, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1898\", \"Dose Order\": \"4\"}, {\"tsne_x\": 68.50119018554688, \"tsne_y\": 30.614763259887695, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1899\", \"Dose Order\": \"4\"}, {\"tsne_x\": 68.09915924072266, \"tsne_y\": 32.05769729614258, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1936\", \"Dose Order\": \"4\"}, {\"tsne_x\": 68.60327911376953, \"tsne_y\": 32.0874137878418, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1937\", \"Dose Order\": \"4\"}, {\"tsne_x\": 68.44709777832031, \"tsne_y\": 32.00054931640625, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1938\", \"Dose Order\": \"4\"}, {\"tsne_x\": 68.07923889160156, \"tsne_y\": 31.783811569213867, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|4|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_4\", \"plate\": \"CPP1939\", \"Dose Order\": \"4\"}, {\"tsne_x\": 67.08795928955078, \"tsne_y\": 39.03399658203125, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1476\", \"Dose Order\": \"5\"}, {\"tsne_x\": 67.6750717163086, \"tsne_y\": 39.24574661254883, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1477\", \"Dose Order\": \"5\"}, {\"tsne_x\": 67.53565979003906, \"tsne_y\": 39.195430755615234, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1478\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.83911895751953, \"tsne_y\": 39.38977813720703, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1896\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.50360107421875, \"tsne_y\": 39.44797897338867, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1897\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.73802947998047, \"tsne_y\": 39.16366958618164, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1898\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.64075469970703, \"tsne_y\": 39.01836013793945, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1899\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.42919921875, \"tsne_y\": 37.63125228881836, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1936\", \"Dose Order\": \"5\"}, {\"tsne_x\": 66.086669921875, \"tsne_y\": 37.38840866088867, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1937\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.97029876708984, \"tsne_y\": 37.128849029541016, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1938\", \"Dose Order\": \"5\"}, {\"tsne_x\": 65.83474731445312, \"tsne_y\": 37.341129302978516, \"Compound Group\": \"Neratinib (Covalent Inhibitor)\", \"label\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)|5|4\", \"compound\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol_covalent\", \"compound_dose\": \"Neratinib (HKI-272; EGFR/HER2 active site covalent inhibitor)_5\", \"plate\": \"CPP1939\", \"Dose Order\": \"5\"}, {\"tsne_x\": -12.253637313842773, \"tsne_y\": -51.36069869995117, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1476\", \"Dose Order\": \"0\"}, {\"tsne_x\": -7.715699195861816, \"tsne_y\": -67.6075210571289, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1477\", \"Dose Order\": \"0\"}, {\"tsne_x\": -11.82774543762207, \"tsne_y\": -50.61711502075195, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1478\", \"Dose Order\": \"0\"}, {\"tsne_x\": -11.085378646850586, \"tsne_y\": -50.14750289916992, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1896\", \"Dose Order\": \"0\"}, {\"tsne_x\": -11.00983715057373, \"tsne_y\": -50.40238952636719, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1897\", \"Dose Order\": \"0\"}, {\"tsne_x\": 1.146166443824768, \"tsne_y\": -55.264339447021484, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1898\", \"Dose Order\": \"0\"}, {\"tsne_x\": -11.432337760925293, \"tsne_y\": -49.860347747802734, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1899\", \"Dose Order\": \"0\"}, {\"tsne_x\": -10.84860610961914, \"tsne_y\": -48.686885833740234, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1936\", \"Dose Order\": \"0\"}, {\"tsne_x\": -10.661066055297852, \"tsne_y\": -48.86863327026367, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1937\", \"Dose Order\": \"0\"}, {\"tsne_x\": -10.423893928527832, \"tsne_y\": -51.22998046875, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1938\", \"Dose Order\": \"0\"}, {\"tsne_x\": -10.473979949951172, \"tsne_y\": -50.292518615722656, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|0|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_0\", \"plate\": \"CPP1939\", \"Dose Order\": \"0\"}, {\"tsne_x\": 6.5977935791015625, \"tsne_y\": -63.923606872558594, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1476\", \"Dose Order\": \"1\"}, {\"tsne_x\": -5.450697898864746, \"tsne_y\": -68.4205093383789, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1477\", \"Dose Order\": \"1\"}, {\"tsne_x\": -6.353880882263184, \"tsne_y\": -36.203651428222656, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1478\", \"Dose Order\": \"1\"}, {\"tsne_x\": 5.3741583824157715, \"tsne_y\": -63.98906707763672, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1896\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.0106072425842285, \"tsne_y\": -65.00420379638672, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1897\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.044728755950928, \"tsne_y\": -64.33260345458984, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1898\", \"Dose Order\": \"1\"}, {\"tsne_x\": 5.818019390106201, \"tsne_y\": -63.97490310668945, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1899\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.104847431182861, \"tsne_y\": -65.19163513183594, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1936\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.138587951660156, \"tsne_y\": -62.814327239990234, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1937\", \"Dose Order\": \"1\"}, {\"tsne_x\": 7.601731300354004, \"tsne_y\": -64.01810455322266, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1938\", \"Dose Order\": \"1\"}, {\"tsne_x\": 6.72633695602417, \"tsne_y\": -64.71649169921875, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|1|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_1\", \"plate\": \"CPP1939\", \"Dose Order\": \"1\"}, {\"tsne_x\": -22.306907653808594, \"tsne_y\": -46.4359130859375, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1476\", \"Dose Order\": \"2\"}, {\"tsne_x\": -7.0965495109558105, \"tsne_y\": -67.34648895263672, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1477\", \"Dose Order\": \"2\"}, {\"tsne_x\": -21.709056854248047, \"tsne_y\": -46.93255615234375, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1478\", \"Dose Order\": \"2\"}, {\"tsne_x\": -20.720312118530273, \"tsne_y\": -47.22614669799805, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1896\", \"Dose Order\": \"2\"}, {\"tsne_x\": -21.28343391418457, \"tsne_y\": -47.21076202392578, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1897\", \"Dose Order\": \"2\"}, {\"tsne_x\": -21.266103744506836, \"tsne_y\": -46.40281677246094, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1898\", \"Dose Order\": \"2\"}, {\"tsne_x\": -20.117298126220703, \"tsne_y\": -46.732582092285156, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1899\", \"Dose Order\": \"2\"}, {\"tsne_x\": -22.05144500732422, \"tsne_y\": -47.827301025390625, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1936\", \"Dose Order\": \"2\"}, {\"tsne_x\": -20.243972778320312, \"tsne_y\": -44.97053909301758, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1937\", \"Dose Order\": \"2\"}, {\"tsne_x\": -20.313817977905273, \"tsne_y\": -44.95728302001953, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1938\", \"Dose Order\": \"2\"}, {\"tsne_x\": -19.831951141357422, \"tsne_y\": -46.76262283325195, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|2|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_2\", \"plate\": \"CPP1939\", \"Dose Order\": \"2\"}, {\"tsne_x\": 0.5545588135719299, \"tsne_y\": -72.95577239990234, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1476\", \"Dose Order\": \"3\"}, {\"tsne_x\": -7.424071788787842, \"tsne_y\": -71.25192260742188, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1477\", \"Dose Order\": \"3\"}, {\"tsne_x\": 1.4936203956604004, \"tsne_y\": -72.35033416748047, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1478\", \"Dose Order\": \"3\"}, {\"tsne_x\": 2.0459580421447754, \"tsne_y\": -72.9336929321289, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1896\", \"Dose Order\": \"3\"}, {\"tsne_x\": 1.3383630514144897, \"tsne_y\": -73.37532806396484, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1897\", \"Dose Order\": \"3\"}, {\"tsne_x\": 1.3375368118286133, \"tsne_y\": -73.41378021240234, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1898\", \"Dose Order\": \"3\"}, {\"tsne_x\": 1.3695183992385864, \"tsne_y\": -73.27898406982422, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1899\", \"Dose Order\": \"3\"}, {\"tsne_x\": 1.9317435026168823, \"tsne_y\": -79.64421081542969, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1936\", \"Dose Order\": \"3\"}, {\"tsne_x\": 1.3687775135040283, \"tsne_y\": -80.8414306640625, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1937\", \"Dose Order\": \"3\"}, {\"tsne_x\": 2.5915398597717285, \"tsne_y\": -79.73790740966797, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1938\", \"Dose Order\": \"3\"}, {\"tsne_x\": 2.2887861728668213, \"tsne_y\": -79.81877136230469, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|3|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_3\", \"plate\": \"CPP1939\", \"Dose Order\": \"3\"}, {\"tsne_x\": 7.35853385925293, \"tsne_y\": -76.04924774169922, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1476\", \"Dose Order\": \"4\"}, {\"tsne_x\": -6.488487720489502, \"tsne_y\": -71.99427032470703, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1477\", \"Dose Order\": \"4\"}, {\"tsne_x\": 6.753958225250244, \"tsne_y\": -76.29905700683594, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1478\", \"Dose Order\": \"4\"}, {\"tsne_x\": 6.0059075355529785, \"tsne_y\": -76.21310424804688, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1896\", \"Dose Order\": \"4\"}, {\"tsne_x\": 6.929783344268799, \"tsne_y\": -76.49437713623047, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1897\", \"Dose Order\": \"4\"}, {\"tsne_x\": 6.5194878578186035, \"tsne_y\": -74.8849105834961, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1898\", \"Dose Order\": \"4\"}, {\"tsne_x\": 5.742264270782471, \"tsne_y\": -75.81269836425781, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1899\", \"Dose Order\": \"4\"}, {\"tsne_x\": 5.796186447143555, \"tsne_y\": -77.90592956542969, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1936\", \"Dose Order\": \"4\"}, {\"tsne_x\": 5.798867225646973, \"tsne_y\": -77.7972412109375, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1937\", \"Dose Order\": \"4\"}, {\"tsne_x\": 3.702357292175293, \"tsne_y\": -79.39765930175781, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1938\", \"Dose Order\": \"4\"}, {\"tsne_x\": 4.964453220367432, \"tsne_y\": -78.15855407714844, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|4|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_4\", \"plate\": \"CPP1939\", \"Dose Order\": \"4\"}, {\"tsne_x\": -2.6745121479034424, \"tsne_y\": -76.46835327148438, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1476\", \"Dose Order\": \"5\"}, {\"tsne_x\": -5.860997200012207, \"tsne_y\": -73.1474380493164, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1477\", \"Dose Order\": \"5\"}, {\"tsne_x\": -2.0089569091796875, \"tsne_y\": -77.12631225585938, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1478\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.4234997034072876, \"tsne_y\": -76.7685775756836, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1896\", \"Dose Order\": \"5\"}, {\"tsne_x\": -2.186951160430908, \"tsne_y\": -76.49127960205078, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1897\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.9448614120483398, \"tsne_y\": -75.99866485595703, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1898\", \"Dose Order\": \"5\"}, {\"tsne_x\": -1.6506565809249878, \"tsne_y\": -76.03321075439453, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1899\", \"Dose Order\": \"5\"}, {\"tsne_x\": 0.1765076369047165, \"tsne_y\": -79.64293670654297, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1936\", \"Dose Order\": \"5\"}, {\"tsne_x\": 0.5853871703147888, \"tsne_y\": -80.57623291015625, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1937\", \"Dose Order\": \"5\"}, {\"tsne_x\": 0.7885215878486633, \"tsne_y\": -81.42871856689453, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1938\", \"Dose Order\": \"5\"}, {\"tsne_x\": 0.7518404126167297, \"tsne_y\": -81.53986358642578, \"Compound Group\": \"Perjeta\", \"label\": \"Pertuzumab (HER2/HER3dimerization blocker)|5|4\", \"compound\": \"Pertuzumab (HER2/HER3dimerization blocker)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"ab\", \"compound_dose\": \"Pertuzumab (HER2/HER3dimerization blocker)_5\", \"plate\": \"CPP1939\", \"Dose Order\": \"5\"}, {\"tsne_x\": 15.966848373413086, \"tsne_y\": 18.326461791992188, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1476\", \"Dose Order\": \"0\"}, {\"tsne_x\": 16.803874969482422, \"tsne_y\": 33.464027404785156, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1477\", \"Dose Order\": \"0\"}, {\"tsne_x\": 15.9501314163208, \"tsne_y\": 17.959047317504883, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1478\", \"Dose Order\": \"0\"}, {\"tsne_x\": 17.4876766204834, \"tsne_y\": 19.27577781677246, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1896\", \"Dose Order\": \"0\"}, {\"tsne_x\": 17.308326721191406, \"tsne_y\": 19.930438995361328, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1897\", \"Dose Order\": \"0\"}, {\"tsne_x\": 17.234426498413086, \"tsne_y\": 18.497451782226562, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1898\", \"Dose Order\": \"0\"}, {\"tsne_x\": 17.115930557250977, \"tsne_y\": 19.151565551757812, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1899\", \"Dose Order\": \"0\"}, {\"tsne_x\": 16.66877555847168, \"tsne_y\": 19.167678833007812, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1936\", \"Dose Order\": \"0\"}, {\"tsne_x\": 15.5374174118042, \"tsne_y\": 19.16088104248047, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1937\", \"Dose Order\": \"0\"}, {\"tsne_x\": 16.095083236694336, \"tsne_y\": 19.711956024169922, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1938\", \"Dose Order\": \"0\"}, {\"tsne_x\": 16.4486026763916, \"tsne_y\": 20.93588638305664, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|0|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 0, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_0\", \"plate\": \"CPP1939\", \"Dose Order\": \"0\"}, {\"tsne_x\": 22.16283416748047, \"tsne_y\": 23.979093551635742, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1476\", \"Dose Order\": \"1\"}, {\"tsne_x\": 17.56044578552246, \"tsne_y\": 34.36207580566406, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1477\", \"Dose Order\": \"1\"}, {\"tsne_x\": 21.970996856689453, \"tsne_y\": 23.87938117980957, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1478\", \"Dose Order\": \"1\"}, {\"tsne_x\": 23.03922462463379, \"tsne_y\": 22.326614379882812, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1896\", \"Dose Order\": \"1\"}, {\"tsne_x\": 22.063880920410156, \"tsne_y\": 22.791240692138672, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1897\", \"Dose Order\": \"1\"}, {\"tsne_x\": 24.548358917236328, \"tsne_y\": 21.739152908325195, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1898\", \"Dose Order\": \"1\"}, {\"tsne_x\": 24.443735122680664, \"tsne_y\": 21.684646606445312, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1899\", \"Dose Order\": \"1\"}, {\"tsne_x\": 20.662580490112305, \"tsne_y\": 21.906646728515625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1936\", \"Dose Order\": \"1\"}, {\"tsne_x\": 21.897485733032227, \"tsne_y\": 20.408872604370117, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1937\", \"Dose Order\": \"1\"}, {\"tsne_x\": 21.956079483032227, \"tsne_y\": 22.078067779541016, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1938\", \"Dose Order\": \"1\"}, {\"tsne_x\": 21.788097381591797, \"tsne_y\": 21.913875579833984, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|1|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 1, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_1\", \"plate\": \"CPP1939\", \"Dose Order\": \"1\"}, {\"tsne_x\": 25.309276580810547, \"tsne_y\": 30.806442260742188, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1476\", \"Dose Order\": \"2\"}, {\"tsne_x\": 18.31904411315918, \"tsne_y\": 36.20579528808594, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1477\", \"Dose Order\": \"2\"}, {\"tsne_x\": 25.950685501098633, \"tsne_y\": 31.8397274017334, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1478\", \"Dose Order\": \"2\"}, {\"tsne_x\": 25.88264274597168, \"tsne_y\": 35.39471435546875, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1896\", \"Dose Order\": \"2\"}, {\"tsne_x\": 26.444475173950195, \"tsne_y\": 35.533992767333984, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1897\", \"Dose Order\": \"2\"}, {\"tsne_x\": 26.405590057373047, \"tsne_y\": 35.967437744140625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1898\", \"Dose Order\": \"2\"}, {\"tsne_x\": 26.106210708618164, \"tsne_y\": 35.96712875366211, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1899\", \"Dose Order\": \"2\"}, {\"tsne_x\": 24.91847801208496, \"tsne_y\": 34.145870208740234, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1936\", \"Dose Order\": \"2\"}, {\"tsne_x\": 24.078815460205078, \"tsne_y\": 35.18519592285156, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1937\", \"Dose Order\": \"2\"}, {\"tsne_x\": 24.24231719970703, \"tsne_y\": 34.82329559326172, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1938\", \"Dose Order\": \"2\"}, {\"tsne_x\": 24.635772705078125, \"tsne_y\": 35.00312423706055, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|2|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 2, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_2\", \"plate\": \"CPP1939\", \"Dose Order\": \"2\"}, {\"tsne_x\": 16.159696578979492, \"tsne_y\": 48.624610900878906, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1476\", \"Dose Order\": \"3\"}, {\"tsne_x\": 18.262493133544922, \"tsne_y\": 37.790985107421875, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1477\", \"Dose Order\": \"3\"}, {\"tsne_x\": 15.879709243774414, \"tsne_y\": 48.785282135009766, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1478\", \"Dose Order\": \"3\"}, {\"tsne_x\": 18.636478424072266, \"tsne_y\": 49.46132278442383, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1896\", \"Dose Order\": \"3\"}, {\"tsne_x\": 19.339853286743164, \"tsne_y\": 48.88010025024414, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1897\", \"Dose Order\": \"3\"}, {\"tsne_x\": 18.484458923339844, \"tsne_y\": 49.039241790771484, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1898\", \"Dose Order\": \"3\"}, {\"tsne_x\": 18.877878189086914, \"tsne_y\": 48.539512634277344, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1899\", \"Dose Order\": \"3\"}, {\"tsne_x\": 16.099477767944336, \"tsne_y\": 50.9760856628418, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1936\", \"Dose Order\": \"3\"}, {\"tsne_x\": 15.673315048217773, \"tsne_y\": 50.7900390625, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1937\", \"Dose Order\": \"3\"}, {\"tsne_x\": 15.161487579345703, \"tsne_y\": 50.91727066040039, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1938\", \"Dose Order\": \"3\"}, {\"tsne_x\": 15.768266677856445, \"tsne_y\": 50.56142807006836, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|3|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 3, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_3\", \"plate\": \"CPP1939\", \"Dose Order\": \"3\"}, {\"tsne_x\": 10.655108451843262, \"tsne_y\": 55.23637008666992, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1476\", \"Dose Order\": \"4\"}, {\"tsne_x\": 8.682143211364746, \"tsne_y\": 54.37492370605469, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1477\", \"Dose Order\": \"4\"}, {\"tsne_x\": 10.466242790222168, \"tsne_y\": 55.36574935913086, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1478\", \"Dose Order\": \"4\"}, {\"tsne_x\": 13.706620216369629, \"tsne_y\": 58.769081115722656, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1896\", \"Dose Order\": \"4\"}, {\"tsne_x\": 13.825063705444336, \"tsne_y\": 57.998897552490234, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1897\", \"Dose Order\": \"4\"}, {\"tsne_x\": 13.758126258850098, \"tsne_y\": 57.991275787353516, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1898\", \"Dose Order\": \"4\"}, {\"tsne_x\": 14.163516998291016, \"tsne_y\": 58.186912536621094, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1899\", \"Dose Order\": \"4\"}, {\"tsne_x\": 12.198609352111816, \"tsne_y\": 54.15299606323242, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1936\", \"Dose Order\": \"4\"}, {\"tsne_x\": 13.177849769592285, \"tsne_y\": 54.41763687133789, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1937\", \"Dose Order\": \"4\"}, {\"tsne_x\": 13.065497398376465, \"tsne_y\": 54.24396514892578, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1938\", \"Dose Order\": \"4\"}, {\"tsne_x\": 13.13547134399414, \"tsne_y\": 54.7559928894043, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|4|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 4, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_4\", \"plate\": \"CPP1939\", \"Dose Order\": \"4\"}, {\"tsne_x\": 9.94282341003418, \"tsne_y\": 56.457862854003906, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1476\", \"Dose Order\": \"5\"}, {\"tsne_x\": 8.24397087097168, \"tsne_y\": 54.36029052734375, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1477\", \"Dose Order\": \"5\"}, {\"tsne_x\": 9.859600067138672, \"tsne_y\": 56.40034866333008, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1478\", \"Dose Order\": \"5\"}, {\"tsne_x\": 13.06825065612793, \"tsne_y\": 59.71957015991211, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1896\", \"Dose Order\": \"5\"}, {\"tsne_x\": 12.431927680969238, \"tsne_y\": 60.177696228027344, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1897\", \"Dose Order\": \"5\"}, {\"tsne_x\": 12.498897552490234, \"tsne_y\": 59.74559020996094, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1898\", \"Dose Order\": \"5\"}, {\"tsne_x\": 12.665122985839844, \"tsne_y\": 59.6701545715332, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1899\", \"Dose Order\": \"5\"}, {\"tsne_x\": 9.401535987854004, \"tsne_y\": 59.03800582885742, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1936\", \"Dose Order\": \"5\"}, {\"tsne_x\": 9.30580997467041, \"tsne_y\": 58.4731559753418, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1937\", \"Dose Order\": \"5\"}, {\"tsne_x\": 9.187443733215332, \"tsne_y\": 58.23120880126953, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1938\", \"Dose Order\": \"5\"}, {\"tsne_x\": 9.32812786102295, \"tsne_y\": 58.597496032714844, \"Compound Group\": \"Head Group Small Molecules\", \"label\": \"Tucatinib (Irbinitinib; HER2-selective)|5|4\", \"compound\": \"Tucatinib (Irbinitinib; HER2-selective)\", \"dose_order\": 5, \"timepoint_order\": 4, \"group\": \"small_mol\", \"compound_dose\": \"Tucatinib (Irbinitinib; HER2-selective)_5\", \"plate\": \"CPP1939\", \"Dose Order\": \"5\"}]}}, {\"mode\": \"vega-lite\"});\n",
              "</script>"
            ],
            "text/plain": [
              "alt.Chart(...)"
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Generate Pairwise Distribution Plots\n",
        "\n",
        "This section generates the grouped pairwise distance distribution plots from the paper."
      ],
      "metadata": {
        "id": "zNgzm9SLG_j8"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "embedding_name = 'skov3' # @param [\"skov3\", \"skov3_noher2\"]\n",
        "TIMEPOINT_ORDER = 1\n",
        "DOSE_ORDER_CUTOFF = 3\n",
        "LABEL_VAR = 'label'\n",
        "NDIMS = 512\n",
        "pdist_df = dfs[embedding_name].copy()\n",
        "pdist_df = pdist_df[pdist_df['timepoint_order'] == TIMEPOINT_ORDER]\n",
        "pdist_df = pdist_df[pdist_df['dose_order'] >= DOSE_ORDER_CUTOFF]\n",
        "pdist_df['group'] = pdist_df['compound'].map(paper_group_map)\n",
        "pdist_df['lapatanib active degrader'] = pdist_df['compound'].isin(['Crews Acvite HER2/EGFR degrader (Lapatinib based)'])\n",
        "pdist_df['lapatanib inactive degrader'] = pdist_df['compound'].isin(['Crews inactive HER2/EGFR degrader (Lapatinib based)'])\n",
        "pdist_df['tucatinib active degrader'] = pdist_df['compound'].isin(['C4T VHL-based active HER2-degrader (Tucatinib based)'])\n",
        "pdist_df['tucatinib inactive degrader'] = pdist_df['compound'].isin(['C4T VHL-based inactive HER2-degrader (Tucatinib based)'])\n",
        "groups = {\n",
        "    'Active Degraders': {'group': 'Active Degraders'},\n",
        "    'Inactive Degraders': {'group': 'Inactive Degraders'},\n",
        "    }\n",
        "group1 = 'Inactive Degraders'\n",
        "group2 = 'Active Degraders'\n",
        "distances = get_pdist_distributions(\n",
        "    pdist_df, groups[group1], groups[group2], ndims=NDIMS,\n",
        "    groupby_cols=None, metric='cosine', exclude_same_cols=[])\n",
        "within_group_distances, between_group_distances = distances\n",
        "sns.histplot(within_group_distances, color=sns.color_palette()[0],\n",
        "            kde=True, stat='density', label=f'Within {group1}')\n",
        "sns.histplot(between_group_distances, color=sns.color_palette()[1],\n",
        "            kde=True, stat='density', label='Between groups')\n",
        "plt.legend(loc='upper right')\n",
        "plt.title(f'{group1} vs {group2}\\n {embedding_name}; Timepoint = {TIMEPOINT_ORDER}; Dose Order >= {DOSE_ORDER_CUTOFF}')\n",
        "plt.xlabel('Cosine Distance')\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 493
        },
        "id": "_QM8LDhnF6zi",
        "outputId": "eda785c8-6dae-4301-d287-d9a343d13357"
      },
      "execution_count": 61,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "F8k-UEeUQB1X"
      },
      "execution_count": null,
      "outputs": []
    }
  ]
}